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ABSTRACT 
Many people living with the Human Immunodeficiency Virus (HIV) (PLWH) experience 
functional limitations caused by either the HIV infection itself and/or the antiretroviral 
treatment. In Rwanda, many PLWH have access to antiretroviral treatment; however, there is 
no information about the extent of disability or functional limitations present among PLWH 
which might be caused by either the HIV infection or the antiretroviral treatment. In addition, 
the service delivery model may well be based on the medical model, rather than the bio-
psychosocial model. As a consequence, PLWH may be receiving medical treatment, but we 
do not know whether they need or are receiving rehabilitation within the hospital 
environment and support within the community. This study used the bio-psychosocial model 
with the International Classification of Functioning, Disability and Health (ICF) as a 
theoretical framework.  
The study aimed to explore the need for and nature of care that PLWH living in Rwanda 
receive from their health care providers using a bio-psychosocial framework. A further aim 
was to determine if the Kinyawanda version of the World Health Organisation Disability 
Assessment Schedule 2.0 (WHODAS 2.0), which was used to gather the functional data, was 
valid within the Rwandan context. A mixed methods approach was used.  
A quantitative survey was used to determine the profile and the prevalence of disability 
among PLWH, by measuring impairment, activity limitation and participation restriction 
amongst PLWH who are also on antiretroviral treatment. In addition the relationship between 
functioning and medication was explored. A Kinyarwanda version of the ICF core set of 
questions and the WHODAS 2.0 outcome instrument was used.  Face-to-face interviews were 
conducted among PLWH at 15 selected hospitals representing all provinces in the country.  
The final sample size included 502 PLWH. Participants‘ health status showed that the longer 
they had HIV and had been on antiretroviral treatment, the more likely they were to have 
impairments. Pain (69%) and fatigue (83%) were more prevalent than any other problems 
found in all domains measured under impairments.  Problems with mobility function (57%) 
scored the highest prevalence under activity limitations, and problems in participation/social 
functions had the highest prevalence in comparison to the other domains. The mean score of 
the different domains were significantly different with participation scoring the highest (46%, 
with 100% the worst score rate). Participants experienced problems for approximately half 
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the days in every month. Various impairments of body function predicted functional 
limitations with regard to activities and the participation/social restriction domains. Energy 
and drive and memory functions were predictive of the means scores of all the domains. 
The qualitative component used focus group discussions among PLWH on antiretroviral 
treatment with associated disabilities, to explore the relationship between the impairments, 
functional limitations, participation restrictions and personal and environmental factors. Two 
focus group discussions consisting of a total of 16 PLWH with associated disabilities (10 
females, six males), were conducted at two hospitals, and purposively selected from among 
the fifteen hospitals involved in the survey. The impairments experienced every day, 
including a lack of energy, pain, paraesthesia, breathlessness and loss of memory 
corroborated the findings of the quantitative survey.  These impairments affected their 
performance of daily activities and their participation in social life. Participants described the 
personal factors that facilitated functioning (such as spiritual beliefs, and positive thinking 
about disclosure as a strategy to improve psychological well-being, to overcome internalized 
stigma and to create awareness about HIV), or limited functioning (for example internalized 
stigma and age), and the social relationship environmental factors that facilitated functioning, 
or limited functioning, which included participants‘ relationships with their families, and with 
their communities. Participants discussed the influence of the hospital environment and 
services (either as a facilitator or a barrier) on their functioning. This included the ARV 
(Antiretroviral) clinic and services in the hospital outside the ARV clinic. Participants made 
recommendations that could improve service delivery provided to PLWH with associated 
disabilities or functional limitations, such as increase in the number of health care providers 
including rehabilitation care using a multidisciplinary approach and the establishment of 
counselling programmes.  
 
The process of translating the English version of the ICF core set of questions and the 
WHODAS 2.0 outcome instrument into Kinyarwanda is documented; it highlights the 
problems encountered, whether related to linguistic meaning or to cultural influence. Despite 
challenges, particularly with regard to words used for disability and impairment, the 
translated versions were found to have appropriate linguistic and cultural meanings, and used 
clear and understandable expressions. Additionally, impairments, activity limitations and 
participation restrictions that were identified by participants in the focus group discussions 
were used to determine content validity. The translated instruments demonstrated good 
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content validity. One way ANOVA was used to establish convergent validity of the 
WHODAS 2.0 and Cronbach‘s Alpha was calculated to test for internal consistency of the 
Impairments Questionnaire and the WHODAS 2.0. The translated instruments demonstrated 
good construct validity and good reliability.   
In conclusion, the prevalence of disability in PLWH on antiretroviral therapy in Rwanda is 
considerable. There were a large range of functional limitations among PLWH associated 
with a variety of impairments which cannot be addressed simply by pharmacological medical 
management. There is a need to establish interdisciplinary collaboration by a 
multidisciplinary team, based on a bio-psychosocial approach, to reinforce referral within the 
hospital system. In addition, the use of a bio-psychosocial model, such as that of the ICF 
framework, might lead to more holistic assessment and management of these patients. 
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1 CHAPTER ONE: INTRODUCTION 
1.1 Background 
Worldwide, there were an estimated of 34 million people living with HIV
1
 (PLWH)  in 2011, 
and sub-Saharan Africa continues to be the region the most severely affected ,  accounting for 
69% of  all PLWH globally (UNAIDS, 2012a). The United Nations joint programme on 
Human Immunodifiency Virus/ Acquired Immunodifiency Syndrome (HIV/AIDS) reported 
that new Human Immunodifiency Virus ( HIV)  infection rates have decreased considerably  
in many countries, especially in the sub-Saharan Africa region (UNAIDS, 2012a, 2012b), and  
the number of the people who have died from Acquired Immunodiciency Syndrome (AIDS) 
related illnesses  declined drastically in 2011 compared to the figure for six years previously 
(UNAIDS, 2012b).  This decline has largely been achieved through investment in, and the 
scaling up of, antiretroviral treatment
2
. It has been indicated that in sub-Saharan Africa, 
approximately 56% of PLWH who are eligible have had access to antiretroviral treatment 
(UNAIDS, 2012a). 
1.1.1 HIV in Rwanda 
 Rwanda is among the ten countries in sub-Saharan Africa most severely affected by the 
pandemic of HIV/AIDS (World Health Organisation (WHO), 2005b), and  HIV infection is 
one of the  two diseases which cause the most significant  burden on  Rwanda‘s  health 
system(Ministry of Health (MoH) of Rwanda, 2009) .  The most recent Rwanda 
Demographic and Health Survey (RDHS) conducted in 2010  indicated that the HIV 
prevalence rate was 3% in the general population (National Institute of Statistics Rwanda, 
Ministry of Health Rwanda, & ICF International US, 2012).   
Enrolment into antiretroviral treatment programmes increased from 35% of PLWH who were 
eligible in 2005 to 76% in 2008. There was a significant reduction in the real cost of 
accessing antiretroviral treatment services by PLWH as a result of the introduction of the 
community based health insurance (CBHI); Mutuelle de Santé
3
, which covers the cost of 
                                                 
1The term People living with HIV (PLWH) is used, referring to the document published by UNAIDS on terminology 
guidelines. This was suggested as it signifies that an infected person may continue living a normal life for a long period  
(UNAIDS, 2011b).  
2 Antiretroviral treatment is used, referring to the document published by UNAIDS on terminology guidelines. It was 
recommended that it is preferable to spell out  “antiretroviral treatment” or” antiretroviral therapy”,  instead of  using an 
abbreviation, so as to avoid confusion with other similar terms such as AZT  (UNAIDS, 2011b).  
3 Mutuelle de Santé is a French term and it is commonly used to mean community based health insurance. 
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antiretroviral treatment. In addition the treatment of opportunistic infections was included in 
other service packages offered by Mutuelle de Sante  (Ministry of Health (MoH) of Rwanda, 
2009).  In the year 2011, antiretroviral treatment reached 93% of the national coverage  
(Ministry of Health (MoH) Rwanda, 2012b). 
1.1.2 PLWH and disability 
There is an accumulation of evidence that suggests that the provision of antiretroviral 
treatment has changed the profile of the HIV infection from being a terminal illness to being 
a chronic, manageable disease:  PLWH can expect to live normal lives (Fillipas, Oldmeadow, 
Bailey, & Cherry, 2006; Mahungu, Rodger, & Johnson, 2009; Rusch et al., 2004a). However, 
numerous impairments are also experienced; these are caused by the HIV infection itself, its 
related pathologies and the side effects of antiretroviral treatment (Hanass-Hancock & Nixon, 
2009a; O'Brien, Bayoumi, Strike, Young, & Davis, 2008; Rusch, et al., 2004a).  
The disability or functional limitations experienced by PLWH are more severe than in the 
general population (Worthington, Myers, O'Brien, Nixon, & Cockerill, 2005). These 
impairments can affect the individual‘s physical, psychological and social functioning 
(Myezwa, Stewart, Musenge, & Nesara, 2009; Rusch, et al., 2004a; Van As, Myezwa, 
Stewart, Maleka, & Musenge, 2009). This can have an impact on the individual‘s health 
related quality of life (HRQoL) (Lorenz, Cunningham, Spritzer, & Hays, 2006). The 
manifestation of these impairments and functional limitations may be episodic, 
multidimensional, and unpredictable   (Hanass-Hancock & Nixon, 2009a; O'Brien, et al., 
2008), or they may be permanent (Hanass-Hancock & Nixon, 2009a).  These are influenced 
by environmental and personal contextual factors which can hinder or facilitate functioning.  
This experience of disability can be accompanied by uncertainty as PLWH struggle to 
readjust to their new situation of living with long-term chronic illness (O'Brien, et al., 2008). 
1.1.3 PLWH and Health service delivery  
Based on a public health perspective, there are four major strategies which health care and 
service providers should consider as essential to deliver comprehensive care: prevention, 
curative care, support and rehabilitation. Curative care refers to a secondary prevention 
whereas rehabilitation sometimes refers to as tertiary prevention. The goal of prevention is to 
maintain the health of the population. Curative care aims to control the disease process. 
Supportive care aims at improving quality of life through the palliation of symptoms and by 
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providing assistance. Rehabilitation aims to optimise functioning (Stucki, Cieza, & Melvin, 
2007).   
―Rehabilitation care achieves its goal by applying and integrating approaches to optimize a 
person‘s capacity, approaches which build on and strengthen the resources of the person, 
which provide a facilitating environment, and which develop performance in the interaction 
with the environment‖  (Stucki, et al., 2007, p. 280).    
 Primary health care provides comprehensive health care to people also includes the health 
care strategies highlighted above: preventive care, curative care, rehabilitative care  and in 
addition,  promotive care (Hall & Taylor, 2003; Walton et al., 2004). It is characterised by 
equity and the universal provision of basic health care services, by affordable and appropriate 
health care services, , and by accessible health care services with community participation 
(Hall & Taylor, 2003; Walley et al., 2008). It includes all levels of the health system, such as 
clinics and health centres in the community, as well as hospitals (Hall & Taylor, 2003).   
There has been a considerable increase in the incidence of chronic illnesses, particularly in 
developing countries; these include cardio-vascular diseases and diabetes in addition to 
tuberculosis and HIV infection.  These conditions require continuous care over a number of 
years rather than months (Goudge, Gilson, Russell, Gumede, & Mills, 2009; Walley, et al., 
2008), and many countries, especially those in Africa, are not prepared to face the challenges 
of these diseases because of poverty and/or weak health systems (Goudge, et al., 2009).  
The majority of HIV programs in Africa, even though these are managed by government 
institutions, are supported by donor funding (Schneider, Blaauw, Gilson, Chabikuli, & 
Goudge, 2006). Management of HIV infection can be integrated within the primary health 
care system.  Despite being a burden, if well planned, its improvement can reinforce the goals 
of the primary health care system (Price, Leslie, Welsh, & Binagwaho, 2009; Walton, et al., 
2004). However, some of the barriers to accessing HIV care, particularly antiretroviral 
treatment, include:  the challenge of reorienting service delivery towards chronic disease care 
and the shortage of skilled and motivated health care providers (this is mostly due to poor 
remuneration and lack of motivation, to national and international immigration and to poor 
distribution (Schneider, et al., 2006). 
Comprehensive primary health care requires team spirit or multidisciplinary/interdisciplinary 
collaboration (especially interdisciplinary collaboration) among health-care providers 
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(Sicotte, D'Amour, & Moreault, 2002). It has been found that, even more than other chronic 
diseases, because of its multifaceted nature; the management of HIV infection requires health 
care providers from different disciplines to come together and to share their responsibilities 
as providers of care: by sharing their knowledge and skills they are better able to respond to 
the complex health needs of the patient. It is also recommended that the patient become 
involved in his or her health management (Van Manen, Laschinger, Stevenson, & Fothergill-
Bourbonnais, 2005).   
The ICF is a globally recognised classification framework to be used in different health care 
situations by health care providers in multidisciplinary teams (Finger, Cieza, Stoll, Stucki, & 
Huber, 2006). Furthermore it could assist in multi-professional patient assessment, goal 
setting, and intervention management and evaluation; it could be a new way of 
communicating, thereby assisting in the continuum of care, and it could serve to 
communicate a comprehensive view of the patient‘s health status by emphasizing the role of 
rehabilitation, especially when transferring the patient from one health care setting to another 
(Stucki, Ewert, & Cieza, 2003).   
1.1.3.1 PLWH and health service delivery in Rwanda. 
In 1994, Rwanda went through genocide.  Many people were killed, especially men (Jones, 
2002; Newbury & Baldwin, 2000). Also, since rape was used as a weapon by the 
perpetrators, it has been reported that a great number of women and girls experienced sexual 
violence (Cohen et al., 2009; Donovan, 2002; Mukamana & Brysiewicz, 2008; Nowrojee, 
1996; Sharlach, 2000), and children were born from raped women (Donovan, 2002; 
Mukamana & Brysiewicz, 2008). This could have contributed to the spread of HIV infection   
(Donovan, 2002; Nowrojee, 1996), particularly among women (Mukamana & Brysiewicz, 
2008). Perpetrators also used HIV as a weapon to destroy and to cause pain and suffering to 
the victims (Donovan, 2002). Thus, it is possible that 1994 genocide has contributed to the 
high prevalence of PLWH (Donovan, 2002). Furthermore, it has destroyed many health care 
infrastructures and contributed to a huge loss in the number of health care professionals; this 
has disrupted the health system and resulted in a weakening of health service delivery.  
(Rusa, Schneidman, Fritsche, & Musango, 2009). 
Despite the aftermath of the genocide, it has recently been observed that the country has 
introduced significant innovations to its health system and to health service delivery (Logie, 
Rowson, & Ndagije, 2008).  During the year 2000, Rwanda developed a vision for what 
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should be achieved by 2020; the vision 2020 relates to policies, laws and regulations and 
helps the government to identify priorities for all sectors that should assist in transforming 
Rwanda from a low-developing country to a middle-developing country by the year 2020. 
With regard to the health sector, Vision 2020 suggests that health-care programmes should 
prioritize the following factors; high population growth rate (3.2% per year), maternal health, 
malaria and HIV/AIDS (Ministry of Health (MoH) Rwanda, 2012b).   
Rwanda‘s health system has integrated primary health care and the Ministry of Health is 
responsible for setting policies and for overall health sector planning (Ministry of Health 
(MoH) of Rwanda, 2009; USAID, 2007).  All components of a comprehensive primary health 
care system, preventive, promotive, curative and rehabilitative, are offered by the various 
health services and are integrated in all programmes, including HIV programmes (Ministry of 
Health (MoH) Rwanda, 2012b). 
Services are provided at different levels of the health care system:  at the community  level; 
there are community-based projects, and also health posts that provide very basic care at the 
lowest community administrative level (village level) (Ministry of Health (MoH) Rwanda, 
2012b; Wyman, 2008). Regarding HIV programmes; the community level is broader in scope 
than other programmes as it can include and target specific public locations, such as markets 
and bars. Activities carried out at the community level may include the prevention of HIV 
infection, reducing mortality and morbidity, and mitigating the impact of HIV (Ministry of 
Health (MoH) of Rwanda, 2009).  
From community level, there are health centres which provide basic primary care of a higher 
standard than that found at village level (Ministry of Health (MoH) Rwanda, 2012b; Wyman, 
2008). The services are provided by qualified health-care providers, the majority of whom are 
only nurses (Wyman, 2008). Health centres supervise community-based projects and health 
posts (Ministry of Health (MoH) Rwanda, 2012b).  Health centres make referrals directly to 
district hospitals where patients are provided with more general care. Majority of health 
conditions are treated at district hospitals. However, difficult cases that require more 
specialised care are referred to referral hospitals, which provide this kind of care (Ministry of 
Health (MoH) Rwanda, 2012a; Wyman, 2008).  
 HIV programmes offered at these levels, particularly at health centres and district hospitals, 
may include HIV testing, treatment, care and support, as well as the prevention of new HIV 
infections. These include programmes related to the prevention of mother-to-child 
 
 
 
 
6 
 
transmission of HIV (PMTCT), male circumcision, sexually transmission infections (STI) 
treatment and sexual and reproductive health service provision (Ministry of Health (MoH) of 
Rwanda, 2009).  It has been indicated that,  in developing countries, the best way to 
understand the problems of PLWH from their perspective is to reach these people at the 
district hospitals, which they attend regularly to get treatment, and to spend time interacting 
with health care providers (Streefland, 2005).                                                                                                                                                                                                                                              
1.2 Conceptual framework: The International Classification of 
Functioning, Disability and Health and PLWH 
In 2001, the World Health Organisation (WHO) published a new and universal model of 
understanding disability; the International Classification of Functioning Disability and Health 
(ICF), which is a classification system able to capture the full range of human functioning 
(World Health Organisation (WHO), 2001). It is based on a bio-psychosocial approach and 
offers a broader multidimensional view, and a comprehensive conception of health, 
functioning and disability (Reed et al., 2005; Shaw & MacKinnon, 2004). It considers the 
impact of a health condition on human functioning (this could result in disability); it does this 
from the biological, individual and societal perspectives rather than from the biological alone  
(Reed, et al., 2005; World Health Organisation (WHO), 2001).  Thus, the interaction between 
the health condition and the health of an individual is looked at from a perspective that goes 
beyond mortality and disease and focusses on how people live with their condition in society 
(Kirchberger, Glaessel, Stucki, & Cieza, 2007).   The concept of disability within the ICF 
framework is an umbrella term for impairments, activity limitations and participation 
restrictions (Reinhardt, Cieza, Stamm, & Stucki, 2006; Vanleit,  2008; World Health 
Organisation (WHO), 2001).   
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Figure 1: Interaction between the components of ICF 
(World Health Organisation (WHO), 2001, p. 26). 
Understanding the complex, multifaceted presentation of the HIV infection requires a holistic 
approach. Disability resulting from the HIV infection itself, its associated pathologies and 
also from antiretroviral treatment varies from individual to individual and may include 
various types of disability (Worthington, et al., 2005). ICF has the potential to provide a 
holistic classification and framework that is able to highlight and to document all the types of 
challenge related to living with HIV. It does this at the level of body structure and function, at 
the level of the individual and at the level of the individual‘s involvement with the society 
(Hanass-Hancock & Nixon, 2009a; Myezwa, et al., 2009; Van As, et al., 2009).  
The researcher has drawn on the ICF framework to develop a conceptual framework for this 
thesis. It is suggested that currently the medical model of management is the dominant 
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approach to intervention in PLWH. This is outlined below in figure 2Error! Reference 
ource not found.. In this model the causation is linear, the primary problem is the infectious 
disease and the primary intervention is to resolve the medical condition.  
 
 
 
Figure 2: The Medical Model of management as applied to PLWH in Rwanda. 
In contrast we propose that the bio-psychosocial model based on the ICF framework and as 
graphically represented in figure 3 Error! Reference source not found. is a better 
epresentation of the experience of living with HIV in Rwanda. In this model, the person 
living with HIV, his/her personal factors and his/her health condition are central to their 
experience. There is interaction between the personal factors, health condition, impairments, 
functional limitation and the hospital environment and community environment. The 
relationship between the above is not linear as the health condition and functional limitations 
both modify and in turn are modified by the environment (which includes hospital provision 
of medication). It is suggested that although the bio-psychosocial model might result in a 
better approach to intervention, it is not currently being implemented to plan and manage 
health related support given to PLWH.  
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Figure 3: The proposed bio-psychosocial model of management applied to PLWH in Rwanda 
This thesis aims to explore the extent to which the bio-psychosocial model correctly reflects 
the experience of PLWH in Rwanda. There are certain questions which need to be answered 
in order to determine whether the bio-psychosocial model is appropriate and whether the bio-
psychosocial model is utilised to any extent.  
1.3 Statement of the problem 
HIV infection manifests as a multi-systemic disease with multiple complications that affect 
the person‘s physical, psychological and the social functioning as a result of the HIV 
infection itself and its related pathologies and the antiretroviral treatment (O'Brien, et al., 
2008; Rusch, et al., 2004a). In Rwanda, many PLWH have had access to antiretroviral 
treatment; however, there is no information about the extent of disability or functional 
limitations present among PLWH which might be caused by either the HIV infection or the 
antiretroviral treatment. In addition, the service delivery model may well be based on the 
Environmental Community 
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Environmental Medically 
related factors (1) 
Impairments of function (2) Functional limitations and 
participation restrictions (3) 
People (including personal factors) 
living with a health condition – HIV,  
 
 
 
 
10 
 
medical model, rather than the bio-psychosocial model. As a consequence, PLWH may be 
receiving medical treatment, but we do not know whether they need or are receiving 
rehabilitation within the hospital environment and support within the community.There is no 
literature that demonstrates the progress made in integrating rehabilitation care into HIV care 
or the role of rehabilitation in the management of functional limitations among PLWH in 
Rwanda. 
1.4 Research questions 
To explore the experience of living with HIV within a Rwandan context through the lens of a 
bio-psychosocial model, it is first necessary to examine the current management of the health 
condition, HIV. We should establish whether PLWH do indeed experience functional and 
contextual barriers despite receiving antiretroviral treatment and whether these problems are 
addressed by their medical care.  We then need to explore whether supportive care is made 
available to them, both within the hospital and within the community setting. The specific 
questions are thus: 
 Who is receiving antiretroviral treatment? In other words what are the personal 
factors, e.g., gender, educational factors of PLWH who are receiving antiretroviral 
treatment? 
 How effective is the antiretroviral treatment received in terms of diminishing 
symptoms and improving the functioning of PLWH? Is there any need for further 
intervention and support? If it is effective, it is suggested that there will be few 
functional limitations present, the functional limitations will be less as the CD4 count 
increases and the longer that the PLWH receive antiretroviral treatment, the better 
their functioning will be.  
 What are the perceptions of PLWH with associated disabilities of the health services 
that address their functional limitations, in a hospital setting, in Rwanda? Are they 
satisfied that the care that they receive addresses all or a majority of their health 
related problems? 
 What are the profile and the prevalence of impairments, functional limitations and 
participation restrictions among PLWH in Rwanda?  Is functional limitation 
common? If it is prevalent, then it is possible that the medical model of care does not 
result in complete recovery of functioning. 
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 What is the relationship between impairments, functional limitations, participation 
restricitions and family and community environmental factors? If support is to be 
offered, it should be targeted at the underlying cause of problems. 
 Do PLWH receive the support that they need within the community? 
In addition, it is necessary to validate the primary data collection tools to ensure that the data 
collected during the survey of impairments and functional limitations and participation 
restrictions were a true reflection of the functional abilities and health of PLWH within the 
context of the study. 
1.5 Aims 
The aim of the study was therefore to explore the need for and nature of care that PLWH 
living in Rwanda receive from their health care providers using a bio-psychosocial 
framework. A further aim was to determine if the Kinyawanda version of the World Health 
Organisation Disability Assessment Schedule 2.0 (WHODAS 2.0), which was used to gather 
the functional data, was valid within the Rwandan context. A mixed methods approach was 
used. Quantitative survey data were collected to document the medical care, impairments, 
functional limitations and participation restricitions, whereas qualitative data were collected 
to explore the functional implications of living with HIV and the impact of environmental 
factors on functioning. Both the quantitative and qualitative data were used to validate the 
survey instruments utilised. 
1.6 Objectives 
The specific objectives of the study were, in PLWH and receiving antiretroviral treatment: 
With regard to personal factors: 
 To establish the proportion of male/female; the age and income distribution; and the 
employment status of participants. 
 To explore the impact of personal factors such as emotional and spiritual factors on 
functional limitations and participation restrictions. 
With regard to the medical management and medical environment (quadrant 1 in the 
representation of the conceptual framework, Figure 3): 
 To establish whether there is a relationship between antiretroviral treatment, CD4 
count and functional limitations. 
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 To describe the reported satisfaction with the hospital service. 
 To explore the experience of PLWH with associated disabilities with regard to how 
the hospital services assist them with their functional limitations. 
With regard to the impairments of function, functional limitations and participation 
restrictions (quadrants 2 and 3 in Figure 3): 
 To determine the prevalence of impairments, functional limitations and participation 
restricitions among PLWH attending health clinics. 
 To determine the relationships between the body function impairments, functional 
limitations and participation restrictions through statistical analysis of survey results 
and analysis of the perceptions of PLWH with associated disabilities with regard to 
the relationship between the health condition , medication and functional limitations.   
With regard to the community related environment (quadrant 4 in Figure 3): 
 To describe the challenges PLWH with associated disabilities encounter in daily life. 
 To validate the instruments used to establish the prevalence of impairments and 
functional limitations: 
 To establish the  linguistic and cultural appropriateness of the translation of the ICF 
core set of questions regarding the Impairment of body functions and the WHODAS 
2.0 outcome  instruments, through consensus group meetings conducted after forward 
and backward translation and a cognitive debriefing interview.  
 To establish the face, construct and content validity and the reliability of the 
instrument. 
1.7 Rationale for the study  
There is no doubt that HIV continues to contribute greatly to the burden of disease in 
Rwanda, with many people affected by the virus. The shift from an acute and terminal health 
condition to a chronic health condition requires a parallel shift in health care delivery for 
PLWH. Health care facilities such as hospitals should be prepared and able to provide holistic 
and comprehensive care that would include preventive, curative, promotive and also 
rehabilitative care in order to respond holistically to the needs of PLWH. Rwanda has made 
substantial gains in the prevention of HIV infection and in scaling up antiretroviral treatment 
across the country, and the majority of health facilities, particularly hospitals, have HIV 
programmes (Ministry of Health (MoH) Rwanda, 2012b). However, it is possible that 
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rehabilitation services and community based support are not made available.  Rehabilitation 
interventions for PLWH have the potential to prevent disability, reduce and prevent 
deterioration of the disability, restore and maximize functional independence and enhance 
and  promote health and HRQoL of PLWH  (Worthington, et al., 2005; Hanass-Hancock & 
Nixon, 2009a). 
 However, to date, there is a scarcity of literature about rehabilitation service delivery and 
HIV. Moreover the ICF is a framework that can be used in rehabilitation and that could assist 
in reconceptualising HIV beyond the focus on HIV as a disease (Hanass-Hancock & Nixon, 
2009a).  Unlike the  medical approach, which focuses on the diagnosis of disease and 
examines symptoms only,  the ICF, because it uses bio-psychosocial approach, emphasises 
the impact of these diagnoses  and symptoms on PLWH and how people deal with their lives; 
it emphasises the influence of personal and environmental (contextual) factors (Nixon, 
Hanass-Hancock, Whiteside, & Barnett, 2011; Worthington, et al., 2005).  This is important 
for rehabilitation.  
Most of the hospitals in Rwanda have rehabilitation services such as physiotherapy and 
psychotherapy. At each hospital the health-care providers responsible for HIV care could 
work in a team with physiotherapists and other rehabilitation health-care providers to address 
any impairment, activity limitation, or participation restriction experienced by PLWH, thus 
preventing disability, deterioration and promoting health. Information regarding the 
perceptions of health services as well as the quantification of the impairments, functional 
limitations, participation restrictions will assist health care managers to plan appropriate and 
comprehensive management programmes for PLWH in Rwanda. 
1.8 Structure of the thesis   
This thesis is structured in the following chapters.  
Chapter One: Introduction. This describes the context of the study, the conceptual 
framework, the statement of the problem that this study aims to address, the research 
questions and aims and objectives and the rationale for doing the study.  
Chapter Two: Literature review. This reviews the literature on HIV and the antiretroviral 
treatment, and on models of disability, body impairments, activity limitations and social 
participation restrictions in PLWH. It examines the contextual factors related to HIV, the 
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hospital environment, health service delivery and rehabilitation care. Finally it looks at the 
measurement of disability/functional limitations among PLWH. 
Chapter Three describes the methodology used to determine information related to the health 
condition and the prevalence and nature of the impairments and functional limitations. This 
chapter describes how a survey was carried out to gather quantitative information. The results 
are included in the chapter.  
The next chapter, Chapter Four describes the methodology and results of the qualitative 
component of the study. In this chapter the participants‘ description of their impairments, 
functional limitations and environmental barriers and facilitators are presented. The chapter 
describes the running of two focus groups and includes the analysis of the results of the 
discussions. 
Chapter Five integrates the results of the above studies to address the research questions. The 
results of the mixed methodologies are discussed and the research questions are addressed. 
The process of the translation of the original English version of the ICF core set of questions 
regarding the impairment of body functions, and the translation of the WHODAS 2.0 
questionnaire is described in Chapter Six. In addition, information gained from both the 
survey and the focus groups discussions is integrated to assist in validating the questionnaire. 
Chapter Seven concludes the thesis.  This includes a summary of the thesis. It reaches a 
conclusion drawn from the findings, discusses the limitations of the study and makes 
recommendations arising from this study.  
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2 CHAPTER TWO: LITERATURE REVIEW 
2.1 Introduction 
This chapter presents a review of the literature on PLWH and functionality. It includes 
sections on the following topics:  HIV/AIDS; antiretroviral treatment; disability models; body 
impairments, activity limitations and social restrictions and contextual factors related to HIV; 
the hospital environment, service delivery and PLWH; and finally, disability measurements.  
Electronic databases were used to search for literature and the following search engines were 
consulted; PUBMED, Science Direct, Scopus, Ebsco web (Academic search complete, 
Health source: Nursing/Academic Edition, Psyc ARTICLES, Medline, CINHAL), World cut, 
and Google scholar. 
The following key search terms were used individually and in combination: HIV, HIV/AIDS, 
HIV and prevalence, HIV and incidence,  HIV and disability, HIV or PLWH and impairment, 
HIV or PLWH and activity limitation, HIV or PLWH and participation restriction, HIV or 
PLWH and impairment, activity limitation and participation restrictions, PLWH and personal 
factors, PLWH and environmental factors, PLWH and functional needs, PLWH and 
functional limitations, HIV and health-related quality of life, PLWH and health-related 
quality of life, ICF, ICF and models of disability, health system, health system and Rwanda, 
health care delivery, health care delivery and Rwanda,  primary health care, health care 
delivery and HIV or PLWH, health care delivery and HIV or PLWH and Rwanda, health 
service delivery, health service and HIV or PLWH, health service delivery and HIV or 
PLWH and Rwanda, hospital-based service delivery and HIV or PLWH; hospital-based 
service delivery and  HIV or PLWH and disability or  functional limitations, and 
rehabilitation, hospital-based service delivery and  HIV or PLWH and functional limitations 
and rehabilitation and Rwanda; WHODAS 2.0  and validity and reliability, ICF and validity 
and reliability, Barthel and validity and reliability, and functional independence 
measure(FIM) and validity and reliability.  
 Books, printed journals and reports were also searched manually for additional information. 
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2.2 HIV and AIDS 
2.2.1 Introduction 
HIV is the virus that causes AIDS (Anderson, 2006; Holodniy & Miller, 2002; Sierra, 
Kupfer, & Kaiser, 2005; Strebel, Luban, & Jeang, 2009).  AIDS is characterised by signs and 
symptoms of serious infections and cancers associated with a severe deficiency of the 
immune system. Infections associated with AIDS are known as opportunistic infections. The 
time between being infected with HIV and occurrence of AIDS symptoms and signs can be 
an average of 10 years (Sellmeyer & Grunfeld, 1996). 
2.2.2 HIV types 
There are two types of HIV: HIV1 and HIV2. They are both transmitted in the same way: by 
sexual contact, through blood (including transmission from mother to child); both types of 
HIV cause AIDS (De Cock et al., 1993; Mörner et al., 1999). HIV1 is the predominant virus; 
HIV2 is commonly found only in West Africa and it is very rare elsewhere in the world. It is, 
however, possible to find a combination of both types (De Cock, et al., 1993; Jaffar, Grant, 
Whitworth, Smith, & Whittle, 2004; Mörner, et al., 1999). In a study conducted in Nigeria; 
83% of the PLWH had HIV1 infection; 16.7% had a combination of both HIV1 and HIV2 
and no one had the HIV2 infection alone (Salawu et al., 2008).  
Studies have indicated that HIV2 is less pathogenic than HIV1 and that the period between 
initial infection and illness is longer compared to that in the case of HIV1 (Jaffar, et al., 2004; 
Mörner, et al., 1999; Popper et al., 1999; Sousa, Carneiro, Meier-Schellersheim, Grossman, 
& Victorino, 2002). This could be because there are higher levels of HIV1 plasma viral RNA 
or viral load compared to that in the case of HIV2, with greater and higher rates of viral 
replication and a greater risk of progression to AIDS (De Cock, et al., 1993; Popper, et al., 
1999; Sousa, et al., 2002).   
HIV1 can be classified into three subtypes or genetic groups:  HIV1 Major ( HIV1M), outlier 
HIV (HIV O) and the HIV N group (non –M/non- O) (Hemelaar, Gouws, Ghys, & Osmanov, 
2006; Osmanov, Pattou, Walker, Schwardländer, & Esparza, 2002). Globally, the majority of 
HIV1 cases belong to HIV1 group M; group O and group N cause only a small minority of 
infections in Central Africa. In addition HIV1M is divided into nine distinct genetic subtypes 
or sub-clades labelled by letter; A-D, F-H, J and K (Hemelaar, et al., 2006). Some studies 
have revealed the existence of inter-subtype recombination; this is found in individuals 
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infected with two or more subtypes of the virus simultaneously (Hemelaar, et al., 2006; 
Osmanov, et al., 2002). In Rwanda, 79% of infections are caused by subtype A (Hemelaar, et 
al., 2006). 
2.2.3 HIV pathology 
HIV is a ribonucleic acid (RNA) virus belonging to the lentivirus subfamily of the retrovirus 
family.  During the life cycle of this family of viruses, it is necessary for replication and 
survival that there is integration of a copy of its genome with that of the human host cell 
genome. This type of virus contains an  enzyme, reverse transcriptase, which the virus uses  
to convert the viral RNA into deoxyribonucleic acid (DNA) which can then be integrated into 
the genome of the host DNA cell it has infected  (Holodniy & Miller, 2002).   
HIV is a complex retrovirus that attacks and destroys the cells of the human immune system    
(Anderson, 2006; Palmer, 2008).  This has a very negative impact on the role of the immune 
system, which is; to protect the body from foreign objects, such as microorganisms, by 
recognising, immobilising, neutralising or destroying them. The immune system contains 
different types of cells, and among these there are those called T-Cells (T-lymphocytes). 
Also, there are many different types of T-cells; one type has a molecule on its surface, a 
specific receptor site called CD4; this is the principal cell receptor for HIV and it is where the 
virus attaches itself before gaining entry (Palmer, 2008; Sierra, et al., 2005; Strebel, et al., 
2009). 
CD4 cells play a crucial role in the immune system, coordinating the actions of other immune 
system cells (Palmer, 2008).  The destruction of the CD4 cell decreases the normal 
functioning of the immune system and inhibits its ability to produce an effective immune 
response to pathogens (Anderson, 2006); this leaves the body at risk and increases its 
susceptibility to opportunistic infections (Palmer, 2008; Sierra, et al., 2005). 
2.2.4 Stages of HIV infection 
The clinical stages of HIV infection progress from an initial acute phase, associated with 
primary infection, to an asymptomatic state and from that, to an advanced state of infection 
(Vajpayee, Kaushik, Sreenivas, Wig, & Seth, 2005). The asymptomatic stage is also called 
―clinical latency‖ and is accompanied by persistent viral replication in the lymph nodes.  
During this phase, the number of CD4+ T-lymphocytes decreases continuously, until the 
patient‘s immune system is no longer capable of controlling opportunistic pathogens (Sierra, 
et al., 2005). Thus; the viral load can reflect progression, whereas a CD4 count is associated 
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with the risk of developing opportunistic infections.  Ideally, a patient would possess a low 
viral load and a high CD4+ T cell level, and it is recommended that both the viral load and 
CD4 counts be examined when determining disease progression (Anderson, 2006; Holodniy 
& Miller, 2002). 
2.2.5 2.2.4.1 Classification of HIV infection 
 Two main classifications of HIV infection have been described; one comes from the Centre 
for Disease Control and Prevention (CDC) and the other from the WHO.  
CDC classification for HIV infection 
In 1993 the CDC revised its 1981 classification. This was the first time the HIV infection had 
been classified, and where the CD4+ T- lymphocyte count was identified as a marker for 
HIV-related immune suppression. The current CDC classification categorises PLWH on the 
basis of CD4+T-lymphocyte counts and the clinical conditions associated with HIV infection. 
Three categories of CD4+ T-lymphocyte and also three categories of clinical condition 
associated with the disease have been identified (Buehler & Berkelman, 1992). The following 
are the categories for  CD4+T-lymphocyte counts: (1) category1; CD4+ T- lymphocyte count 
is greater than or equal to 500 cells/ul; (2) category2; CD4+T- lymphocyte count ranges 
between 200-499 cells/ul; (3) category3;  CD4+T-lymphocyte count is less than 200 cells/ul 
(Buehler & Berkelman, 1992). 
With regard to the clinical conditions associated HIV disease; the following are the relevant 
categories: (1) category A (Asymptomatic HIV infection); this includes acute (primary) HIV 
infection and persistent generalised lymphadenopathy. (2) Category B (symptomatic HIV 
infection). It includes conditions such as bacillary angiomatosis, candidiasis vulvovaginal, 
(persistent, frequent, or unresponsive to therapy), cervical dysplasia (moderate or 
severe)/cervical carcinoma. It includes constitutional symptoms, such as fever (38.5 C) or 
diarrhoea lasting for longer than one month, and herpes zoster, involving at least two distinct 
episodes or more than one dermatome, as well as peripheral neuropathy (Buehler & 
Berkelman, 1992). 
(3) Category C: it includes conditions that are indicators for AIDS: once a person has 
experienced one of the conditions; he or she will remain in the C category.  This includes 
conditions such as candidiasis of bronchi, trachea, or lungs , oesophagus ,  cervical cancer,  
cryptococcosis (extrapulmonary) ,  diarrhoea  (for longer than  one month), encephalopathy,  
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herpes simplex( chronic ulcer(s) for longer than one month),  bronchitis, pneumonitis, 
oesophagitis ,  Kaposi's sarcoma,  Burkitt's Lymphoma,  mycobacterium tuberculosis 
(pulmonary or extrapulmonary),  pneumocystis carinii pneumonia,  pneumonia (recurrent),  
progressive multifocal leukoencephalopathy,   salmonella septicemia, recurrent ,  
toxoplasmosis of brain and wasting syndrome due to HIV (Buehler & Berkelman, 1992).  
WHO classification for HIV infection 
The WHO classification has undergone several revisions (most recently in 2005). This 
classification was based on the stages of the clinical conditions associated with HIV, with or 
without access to CD4+ T-lymphocyte counts. However CD4+ testing is still considered 
useful to determine the degree of immunosuppression and to support clinical decision-
making. For example, it helps to determine the need for antiretroviral treatment and other 
therapies. The system is intended to improve the management, treatment monitoring and 
surveillance of PLWH (World Health Organisation (WHO), 2005a). 
Clinical staging of HIV/AIDS for adults and adolescents includes the following stages:  
primary HIV infection is asymptomatic and acute retroviral syndrome. Clinical stage 1 is 
asymptomatic with persistent generalized lymphadenopathy. Clinical stage 2 involves 
moderate unexplained weight loss (<10% of presumed or measured body weight), recurrent 
respiratory tract infections (sinusitis, bronchitis, otitis media, pharyngitis), herpes zoster, 
angular cheilitis, recurrent oral ulcerations, papular pruritic eruptions, seborrhoeic dermatitis 
and fungal nail infections of the fingers (World Health Organisation (WHO), 2005a). 
 Clinical stage 3 involves conditions where a presumptive diagnosis can be made on the basis 
of clinical signs or simple investigations. The indicators include severe weight loss (>10% of 
presumed or measured body weight), unexplained chronic diarrhoea for longer than one 
month, unexplained persistent fever (intermittent or constant for longer than one month), oral 
candidiasis, oral hairy leukoplakia, pulmonary tuberculosis (TB) diagnosed in the two 
previous years, severe presumed bacterial infections (e.g. pneumonia, pyomyositis, bone or 
joint infection, meningitis, bacteraemia), acute necrotizing ulcerative stomatitis, gingivitis or 
periodontitis. It also involves conditions where confirmatory diagnostic testing is necessary, 
including unexplained anaemia (< 8 g/dl), and/or neutropenia (<500/mm3) and or 
thrombocytopenia (<50 000/ mm3) for more than one month (World Health Organisation 
(WHO), 2005a). 
 
 
 
 
20 
 
Clinical stage 4 involves conditions where a presumptive diagnosis can be made on the basis 
of clinical signs or simple investigations. The indicators include HIV wasting syndrome, 
pneumocystis pneumonia,  recurrent severe or radiological bacterial pneumonia, chronic 
herpes simplex infection (orolabial, genital or anorectal of more than one month‘s duration), 
oesophageal candidiasis,  extrapulmonary TB, Kaposi‘s sarcoma, central nervous system 
(CNS) toxoplasmosis, etc. This also involves conditions where confirmatory diagnostic 
testing is necessary, such as extrapulmonary cryptococcosis (including  meningitis), 
disseminated non-tuberculous mycobacteria infection, candida of the trachea, bronchi or 
lungs, visceral herpes simplex infection, cytomegalovirus (CMV) infection (retinitis or of an 
organ other than the liver, spleen or lymph nodes),  recurrent non-typhoidal salmonella 
septicaemia lymphoma (cerebral or B cell non-Hodgkin), and invasive cervical carcinoma  
(World Health Organisation (WHO), 2005a) .  
The World Health Organisation (WHO)  (2005a) immunological staging of HIV infection 
includes the following stages: no significant immunosuppression: >500/mm3; mild 
immunosuppression: 350-499/mm3; advanced immunosuppression:  200 −349/mm3; and 
severe immunosuppression: <200/mm3. 
2.2.6 Antiretroviral treatment   
HIV encodes at least three types of enzymes: protease, reverse transcriptase and 
endonuclease (Aymard, Legrand, Trichereau, & Diquet, 2000). In order to inhibit 
reproduction of the virus in the human body; pharmaceutical scientists have produced 
antiretroviral drugs, which are described as a treatment for people infected with HIV. 
Following advanced research on this treatment, scientists have introduced the highly active 
antiretroviral treatment. This consists of a triple combination of drugs, and significantly 
assists the suppression of HIV replication (Miranda et al., 2007); it results in reconstitution 
and augmentation of the CD4 count.  Unfortunately, due to the persistence of viral reservoirs, 
highly active antiretroviral treatment does not eradicate HIV (Mahungu, et al., 2009). 
There are three main types of antiretroviral drugs:  the nucleoside reverse  transcriptase 
inhibitors (NRTIs), the non-nucleoside reverse transcriptase inhibitors (NNRTIs) and the 
protease inhibitors (PIs) (Aymard, et al., 2000).  NRTIs include Abacavir, Didanosine, 
Dideoxycytidine, Lamivudine, Stavudine and Zidovudine etc. The NNRTIs include 
Delavirdine, Efavirenz and Nevirapine etc. The PIs include Amprenavir, Indinavir, 
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Nelfinavir, Ritonavir and Saquinavir etc. Therapeutic strategy regimens are based on a 
combination of these antiretroviral drugs (Aymard, et al., 2000). 
World Health Organisation (WHO) (2006b) recommends that the first-line treatment regimen 
for adults and adolescents should contain two NRTIs plus one NNRTI.  It has been found that 
this combination is efficacious, less expensive and has generic formulations.  The following 
NRTIs are considered preferable as a first-line regimen: Zidovudine (AZT) or Stavudine 
(D4T), Lamivudine (3TC) or   Emtricitabine (FTC), Tenofovir (TDF) or Abacavir (ABC). If 
the choice is NNRTI, then Efavirenz (EFV) and Nevirapine (NVP) are preferable. The PIs are 
reserved for the second-line treatment regimen and are combined with an NRTI (Gilks et al., 
2006; World Health Organisation (WHO), 2006b). 
The antiretroviral treatment regimen in Rwanda follows the WHO recommendations, so the 
usual combinations comprise two NRTIs plus one NNRTI or two NRTIs plus one PI (MoH-
Rwanda, 2011a).  As it is shown in Table 1, in Rwanda, there are  four combinations of drugs 
recommended for the first-line regimen (Ministry of Health (MoH) Rwanda, 2011a). 
Table 1: Antiretroviral drugs combination recommended for the first line regimen, in Rwanda  
NRTI NNRTI 
Tenofovir (TDF) + Lamivudine (3TC) or FTC Efavirenz (EFV) 
Tenofovir (TDF) + Lamivudine (3TC) or FTC Nevirapine (NVP) 
Abacavir (ABC) + Lamivudine (3TC) or FTC Efavirenz (EFV) 
Abacavir (ABC) + Lamivudine (3TC) or FTC Nevirapine (NVP) 
(Ministry of Health (MoH) Rwanda, 2011a) 
2.2.5.1 Antiretroviral treatment side effects 
Various side effects of antiretroviral treatment as a result of toxicity have been observed and 
these can vary in severity from mild to severe and may sometimes be life-threatening. 
Kumarasamy et al. (2008), in a prospective study, found that over half of PLWH developed at 
least one treatment-associated adverse event and this contributed to the need to change or 
discontinue the initial regimens. However, at times it might be difficult to distinguish 
between the complications of the HIV infection and the side-effects of antiretroviral 
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treatment toxicity. The common side effects are shown in Table 2 (World Health 
Organisation (WHO), 2006b). 
Table 2: Antiretroviral drugs first line treatment regimen side effects  
Antiretroviral drug Common associated side effects 
ABC Hypersensitivity reaction 
AZT Severe anaemia or neutropenia 
Severe gastrointestinal intolerance (example of symptoms may be 
persistent nausea and vomiting)  
Lactic acidosis 
D4T Lactic acidosis 
Lipoatrophy/ metabolic syndrome 
Peripheral neuropathy 
TDF Renal toxicity (renal tubular dysfunction) 
EFV Persistent and severe central nervous system toxicity 
Potential teratogenicity (first trimester of pregnancy or women not 
using adequate contraception) 
NVP Hepatitis 
Hypersensitivity reaction 
Severe or life-threatening rash (Stevens-John syndrome). Severe rash 
with desquamation or sometimes with other health problems such as; 
fever, oral lesions, blistering, facial oedema or conjunctivitis 
(World Health Organisation (WHO), 2006b) 
The World Health Organisation (WHO) (2006b) has suggested that countries select and keep 
a considerable stock of  first-line treatment  regimen  drugs; they should also  have a limited 
quantity of second-line regimen drugs available. Despite the side effects or toxicity of the 
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antiretroviral treatment; the majority of PLWH who are able to access and adhere to 
antiretroviral treatment can expect an improvement in their CD4 count and a decreased viral 
load (Heaton et al., 2011; Howard et al., 2002), a reduction in the occurrence of opportunistic 
infections and an overall reduction in disease-related morbidity and mortality (Heaton, et al., 
2011; Russell et al., 2007). 
2.2.7 Epidemiology of HIV 
 Towards the end of 2011, there were an estimated of 34 million PLWH globally, with one in 
every 20 adults living with HIV, or 4.9% of the global population (UNAIDS, 2012a). 68% of 
PLWH reside in Sub-Saharan Africa, which has only 12% of the total population of the 
world. Half of PLWH are women, and in sub-Saharan Africa this population is much higher 
than in other countries.  In 2010 it was estimated that 59% of the women adults were HIV-
positive (UNAIDS, 2011a; World Health Organisation (WHO), UNAIDS, & UNICEF, 
2011). Of the 34 million PLWH,  2.7 million were newly infected  (UNAIDS, 2012a; World 
Health Organisation (WHO), et al., 2011) and 70% of these new infections (which is the 
equivalent of 1.9 million people)  were found in sub-Saharan Africa (UNAIDS, 2012a; World 
Health Organisation (WHO), et al., 2011).  
Worldwide, the number of people dying from AIDS has decreased from 2.2 million in 2005 
to 1.8 million in 2010  (World Health Organisation (WHO), et al., 2011).  Sub-Saharan 
Africa reduced the rate of death by 32% between 2005 and 2011. The decrease was greater in 
some countries: Botswana, 71%,  Rwanda, 68%, Namibia,  60% and Zambia 56%  
(UNAIDS, 2012b). 
The reduced mortality rate has contributed to an increase in the number of PLWH.  For 
example; globally, in 2001 the prevalence of PLWH was declared to be 28.6 million whereas, 
as is shown above, in 2010 it reached 34 million. This reflects a population increase of 17% 
in ten years. Sub-Saharan Africa had a total of 22.9 million PLWH in 2010, 12% more than 
in 2001.  This can be explained by the improved availability of antiretroviral treatment, by 
the provision of   quality care and by social/welfare support given to PLWH. Such support 
includes the creation of HIV associations, the initiation of HIV projects by local and 
international Non- Governmental Organisations (NGOs) and the design of HIV prevention 
policies and programmes. This has help to boost the life expectancy of PLWH (UNAIDS, 
2011a).  
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In 2010, in low-and middle-income countries, around 6 650 000 PLWH had access to 
antiretroviral treatment. Sub-Saharan Africa has shown the greatest increase, with a total of  
5 064 000 PLWH on antiretroviral treatment in 2010, up from 3 911 000 in December 2009. 
Ten Sub-Saharan Africa countries, including Rwanda, have achieved greater access to 
antiretroviral treatment: that is, drugs have been provided to at least 80% of the population in 
need (UNAIDS, 2011a).  It has been observed that antiretroviral treatment coverage in these 
low- and middle-income countries is higher in women (68%) than in men (47%) (UNAIDS, 
2012a). 
In Rwanda, HIV prevalence statistics are available from the 2005 and 2010 Rwanda RDHS. 
Both surveys were population based surveys.  The prevalence of HIV in the population aged 
15-49 years was 3.0% in both surveys.  This was higher in women (4%) than in men (2%) 
(National Institute of Statistics Rwanda, et al., 2012) . The prevalence increases with age in 
both sexes.  It is highest among women aged 35-39 years (8%), and among men aged 40-44 
years (8%). Between the ages of 45-49, the prevalence was reduced to 6% for both women 
and men. (National Institute of Statistics Rwanda, et al., 2012). 
Among those aged between15-49 years, the prevalence of HIV infection in the Rwandan 
population varies according to the socio-demographic and economic characteristics of the 
people surveyed.  The prevalence of women and men living with HIV infection is 7% in 
urban areas, compared to 2% in rural areas. HIV prevalence is generally higher among those 
with no education (4%) than among those with primary education or higher (3%). Regarding 
employment status among men, HIV prevalence is higher among those who are employed 
(2%) than among those who are not employed (< 1%). Amongst women, the variation in HIV 
prevalence according to employment status is not significant.  With regard to marital status, 
the prevalence of HIV is 17% amongst widows, 7% amongst divorced or separated women 
and 4% amongst married women. The rates are similar for men (National Institute of 
Statistics Rwanda, et al., 2012). 
The social groups most affected include female sex workers, prisoners, men who have sex 
with men, and truck drivers. Among female sex workers, the prevalence of HIV infection is 
50.8% and it is even higher in women aged 25 years and above (57%) (Ministry of Health 
(MoH) Rwanda, 2012a). In Rwanda, there has been a decline  in incidence from 10.8% in 
2004 to 1.7%  in 2011, including  1.7% among women and 1.5% among men  (MoH-
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Rwanda, 2011b), 91.4% of PLWH who are eligible and need antiretroviral treatment are 
receiving the drugs (Ministry of Health (MoH) Rwanda, 2012a). 
2.3 Models of Disability  
There are a number of disability models that help to understand how people experience 
disability, how disability is understood and how people living with disability are treated. The 
most common models are the medical model, the social model, and the ICF (Vanleit, 2008).  
According to Vanleit (2008), the medical model is a clinically oriented model. Disability is 
viewed as an attribute of the person, and can be directly caused by disease, trauma, or other 
health conditions and requires intervention provided by professionals to treat and fix the 
problem (Jette, 2006; World Health Organisation (WHO), 2001). The treatment deals with 
what the person cannot do, and the goal of the treatment is to try to correct or minimize 
impairments, with the aim of gaining or recovering function (Reed, et al., 2005; Vanleit, 
2008). The Social model is a socially oriented model and considers disability as a problem 
resulting from exclusion from ordinary life rather than as a medical problem. With the social 
model, there is a shift from what is wrong with the person to what is wrong with society and 
the environment (Kearney & Pryor, 2004; Vanleit, 2008; World Health Organisation (WHO), 
2001). 
The ICF is a comprehensive classification system for health and functioning that integrates 
the medical and social models of disability. (Guscia, Ekberg, Harries, & Kirby, 2006; World 
Health Organisation (WHO), 2001). In the ICF, health and human functioning are considered 
to be more than the result of biological factors. It also includes psychological, social and 
contextual factors (Shaw & MacKinnon, 2004; World Health Organisation (WHO), 2001). 
The ICF is based on a bio-psychosocial model of human functioning and disability that brings 
together the components of health with the aim of achieving a holistic understanding of 
disability (Geyh et al., 2011; World Health Organisation (WHO), 2001). 
 With the ICF, disability is considered to be a social construction; this is contrary to the 
traditional medical view that disability resides within the person. Disability is affected by the 
interaction between a person and the environment (Rosenbaum & Stewart, 2004). This allows 
for a more comprehensive conception and understanding of a person‘s experience with 
disability, an understanding that includes the environmental barriers and facilitators that 
impact on a person‘s functioning. The recognition of the central role played by the 
environmental factors has had a big impact on the design of intervention strategies; these seek 
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to overcome the disability and improve function, and the focus of the intervention might shift 
from the individual to the environment in which the person lives (Hwang & Nochajski, 2003; 
Rusch, et al., 2004a).   
―The overall aim of the ICF classification is to provide a unified and standard language and 
framework for the description of health and health-related states‖  
(World Health Organisation (WHO), 2001, p. 3). 
2.3.1 Principles of the ICF 
Some of the ICF principles have been highlighted in certain articles. (i) The universal 
application: ICF has to be understood in a broader context: it is for all people and not only for 
people living with disability. (ii) It is a classification where all people can have their health, 
and experience of health condition described using the ICF (Chapireau, 2005; Schneidert, 
Hurst, Miller, & Üstün, 2003). (iii) It is an integrative approach: this principle recognises the 
impact of both the individual and the society in the understanding and treatment of disability 
(Schneidert, et al., 2003). (iv) It is an interactive approach: the ICF considers and 
acknowledges the complex and multi-dimensional aspect of disability (Schneidert, et al., 
2003). (v) There is a shift from a classification of ―disease consequences‖ to one that looks at 
―components of health‖. This principle suggests that, to understand disability, ICF goes 
beyond the particular  health condition and incorporates all aspects of human health, 
including some health components of well-being; it describes these in terms of ―health 
domains‖ and ―health-related domains‖ (Chapireau, 2005). 
2.3.2 Components of the ICF 
The ICF describes various components that combine or interact with any health condition that 
may be associated with the development of disability (Vanleit, 2008).   
The ICF has two parts, and each part has two components. The first part deals with 
functioning and disability, while the second covers contextual factors. Components of 
functioning and disability are divided into (i) a body component (body structures and 
functions) and (ii) an activity and participation component. Contextual factors may be both 
environmental and personal (Cieza & Stucki, 2005; Kuijer et al., 2006; Perenboom & Chorus, 
2003; Rentsch, Fluri, & Wenger, 2003; Steiner et al., 2002; World Health Organisation 
(WHO), 2001). Each ICF component can be expressed in both positive and negative terms 
(World Health Organisation (WHO), 2001).  
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2.3.2.1 Part one: Functioning and disability 
Functioning is considered to be a positive term whereas disability is a negative term; 
therefore in the ICF positive or non-problematic aspects of health are summarised using the 
umbrella term ―functioning,‖ while the negative or problematic aspects are described using 
the term ―disability‖. An individual‘s functioning or disability in a specific domain represents 
an interaction between the individual and a health condition (e.g. one caused by injury, 
disease, or trauma) and the contextual factors (which include both environmental factors and 
personal factors) (Coenen et al., 2006; Steiner, et al., 2002). Schneidert et al. (2003) 
suggested that, if the interaction has an outcome resulting in less than the full range of 
functioning, then the person is said to experience disability or be disabled. 
The components of functioning and disability include body function and structure, and 
activity and participation. Body structures include anatomical parts of the body, such as the 
organs and the structures of the nervous, sensory, and musculoskeletal systems. Body 
functions include physiological and psychological functions, and can be categorized as 
follows: mental; sensory and pain; voice and speech; cardiovascular; immunological; 
respiratory; digestive; metabolic and endocrine; genitourinary and reproductive; 
neuromuscular and movement-related; and functions related to the skin. Problems in body 
function or structure are referred to as ―impairments‖ (Palisano, 2006; Vanleit, 2008; World 
Health Organisation (WHO), 2001). The ICF defines impairment as an anomaly, defect, loss, 
or other significant deviation or change in body function or structure (World Health 
Organisation (WHO), 2001) which is the manifestation of pathology (Hwang & Nochajski, 
2003). 
―Activity‖ is defined as the execution of a task or an action by an individual (Palisano, 2006; 
Vanleit, 2008; World Health Organisation (WHO), 2001). Difficulties are referred to as 
―activity limitations‖ (Palisano, 2006; Vanleit, 2008; World Health Organisation (WHO), 
2001), and these limitations are experienced at the level of the individual (for instance an 
inability to walk) (Worthington, et al., 2005) An activity limitation occurs when an individual 
either has difficulty performing the activity in an expected manner, or is unable to perform it 
at all. It is assessed based on the individual‘s ability to perform a task and does not take into 
account external influences, such as environmental factors (Gray & Hendershot, 2000).  
―Participation‖ indicates involvement in life situations (World Health Organisation (WHO), 
2001). It signifies also taking part, being included or engaged in an area of life, and being 
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accepted or having access to needed resources (Coster & Khetani, 2008). It represents the 
societal perspective of functioning (Stucki & Sigl, 2003; World Health Organisation (WHO), 
2001).  Participation restrictions are defined as limitations in an individual‘s ability to interact 
with society, for example an inability to work. This may be due to the external factors, such 
as the existence of barriers, and/or a lack of facilitators in the environment (Gray & 
Hendershot, 2000).The presence of a  participation restriction  is determined by comparing an 
individual‘s participation profile to that which would be expected of an individual without 
any disability in that particular society (Hwang & Nochajski, 2003). 
Heerkens, Engels, Kuiper, Van Der Gulden, and Oostendorp (2004), Gibson  and Strong 
(2003) and the World Health Organisation (WHO)  (2001) all indicate that activity and 
participation components are also subject to the qualifiers, capacity and performance. While 
―performance‖ refers to what the person actually does in his or her environment, ―capacity‖ 
denotes an individual‘s ability to accomplish a task. Ability and performance are influenced 
by the environment, which is considered to be an external factor. Transformation of the 
environment may be a way of improving participation (Chapireau, 2005).  
2.3.2.2 Part two: Contextual factors  
The ICF recognises aspects of social orientation that have reinforced the philosophy of social 
construction disablement. Contextual factors have two components, the environmental and 
the personal. (Rosenbaum & Stewart, 2004; Schneidert, et al., 2003; Stucki & Sigl, 2003; 
World Health Organisation (WHO), 2001). Environmental factors consist of all aspects of the 
world that are external or extrinsic to the individual and that have an impact on his or her 
functioning (Stucki & Sigl, 2003). These could involve the physical world and its features; 
the human-made physical world; other people in different relationships and roles; attitudes 
and values; social systems and services; and/or policies, rules and laws (Jette, 2006; 
Nieuwenhuijsen, Zemper, Miner, & Epstein, 2006; Schneidert, et al., 2003; Stucki & Sigl, 
2003; Vanleit, 2008; World Health Organisation (WHO), 2001).  Environmental factors can 
facilitate or hinder a person‘s level of functioning or participation in society (Hwang &  
Nochajski, 2003; Jette, 2006; World Health Organisation (WHO), 2001). 
Personal factors are contextual factors that are intrinsic to the individual (Stucki & Sigl, 
2003; Vanleit, 2008). There are individual characteristics which are unique and which are not 
part of the individual‘s health condition (Reinhardt, et al., 2006; Stucki & Sigl, 2003; World 
Health Organisation (WHO), 2001). These include individual characteristics, demographic 
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characteristics, a person‘s socio-economic background (age, gender, employment, education 
etc.), lifestyle, coping styles, psychological factors, and past and current experiences. These 
can have a positive or negative influence on functioning (Reinhardt, et al., 2006)  and 
disability, and they can play the role of moderators or modifiers with regard to functioning, 
disability and health. Additionally, in the context of clinical intervention, a consideration of 
personal factors encourages a patient-centred care approach (Geyh, et al., 2011). 
2.4 PLWH and body impairments, activity limitations, social participation 
restrictions and contextual factors  
Studies have shown that PLWH encounter health-related challenges which manifest as 
various types of condition and impairment; these may be classified as belonging to both the 
physical and the mental or psychological and the social domains. These can  affect the 
general functional status of PLWH  and may restrict them from participating fully in society 
or like any other person without HIV infection (Crystal, Fleishman, Hays, Shapiro, & 
Bozzette, 2000; Heidari & Kippax, 2009; Lorenz, Shapiro, Asch, Bozzette, & Hays, 2001; 
Myezwa, et al., 2009; O'Brien, et al., 2008; Rusch, et al., 2004a; Van As, et al., 2009). 
Participants in a study conducted by Rusch et al. (2004a) in Canada demonstrated that even 
PLWH with high CD4 counts experienced impairments, activity limitations and participation 
restriction as a consequence of HIV infection: there was little difference in the functional 
limitations of people with different levels of CD4 count. Functional limitations can affect the 
HRQOL of PLWH (Lorenz, et al., 2006). 
 O‘Brien et al. (2008) found the disability or the functional limitations from HIV infection, 
were multidimensional and episodic by nature, characterised by unpredictable periods of 
wellness and illness. Participants in their study believed this was due to HIV infection itself 
and to the side effects of antiretroviral treatments. They reported that they experienced 
numerous impairments, limitations in daily activity performance, and restrictions on social 
life. They also recognised the influence on functioning (either positively or negatively) of 
external factors such as support from friends, access to health services, and internal factors 
(factors within themselves), such as age, and coping strategies that assist in dealing with HIV 
infection. In addition, they were uncertain prognosis and progression of the disease (O'Brien, 
et al., 2008) . The most frustrating experience for PLWH is the situation of uncertainty and 
the inability to predict disease complications or progression and obtain a clear prognosis. 
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PLWH live with the worry and fear that some complication or functional problem may occur 
in the future – the next day or the next year (McReynolds & Garske, 2001).   
2.4.1 PLWH and body impairment 
Impairments identified in PLWH may be caused by the HIV infection and its associated 
pathologies or by antiretroviral treatment (Alexander, 2011).  
Vogl et al. (1999) indicated that PLWH rarely present with a single impairment. This was 
confirmed by the findings of their study, conducted in USA, that aimed at assessing physical 
and psychological functioning among PLWH. They identified several impairments, ranging 
in prevalence from 19% to 85.5%. Twelve impairments had a prevalence of more than or 
60%: these were worrying (85,5%), lack of energy (85,1%), feeling sad (81.5%), pain (75,6 
%), feeling irritable (75,1%), difficulty sleeping (73,8%), feeling nervous (68%), dry mouth 
(67,6%), difficult concentrating (64,5%), shortness of breath (62,4%), feeling drowsy(61,9%) 
and a persistent cough (60.3%)  (Vogl, et al., 1999).   
Similarly, Newshan, Bennett, and Holman (2002), found in their study that two-thirds (68%) 
of their sample reported at least one impairment. Of these 96% reported more than one 
impairment and almost half of the sample reported more frequent problems. These varied 
from moderate to severe: fatigue scored 43%, insomnia 35%, anxiety 34% and pain 31%. 
However; multiple problems were often present.    
A more recent study by Lee et al. (2009)  of another selected population in the USA 
demonstrated almost similar findings: it found that the mean number of present impairments 
was nine. Remarkably, those who were on antiretroviral treatment had more impairments 
than the naive patients. The most prevalent impairments were: lack of energy (65%), 
drowsiness (57%), difficulty sleeping (56%), and pain (55%) (Lee, et al., 2009). Furthermore, 
in Canada, the results from a cross-sectional population-based survey, carried out among 
PLWH, have shown a higher proportion (90%) of the study population experiencing one or 
more impairments, with approximately one-third reporting more than ten impairments.  Both 
physical and psychological symptoms were present (Rusch, et al., 2004a).  
Alexander (2011) reported on reviewed studies from some of the developed countries; 
including France, Italy and USA. Participants in all the reviewed studies were receiving a 
combination of antiretroviral treatments. Findings from those studies often revealed repeated 
impairments in PLWH. The most common were fatigue (55%-85%), anorexia (34%-55), 
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worry or feelings of sadness/depression ( 47%-82%) , pain  from multiple parts of the body 
(29%-76%), dyspnea/shortness of breath (19%-62.4%), a persistent cough  (30.4%-60.3%),  
problems with sleep ( 48%-73.8%),  weight loss (37.1%-60%),  and fever (14%-59%). In 
Africa, only a few studies have looked at the functional status of PLWH. For example; a 
cross-sectional descriptive study utilising the ICF checklist conducted in South Africa by Van 
As et al. (2009) reported many impairments affecting different body functions among PLWH. 
The most common problems were haematological problems (96%), followed by problems 
with sensory functioning, particularly sight and pain (71%), and mental health problems 
(69%). A similar South African study by Myezwa et al. (2009) demonstrated that 100% of 
the participants experienced one or more impairments, with a mean of eleven impairments 
per person. There was a high rate of impairment of physical and mental/psychological 
functions . The most common problems were digestive, metabolic and endocrine system 
problems (83.9%), sensory problems (83.5%), and mental problems (72.6%) etc. 
In Rwanda, a study by Uwimana and  Struthers (2008)  found that most PLWH in Rwanda 
also experienced impairments related to HIV infection. Their study has shown that 69% of 
PLWH experience impairments most of the time. Physical problems were complained of by 
92%; among these; neuromuscular conditions were reported by 70% of PLWH. 
Mental/psychological problems were complained of by 65% of PLWH. 
2.4.1.1  PLWH and impairments in mental function 
In the ICF, mental function is broadly described as referring to the functions of the brain and 
the central nervous system (CNS), including both global mental functions and specific mental 
functions (World Health Organisation (WHO), 2001).  There is increasing evidence that HIV 
infection affects the mental functionality of PLWH and that the prevalence of mental health 
conditions is very high (Ciesla & Roberts, 2001; Collins, Holman, Freeman, & Patel, 2006).   
In a study by Rusch et al. (2004a), mental impairments are the most commonly reported 
problems among PLWH, with a prevalence of 62.9%.  These were also found to have a 
strong association with participation restrictions in society. The results of a study in South 
Africa by Freeman, Nkomo, Kafaar, and Kelly (2007) demonstrated a prevalence rate of 
various mental disorders among PLWH of 43.7%. Another South African study by Van As et 
al. (2009) reported that mental health impairment was among the most frequently complained 
about body function problems: it was the third most commonly reported problem (69%). 
Energy and drive, and sleeping and emotional problems were commonly reported. 
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It is likely that among the reasons for the high prevalence of mental health problems in 
PLWH are the effects of the virus on the central nervous system, the psychological and 
emotional impact of the disease, the side-effects of the antiretroviral treatment and the 
consequences of stigmatization and discrimination against PLWH (Freeman, Patel, Collins, 
& Bertolote, 2005). 
HIV and psychological/emotional disorders  
Collins et al. (2006) evaluated a number of studies on the impact of HIV infection on mental 
health ; these have shown that  there is a high  rate of psychological distress and depression 
among PLWH, and this might be associated  with the severity of their physical impairments. 
Likewise,  as was demonstrated above, emotional impairment was among the three most 
frequently cited mental health problems, as expressed by a group of  PLWH in a selected area  
in South Africa (Van As, et al., 2009).  Coleman et al. (2006) have shown that more than half 
of the participants in their study suffered from depression. Hudson, Kirksey, and Holzemer 
(2004) reported that there was a very high prevalence rate for depression (83%) among 
PLWH in their study. Similarly Rusch et al. (2004a) found that depression was the most 
commonly complained about mental impairment, with a prevalence of 58.1%.     
 It has been observed that in the era of antiretroviral treatment, psychological distress has 
shifted from fears, worries and sadness about the death of relatives, children, partners and 
others to problems and anxieties with regard to forming relationships and the disclosure of a 
person‘s serostatus to others (Catalan, Meadows, & Douzenis, 2000). There is also 
discouragement and anxiety regarding the multiple complications of antiretroviral treatment 
(Catalan, et al., 2000; Ciesla & Roberts, 2001).  
 In addition, the uncertainty of the disease prognosis affected patients‘ psychological 
adjustment to a lifelong and life-threatening disease. This limited the individual patient‘s 
ability to plan for the future, created barriers in family and social relationships, and led to 
difficulties with regard to social, work and recreational activities; these factors could severely 
affect the psychological well-being of PLWH (McReynolds & Garske, 2001).     
Several other studies have shown that there is evidence that PLWH experience a multitude of 
emotions, including psychological distress; this occurs from the onset of the disease and 
throughout its progression (Vogl, et al., 1999). However, such cases are more likely to be 
found during the period following the diagnosis than other times. The occurrence of 
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psychological distress /depression disorders in PLWH may be approximately twice that found 
in HIV-negative people (Ciesla & Roberts, 2001; Valente, 2003).  In addition, this is 
supported by findings from a study carried out by Miles, Holditch-Davis, Pedersen, Eron Jr, 
and Schwartz (2007); this aimed to determine the relationship of personal factors such as 
demographic characteristics and perceptions of health with emotional distress and depression 
among PLWH. Their study revealed that there was a highly significant association between 
youth and depression. A significant association was also found between depression and 
adverse perceptions of a person‘s health status.  
Chan et al. (2006) and Vosvick et al. (2002) discovered  that individual patient‘s positive  
thinking  about his or her health correlates positively with lower levels of psychological 
distress, whereas avoidance was associated with higher levels of distress; moreover, it also 
impacts negatively on quality of life  (Vosvick, et al., 2002).  Furthermore,   studies by Kowal 
et al. (2008) and Vosvick et al. (2002) demonstrated that PLWH who dealt with 
psychological stressors and faced their problems in an active manner and used adaptive 
coping strategies were found to have fewer depressive emotional symptoms and a higher 
quality of life, compared to those who used avoidance, or emotionally oriented and 
maladaptive strategies.  
Social support particularly emotional social support, was found to be associated with less 
psychological distress and improved psychological quality of life (QoL)  (Friedland, 
Renwick, & McColl, 1996). Notably, Jia et al. (2004) and Ashton et al. (2005) reported that 
in their studies social support was found to be a very strong predictor of patients‘ general 
health status and of their physical and psychological and social functioning; it also improved 
overall quality of life. 
Signs and symptoms of psychological distress could take the form of feelings of shock, 
feelings of guilt, decreased self-esteem, feelings of anxiety, loss of identity, fear, anxiety, 
sadness, and a depressed mood (Vogl, et al., 1999). Temporary emotional distress such as 
that expressed by mood (for instance, anger, sadness, fear etc.) could be a reaction to 
immediate psychological distress, whereas depressive symptoms could manifest after a 
prolonged state of psychological distress (Miles, et al., 2007). Assessments of health should 
focus on such things as the persistent experience of sadness, discouragement, lack of 
motivation and activity (Richardson et al., 2009).     
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Failure to detect depression due to the health care provider‘s mistaken diagnosis or to patients 
not reporting their  symptoms (perhaps for of  being judged or because of shame for their 
mental health dysfunction) can result in severe depression on the part of PLWH, with 
possible consequences such as lower life expectancy and poor treatment adherence. The 
immune function could be adversely affected and there could be an increased risk of suicide 
(Valente, 2003). 
There is accumulated evidence that emotional distress and depression could be caused by 
HIV stigma and discrimination, and positive associations have been found between 
depression and both perceived and internalised stigma (Emlet, 2007; Freeman, et al., 2007; 
Kalichman et al., 2009; Simbayi et al., 2007; Vyavaharkar et al., 2010) and between 
emotional distress and depression and discrimination (Freeman, et al., 2007).  Furthermore, a 
multi-country study conducted by Holzemer et al. (2009) among PLWH reported high HIV 
stigma scores that were significantly and negatively correlated with the quality of life of the 
participants.   
HIV Stigma and discrimination  
Several studies have highlighted the effects of stigma on PLWH (Emlet, 2006; Holzemer, et 
al., 2009; Kalichman, et al., 2009; Lee, Kochman, & Sikkema, 2002; Simbayi, et al., 2007), 
as well as the effects of discrimination (Duffy, 2005; Freeman, et al., 2007; Simbayi, et al., 
2007). 
For example, the findings of a qualitative study carried out by Zukoski and Thorburn (2009)  
in one selected rural area in USA indicated that, of sixteen PLWH who participated in the 
study, fourteen had experienced stigma and discrimination from people in their community, 
including in their health-care community. Participants complained mostly about feeling 
socially isolated and rejected by friends and family. They were sometimes asked to follow 
rules and were treated differently because of their HIV status. With regard to the health-care 
setting, participants complained that health care providers were sometimes afraid of them, 
thinking that they would be contaminated; they also refused to treat them or they treated them 
differently from other people; they sometimes referred them to other health care providers 
when they were in fact able to treat them. 
In various surveys Simbayi et al. (2007) have also looked at the issue of discrimination 
among PLWH in one selected area in South Africa. These results have shown an increased 
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presence of discrimination and HIV stigma. The following are examples of discrimination: 
almost one person in three said there were treated differently after they had disclosed their 
HIV status to friends and family. Nearly 40% experienced discriminated from others because 
they were living with the HIV infection. One in five individuals indicated that they had lost 
their job or a place to stay because of their HIV status. Many participants said also that there 
were friends and family members who had stopped visiting them after learning that they were 
HIV positive.  
The HIV stigma is a very complex and multidimensional problem (Emlet, 2007). Herek and 
Capitanio (1999) identified four characteristics that explain why HIV is a much stigmatized 
disease. (1) It is a disease which is seen as the bearer‘s responsibility; this is because the 
mode of infection transmission often involves behaviour that is considered voluntary and 
therefore avoidable. (2) Despite the tremendous impact of antiretroviral treatment on the 
general health status of PLWH, the HIV disease is still considered to be a life threatening 
disease. (3) The HIV disease is perceived to be contagious. (4) HIV disease is also apparent 
to others; symptoms are often obvious, particularly when the disease is far advanced. 
HIV stigma can be expressed in different ways. It can be related to the individual‘s inner 
feelings and thoughts; for example, the individual may feel ashamed, and may be aware that 
other people are not comfortable living with an HIV infected person. Types of 
internal/internalised stigma include personalized stigma and having a negative self-image  
(Emlet, 2007).  
Simbayi et al. (2007) have also looked at the issue of internalised stigma among PLWH. 
Many participants complained about internalised stigma, such as the emotions they 
experienced since being diagnosed. The most commonly experienced feelings connected to 
the HIV stigma were: feeling dirty and ashamed, feeling guilty and worthless, blaming 
oneself, and lack of disclosure of their HIV serostatus to others. Makoae et al. (2008) carried 
out a multisite study involving five African countries; using qualitative methods; they showed 
that internalised stigma can include the following: negative perceptions of the self, social 
withdrawal, self-exclusion, and fear of disclosure.      
Lee et al. (2002) found that PLWH who demonstrated higher levels of HIV-related 
impairments also had significant levels of internalised stigma. Moreover, the same group with 
increased levels of internalised stigma and greater HIV impairments was reluctant to look for 
social support, perhaps because of feelings of shame and embarrassment. They complained of 
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receiving less support from their families, because their families did not accept their disease. 
The stigma was also more prevalent among those recently diagnosed with the HIV infection. 
 HIV stigma can also find its source outside the individual patient: it can come from the 
patient‘s family and from the society in general in this case it is social stigma. For example 
HIV-infected individuals can experience rejection from their parents or from their employer 
(Emlet, 2007). Social stigma can be reflected by negative treatment or negative attitudes from 
other people in the society towards PLWH; this can take the form of avoidance, disdain, 
denial of recognition, and job loss (Li, Ji, Ding, Tian, & Lee, 2012).  Makoae et al. (2008) 
conducted a study in five African countries; they reported that  external stigma or  social 
stigma could include the following: neglecting, negating, avoiding, rejecting, labelling, 
gossiping, pestering, and abusing.     
Emlet (2007) suggested that generally stigma can result in the following: (1) rejection:  this is 
when PLWH are rejected by their society and do not receive any support from other people. 
However lack of social support is a factor in social stigmatization and can also lead to 
internalized stigma (Kalichman, et al., 2009). This can cause someone to isolate himself or 
herself (Li, et al., 2012). Rejection can be observed in the relationship between PLWH and 
family members, for instance, parents, siblings and partners, and also in the relationship with 
other people in the society; such as friends, employers, church members and health care 
providers.   
Emlet‘s (2007) other suggestions were (2) fear of contagion: sometimes PLWH are 
stigmatized because non-infected people in their society fear contamination; as a result; 
PLWH feel isolated and lonely. Isolation and loneliness could also be a consequence of 
rejection and lack of trust from other people. (3) Negative self-image: it often happens that 
PLWH feel ashamed, embarrassed, humiliated and guilty about their HIV status. (4) Self-
depreciation is also an issue to consider in relation to HIV and stigma: it is expressed in low 
self-esteem. To the extent that the individual is affected by self-depreciation and is not able to 
value himself or herself, the person might see himself or herself as different from others, thus 
limiting his or her participation in the society. 
Findings from the study conducted by Makoae et al. (2008) identified the different coping 
strategies PLWH have adopted to deal with issues such stigma, described above. Two kinds 
of strategy were identified: (1) emotional coping strategies in which the individual patient 
looked for solutions from within: this involved emotional behaviour to be able to cope with 
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stigma. This included rationalization: that is, trying to make stigma less painful, seeing 
oneself as normal, avoidance of confrontation and accepting or ignoring stigmatization from 
others. It could include turning to God; which would involve activities such as praying, 
joining religious groups, and depending on and building up hope in God in response to the 
illness. Hope and having sense of humour about the illness were also identified as important 
factors. (2) The second category included problem-oriented coping strategies. These included 
being more active and involving other people or taking part in certain activities, such as 
joining a group  (for example an HIV group), disclosure, going for counselling, interacting or 
socializing with others, helping others, acquiring more knowledge about HIV illness, 
educating others, changing one‘s lifestyle, keeping oneself busy, and learning from others. 
A household survey carried out by Genberg et al. (2009) involved four countries (Northern 
Thailand, South Africa, Zimbabwe and Tanzania) and showed that in general knowledge 
about HIV and related issues had a big impact on people‘s attitudes towards  PLWH. For 
example; never being involved in HIV talks, and never having taken an HIV test, as well as a 
lack of knowledge about antiretroviral treatment, were all significantly associated with 
negative attitudes towards PLWH. In addition, never having been involved in HV discussions 
and lack of knowledge about antiretroviral treatments were associated with increased 
perceived discrimination against PLWH. It was also observed that high levels of 
discrimination were predominant in the sites where there was insufficient support and 
unsatisfactory care for PLWH.  
PLWH and disclosure  
The literature suggests that the majority of PLWH do not easily disclose their HIV serostatus. 
Emlet (2007) stressed that many PLWH  refuse to disclose because they do not understand 
why they should tell others that they are infected. Others (because of internalised 
stigmatization), are embarrassed by being infected and are very reluctant to inform other 
people (Kalichman, et al., 2009; Lee, et al., 2002). Sometimes they decide to keep their status 
a secret because they fear discrimination (Tarakeshwar, Pearce, & Sikkema, 2005). It has also 
been observed that there are PLWH who express anxiety and fear of disclosure while at the 
same time feeling a need to share their serostatus with others; this creates a dilemma and 
leaves them uncertain of what to do (Emlet, 2007).   Li et al. (2012); found that PLWH who 
refused to disclose their HIV status were able to live normal physical and social lives but 
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were not psychologically healthy. These participants revealed that secrecy and pretending to 
be normal was not only for their own protection but also for the protection of their families. 
Gaskins, Foster, Sowell, Lewis, Gardner, and Parton (2012) describe disclosure as an 
ongoing process, and that can take years. Soon after being diagnosed, people tend to 
experience denial and fail to communicate what they themselves have not accepted. For many 
there is a need for time to try to understand the mysterious world of HIV and how to change 
their lives and adapt to a new way of living, before making disclosure. Moreover, participants 
revealed also that there were other factors which could influence how decisions were made. 
This included social, cultural, and environmental factors and, most importantly, the 
anticipated response from the recipients of disclosure.  
Some of the advantages of disclosure include: (1) being provided with social and emotional  
support (Emlet, 2006, 2007; Gaskins, et al., 2012; Kalichman, DiMarco, Austin, Luke, & 
DiFonzo, 2003); (2) a reduction of the stress caused by the disease (Gaskins, et al., 2012; 
Kalichman, et al., 2003);  and (3) the ability  to make others  aware of  the disease and to 
observe preventative measures (Gaskins, et al., 2012). 
Studies have also demonstrated that the disadvantages and risks of disclosure can also 
discourage someone from disclosing. Some of the disadvantages and risks include the 
negative attitudes and reactions of others – this can be expressed through rejection, 
discrimination and stigma (Emlet, 2007; Gaskins, et al., 2012; Sowell, Seals, Phillips, & 
Julious, 2003). There is also a fear that this information might be spread more widely 
(Gaskins, 2006; Gaskins, et al., 2012). Fear of the consequences of disclosure also affects 
people‘s involvement in relationships (Emlet, 2007). 
PLWH who are willing to disclose have preferences when it comes to the choice of recipient 
to be told. Several studies have identified the following possibilities, in rough order of 
preference: family members, partners, friends, neighbours, church leaders or members and 
health care providers (Emlet, 2006; Gaskins, 2006; Gaskins, et al., 2012; Maman, Cathcart, 
Burkhardt, Omba, & Behets, 2009).  Gaskins et al. (2012) found that family members were 
likely to be trusted by most PLWH, with mothers the most likely to be told first, followed by 
the siblings. However Emlet (2006) found the majority of older PLWH preferred to disclose 
their status to their children.  Maman et al. (2009); in a study conducted in Kinshasa, DRC; 
found that participants had chosen  to divulge their HIV status first to their partners and also 
to their church leaders or pastors because they believed pastors were gifted by the power of 
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God and were able to keep secrets. Furthermore, participants in Gaskins (2006) suggested it 
was best to avoid informing the employers of one‘s HIV serostatus as this could affect their 
work status. They believed employers were not supportive. 
PLWH and Spirituality 
Studies have shown that  PLWH use their spiritual beliefs as one of the most effective 
strategies to cope with  challenges linked to HIV  (Makoae, et al., 2008; Siegel & 
Schrimshaw, 2002), including stigma (Makoae, et al., 2008).   
It has been found that PLWH‘s spiritual beliefs can interfere with their understanding about 
HIV to the extent that it affects their adherence to antiretroviral treatments. For example, a 
prospective observational study conducted in Uganda by Wanyama et al. (2007) found that 
some PLWH decided to interrupt their therapy because they believed they had been cured by 
the power of God and no longer needed antiretroviral treatments. This behaviour could lead 
to drug resistance and affect the viral load and the general clinical status of these patients 
(Oyugi et al., 2007). 
Siegel and Schrimshaw (2002), and Ironson, Stuetzle, and Fletcher (2006) found an increase 
in the practice of spirituality after HIV diagnosis. Furthermore Siegel and Schrimshaw  
(2002)  revealed  that  some PLWH  who had stopped practicing their faith or who did not 
have strong spiritual beliefs before the diagnosis  found  themselves seeking  spiritual 
involvement and support and  developing very strong spiritual beliefs. However, the majority 
of the participants in their study had not opted for formal religious practices, such as 
attending church; instead they preferred prayer and meditation in the home setting. Other 
spiritual practices included watching religious television programs and listening to services 
and religious music on the radio. 
Scarinci, Quinn Griffin, Grogoriu, and Fitzpatrick (2009) found that PLWH in the USA had 
also exhibited stronger spiritual beliefs. Many prayed alone and or listened to gospel music. 
A preference for private spiritual practices was also described by Dalmida, Holstad, Diiorio, 
and Laderman (2009). 
A growing body of research indicates the benefits PLWH gain from religious/spiritual beliefs 
and practices. Spirituality beliefs encourage positive emotions, such as tranquillity, 
contentment and feelings of peace (Maman, et al., 2009; Siegel & Schrimshaw, 2002; 
Tarakeshwar, et al., 2005). They reduce the reaction to the diagnosis and reduce feelings of 
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self-blame and guilt and shame, thus enhancing self-acceptance (Siegel & Schrimshaw, 
2002). 
 PLWH indicate that faith and belief in God‘s power increased their resilience and ability to 
deal with HIV and take control of their lives (Maman, et al., 2009; Siegel & Schrimshaw, 
2002; Tarakeshwar, et al., 2005). Most importantly, some PLWH believed that their illness 
could be cured by God (Maman, et al., 2009; Siegel & Schrimshaw, 2002).  Participants in a 
study by Siegel and Schrimshaw (2002) reported that spiritual beliefs reduced the fear and 
uncertainty of death. Coleman et al. (2006) found PLWH used prayer as a self-care 
management strategy to overcome some of the symptoms associated with HIV, such as 
fatigue, nausea, anxiety and depression.  
Maman et al. (2009) reported that participants in their study said that their religious leaders 
(pastors) and  even their health care providers, particularly their counsellors, also had a 
conviction in the power of God.  They believed that prayer could heal the HIV disease and 
encouraged them to continue praying and have faith in God.  
 Spiritual practices, such as prayer, are described as assisting PLWH to be able to surrender 
their destiny and the burden of HIV disease into God‘s hands. This helps them to feel better 
and alleviates their emotional and psychological distress (Maman, et al., 2009; Siegel & 
Schrimshaw, 2002).   
Through spiritual practices such as prayer and meditation, whether in private or public, 
participants said that they managed to develop a relationship with God and talk to him; this 
provided them with support and comfort (Maman, et al., 2009; Siegel & Schrimshaw, 2002). 
This enabled them to accept and give meaning to their illness (Siegel & Schrimshaw, 2002), 
and to find meaning and purpose in their lives (Litwinczuk & Groh, 2007). Studies have 
demonstrated that PLWH‘s stronger spiritual beliefs and practices have been positively 
associated with improved physical and mental health (Frame & Reid, 2005). Spiritual well-
being can predict lower depressive symptoms (Braxton, Lang, Sales, Wingood, & 
DiClemente, 2007; Dalmida, et al., 2009; Tarakeshwar, et al., 2005).  Spiritual practices can 
also positively influence social functioning (Frame, et al., 2005). For those who are able to 
attend church services, this improves their social interaction and fosters the sense of social 
acceptance and of belonging to a religious community (Siegel & Schrimshaw, 2002). 
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 There is evidence that spiritual beliefs and practices not only improve health but also assist 
PLWH to maintain their health by slowing the progression of HIV illness (Ironson, et al., 
2006; Siegel & Schrimshaw, 2002). A longitudinal study by Ironson et al. (2006) found  that 
PLWH who indicated increased spiritual beliefs and practices; maintained their CD4 cell 
counts and had good control of their viral load throughout the four-year period of 
observation. This was also demonstrated by Dalmida et al. (2009), who found a  positive 
relationship between higher scores in the spiritual well-being of PLWH and higher CD4 cell 
counts. 
PLWH and sleep disorders  
There is a large body of research indicating that PLWH often suffer from problems with sleep 
quality (Cruess et al., 2003; Hudson, et al., 2004; Lee, et al., 2009; Lee et al., 2012; Reid & 
Dwyer, 2005; Rubinstein & Selwyn, 1998; Taibi, 2013; Vosvick et al., 2004). Sleep 
disturbance has been reported in the early stages of HIV illness (White et al., 1995).  A 
review of the literature by Reid and Dwyer (2005) indicated that sleep disturbance continues 
to manifest and is often present across all stages of the disease, accompanied by changes in 
an individual patient‘s sleep profile.  Furthermore, there is evidence that sleep disturbance is 
associated with other HIV impairments (Robbins, Phillips, Dudgeon, & Hand, 2004). 
Rubinstein and Selwyn (1998) found that 73% of the PLWH  complained about sleep 
disturbance, and among them 41% experienced depression, whereas in the group of those 
without sleep disturbance only 10% were detected with depression ( P value < .005). A 
correlation between depression and sleep disturbance was also shown in studies conducted by 
Lee et al. (2012); Robbins et al. (2004), Rubinstein and Selwyn (1998) and also in a review of 
literature by Reid and Dwyer (2005).  
Other mental and psychological problems found to be associated with sleep disturbance 
among PLWH were psychological/emotional distress and anxiety, and cognitive impairment. 
Cruess et al. (2003) and Robbins et al. (2004) found a significant relationship between sleep 
disturbance and psychological distress. Sleep disturbance was also shown to be correlated 
with anxiety by Robbins et al. (2004), by Reid and Dwyer (2005) and by Newshan, Bennett 
and Holman (2002). A relationship between cognitive impairment and sleep disturbance was 
found by Rubinstein and Selwyn (1998).  
A relationship has been demonstrated between sleep disturbance and impairments such as 
fatigue and pain. Robbins et al. (2004) and Vosvick et al. (2004) found that increased levels 
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of sleep disturbance were significantly correlated with increased pain. Significant correlations 
were also demonstrated between sleep disturbance and fatigue by Salahuddin, Barroso, 
Leserman, Harmon, and Pence (2009), Robbins et al. (2004), and Lee et al. (2009).  
An environmental factor was also found to have an impact on quality sleep.  It was found that 
the greater the number of adults living in a house, the poorer the quality of sleep (Robbins, et 
al., 2004). One type of antiretroviral treatment in the group of NNRTIs; EFV, is related to 
poor quality of sleep (Raines, Radcliffe, & Treisman, 2005; Reid & Dwyer, 2005).  
2.4.1.2 PLWH and neurological disorders 
HIV can affect every part of the nervous system and it is possible that more than one 
pathology can simultaneously affect the same part (Verma, 2001). Neurological impairments 
that manifest in PLWH may be primary complications that are directly associated with HIV 
infection, but they can also be secondary complications (Clifford & Mitike, 2008; Koppel & 
Akfirat, 2003) . The primary complications result from infection in the nervous system. The 
HI virus could enter the brain and the cerebrospinal fluid immediately after exposure or early 
in the course of infection.   Primary complications include HIV-associated dementia, 
cognitive motor disorders, HIV-associated myelopathy and HIV-associated peripheral 
neuropathy (Clifford & Mitike, 2008). Secondary complications are consequences of the 
dysfunction or changes that occur to the immune status of the person who has been infected. 
These changes may be due to immunodeficiency and may include cryptococcal meningitis, 
toxoplasma encephalitis, cytomegalovirus encephalitis and radiculomyelitis, progressive 
multifocal leukoencephalopathy, and varicella zoster (Clifford & Mitike, 2008). These 
changes may also be due to dysregulation of the immune system. The most commonly 
affected site is the peripheral nervous system, leading to chronic inflammatory demyelinating 
polyneuropathy or Guillain-Barre syndrome, and mononeuritis multiplex (Koppel & Akfirat, 
2003). 
The use of antiretroviral treatment had decreased the incidence of primary and secondary 
neurological complications (Clifford & Mitike, 2008; Portegies et al., 2004).  Where drugs 
are available the majority of the neurological conditions may only manifest in advanced 
stages of the disease, especially when the immune system has been severely impaired and the 
CD4 count has gone below 200 cells/ul (Clifford & Mitike, 2008).The prevalence of HIV 
dementia with its marked neurocognitive and motor impairments, once a common   
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neurological complication (Nath & Berger, 2004), has dropped below 5% (Clifford & Mitike, 
2008; Heaton et al., 2010).  
Cognitive impairments 
However, despite the substantial benefits of antiretroviral treatment there are still mild to 
moderate neurocognitive impairments among PLWH who are on antiretroviral treatment 
(Clifford & Mitike, 2008; Heaton, et al., 2011; Robertson et al., 2007; Vance, Fazeli, 
Moneyham, Keltner, & Raper, 2013). Even among those with undetectable plasma viral 
loads, neurocognitive impairments are present (Cysique, Maruff, & Brew, 2004). Memory 
loss, slowing of mental functions (McArthur, Brew, & Nath, 2005; Simioni et al., 2010), and 
difficulty in performing tasks that require reasoning are common (McArthur, et al., 2005). 
  Ciccarelli et al. (2011) found a prevalence of 47%, particularly for minor cognitive 
disorders. Salawu et al. (2008) found a prevalence of 30% for attention impairment, 30% for 
calculation impairment, 27% for memory recall impairment, and 27% for orientation to place 
impairment. Similarly, in another group of PLWH from Switzerland, Simioni et al. (2010) 
found that PLWH with suppressed HIV viremia had no history of major  opportunistic 
infections of the central nervous system;  27%  complained of  cognitive impairments, the 
most frequent being memory loss (18%), slowing of mental functions (16), and attention  
deficit (9%).  
Heaton et al. (2011) listed factors  that could lead to persistent neurocognitive impairments; 
these could  include irreversible brain damage prior to the initiation of antiretroviral 
treatment, incomplete viral suppression in the CNS (this might be due to poor penetration of 
antiretroviral treatment into the CNS and/or medication-resistant viral strains or also  possibly 
the neurotoxicity of antiretroviral  treatment). Ciccarelli et al. (2011) found evidence that 
efavirenz is a risk factor for cognitive impairments.  
 Poor cognitive functions can have also an impact on adherence to antiretroviral treatment 
(Becker, Thames, Woo, Castellon, & Hinkin, 2011; Vance, et al., 2013). There is evidence 
that the presence of cognitive impairments in PLWH could lead to a decline in adherence to 
antiretroviral treatment (Becker, et al., 2011; Harzke et al., 2004). On the other hand studies 
have shown that an interruption to antiretroviral treatment can adversely affect cognitive 
impairments (Becker, et al., 2011; Parsons, Braaten, Hall, & Robertson, 2006).  
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Cognitive impairments can also have a negative influence on daily functioning, increase 
patient dependence and reduce the quality of life (Vance, et al., 2013). In addition, it has been 
observed also that PLWH who are affected by neurocognitive impairments might show 
behavioural abnormalities, such as apathy and emotional distress (Simioni, et al., 2010). 
 Corless et al. (2000) found that the general functional status of individual patients could 
influence cognitive functioning, and depression could predict impairment of the cognitive 
function. This was also described by  Vance, Larsen, Eagerton, and Wright  (2011), Thames 
et al. (2011),  Atkins et al. (2010), and  Fazeli, Marceaux, Vance, Slater, and Long (2011).  
PLWH who receive greater social support show higher levels of cognitive function (Atkins, 
et al., 2010).  
Peripheral neuropathy  
Peripheral neuropathy is a common neurological condition among PLWH (Clifford & Mitike, 
2008; Moylett & Shearer, 2002;  Nicholas et al., 2007a; Wulff, Wang, & Simpson, 2000), and 
can occur at every stage of HIV infection (Verma, 2001).  The most common types of 
peripheral neuropathy in HIV infection disease are the following: distal symmetrical 
polyneuropathy, inflammatory demyelinating polyneuropathy, mononeuritis multiplex, 
progressive polyradiculopathy and autonomic neuropathy (Wulff, et al., 2000). In the early 
stages of the infection, sometimes even when the patient is unaware that he or she has been 
infected, inflammatory demyelinating polyneuropathy may already be present (Koppel & 
Akfirat, 2003; Wulff, et al., 2000). However the manifestation of peripheral neuropathy is 
usually associated with the severe or advanced stage of the disease (Lopez, Becker, Dew, & 
Caldararo, 2004; McArthur, et al., 2005; Nicholas et al., 2007; Wulff, et al., 2000), along 
with a low CD4 count (Luma et al., 2012). 
The most common peripheral neuropathy is the distal symmetrical polyneuropathy (Koppel 
& Akfirat, 2003; Moylett & Shearer, 2002; Ownby & Dune, 2007; Wulff, et al., 2000), also 
known as distal sensory polyneuropathy (Clifford & Mitike, 2008; Mullin, Temu, Kalluvya, 
Grant, & Manji, 2011; Nicholas, et al., 2007b; Verma, 2001; Wiebe, Phillips, Li, Allen, & 
Shetty, 2011). This is usually chronic   (Moylett & Shearer, 2002; Ownby & Dune, 2007),  
very painful and may lead  to disability (Nicholas, et al., 2007a; Verma, 2001); and  it can  
have a negative impact on  quality of life  (Luma, et al., 2012).  Its symptoms are reported by 
almost 50% of PLWH (Moylett & Shearer, 2002), and usually involve numbness, burning 
sensations, tingling, intense pain, paraesthesias, dysesthesias and allodynia (Ownby & Dune, 
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2007).  Nicholas et al. (2002) suggest that pain is the most common descriptor of peripheral 
neuropathy, followed by numbness.  
Distal symmetrical polyneuropathy  can also occur as a  side effect of antiretroviral treatment 
(Anwikar et al., 2011; Kumarasamy, et al., 2008; Lopez, et al., 2004; Moylett & Shearer, 
2002; Nicholas, et al., 2007a; Nicholas et al., 2007b; Ownby & Dune, 2007; Peltier & 
Russell, 2006; Verma, Estanislao, & Simpson, 2005).  In particular  the group of NRTIs, such 
as Zalcitabine, Didanosine, Stavudine, and Lamivudine (Clifford & Mitike, 2008; Huang et 
al., 2013; Peltier & Russell, 2006), and occasionally  in the group of Protease Inhibitors (PIs)  
(Centner, Bateman, & Heckmann, 2013),  and it is branded; ―antiretroviral toxic neuropathy‖ 
(Clifford & Mitike, 2008; McArthur, et al., 2005; Wiebe, et al., 2011).  
There is accumulative evidence concerning the prevalence of peripheral neuropathy in 
PLWH, especially with regard to distal symmetrical polyneuropathy, which is the most 
common (as described above) and is frequently related to the side effects of antiretroviral 
treatment.  Kumarasamy et al. (2008) found a prevalence of 9% in PLWH on a combination 
of one or two drugs in the group of NRTI. Furthermore, there is evidence that peripheral 
neuropathy is frequently found in PLWH living in sub-Saharan Africa (Mullin, et al., 2011).  
Among a group of PLWH in Malawi, Van Oosterhout et al. (2005) found more than half 
(56%) complained of peripheral neuropathy, which they described as causing pain and 
numbness in the lower extremities. In Cameroun, Luma et al. (2012) found a prevalence of 
neuropathic symptoms of 28.5%, the most common of which was pins and needles in the legs 
or feet. The prevalence of symptomatic distal symmetrical polyneuropathy was 21%.  In 
Kenya, Cettomai et al. (2010) found that 20% of PLWH demonstrated moderate to severe 
peripheral neuropathy. In India, Lopez et al. (2004) found a percentage of 22% of PLWH 
with peripheral neuropathy.  
A comparative study in Tanzania by Mullin, Temu, Kalluvya, Grant, and Manji (2011) 
involving PLWH who were taking antiretroviral treatment and those who were not; found 
that the prevalence of distal symmetrical polyneuropathy was much higher (43.2%) in the 
group who were on antiretroviral treatment, particularly with a combination of one NRTI, 
mostly Stavudine; the prevalence for those who were not on antiretroviral treatment was 
22.1%.  The most common symptom was numbness.  
A large randomised controlled trial study which involved twelve selected sites from USA, 
Puerto Rico and Kenya and South Africa by Nicholas et al. (2010) found that 44% of the 
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overall study population reported neuropathy symptoms, and antiretroviral treatment was 
found to increase the frequency of neuropathy symptoms by 28%.  Their findings indicated 
that the intensity of neuropathy and its impact on the quality of life were higher in the African 
populations. In both South-Africa and Kenya it was reported that the antiretroviral treatment 
regimens included NRTIs with Didanosine and Stavudine, which could contribute to the 
peripheral neuropathy. In addition, this study also revealed that antiretroviral treatment 
regimens in the group of PIs could also contribute to an increased prevalence of peripheral 
neuropathy.   
2.4.1.3 PLWH and musculoskeletal disorders 
Musculoskeletal impairments are common in PLWH (Cuellar & Espinoza, 2000; Mody, 
Parke, & Reveille, 2003). Bony conditions associated with HIV infection include; 
osteomyelitis (Cuellar & Espinoza, 2000; Walker, Tyndall, & Daikeler, 2008), osteoporosis 
and bone necrosis (Walker, et al., 2008). However, bone necrosis has at times been reported 
to be linked to antiretroviral treatment and its metabolic complications, such as 
hyperlipidaemia (Mody, et al., 2003). 
Articular conditions associated with HIV include arthralgia, psoriatic arthritis, Reiter‘s 
syndrome, acute syndrome polyarthritis and undifferentiated spondyloarthropathy (Biviji, 
Paiement, & Steinbach, 2002; Cuellar & Espinoza, 2000). These conditions are more 
prevalent in PLWH than in those who are HIV-negative (Biviji, et al., 2002).  Articular 
conditions are usually caused by the HIV infection itself, triggered by changes in the immune 
system and also at times by microbial infections (Walker, et al., 2008). 
Articular pain is the most frequent impairment among the conditions affecting the joints in 
PLWH (Cuellar & Espinoza, 2000; Mody, et al., 2003); its prevalence can reach 40% to 45% 
(Buskila et al., 1990; Cuellar & Espinoza, 2000). Both small and large joints are involved 
(Cuellar & Espinoza, 2000). Arthralgia does not show signs of inflammation and the affected 
joint are not expected to become damaged (Reveille & Williams, 2006). 
Reiter‘s syndrome occasionally manifests in PLWH. It is in the arthritis family, and it is also 
termed ―reactive arthritis‖ (Cuellar & Espinoza, 2000; Moylett & Shearer, 2002).  It involves 
large joints of the lower extremities and sacroilitis (Moylett & Shearer, 2002). Articular 
manifestations are accompanied by other non-articular symptoms, for example, keratoderma, 
blenorrhagica, conjunctivitis and circinate balanitis (Cuellar & Espinoza, 2000; Moylett & 
Shearer, 2002). 
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Psoriatic arthritis, which is arthritis with epidermal disorders, is also sometimes present in 
PLWH, and at times it is noticeable in the early course of HIV infection. Generally, however, 
it occurs in late stages of the disease, and its prevalence among PLWH varies from 1 % to 
32%. Joint involvement pattern is frequently poly-articular and asymmetric; however in rare 
cases the mono-articular pattern may occur (Cuellar & Espinoza, 2000).  
Other articular conditions have been identified as associated with HIV infection. These 
include HIV-associated arthritis, septic arthritis, undifferentiated spondyloarthropathy, and 
infiltrative lymphocytosis syndrome (Mody, et al., 2003; Reveille & Williams, 2006). Gout 
can also occur, mostly due to the side effects of metabolic changes related to antiretroviral 
treatment (Walker, et al., 2008). In rare cases; rheumatoid arthritis, systemic lupus 
erythematosus, and sarcoidosis may be present (Reveille & Williams, 2006).  
Muscular impairment in PLWH can be manifested in both inflammatory and non-
inflammatory conditions (Cuellar & Espinoza, 2000). Myopathies such as pyomyositis and 
polymyositis are common (Biviji, et al., 2002; Buskila, et al., 1990; Owczarek, Jasinska, & 
Orszulak-Michalak, 2005; Scruggs & Naylor, 2008; Walker, et al., 2008).    
 Polymyositis is an autoimmune disease (Koppel & Akfirat, 2003); it is common among 
PLWH and is likely to occur at any stage during the course of the disease. It is usually sub-
acute, and presents the following symptoms: progressive proximal muscle weakness 
associated with elevated creatine phospho- kinase levels (Koppel & Akfirat, 2003; Moylett & 
Shearer, 2002; Sangle, Dasgupta, Ratnalikar, & Kulkarni, 2010). Weakness of proximal 
muscle could lead to limitations in the performance of certain daily activities, such as 
combing hair, climbing stairs, rising out of a chair etc. (Koppel & Akfirat, 2003; Sangle, et 
al., 2010).   Infectious pyomysitis is usually caused by staphylococcus aureus (Moylett & 
Shearer, 2002). 
Myopathy is also related to antiretroviral treatment, especially zidovudine in the group of 
NRTIs (Owczarek, et al., 2005; Sangle, et al., 2010; Scruggs & Naylor, 2008). There is 
evidence that Zidovudine, like other NRTIs, has an affinity for the mitochondrial gamme 
DNA polymerase,  and this results in mitochondrial DNA depletion and dysfunction and 
oxidative stress (Scruggs & Naylor, 2008).  Zidovudine myopathy   presents with the 
following clinical symptoms: myalgia, muscle tenderness, proximal muscle weakness 
(Cuellar & Espinoza, 2000; Moylett & Shearer, 2002; Sagar, Mohanty, & Bahal, 2010), 
muscle wasting, elevated serum concentrations of creatine phospho-kinase and intense 
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fatigue (Owczarek, et al., 2005; Sagar, et al., 2010).  Other HIV-associated myopathies 
include nemaline myopathy, diffuse infiltrative lymphocytosis syndrome, HIV wasting 
syndrome, myasthenia gravis and reversible mitochondrial myopathy (Authier, Chariot, & 
Gherardi, 2005; Gherardi, Chariot, & Authier, 1995). 
2.4.1.4 PLWH and skin disorders 
Skin and mucous membrane diseases are very often present in PLWH (Tschachler, 
Bergstresser, & Stingl, 1996). The skin has often been found to be the first organ affected and 
the complications can be seen in almost 90% of PLWH   (Osborne, Taylor, & Fuller, 2003; 
Tschachler, et al., 1996; Uthayakumar, Nandwani, Drinkwater, Nayagam, & Darley, 1997).  
Skin diseases associated with HIV include viral infectious diseases such as  Herpes simplex, 
characterised by chronic and painful ulcers frequently located at the junction between skin 
and mucous membranes   (Tschachler, et al., 1996)  Common clinical manifestations are 
orolabial, genital and anorectal mucocutaneous diseases (Osborne, et al., 2003). Varicella 
zoster is also in the family of herpes viruses and may be the first sign of HIV infection 
(Osborne, et al., 2003). Its clinical symptoms involve vesicular eruptions that occur in a 
dermatome pattern and sometimes progress to haemorrhagic and then necrotic lesions, and 
this can extend to several dermatomes (Osborne, et al., 2003; Tschachler, et al., 1996). It is 
accompanied by symptoms of localised itching, tenderness or burning pain. If it attacks the 
ophthalmic division of the trigeminal nerve, the eyeball may become infected, resulting in 
conjunctivitis, uveitis and even keratitis, and, if not well treated; this can lead to serious 
disabling complications (Osborne, et al., 2003).  Human papillomavirus is a very common 
condition (Osborne, et al., 2003; Tschachler, et al., 1996) and can most frequently affect the 
women‘s genital organ; the severity of the symptoms is associated with the progression of the 
disease (Tschachler, et al., 1996). 
Bacterial skin infections also exist in PLWH, such as a skin infection related to 
staphylococcus aureus, which is the most frequent bacterial skin infection (Osborne, et al., 
2003; Tschachler, et al., 1996). Mycobacteria, syphilis, and bacillary angiomatosis are also 
sometimes present. Bacillary angiomatosis is most common in patients with low CD4 counts 
and might also involve the internal organs (Osborne, et al., 2003; Tschachler, et al., 1996).  
 Fungal and dermatophytes infections may manifest in PLWH.  Common fungal infections 
involve mucous disorders, and the most common are oral and vulvo-vaginal candidosis. 
Dermatophyte infections affect the skin and the nails (Tschachler, et al., 1996). 
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Other common skin disorders include seborrhoeic dermatitis, which is the most common 
dermatosis associated with HIV infection. Psoriasis vulgaris is also present at times and 
pruritus is a common complaint among PLWH and correlates with some of the disorders 
mentioned above, such as staphylococcus aureus infection. Cases of adverse cutaneous drug 
reaction are also common, associated with the antiretroviral treatment Zidovudine 
(Tschachler, et al., 1996). Skin tumours have been seen also in PLWH, and the most 
frequently reported is Kaposi‘s sarcoma, especially in people with AIDS. It is strongly 
associated with immunosuppression (Ledergerber, Telenti, & Egger, 1999; Tschachler, et al., 
1996).   
2.4.1.5 PLWH and pain  
Pain has been recognised as an impairment among PLWH (Alexander, 2011; Koeppe, 
Armon, Lyda, Nielsen, & Johnson, 2010), and affects different parts of the body (Alexander, 
2011). The most frequent painful conditions include  headache,  peripheral neuropathy  (Nair, 
Mary, Prarthana, & Harrison, 2009) , oral cavity pain, throat and oesophagus pain 
(Alexander, 2011; Gray & Berger, 2007; Larue, Fontaine, & Colleau, 1997; Singer et al., 
1993), genital and rectal pain (Alexander, 2011), back pain  (Nair, et al., 2009; Newshan, et 
al., 2002), herpes zoster  (Singer, et al., 1993), arthralgia (Hewitt et al., 1997; Larue, et al., 
1997; Singer, et al., 1993), myalgia (Hewitt, et al., 1997; Larue, et al., 1997), chest and 
abdominal pain (Del Borgo et al., 2001; Gray & Berger, 2007) , and dermatological 
conditions and pain that are caused by extensive Kaposi‘s Sarcoma (Gray & Berger, 2007). 
However, according to Singer et al. (1993) headache, throat pain and arthralgia were 
identified as having been induced by Zidovudine.  
It is reported that painful conditions are present at all stages of HIV infection, but most 
predominantly in the later stages of the disease (Del Borgo, et al., 2001; Larue, et al., 1997; 
Singer, et al., 1993). There is evidence that pain is correlated with a low CD4 count and a 
higher viral load (Aouizerat et al., 2010; Richardson, et al., 2009; Tsao & Soto, 2009), and 
also with increased age (Tsao & Soto, 2009; Tsao, Dobalian, & Stein, 2005).  HIV-related 
pain is more frequent in women than in men (Breitbart et al., 1996; Dobalian, Tsao, & 
Duncan, 2004; Gray & Berger, 2007; Mathews et al., 2000; Miaskowski et al., 2011; Tsao, et 
al., 2005). Gray and Berger (2007) argue that this is  because of women‘s biological nature, 
and the psychological  factors and social factors that affect women.   
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The aetiology of pain in HIV could involve the HIV infection itself and its complications,   
antiretroviral treatment  and related side effects and pre-existing unrelated conditions, but 
sometimes the cause of the pain is unknown (Hewitt, et al., 1997; Larue, et al., 1997).  Many 
authors have reported the association between pain and depression (Richardson, et al., 2009; 
Rosenfeld et al., 1996; Singer, et al., 1993), and between pain and anxiety and mood 
disorders   (Tsao & Soto, 2009), and sleep disturbance  (Aouizerat, et al., 2010).  Richardson 
et al. (2009) commented that depression and pain influence one another in a such a way that  
those who are depressed could also experience pain; on the other  hand those who experience  
pain could become depressed. Both problems could affect a patient‘s functioning.  
 Like depression, pain has been also identified in many studies as a predictor of increased 
disability in PLWH (Singer, et al., 1993), and it affects their quality of life (Hughes, 2004; 
Larue, et al., 1997; McCormack, Li, Zarowny, & Singer, 1993; Nair, et al., 2009; Newshan, 
et al., 2002).  Pain affects both physical and psychological functions (Gray & Berger, 2007; 
Nair, et al., 2009). 
The prevalence of pain among PLWH is estimated at 25% to 80%, depending on the 
methodology used in the study and the characteristics of the sample (Dobalian, et al., 2004; 
Singer, et al., 1993).   Dobalian et al. (2004) found a prevalence of 67% among PLWH; Del 
Borgo et al. (2001) found 61% of the sample experienced pain: for the majority, the intensity 
of the pain was very high; ranging from moderate to unbearable.  Richardson (2009) found a 
prevalence  of 56% among PLWH.  The pain was persistent and its intensity was very high, 
with almost 50% of the sample reporting levels of grade four or five, where five indicates 
extreme pain.  Aouizerat (2010) found a prevalence of 55%. Of those who felt pain, 67% 
reported that it occurred frequently, while 82% indicated that it was severe or very severe 
(Aouizerat, et al., 2010).  
2.4.1.6 PLWH and pulmonary disorders 
The lungs are frequently involved throughout the course of HIV disease (Murray, 1996).  
Diaz et al. (2003) found respiratory symptoms occurred more often in PLWH; this included 
dyspnea or shortness of breath (41.6% vs 7.7% in those without HIV); a persistent cough 
(40% vs 25%) and mucus production (41.9% vs 23.1%). Cigarette smoking is an important 
predictor of respiratory symptoms among PLWH.  George, Kannass, Huang, Sciurba, and 
Morris (2009) found that the prevalence of all respiratory symptoms was 31.5% among 
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PLWH; a cough was the most often reported complaint (23%), followed by dyspnea (16%).  
Malignant respiratory pathologies are also often present in PLWH (Moylett & Shearer, 2002). 
Before the era of antiretroviral treatment, pneumocystis cariini pneumonia (PCP) was very 
common in PLWH; it was among the most prevalent opportunistic infections, and was found 
to correlate with the decline of the CD4 count (Murray, 1996; Wagner & Chaisson, 2003). 
However, with the introduction of antiretroviral treatment; the incidence of PCP has 
significantly decreased (Hull, Phillips, & Montaner, 2008; Wagner & Chaisson, 2003).  PCP, 
also named pneumocystis Jirovecii pneumonia, belongs to the family of fungal infections. 
The most commonly observed clinical manifestations involve fever, dyspnea, non - 
productive cough, night sweats, anorexia and weight loss, fatigue and chest tightness 
(Wagner & Chaisson, 2003).    
Aderaye et al. (2007) indicate there has been a rising prevalence of PCP in sub -Saharan 
Africa. In Ethiopia bacterial pneumonia was most commonly found (33.6%), and the 
prevalence of PCP was 29.8%, followed by pulmonary tuberculosis (23.7%). 
 Another study in Uganda found a prevalence of PCP of 38.6%, followed also by pulmonary 
tuberculosis (24%) and by a small prevalence of pulmonary Kaposi‘s sarcoma (11%) 
(Worodria, Okot-Nwang, Yoo, & Aisu, 2003). In Malawi, the prevalence of PCP was 9% 
(Hargreaves et al., 2001). Other fungal infections in PLWH that are associated with advanced 
immunodeficiency include pulmonary histoplasmosis, coccidioido mycosis and aspergillosis 
(Wagner & Chaisson, 2003).  
Bacterial pneumonia was very common in PLWH before the introduction of antiretroviral 
treatment (Hull, et al., 2008); it can occur with all CD4 cell count levels, but there is a higher 
incidence in people with very low CD4 levels (Wagner & Chaisson, 2003). Common signs 
and symptoms include fever, dyspnea, productive cough with purulent sputum, and pleuritic 
chest pain  (Wagner & Chaisson, 2003).  Another common bacterial infection in PLWH is 
tuberculosis. Evidence has shown that in sub-Saharan Africa, there is an increased incidence 
of tuberculosis associated with HIV, particularly in those countries where it is difficult to 
access antiretroviral treatment (Corbett, Marston, Churchyard, & De Cock, 2006; Murray, 
1996). This has caused rate of death among PLWH to increase (Corbett, et al., 2006).  The 
clinical symptoms  include fever, weight loss and cough  (Wagner & Chaisson, 2003). Extra-
pulmonary tuberculosis may also occur and the pathogen frequently attacks the lymphatic 
system. Other common bacterial infections in HIV patients include cryptococcosis 
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pneumonia, non-tuberculous mycobacteria, rhodococcus equi, and nocardiosis (Wagner & 
Chaisson, 2003). 
Influenza, which is a viral infection, is present in upper respiratory tract infections and 
bronchitis, often with the following clinical manifestations: fever, myalgia, and a non-
productive cough.  Another common viral infection that affects the lungs is cytomegalovirus 
pneumonitis, which has the following symptoms: shortness of breath, dyspnea, a non-
productive cough, and hypoxemia (Wagner & Chaisson, 2003). However, with the advent of 
antiretroviral treatment, there has been a change in the manifestation of HIV-related 
pulmonary complications, especially in settings where there is wide antiretroviral coverage, 
HIV-related infectious pulmonary complications have declined considerably, but there has 
been an increase in non -infectious pulmonary disorders, such as chronic obstructive 
pulmonary diseases, malignancies and immune reconstitution inflammatory syndrome (IRIS) 
(Hull, et al., 2008). 
Various studies have reported a significant prevalence of airway obstruction disorders or of 
varieties of obstructive pulmonary diseases in PLWH. George et al. (2009) found airway 
obstruction symptoms present in 6.8% of a sample of PLWH.  A study conducted by Hirani 
et al. (2011) found that the prevalence of obstructive pulmonary disease among a sample of 
PLWH was significantly higher (16.3%) than in the general population (6.8%). Obstructive 
pulmonary diseases, including asthma, bronchitis, and chronic obstructive pulmonary disease, 
are non-infectious respiratory diseases, and are characterised by airway obstruction (Hirani, 
et al., 2011).  
Crothers et al. (2006) found that 10% of the sample of PLWH suffered from chronic 
obstructive pulmonary disease, compared to 9% in the group of HIV-negative people (using 
the ICD 9 codes). When using a self-report method, the prevalence increased to 15% among 
PLWH and 12% among HIV-negative people. The risk of developing chronic obstructive 
pulmonary   disease increased with age, with smoking behaviour and with a medical history 
of bacterial pneumonia. The discrepancy in prevalence was more exaggerated in a study 
conducted by Diaz and King (2000); where the prevalence of emphysema was 15% in the 
group of PLWH, compared with 2% in the HIV-negative group.  Gingo et al. (2012) found 
asthma to be the most commonly diagnosed chronic pulmonary condition among PLWH, 
with a prevalence of 20.6% more than double the estimated prevalence in the general 
population (8.2%).  
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There is no clear evidence of the side effect of antiretroviral treatment on the respiratory 
system. However, there is a problem with drug interaction, particularly between inhaled 
corticosteroids (used in the management of certain obstructive lung diseases such as asthma 
and chronic obstructive pulmonary disease), and the antiretroviral treatment Ritonavir, a 
protease inhibitor (Foisy, Yakiwchuk, Chiu, & Singh, 2008; Gillett, Cameron, Nguyen, 
Hurley, & Mallal, 2005; Hirani, et al., 2011; Kedem, Shahar, Hassoun, & Pollack, 2010). 
This is also known as Cushing‘s syndrome (Gillett, et al., 2005; Kedem, et al., 2010).  The 
corticosteroids are metabolised by cytochrome P4503A4 (CYP3A4), while Ritonavir,  a 
potent CYP3A4 inhibitor, may inhibit the corticosteroid degradation and increase its 
accumulation (Kedem, et al., 2010). Fluticasone is the most affected inhaled corticosteroid 
(Foisy, et al., 2008; Gillett, et al., 2005; Kedem, et al., 2010). The most common symptoms 
include increased appetite with significant weight gain, abdominal striae, buffalo hump   
(Foisy, et al., 2008; Gillett, et al., 2005), facial acne, and (in rare cases) hypertension, 
osteoporosis, irritability and depression (Foisy, et al., 2008).  
IRIS is the development of an autoimmune response (Lipman & Breen, 2006; Twigg Iii & 
Knox, 2007). This usually manifests within six to eight weeks after starting antiretroviral 
treatment (Hull, et al., 2008). The PLWH who are more predisposed to IRIS  are those  with 
lower CD4 cell counts and higher levels of viral load at the initial stage of antiretroviral 
treatment (Grubb, Moorman, Baker, & Masur, 2006; Hull, et al., 2008).  IRIS is also found 
among those who start the antiretroviral treatment when they have already experienced 
opportunistic infections (Gilks & Vitoria, 2006; Grubb, et al., 2006); and it is found among 
those who have experienced a rapid decline in their HIV viral loads in response to 
antiretroviral treatment (Shelburne et al., 2005). 
 IRIS has been associated with HIV related infection and inflammatory pathologies, in 
particular tuberculosis or mycobacterium avium complex infection and cryptococcal disease 
(Gilks & Vitoria, 2006). In addition,  PLWH  who have been affected with mycobacterium 
tuberculosis but  who have had  only a short period  of tuberculosis therapy before starting 
antiretroviral treatment have been found to be more at risk of IRIS (Hull, et al., 2008). 
Common symptoms may involve fever and lymphadenopathy (Crothers & Huang, 2009; 
Grubb, et al., 2006). 
Kaposi‘s sarcoma and non-Hodgkin‘s lymphoma are the most common HIV-related 
malignancies and that may affect the lungs. Pulmonary involvement with Kaposi‘s sarcoma   
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follows the manifestation of mucocutaneous lesions (Murray, 1996; Wagner & Chaisson, 
2003), and occurs in almost 20 to 40% of patients with mucocutaneous Kaposi‘s sarcoma       
(Wagner & Chaisson, 2003). Pulmonary symptoms include shortness of breath or dyspnea, 
dry cough  (Grubb, et al., 2006; Wagner & Chaisson, 2003), and  chest pain (Grubb, et al., 
2006).  Other symptoms include night sweats, fevers and weight loss. Non-Hodgkin‘s 
lymphoma  usually  manifests  at an advanced stage of the disease  (Wagner & Chaisson, 
2003), and occurs primarily in a lymph node; it may  be disseminated to various extranodal 
sites involving the lungs (Wagner & Chaisson, 2003; Zar & Bye, 2009)  and can  also involve 
the gastrointestinal track, the bone marrow, the central nervous system and mucocutaneous 
sites  (Wagner & Chaisson, 2003). 
2.4.1.7 PLWH and cardio-vascular disorders 
Various studies have reported on cardiovascular diseases in PLWH.  The incidence and the 
prevalence may continue to increase with the improvement in life expectancy of PLWH 
(Monsuez et al., 2009). Conditions such as dilated cardiomyopathy, pulmonary hypertension 
and right ventricular dysfunction, endothelial dysfunction, coronary heart disease, 
hypertension and coagulative disorders, endocardial and pericardial dysfunction and cardiac 
HIV-related tumours may be  present (Barbaro, Fisher, & Lipshultz, 2001).   
The risk of cardiovascular diseases in PLWH occurs with advanced HIV infection. Possible 
causes include  myocardial infection, opportunistic infections, viral infections, autoimmune 
response to viral infection, toxicity of antiretroviral treatment or other drugs with regard to 
opportunistic infections, neoplasms management   (Barbaro, Fisher, Giancaspro, & Lipshultz, 
2001; Lewis, 2000), and prolonged immunosuppression (Lewis, 2000). There are also factors 
that are unrelated to HIV infection or to its treatment, which might be intrinsic or extrinsic. 
PLWH might have a family history of cardiovascular diseases or a higher prevalence of 
smoking behaviour, and this could contribute to higher risk of cardiovascular disease (Currier 
et al., 2008). Nutritional deficiencies have been reported to be among the risk factors (Lewis, 
2000). 
Evidence suggests that PLWH are at a higher risk of cardiovascular events (Currier, et al., 
2008; McDonald & Kaltman, 2009). In a longitudinal study by Triant, Lee, Hadigan, and 
Grinspoon (2007) increased incidence of myocardial infarction and cardiovascular risk 
factors were found in PLWH, particularly women (11.13/1000 persons/year) compared to the 
HIV-negative group (6.98/1000 persons/year). Moreover, PLWH had significantly higher 
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proportions of hypertension (21.2%), compared to non- infected people (12.9%). The same 
was found for diabetes (11.5%), in comparison to non-infected people (6.6%).    
There is a substantial relationship between risk of cardiovascular disorders and antiretroviral 
treatment among adults, especially when using a combination of drugs (Friis-Møller et al., 
2003; McDonald & Kaltman, 2009; Worm et al., 2010).  Friis-Møller et al. (2003) found that 
among PLWH starting antiretroviral treatment the most important risk factor for cardio 
vascular disease was a high prevalence of dyslipidaemia.  
 Friis-Møller et al. (2007) found that increased exposure to a combination of antiretroviral 
treatments was associated with an increased risk of myocardial infarction. The incidence 
increased significantly when PLWH were exposed to protease inhibitors (6.01 vs 1.53 per 
1000 persons per year). In this study 60.8% of the sample were smokers or had smoked 
before. Crane, Van Rompaey, & Kitahate (2006) found that patients on Ritonavir or 
Lopinavir demonstrated a significant risk of developing hypertension.  
2.4.1.8 PLWH and metabolic disorders 
Metabolic disorders, such as dyslipidaemia, body fat redistribution or lipodystrophy 
syndrome , insulin resistance   (Calza, Manfredi, & Chiodo, 2003; Grinspoon & Carr, 2005; 
Moylett & Shearer, 2002), hyperglycaemia and  lactic acidosis (Gilks & Vitoria, 2006; 
Moylett & Shearer, 2002)  and reduced  bone mineral density (Gilks & Vitoria, 2006) are 
common among PLWH; and may be caused  by HIV infection   (Sellmeyer & Grunfeld, 
1996) or  they may be  a  side effect of the  antiretroviral treatment (Calza, et al., 2003; 
Grinspoon & Carr, 2005; Tsiodras, Mantzoros, Hammer, & Samore, 2000),  particularly  
where a combination of antiretroviral treatment is used (Calza, et al., 2003). Tsiodras et al. 
(2000) found that PIs was the most effective antiretroviral treatment for metabolic disorders. 
In a five-year study after the initiation of PI treatment, the prevalence of hyperglycaemia 
increased by 5%, of hypercholesterolemia  by 24%, of hypertriglyceridemia  by 19%, and of 
lipodystrophy by 13% 
Dyslipidaemia or disorders in lipid metabolism manifest frequently among PLWH and may 
 be secondary to the HIV infection itself. The reduction in higher density lipoprotein (HDL) 
and lower density lipoprotein (LDL) cholesterol may occur at any stage of HIV infection; this 
may manifest in early stage asymptomatic patients, and could contribute to elevated 
triglycerides levels (Grinspoon & Carr, 2005; Penzak & Chuck, 2000; Sellmeyer & Grunfeld, 
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1996). However, there is accumulative evidence about the influence of  antiretroviral 
treatment on disorders in lipid metabolism among PLWH; particularly  those receiving a 
combination regimen that contains PIs  (Calza, et al., 2003; Gilks & Vitoria, 2006), with 
Ritonavir having  the most significant influence on hyperlipidaemia (Calza, et al., 2003; 
Penzak & Chuck, 2000; Tsiodras, et al., 2000), or Ritonavir in combination with Saquinavir 
(Calza, et al., 2003; Penzak & Chuck, 2000) or  Ritonavir with Lopinavir (Calza, et al., 
2003). Disturbance in lipid metabolism predisposes people to cardiovascular complications 
(Grinspoon & Carr, 2005). Dyslipidaemia may mediate the effect of antiretroviral treatment 
on the risk of developing cardiovascular complications, particularly for the therapy regimen 
with PIs combination.  
Disorders in insulin metabolism that might lead to hyperglycaemia and cause diabetes are 
also not uncommon among PLWH, and may be related to the HIV infection itself (Florescu 
& Kotler, 2007). The incidence  can increase as a result of the use of combination  
antiretroviral treatment  (Brown et al., 2005; Florescu & Kotler, 2007; Ledergerber et al., 
2007) , particularly those in the group of PIs  (Brown, et al., 2005; Justman et al., 2003). 
Evidence from a study conducted by Brown et al. (2005) showed that the prevalence of 
diabetes among PLWH who were on antiretroviral treatment (especially with PIs 
combination) was almost triple (14%) that of non-infected people (5%), and was positively 
associated with a low CD4 count. 
Deficiencies in bone density and bone disease have been reported to occur in PLWH due to  a 
disturbance in bone metabolism which can be caused by antiretroviral medication (Gilks & 
Vitoria, 2006; Valencia et al., 2003). Tebas et al. (2000) found that PLWH receiving 
antiretroviral treatment with PIs combination were more likely to lose bone minerals. They 
highlighted a significant association between antiretroviral treatment and the increased 
prevalence of osteopenia and osteoporosis among PLWH; this might lead to more frequent 
pathological fractures. 
Lipodystrophy syndrome which consists of lipoatrophy or peripheral fat loss and central fat 
accumulation is common in PLWH and it is characterised by morphological changes in the 
body(Carr, 2003; Jacobson et al., 2005). Peripheral fat loss includes the loss of subcutaneous 
fat in the face, arms, legs and buttocks (Gilks & Vitoria, 2006; Grinspoon & Carr, 2005), and 
can also manifest in the trunk (Grinspoon & Carr, 2005). Central or localized fat 
accumulation involves the abdomen and visceral fat accumulation, the neck (buffalo hump), 
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and the breasts (Gilks & Vitoria, 2006; Grinspoon & Carr, 2005). These morphological 
changes can affect the psychosocial well-being of the patient and lead to low self- esteem, 
poor body image, anxiety and/or depression; they can also have an effect on intimate 
relationships. There may be problems with low libido, and these might result in poor social 
functioning, in social isolation (Power, Tate, McGill, & Taylor, 2003) and in stigmatisation 
(Gilks & Vitoria, 2006). 
In addition, the lipodystrophy syndrome often manifests in association with metabolic 
changes, including hyperlipidaemia, fat redistribution, and insulin resistance (Caron-Debarle, 
Lagathu, Boccara, Vigouroux, & Capeau, 2010; Gilks & Vitoria, 2006; Hadigan et al., 2001; 
Norris & Dreher, 2004), and hypercholesterolemia   (Hadigan, et al., 2001; Mutimura, 
Stewart, Rheeder, & Crowther, 2007).  Mutimura et al. (2007) found that in Rwanda, 34% of 
the participants showed a combination of lipodystrophy and peripheral lipoatrophy; 
abdominal lipohypertrophy was observed in about 72% of lypodystrophic patients.  The total 
cholesterol concentrations were significantly higher in PLWH with lipodystrophy than in 
those who were found to be non-lipodystrophic and who were in the control group.  There is 
evidence that the metabolic disorders that occur in PLWH with lipodystrophy  could 
predispose them  to cardiovascular diseases such as hypertension, coronary artery disease, 
myocardial infarction  and diabetes  (Caron-Debarle, et al., 2010) and sometimes also hepatic 
complications; which may even be fatal (Caron-Debarle, et al., 2010). 
Studies have reported also that lipodystrophy is caused by antiretroviral treatment and mainly 
manifests after the initiation of antiretroviral treatment (Gilks & Vitoria, 2006; Haubrich et 
al., 2009).  Carr and Cooper (2000) found that the prevalence of lipodystrophy among PLWH 
ranged from 18% to 83% and seemed to occur after 12 to 18 months of therapy. This was 
also confirmed by Miller et al. (2003) who found the prevalence of lipodystrophy was 53%; 
the presence of lipodystrophy correlated significantly with prolonged exposure to both NRTIs 
and PIs. Lipodystrophy was associated also with increased age, the presence of HIV-
infection-related impairments and HIV viral suppression. 
 Duran et al. (2001) found that four months after initiating antiretroviral treatment with PIs  in 
its combination drugs; 76.4% of the sample reported at least one symptom of lipodystrophy. 
Consequently 30% had discontinued the treatment due to the appearance of these symptoms. 
However Mutimura et al. (2007) found that majority of participants with lipodystrophy 
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(81.6%) were receiving a combination of antiretroviral treatment including Stavudine, 
Lamivudine, and Nevirapine, but none were receiving PIs  
2.4.1.9 PLWH and digestive disorders 
Problems related to the digestive system are common among PLWH, and the gastrointestinal 
tract is among the major target organ for HIV infection and related conditions (Lew, Poles, & 
Dieterich, 1997). Several studies have identified numerous digestive impairments. In a 
multisite comparative  study in South Africa and  Brazil, digestive problems, such as nausea, 
difficulty with  weight maintenance, and problems with  defecation, were reported by 57% to 
75% of PLWH (Myezwa, Buchalla, Jelsma, & Stewart, 2011). Similarly Alexander‘s (2011) 
review found that PLWH and who were on antiretroviral treatment experienced nausea, 
diarrhoea, anorexia and weight loss. Mathews et al. (2000) found that diarrhoea, nausea, 
anorexia and weight loss were present;  Lee et al. (2009) reported  nausea, diarrhoea, weight 
loss, constipation as well as lack of appetite, vomiting and difficulty swallowing.   
2.4.1.10 PLWH and reproductive disorders 
 The most significant reported reproductive impairment among PLWH is sexual dysfunction 
(Bell, Richardson, Wall, & Goldmeier, 2006; Rusch, et al., 2004a; Scanavino & Abdo, 2010). 
Bell et al. (2006) found that women experienced significant sexual problems, including lack 
of desire (33%) and lack of orgasm (7%). In Scanavino and Abdo (2010) 36% of the females 
reported sexual inactivity; they found sex unsatisfactory and were not able to maintain sexual 
arousal until the end of the sex intercourse. As much as 50% of males reported problems with 
ejaculation and 33% experienced erectile dysfunction. Van As et al. (2009) and Rusch et al. 
(2004a) found that reduced libido was major problem. 
 A qualitative study in Tanzania found that the majority of the participants revealed that they 
had ―forgotten‖ about sexual intercourse and viewed it as a leading cause of transmittable 
diseases and the cause of many deaths.  Schrooten et al. (2001) found that a decrease in  
sexual interest was more frequently reported by those who were receiving antiretroviral 
treatment that contained  PIs  (40%) than by those on  non-PIs in their antiretroviral treatment 
(16%). In addition, 34% of the males on PIs complained about decreased sexual potency, 
compared to 12% in the non-PIs group.  
2.4.1.11 PLWH and haematological disorders 
Haematological disorders are very common among PLWH.  Van As et al. (2009) found that 
almost 96% of their sample demonstrated haematological deficiencies. Anaemia is frequently 
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reported (Barroso, 1999; Sullivan, Hanson, Chu, Jones, & Ward, 1998; Volberding, 2000), 
and its prevalence seems to be higher in African countries than in industrialized countries 
(Ssali et al., 2006). Its diagnosis is confirmed when haemoglobin falls below 14g/dl in men 
and below 12g/dl in women (Adinolfi, 2001). Fatigue is one of the most important symptoms 
of anaemia in PLWH (Barroso, 1999; Breitbart, McDonald, Rosenfeld, Monkman, & Passik, 
1998). 
 Risk factors for anaemia include the HIV infection itself and its associated conditions, 
including opportunistic infections, particularly those which attack the bone marrow. Other 
risk factors are HIV infection treatment, anti-neoplastic and anti-microbial drugs (Adinolfi, 
2001; Volberding, 2000; Volberding et al., 2004), nutritional problems/deficiencies; (such as 
malnutrition, malabsorption and or difficulty with the digestion of certain important nutrients) 
(Adinolfi, 2001; Volberding, 2000). 
 The antiretroviral treatment zidovudine has been found to cause anaemia. Anwikar et al. 
(2011) found that anaemia occurred in patients receiving antiretroviral treatment in 
combination with zidovudine, within the first month after the initiation of therapy. Similarly 
Kumarasamy et al. (2008) found more than half of those who developed anaemia within one 
year of initiation of antiretroviral treatment were receiving a combination therapy containing 
zidovudine. Anaemia can increase the progression of the disease and can have a negative 
impact on patient survival; it can also affect a patient‘s physical functioning and quality of 
life  (Volberding, 2000; Volberding, et al., 2004). 
2.4.1.12 PLWH and fatigue  
Fatigue has been identified  as a very common symptom among  PLWH (Aouizerat, Gay, 
Lerdal, Portillo, & Lee, 2012; Jong et al., 2010; Newshan, et al., 2002; Rusch, et al., 2004a; 
Sullivan & Dworkin, 2003). Its prevalence ranges from 50% and up (Alexander, 2011; 
Anandan, Braveman, Kielhofner, & Forsyth, 2006; Aouizerat, et al., 2012; Breitbart, et al., 
1998; Henderson, Safa, Easterbrook, & Hotopf, 2005). In some studies, fatigue is described 
as a lack of energy or tiredness (Aouizerat, et al., 2012; Corless et al., 2002; Rose, Pugh, 
Lears, & Gordon, 1998; Siegel, Bradley, & Lekas, 2004), or weakness or sometimes even as 
malaise (Sullivan & Dworkin, 2003).  Aouizerat (2012) states that although the term ―lack of 
energy‖ has been used interchangeably with fatigue, many studies emphasise measuring 
fatigue in an attempt to determine a measure of energy. 
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Siegel et al. (2004) found that fatigue was the most difficult symptom for PLWH to live with, 
and 88% of participants thought that it was caused by the HI virus.  However, according to 
some researchers their findings have demonstrated a lack of association between the presence 
of fatigue and decreased CD4 cell counts and increased HIV viral loads (Breitbart, et al., 
1998; Henderson, et al., 2005; Sullivan & Dworkin, 2003). Few participants recognised the 
influence of antiretroviral treatment as a contributing factor to fatigue (Adinolfi, 2001; Siegel, 
et al., 2004). Surprisingly Pence et al. (2009) in a longitudinal study found that patients who 
had diagnosed with HIV for long time and who used antiretroviral treatment, demonstrated 
low fatigue scores.  
Factors contributing to fatigue have been reported in various studies. These include 
pathologies and physiological abnormalities associated with HIV infection, such as anaemia, 
diabetes (Adinolfi, 2001; Barroso, 1999; Breitbart, et al., 1998; Siegel, et al., 2004; Sullivan 
& Dworkin, 2003), and abnormality of thyroid gland (Adinolfi, 2001; Barroso, 1999). 
Medicines used for HIV-infection-associated conditions, such as chemotherapy for cancer, or 
interferon for hepatitis (Adinolfi, 2001; Breitbart, et al., 1998; Siegel, et al., 2004) also 
contributed to fatigue. Many studies report and emphasise the contribution of psychological 
factors, including stress, depression, anxiety and sleep problems, as significant causal factors 
of fatigue (Adinolfi, 2001; Barroso, 1999; Henderson, et al., 2005; Jong, et al., 2010; Pence, 
et al., 2009; Siegel, et al., 2004; Sullivan & Dworkin, 2003). Others highlight the influence of  
socio-economic and demographic factors such as  age (Siegel, et al., 2004), income and 
employment status (Jong, et al., 2010; Pence, et al., 2009) and lifestyle  habits, such as poor 
diet, lack of exercise and lack of  rest  (Adinolfi, 2001; Siegel, et al., 2004). There is evidence 
that fatigue can lead to a  limitation in physical functioning (Ferrando et al., 1998), and this 
can interfere with activities that are part of daily functioning  (Aouizerat, et al., 2012) and  
contribute to a poor quality of life (Breitbart, et al., 1998). 
2.4.2 PLWH and activity limitations and participation restrictions 
Various studies have found the presence of impairments in PLWH, whether due to the HI 
virus itself or to the antiretroviral treatment. These can affect their activity performance levels 
and their participation in society (Crystal, et al., 2000; Ferrando, et al., 1998; Gaidhane et al., 
2008; Myezwa, et al., 2009; Rusch, et al., 2004a; Van As, et al., 2009).  
 Rusch et al. (2004b) indicated that even those with CD4 counts higher than 500 cells/mm3, 
still experience significant limitations in activity, compared to the general population, and to 
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people who experience other chronic diseases, such as arthritis and cancer. HIV infection and 
related physical and psycho-social complications as well as the side effects of the 
antiretroviral treatment might be contributing factors to the activity limitations among 
PLWH. Socio-economic factors could also influence the situation (Rusch, et al., 2004b). 
The key findings of the studies reviewed are summarised in Table 3  
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Table 3: PLWH, activity limitations and participation restrictions   
Author and 
date of 
publication 
Methods Major findings 
Myezwa et 
al., 2009 
Study design: cross-
sectional descriptive 
study conducted at the 
hospital  
Tool used: ICF checklist 
Sample size: 80 PLWH ; 
23 males and 57 females 
 
Higher rate of activity limitations in mobility function (56.4%), in major life areas (55.1%) and in 
community, social and civic life (50%). 
Patients with sensory impairments were four times more likely to experience self-care problems, 
and five times more likely to experience problems with domestic life activities compared to people 
without sensory problems. 
Patients with digestive impairments were 20 times more likely to have problems with general 
tasks, compared to those without digestive problems. 
Patients with cardiovascular, haematological, immunological and respiratory impairments were 14 
times more likely to experience problems with the execution of general tasks than those without 
these impairments. 
Patients with voice and speech function limitations were six times more likely to experience 
problems with communication than those without this problem. 
Participants reported that they had limited access to the community because of stigma and 
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sometimes the inability to find a toilet quickly. 
Van As et 
al.,  
2009 
Study design: cross-
sectional descriptive 
study conducted at an 
HIV clinic in a hospital.  
Tool used: ICF checklist. 
Sample; 45 PLWH; 29 
females and 16 males. 
The functions most affected involved major life areas (58%), interpersonal interactions and 
relationships (56%), and mobility functions (40%). 
Participants reported having problems with participation in society. The domains of learning and 
applying knowledge and that of major life areas, such as participation in paid employment were 
problematic. 
Various impairments predicted activity limitations and participation restrictions. Sensory and pain 
impairments predicted problems with the mobility function (p=0.04), as well as difficulties with 
interpersonal interactions and with relationships (p=0.002). 
Digestive, metabolic, and endocrine system impairments predicted limitations in mobility function 
(p=0.02). 
Impairments in neuro-musculoskeletal and movement-related functions predicted problems in 
learning and applying knowledge (p=0.04), mobility (p=0.007), interpersonal interactions and 
relationships (p=0.04). 
Gaidhane et 
al., 2008 
 
Study design: cross-
sectional descriptive 
study conducted at the 
hospital.  
64% of the participants had problems with self-care activities, as measured by performance 
qualifier (patient current environment). 
Around 30% of the participants had problems with bathing a body part or bathing the whole body 
or with drying themselves, measured by capacity qualifier (in a standard environment), and 15% 
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Tool used: ICF checklist 
(only the self-care (d5) 
component of activities 
and participation domain 
(d) of the ICF was used). 
Sample; 194 PLWH; 82% 
male. 
 
by performance qualifier. 
28% of the participants had problems with eating, measured by capacity qualifier and by 
performance qualifier; it was 16%. 
45% of the participants had problems with urinating, measured by capacity qualifier and 25% by 
performance qualifier.  
64% of the participants had problems with defecating measured by capacity qualifier, but 45% by 
performance qualifier. 
57% of the participants had problems with dressing.  
  
 
 
 
 
65 
 
Rusch et 
al., 2004a 
Study design: cross-
sectional descriptive 
population-based survey. 
Tool used: developed a 
self-administered 
questionnaire based on ICF 
checklist  
Sample; 762 PLWH 
completed and returned the 
questionnaires; however 
only 614 were considered 
for analysis as the rest did 
not provide information 
about their CD4 counts.  
Activity limitations were reported by 80.6% of the participants, and participation restrictions 
were reported by 93.2%.  
Logistic regression models were used to test for associations between impairments, activity 
limitations and participation restrictions. All impairments and activity limitations were 
significantly associated with social role restriction.  
It was demonstrated that social role restrictions were more often associated with mental function 
impairments than with other impairments. 
Crystal et 
al., 2000 
Study design: cross- 
sectional population-based 
survey using questionnaire. 
Tool used: Designed 9-
item physical limitation 
 51% of the participants experienced functional limitations in performing   role functioning 
activities such as work, school and household activities. 
64% of the participants experienced functional limitations in energy-demanding or vigorous 
activities, such as climbing stairs, walking long distances. 
Significant associations were found between physical and role functioning limitations and 
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scale  and  2-item ACTG 
SF21 role functioning scale 
 Sample; 2836: 77.5% 
males and 22.5% females 
increasing age, lower education, low CD4 cell counts, advanced disease and higher levels of pain 
and fatigue impairments. 
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Ferrando et 
al.,1998 
Study design: Longitudinal 
comparative study 
Tool used: Designed self- 
reported questionnaires 
(for fatigue, physical 
limitations and depression)  
 Sample: 187 PLWH 
(Men) 
46 HIV negative  (Men) 
Fatigue and physical functional limitations were very common; both were significantly associated 
with advanced disease progression.  
The prevalence of fatigue in PLWH with CD4 counts <500 was 14%, and it was significantly 
higher than in the HIV-negative group, and in the group of PLWH with CD4 counts>500. 
Fatigue appeared to be a chronic symptom over a one-year period of follow up, and it contributed 
independently to physical functional limitations and disability. It was found to be a strong 
predictor for physical activity limitations at both the baseline and after one year. In the linear 
regression, fatigue accounted for 12% of the variance in physical limitations. 
The presence of physical functional limitations in PLWH after one year was highly predicted by 
physical functional limitations at intake, and which accounted for one third of the variance. This 
proves that, like fatigue, physical functional limitations tended to be chronic.  
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2.4.3 PLWH and contextual factors 
There is a dearth of information in the literature regarding contextual factors that influence 
functioning among PLWH, and that could be categorised as either personal or environmental 
contextual factors. O‘Brien et al. (2009) highlighted four contextual factors that can influence 
functioning among PLWH. These were social support, stigma, living strategies and personal 
attributes. They considered two categories, intrinsic and extrinsic factors, and further 
described extrinsic factors as factors that come from the external environment to the person, 
while intrinsic factors are the personal attributes of the individual. 
According to O‘Brien et al. (2009), intrinsic factors that influenced functioning involved 
living strategies and personal attributes.  Living strategies were considered to be behaviours, 
attitudes and beliefs PLWH could adopt to help them face the challenges of living with HIV, 
and its consequences for their daily functioning.  An example of a living strategy was being 
able to create and seek social relationships or interaction with others; self-acceptance could 
be expressed through the ability to remove HIV from the mind and fight internalised stigma. 
Another reported strategy was the person‘s ability to maintain a sense of control over his or 
her own life and over the HIV infection. This included being  able to rebuild oneself and re-
establish a sense of purpose in life, being  able to control one‘s own nutrition, avoiding  stress 
and improving adherence to antiretroviral treatment. Personal attributes were regarded as an 
individual‘s particular characteristics, such as age and inherent or genetic diseases. Increasing 
age was reported by the participants in Crystal et al. (2000) to be a strong barrier to effective 
functioning. 
According to O‘Brien et al. (2009) extrinsic factors that influenced function included social 
support and stigma. Social support was found to be a facilitator for functioning, whereas lack 
of support was considered to be a barrier. Possible sources for social support were identified. 
These included support from friends and family, support from the health care services and 
personnel, and programme and policy support, including the medical insurance cover. Stigma 
was experienced from family members, from the workplace (employers and colleagues) and 
from health care providers. Similarly, Myezwa et al. (2009) reported that most participants 
experienced barriers to functioning from community services, from systems and policies and 
also from relationships and interactions with friends and other people in their community. 
Van As et al. (2009) also found that a lack of support from services, systems and policies and 
other people‘s negative attitudes constituted barriers to effective functioning. Health care 
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providers‘ positive attitudes and support and good relationships with other people were found 
to be strong facilitators of effective functioning. Myezwa et al. (2009) found PLWH were 
satisfied with the attitude and support provided by health care providers.  
 
Figure 4 Contextual factors of disability in PLWH 
(O'Brien, et al., 2009) Permission granted for reproduction 11
th
 November 2013. 
2.5 PLWH and the Hospital environment 
2.5.1 Health for all and the primary health care approach 
In the WHO constitution, health is defined as a state of complete physical, mental and social 
well-being, and not merely as the absence of disease or infirmity (World Health Organisation 
(WHO), 2006a).  It should be noted that the WHO international primary health care 
conference at Alma Ata in 1978 reinforced the consideration of health as a holistic 
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conception and declared that health was for all people: the whole of humanity without 
distinction of race, religion, economic or social status needs to enjoy health of a satisfactory 
standard (Cueto, 2004; Lawn et al., 2008; Magnussen, Ehiri, & Jolly, 2004; World Health 
Organisation (WHO), 2006a). 
To achieve the goal of health for all people, the Alma Ata conference launched and decided 
on a philosophy of comprehensive primary health care that consists of strategies which  
promote health and assist people to respond more equitably, appropriately and effectively to 
their health needs (Magnussen, et al., 2004); this requires health systems which empower 
people and which base health interventions on what people value as relevant for their own 
health needs (World Health Organisation (WHO), 2008).  
There is evidence that health systems that adopt the approach of providing comprehensive 
primary health care deliver better health outcomes (Gillam, 2008). Comprehensive primary 
health care provides prevention services, such as immunisation against some infectious 
diseases; it also promotes health, for example by the promotion of the food supply and by 
providing proper nutrition, curative  services (such as treatment of common diseases and 
provision of essential medications), and rehabilitative services (De Sa, 1993; Lawn, et al., 
2008; World Health Organisation ( WHO), 1979). Primary health care interventions 
recognise and consider the impact of environmental, social and economic and political factors 
such as education, a lack of resources on health management and improvement (Lawn, et al., 
2008; Magnussen, et al., 2004). This means that, in order to  successfully and holistically 
respond to the health needs of people, health systems based on the primary health care 
approach, look beyond the health sector, and adopt multisectoral and intersectoral 
approaches: this involves other sectors such as education, social welfare, agriculture, public 
labour, etc (Lawn, et al., 2008).  
However, it should be noted that, most countries; both developed and under-developed, face 
the challenge of an increased prevalence of non-communicable diseases, such as 
cardiovascular diseases, and the presence of persistent infectious diseases, such as HIV 
infection; these challenges lead to increased health demands and might require policy makers 
to revisit and if necessary  rethink  strategies and priorities with regard to primary health care 
in order to achieve the ultimate goal of health for all (Gillam, 2008; Lawn, et al., 2008). 
Noticeably, for the middle- and low-income countries, in addition to the increased prevalence 
of the above-mentioned diseases, persistent infectious disease such as HIV and its associated 
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pathologies such as tuberculosis place a strain on limited resources and weak health care. 
This means that access to health services is sometimes limited (Goudge, et al., 2009).  
2.5.2 Barriers and facilitators to hospital care  
A study conducted in a  selected rural area with poor resources in South Africa by Goudge et 
al. (2009) found the following barriers to accessing chronic care, including care related to 
complications arising from  HIV infection: the inability to pay for the treatment cost because 
of low income; an inadequate availability of the inputs and services required for chronic care. 
The following problems were identified: clinical weaknesses in management, diagnosis and 
prescribing medication at clinics; a shortage of drugs leading to interrupted drug supplies; 
weaknesses in the referral system; and poor transport facilities. Another important barrier was 
poor communication between patients and health care providers, which could lead to poor 
treatment. The health care providers were unable to engage effectively with the patients, and 
were unable to give patients adequate explanation regarding their illnesses.  
Gilson, Palmer, and Schneider (2005) reported similarly that, in another sector of the South 
African population, respectful treatment was identified as a very important factor influencing 
patients‘ levels of satisfaction and demand for care. Respectful treatment was defined as 
respectful attitudes and behaviour on the part of health care providers; this included good 
communication with patients; health care providers should possess the necessary technical 
competence, and should give due consideration and attention to patients.    
2.5.3 Comprehensive care and collaboration 
One of the key strategies of primary health care is quality training of competent and 
comprehensive health care providers able to deliver preventive, promotive, curative and 
rehabilitative health care at all levels, that is, at community, district, regional and national 
levels (Lawn, et al., 2008; Magnussen, et al., 2004). It has been demonstrated that appropriate 
training for a comprehensive health care provision should also emphasise interdisciplinary 
collaboration and team spirit among health care providers at all levels (Gillam, 2008; Lawn, 
et al., 2008). Interdisciplinary collaboration is regarded as one of the characteristics of the 
primary health care approach. It is a process by which individuals from different professions 
structure a collective action in order to coordinate the services they render to individual 
clients or groups (Sicotte, et al., 2002). 
Sicotte et al. (2002) describe interdisciplinary collaboration in clinical practice as requiring 
health care providers from different professional backgrounds to share their expertise, for 
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example, in assessment-diagnostic activities, and in planning treatment, reassessment and 
intervention adjustment. Interdisciplinary collaboration requires sharing information and joint 
decision-making. This process of collaboration is found to strengthen inter-professional 
relationships, for example with respect to the mode and frequency of communication; it also 
assists with patient referrals. A two-way referral system has been identified as an outcome 
and benefit of using a collaborative approach, with the patients being the beneficiaries 
(Gaboury, Bujold, Boon, & Moher, 2009). A systematic review by Van Manen et al. (2005) 
found that due to the multiple problems caused by HIV infection, an  interdisciplinary 
approach involving collaboration  between  and within health care disciplines is  essential  in 
the provision of care for PLWH. 
 There is evidence that low-income countries, particularly African countries, experience a 
shortage of health care providers, particularly in public (government) institutions. There are a 
number of factors that could contribute to a shortage of health care providers in African 
countries: these include inadequate funds allocated to the training of health care providers, a 
lack of strong retention strategies, internal and international immigration, and the loss of 
health care providers due to HIV infection.  HIV has become an area of interest for many 
NGOs and that mobilise  funds and establish projects and they are able to pay better salaries 
than government institutions, thus  attracting health care workers from the public sector   
(Schneider, et al., 2006). It has been argued that retention strategies are crucial: it is important 
that these are put  in place, particularly for those working in rural areas (Magnussen, et al., 
2004). 
2.5.4 Health service delivery in Rwanda 
The Rwandan health system employs a primary health care approach (Ministry of Health 
(MoH) of Rwanda, 2009; USAID, 2007). Health services offer preventive, promotive, 
curative and rehabilitative services (Ministry of Health (MoH) Rwanda, 2012b).  
Health services in Rwanda comprise five referral hospitals, 40 district hospitals, 450 health 
centres, and various health posts within the community which operate under the supervision 
of the health centres; there  also community-based associations that offer community 
outreach activities. The Ministry of Health coordinates, oversees and supports the provision 
of the different services. It has an organ, the ―Rwanda Biomedical Centre‖, that consists of 
specialised programs and technical working groups that provide policies and technical 
 
 
 
 
73 
 
guidance to assist with improving health service delivery (Ministry of Health (MoH) 
Rwanda, 2012b). 
 As it was mentioned in Chapter One, in 2000 the government of Rwanda committed itself to 
Vision 2020 (Logie, et al., 2008). In 2004, the Ministry of Health revised its health policy, 
based on vision 2020 and a strategy to reduce poverty; this led to the Good Governance and 
Decentralization policy (Ministry of Health (MoH) Rwanda, 2012b). The following points 
were emphasised:  the need to improve the availability of quality drugs, vaccines and 
consumables; the need to make the health services more accessible; the need to make the 
health services more affordable; the need to improve the quality and demand for services that 
control the disease; the need to strengthen national referral hospitals and research and 
treatment; and the need to reinforce institutional capacity (Ministry of Health (MoH) 
Rwanda, 2012b). 
 The recent health sector strategic plan, elaborated in 2012, sets up priorities based on key 
elements of the policies described above. Firstly, in relation to the Millennium Development 
Goals, by 2015 it aims to improve nutrition, maternal and child health and disease control. 
Secondly, it aims to improve the accessibility of health services in terms of financial, 
geographical and community health. It also aims to improve the quality of health provision 
through quality assurance, improved training, ensuring the availability of medical equipment 
and proper supervision; it will strengthen institutions; and, finally, it will improve the 
quantity and quality of human resources for health (Ministry of Health (MoH) Rwanda, 
2012b). 
Disease prevention and control in the recent health sector strategic plan emphasized various 
health conditions, among them; HIV infection and related disability conditions. Some of the 
strategies to prevent and control disability include establishing preventive, promotive and 
rehabilitative interventions to reduce mortality and morbidity.  Studies will be conducted to 
determine the burden of disability in Rwanda and to develop guidelines for managing 
disability and for rehabilitation.  The aim is to improve access to health services for people 
with disabilities; this could involve developing and disseminating  protocols for the provision 
of services to people with disabilities and training health care providers in the control, 
prevention and treatment of disability  (Ministry of Health (MoH) Rwanda, 2012b). 
An improvement in the quantity and quality of health care providers has been identified as a 
priority of the Rwandan ministry of Health. The ratio for medical doctors to population, 
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changed from 1:33 000 in 2008 to 1:20 000 in 2010; the ratio for nurses in 2010 was 1:1 500. 
The number of physiotherapists in Rwanda increased from 58 in 2009 to 70 in 2011, and that 
of mental health workers  from 50 in 2009 to 67 in 2011  (Ministry of Health (MoH) Rwanda, 
2012b).  According to the Ministry of Health this was still not sufficient to respond to the 
health needs of the Rwandan population (Logie, et al., 2008; Ministry of Health (MoH) 
Rwanda, 2012b).  There has been internal migration from the public government health 
institutions to NGOs and from rural to urban areas (Logie, et al., 2008). In an attempt to 
prevent this, the Ministry of Health has established a performance-based pay strategy, aimed 
at staff retention (Logie, et al., 2008; Ministry of Health (MoH) Rwanda, 2012b). 
With regards to quality, the norms and standards that guide practice have been established, 
and the Ministry of Health has also developed human resources for strategic health planning 
(2011-2016); this aims to coordinate all activities specifically related to human resources for 
health. For example, the strategic plan could involve developing and implementing a 
curriculum for Continuing Professional Education training for various medical professionals. 
Additionally, there is a plan to strengthen the capacity of teaching institutions that are 
mandated to train health care providers, and which provide both pre-service and in-service 
training (Ministry of Health (MoH) Rwanda, 2012b). 
Access to health services has been improved; this is due in part to increased health insurance 
coverage (Logie, et al., 2008; Ministry of Health (MoH) Rwanda, 2012b; National Institute of 
Statistics Rwanda, et al., 2012). Many people in Rwanda have health insurance. The types of 
insurances include: RAMA (Rwandaise d’Assurance Maladie) which is usually for civil 
servants and private people; MMI (Military Medical Insurance); and a few other private 
health insurance schemes (Ministry of Health (MoH) Rwanda, 2010; National Institute of 
Statistics Rwanda, et al., 2012). 
 However, most people have the Rwandan community-based health insurance, Mutuelle de 
santé (Ministry of Health (MoH) Rwanda, 2010; National Institute of Statistics Rwanda, et 
al., 2012). This enables even the most vulnerable and poorest people in the community to be 
included in the health insurance system and to access quality health care (Ministry of Health 
(MoH) Rwanda, 2010). Its management is decentralised and involves community 
participation. In each health centre there is a department for Mutuelle de Sante with a 
coordinator.  At the community level, that is, at the village, cell, and sector levels, there is a 
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mobilisation committee for the insurance system which is composed of people elected by the 
community (Ministry of Health (MoH) Rwanda, 2010). 
 Each member is required to pay 1000 Rwandan Francs per year, (approximately US$2), and 
for every consultation a member pays 10% of the overall cost, including the cost of 
medication. The poorest people in the community and PLWH are exempt from this payment. 
However, despite its significant impact on access to health services; the Mutuelle de Sante 
covers only limited services, such as basic laboratory examinations, generic drugs and some 
tertiary care   (Logie, et al., 2008). 
2.5.5 Rehabilitation care and PLWH 
Through its various disciplines, such as physiotherapy, occupational therapy, speech therapy 
and psychology, rehabilitation can transform the concept of HIV infection from a disease 
perspective to one where it is seen as a health condition that impacts on people‘s  physical, 
psychological and social functioning (Hanass-Hancock & Nixon, 2009b; S. Nixon, et al., 
2011). 
 Worthington et al. (2005) suggest that the goal of rehabilitation for PLWH should be  to 
improve their overall health and quality of life, including the maintenance or restoration of 
physical, psychological and social functions and vocational safety. However, because of the 
unpredictable and complex nature of HIV and its associated pathologies, monitoring is 
imperative to ensure the individual‘s needs are addressed adequately. There might be a need 
for some adjustment of the goals to be met.  
 In western countries such as Canada, as well as in sub-Saharan countries such as Kenya, 
Ethiopia and Mozambique, there is evidence that an increasing number of  PLWH are 
seeking rehabilitation services, including physiotherapy, psychotherapy, nutrition care and 
occupational therapy. These practices may contribute to individual well- being and improve 
quality of life (Nixon, et al., 2011).  
2.5.5.1 Physiotherapy and PLWH 
There is evidence that physiotherapy techniques such as exercise can combat or alleviate the 
severity of some impairments such as fatigue that manifest in PLWH (Barroso & Voss, 
2013). 
A Cochrane systematic review by O‘Brien, Nixon, Tynan, and Glazier (2010) indicates that 
aerobic exercise contributes to improvement in certain health conditions associated with HIV. 
 
 
 
 
76 
 
These include cardiopulmonary function, improvement in body composition (such as 
reducing fat mass, strengthening of leg muscles) and also improvement in psychological 
functions, particularly with regard to depression. A systematic literature review by Fillipas, 
Cherry, Cicuttini, Smirneos, and Holland (2010) demonstrated that aerobic exercise such as 
walking, jogging, swimming, etc. had a significant effect in the decreasing body-mass index 
among PLWH who presented with central adiposity. Progressive resistive exercise (weight 
training, isotonic and isometric exercises) had a significant effect in increasing body weight 
and muscle mass, particularly in relation to peripheral muscular atrophy. Mutimura, 
Crowther, Cade, Yarasheki, and Stewart (2008) reported that among a group of PLWH on 
ART in Rwanda, cardiorespiratory exercise training significantly improved cardiorespiratory 
functioning, reduced central adiposity, improved metabolic function (by reducing total 
cholesterol and insulin levels), and improved cardiovascular functions. 
Ownby (2006) found that pain scores and pain intensity in PLWH reduced overtime with the 
use of both the ice massage and dry towel massage on peripheral pain.  There was no 
significant difference between the two treatments. A systematic search by Hillier, Louw, 
Morris, Uwimana, and Statham (2010) found that massage therapy can improve the quality of 
life of PLWH, and its effects and benefits increased when used with other treatment 
modalities such as stress management modalities.  
2.5.5.2 Psychotherapy/psychosocial therapy and PLWH 
 Using a systematic review and meta-analysis of double-blinded randomized controlled trials 
to test the effect of group psychotherapy treatment on depressive symptoms that manifest in 
PLWH, Himelhoch, Medoff, and Oyeniyi (2007) found that group psychotherapy, 
particularly group cognitive behavioural therapy, could be effective in the management of 
depressive symptoms.   
Post and Wade (2009) and Belcher (2002) found that spiritual/religious interventions could 
be effective in the management of psychological or mental distress and could be integrated 
into psychotherapy.  It has been demonstrated that spiritual practices can combat the side 
effects of stress resulting from HIV; they can also reduce the symptoms of depression and 
can improve the psychological well-being of PLWH (Braxton, et al., 2007).  
2.5.5.3 PLWH and nutrition care 
Reid and Courtney (2007), using an experimental design, found that an individualised diet 
programme for healthy eating, supervised  by a dietician, has a positive effect on the quality 
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of life of PLWH and on the treatment of lipodystrophy; it was strongly recommended for 
weight loss.  
Evidence from a randomized clinical trial by Anastasi, Capili, Kim, McMahon, and 
Heitkemper (2006) showed that nutritional intervention can be efficacious in decreasing stool 
frequency and can improve stool consistency in PLWH who experience chronic diarrhoea.  A 
diet low in fat, lactose, insoluble fibre and caffeine and high in soluble fibre was found very 
beneficial.  
2.5.5.4 PLWH and occupational therapy  
Occupational therapy interventions have been found to assist PLWH to identify goals and to 
improve their perceptions of their ability to work (Bedell, 2008). The use of self-management 
strategies can assist those who are not ready to work to identity their potential to work 
(Bedell, 2008). 
Martin, Arns, Batterham, Afifi, and Steckart  (2006) found  that  in a comparative 
intervention  among PLWH that consisted of vocational case management and 
encouragement, together with basic education and job training,  individuals in the 
intervention group  took less time and were more motivated and more likely to return to work 
than those in the comparison group. 
2.6 Disability/functional limitations and outcome instruments 
There are a number of outcome instruments that measure people‘s disability or functional 
limitations. They can be grouped into those that are generic, and which are designed to assess 
the functional status of an individual with or without the presence of impairment or disability, 
and those which are designed to assess functional status in specific health conditions (Cohen 
& Marino, 2000). As is described in Chapters Three and Four, WHODAS 2.0 outcome 
instrument was used in this study. It was based on the ICF model, and designed to be used 
within surveys or population-based studies (Chisolm, Abrams, McArdle, Wilson, & Doyle, 
2005; Üstün, Kostanjsek, & Chatterji, 2010a). WHODAS 2.0 has been mostly validated in 
developed countries (Üstün, et al., 2010b). Other disability outcome instruments such as the 
Barthel index and the functional independence measure (FIM) are designed for more clinical 
settings (Gosman-Hedström & Svensson, 2000). 
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2.6.1 Validity and reliability and disability/functional limitations outcome 
instrumentations 
Validity and reliability are two important concepts to consider when determining the value of 
any assessment tool.  The validity of a measure is the extent to which it measures what it was 
intended to measure, while reliability is concerned with the degree to which a measure is 
consistent and can be replicated. 
2.6.1.1 Validity and reliability of WHODAS 2.0 
The WHODAS 2.0 is applicable across diverse populations and cultures (Cohen & Marino, 
2000; Kucukdeveci et al., 2012). When used in health services research, WHODAS 2.0 can 
assist in identifying the changes that follow treatment under specific conditions (Üstün, et al., 
2010b).  
WHODAS 2.0 has been through numerous field-tests in the course of its development. It was 
found to have good validity and reliability across cultures and populations and among people 
with both physical and mental health problems. Its internal consistency was found to be very 
high: for example for the 36 items; it was 0.96. Factor analysis showed a stable factor 
structure; the test-retest reliability was very good, and the overall intra-class correlation 
coefficient was 0.98. It had a good concurrent validity in patient disability classification when 
compared with other disability instruments, such as FIM and the Short Form Health Survey 
(SF) (Üstün, et al., 2010b). 
Garin et al. (2010) conducted a study that aimed at assessing the validity and reliability of 
WHODAS 2.0 in relation to chronic diseases. It involved a large number of patients 
presenting one of 13 identified chronic health conditions. Patients were selected from various 
health centres in seven countries in Europe. The findings confirm the ability of WHODAS 
2.0 to measure disability in both physical and mental chronic health conditions. It showed a 
very high reliability and validity. 
Schlote et al. (2009) reported in their article that WHODAS 2.0 was also found to be a valid, 
reliable and useful instrument in the assessment of stroke patients. Its internal consistency as 
assessed by Cronbach‘s alpha was rated good to excellent. Validity was generally satisfactory 
for its applicability to stroke patients, using their relatives as proxies.  
A literature review by Noonan, Kopec, Noreau, Singer, and Dvorak (2009) identified 
instruments that assess participation as defined by ICF, and found that the WHODAS 2.0 was 
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among the ten selected outcome instruments. Most of the instruments showed a higher 
validity and reliability (with WHODAS 2.0, construct validity was the most tested feature) 
with sufficient evidence for all instruments of good internal consistency among the domains, 
supporting their use for the different health conditions being assessed. WHODAS 2.0 was 
found to be the most broadly tested instrument. The instruments also varied, especially with 
regard to whether the self-care domain should be included in participation functions; in 
WHODAS   2.0, it was recommended that this be considered under activity functions instead 
of under participation (Noonan, et al., 2009). 
2.6.1.2 Validity and reliability of ICF  
ICF is a multidimensional and multipurpose classification, which is not restricted to a single 
health condition (Stucki, et al., 2003).   
 Soberg, Sandvik, and Ostensjo (2008) examined the applicability and reliability of the ICF 
codes in the rehabilitation service at one university hospital in Norway, in order to improve 
functional status of patients. The emphasis was on determining the level of agreement among 
physiotherapists in assigning ICF codes to clinical problems,  and on setting goals for 
rehabilitation, particularly, the rehabilitation of persons with multiple injuries. The findings 
demonstrated at least moderate inter-rater and excellent intra-rater reliability.  Kappas for the 
inter-rater reliability ranged from 0.41 to 0.73 while most of the Kappas for the intra-rater 
were above 0.80. The findings have reinforced the importance of the use of the ICF by 
physiotherapists when documenting a patients‘ problems and resources and setting goals for 
rehabilitation. 
 Devoogdt, Van Kampen, Geraerts, Coremans, and Christiaens (2011) assessed the reliability 
and validity of the ICF by measuring the functioning (impairment, activity limitations and 
participation restrictions) of people experiencing lymphedema after axillary dissection for 
breast cancer in a selected hospital in Belgium. The findings have demonstrated that the 
overall reliability of the ICF-lymphedema was good. The intra-class correlation coefficients 
for test-retest reliability ranged from 0.65 to 0.93. The Cronbach alpha coefficients for 
internal consistency were higher than 0 .70, and measurement variability was acceptable with 
standard errors of measurement equal to 4.8 – 12.5. Content validity and construct validity 
were good. Furthermore, there was also good convergent validity as five expected domains of 
the lymphedema-ICF had a strong correlation with the five expected domains of the 36-item 
short-form health survey questionnaire (SF-36).   
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 Ewert, Allen, Wilson, Üstün, and Stucki (2010) described how a retrospective international 
multicentre study ( of 32 countries); involving  different rehabilitations centres, with 3227 
rehabilitation patients presenting different chronic conditions (such as low back pain 
osteoarthritis) supported the construct validity of the functioning  part of the ICF.  
Additionally, findings have shown a strong correlation between the functioning components 
of the ICF, and thus support the use of the multidimensional ICF core set of questions on 
functioning. These involve all functioning components: body structures and functions, and 
activities and participation, instead of dealing with functioning components separately.  Also, 
the findings encouraged researchers and clinicians to construct functioning instruments while 
integrating the ICF categories related to functioning components. 
2.6.1.3 Validity and reliability of FIM 
Küçükdeveci et al. (2001) discussed the adaptation of the FIM in Turkey and the assessment 
of its validity and reliability. The instrument was first translated, and thereafter its reliability 
and validity were tested among stroke and spinal cord injury patients admitted for 
rehabilitation care. The overall internal consistency of the instrument for both health 
conditions was tested by Cronbach‘s alpha, and was very high (>0.92), which justified a 
strong association of items in the FIM scale. The intra-class correlation coefficients were 
good and were all above 0.9 for both the spinal cord injury and stroke scales.  Construct 
validity was assessed by Rasch analysis and revealed that items in both scales were not in the 
same hierarchical order. Convergent validity was tested and showed expected levels of 
agreement with other disability instruments. For example, for the spinal cord injury scale, 
convergent validity showed a significant relationship between the FIM and the ASIA 
impairment scale; an exception, however, were the cognitive motor/sensory scores. 
 Gosman-Hedström & Svensson (2000) carried out a study in Sweden among stroke patients 
admitted at one of the University Hospitals;  this aimed to assess the concordance between 
FIM and the Barthel index, while assessing the activities of daily living. The results showed 
that items of the FIM and Barthel  index had high levels of construct validity and face 
validity, and that the concordance between the two scales was high. 
2.6.1.4 Validity and reliability of Barthel ADL index 
Leung, Chan, and Surya (2007) developed a Chinese version of the Barthel index and 
assessed its validity and reliability. The subjects involved in the testing were old people 
(mean age 76.0; SD 7.6) who had suffered a stroke. The instrument was first translated into 
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Chinese language.  The findings demonstrated that the test-retest reliability of the items in the 
Chinese version was comparable with that of the original version, with Kappa statistics 
ranging from 0.63 to 1.000 (P<0.001). Additionally, the items in the Chinese version showed 
higher internal consistency, and this was comparable to that of the original instrument. Its 
items showed satisfactory inter-rater reliability and they seemed to have higher inter-rater 
consistency than those in the original version. Furthermore, there was the influence of 
cultural issues, especially for items in the self-care activities. For example for the item 
―toileting‖ and ―bathing‖; it was indicated that older Chinese people tended to use various 
methods, compared to their counterparts from Western countries. For instance while bathing; 
some would prefer a towel (or a sponge) bath while sitting on a low stool and using a basin of 
water rather than immersion in a bathtub or a shower. 
2.7 Conclusion 
This chapter has demonstrated that the HIV infection can have a significant influence on the 
functioning of the whole human body and can affect both physical and psychological/mental 
functions as well as the social functions. The literature related to HIV was reviewed to 
provide a general overview of the types of HIV, the pathology of HIV, the stages of HIV 
infection, the effect of antiretroviral treatment, and the epidemiology of HIV worldwide and 
in Rwanda. The literature review also highlighted models of disability with an emphasis on 
the ICF as the model used to guide and achieve the objectives of the present study. This was 
followed by a description of several body impairments that manifest in PLWH, and by a 
summary of reviewed studies on activity limitations and social restrictions and contextual 
factors related to HIV. The literature review gave also a general overview of the approach to 
health service delivery in a hospital environment, with a focus on health service delivery in 
Rwanda and the impact of rehabilitation services on the functioning of PLWH. Finally, the 
literature review discussed the WHODAS 2.0, the outcome instrument used in this study, as 
well as other outcome instruments that measure disability/functional limitations, with 
particular reference to their validity and reliability.   
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3 CHAPTER THREE:  THE PROFILE OF PLWH ATTENDING ARV 
CLINICS – METHODOLOGY AND RESULTS 
3.1 Introduction 
Chapter Three describes the profile of PLWH and discusses the prevalence of impairment, 
activity limitation and participation restriction amongst PLWH. The chapter provides a brief 
background, describes the aims and objectives and the methodology of the study and the 
findings obtained. 
3.2 Background 
A while back, HIV disease was a progressive, deteriorating terminal illness with no effective 
treatment; it caused an often rapid decline in health, leading to death (Gaidhane, et al., 2008). 
However, in the past two decades, HIV management has undergone some important changes. 
Today, people are living longer with the disease and its numerous complications.  These 
include musculoskeletal, neurological, and cardio-respiratory complications due to the HIV 
infection and the antiretroviral treatment (O'Brien & Brooks, 2006; Tehranzadeh, Ter-
Oganesyan, & Steinbach, 2004; Vidrine, Amick, Gritz, & Arduino, 2005). 
The disease is increasingly viewed as a chronic, long-term condition and as a disabling 
condition (Ferrier & Lavis, 2003; Mkanta & Uphold, 2006; Paul-Ward, Braveman, 
Kielhofner, & Levin, 2005). The disability associated with HIV and antiretroviral treatment is 
multi-dimensional, characterized by unpredictable periods of wellness or illness, and it 
includes several impairments, as well as limitations to physical and mental functions. These 
might lead to difficulties in carrying out day-to-day activities, difficulties with community 
participation/social inclusion; these difficulties might lead to feelings of uncertainty, and 
these serve as a source of emotional distress, fear and anxiety (O'Brien, et al., 2008). One of 
the methods of understanding the impairments, functional limitations and participation 
restrictions associated with HIV, is to classify the condition according to the ICF, which is a 
systematic framework for describing the full range of human functions that might be affected 
by a health condition. It is based on a bio-psychosocial approach that allows users to 
document the impact of health conditions on human functioning from biological, individual, 
and social perspectives (Reed, et al., 2005). 
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3.3 Aims and Objectives 
3.3.1 Aim 
The aim of this section is to determine the profile and the prevalence of disability among 
PLWH, by measuring impairment, activity limitation and participation restriction amongst 
PLWH who are also on antiretroviral treatment. In addition the relationship between 
functioning and medication is explored. 
3.3.2 Objectives 
 To determine the proportion of PLWH who have impairments;  
 To determine the proportion of PLWH who have activity limitations and participation 
restrictions; 
 To determine the prevalence of disability among PLWH attending ARV clinics; 
 To establish whether there is a relationship between the body function impairments, 
the functional limitations and participation restristions. 
 To document the relationship between length of time on antiretroviral treatment, CD4 
count and functioning.  
3.4 Methodology  
3.4.1 Research design 
A quantitative, exploratory, cross-sectional analytical and descriptive design was used. 
3.4.2 Research setting 
The study was carried out in hospitals in Rwanda. Rwanda consists of five provinces, namely 
Eastern, Western, Southern, Northern and Central. There are 30 Districts extending 
throughout the five provinces, and there are 45 public hospitals, most of which contain an 
ARV clinic. The study was carried out in selected public hospitals among the 30 Districts. 
3.4.3 Study population, sampling technique and sample size, selection of 
districts and hospitals 
Each province (big cluster) contains a number of districts (small clusters).Three districts per 
province were purposively chosen to ensure both urban and rural areas were represented.    
Fifteen hospitals were selected, one hospital from each district. A simple random sampling of 
hospitals was done from the lists of all hospitals in the selected districts that had an ARV 
clinic and  a physiotherapy department. The selected hospitals were considered study areas.  
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Table 4: Hospitals selected for the study 
Province District Hospital 
Western province Rusizi Gihundwe  Hospital 
Rubavu Gisenyi  Hospital 
Karongi Mugonero Hospital 
Northern province Gicumbi Byumba  Hospital 
Musanze Ruhengeri Hospital 
Rulindo Rutongo Hospital 
Eastern province Bugesera Nyamata  Hospital 
Rwamagana Rwamagana  Hospital 
Kayonza Gahini District Hospital 
Southern province Kamonyi Remera Rukoma Hospital 
Muhanga Kabgayi  Hospital 
Huye CHUB Hospital 
Kigali city Gasabo Kibagabaga  Hospital 
Kicukiro Kanombe Military Hospital 
Nyarugenge Muhima Hospital 
  
3.4.3.1 Selection of participants: Study population, sampling technique and sample 
size  
Study population: This consisted of adult PLWH (females and males). 
Inclusion criteria: 
Participants had to be HIV positive, on antiretroviral treatment and attending an ARV clinic 
at one of the selected hospitals. 
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Participants had to be aged 18 years and above. 
Participants could be either employed or unemployed. 
Sampling technique and sample size: All PLWH on antiretroviral treatment who attended 
the ARV clinic at the selected hospitals during the period of data collection, and who 
voluntarily agreed to participate in the study, were recruited. Patients were identified by the 
clinical team, the majority of whom were nurses. Five hundred and twenty (520) people were 
approached to participate in the study.  
3.4.4 Instrumentation  
 In this study, the WHODAS 2.0 questionnaire (36-item version) was used as the research 
instrument, with a recall period of 30 days and response options on the following scale: 1=no 
difficulty, 2=mild difficulty, 3=moderate difficulty, 4=severe difficulty and 5=extreme 
difficulty (or cannot do). Impairment items are lacking in WHODAS 2.0  ( Üstün, et al., 
2010).   
An ICF core set of questions on impairments identified among people living with HIV by 
Myezwa et al. (Myezwa, et al., 2011) was therefore added.  It was necessary to include 
impairment questions which assess body problems, as one of the objectives of the study was 
to examine the interaction of impairments and functional limitations. The validation of these 
instruments was done post-hoc and is presented in Chapter Six. 
3.4.5 Procedure 
Step1: Prior to data collection, permission was first given by the University of the Western 
Cape (UWC) (Appendix I) and the WHO to use the questionnaire. In order to obtain ethical 
clearance and permission in Rwanda, the proposal was sent for assessment by two research 
bodies in the country: these were the   National Aids Control Commission; ―Commission 
Nationale de Lutte contre le Sida
4‖ (CNLS), which is the institution that supervises and 
coordinates all activities related to HIV in Rwanda, the KHI Institutional Review Board (KHI 
IRB), which represents the National Research Ethical Committee in Rwanda at the 
institutional level.   
After one month, the researcher was called to present the proposal at CNLS; the panel 
consisted of five medical doctors, two psychologists, and one person living with physical 
                                                 
4 Commission Nationale de Lutte contre le Sida (CNLS) is a French word, it means National Aids Control Commission, 
 and it is what is commonly  used. 
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disability with a qualification in Public Health, working at the National Disability 
Organisation, but under the umbrella of disability and HIV organisation; this person was the 
principal reviewer of the research proposal. Thereafter, the researcher presented the proposal 
at KHI IRB; this panel included two physiotherapists, one medical doctor with a qualification 
in Public Health, and one nurse with a qualification in Medical Education. One of the 
physiotherapists and the nurse with the Medical Education qualification were the reviewers of 
the proposal.  
Step 2: After getting authorisation from CNLS (Appendix I) and KHI IRB, the next step was 
to ask permission for data collection from the hospitals. Letters requesting permission were 
sent to all fifteen selected hospitals via the post office (Appendix II). Thereafter, the 
researcher visited each site. This enabled face-to-face contact with the directors of each 
hospital after they had received the letters.  The researcher reiterated the purpose of the study, 
and this resulted in some of the directors granting permission on the day of the visit.  
Preparation for the fieldwork was done, and the appointments and days for data collection 
were confirmed. 
After a month and a half, permission was obtained from fourteen (14) hospitals. One hospital, 
Centre Hospitalier Universitaire de Kigali (CHUK), did not wish to participate as most of its 
patients were in-patients, and out patients were usually referred to the Treatment and 
Research AIDS Centre Plus (TRAC Plus), a Centre for treatment and research in HIV/AIDS 
in Rwanda. The researcher then decided to include Muhima Hospital, which was selected for 
the debriefing interview/pre-test, and which is in the same province and same district as 
CHUK. The Director of Muhima granted permission. However, all patients who participated 
in the debriefing interview/pre-test were excluded.  
Step 3: The researcher‘s visits to the sites were followed by the training of two research 
assistants. The training took place at Kigali Health Institute (KHI), and only took two days as 
the research assistants were already familiar with the research instrument. They had 
participated in the consensus meetings and the debriefing interview/pre-test, and had 
contributed to the development of the Kinyarwanda version. The training covered the 
assistants‘ roles in the study and their understanding of the research topic, as well as their 
understanding of the aims and ethical considerations of the study.  
Step 4: Face-to-face interviews were conducted in 15 hospitals scattered all over the country, 
from June 2010 to August the same year. Interviews were conducted by the researcher and 
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the research assistants. An average of two to three days was spent at each site; the time spent 
depended on the location of the hospital and the frequency of patients‘ attendance.  At each 
site, patients preferred morning hours (7h30-12h30) which allowed them to return home 
early, as in certain areas the hospital was located some distance from their homes. At each 
daily session, the nurse responsible for the clinic had to first give a general introduction, 
welcoming the patients and the interviewers, and explaining the reason for the visit. Then the 
researcher or the research assistant had to explain the purpose of the study by using the 
Participant Information sheet (Appendix III); participants were informed of their right to 
participate in, or indeed to withdraw from the study at any time should they feel 
uncomfortable.  
Participants were further assured that their participation in the study would remain 
anonymous and confidential. Comfortable rooms were prepared for interviews. Participants 
who volunteered were then invited to join the interviewers where they were seated, one 
interviewer per room for privacy. An interview session took at least 20-25 minutes, and 
began with some small talk, for example, regarding the environment; this helped the 
participants to relax. Participants were requested to sign a consent form agreeing to their 
participation in the study (Appendix IV). In addition, they were requested to give permission 
to access their medical records/files. Ethical issues were considered throughout the process of 
data collection, and at the end of every interview, the participant was thanked.      
3.4.6 Ethical considerations 
Following approval of the research proposal by the Senate Higher Degrees Committee of 
UWC and ethical approval by the Senate Research, Ethics and Study Leave Committee, 
permission was granted by the WHO to use and translate the WHODAS 2.0 instrument.  
Ethical clearance was sought from KHI IRB, and from CNLS and permission was sought 
from different hospitals where the study was to be conducted. The participants‘ information 
letter explaining the nature of the study and inviting participants to participate in the study 
was read out to them prior to their recruitment for the study. Participants were requested to 
sign a consent form agreeing to their participation in the study. In addition, they were 
requested to give their permission to access their medical records/files. Participation was 
voluntary, and confidentiality and the anonymity of the participants were maintained.  
Participants were assured of their right to withdraw from the study at any time without any 
repercussions. 
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3.4.7  Data management analysis  
Data was entered into Excel, and then analysed using SPSS packages. Descriptive statistics 
were produced for all demographic variables. For categorical variables, cross tables and bar 
charts were used to present the data; while for continuous variables, measures of central 
tendency (mean and standard deviations) were used. The T test was used to test equality of 
the means for the age of females and of males. The Pearson correlation was also used to 
determine the relationship between years spent at school and the age of participants. The Chi-
Square and Spearman tests were used to determine the association and the relationship 
between certain categorical variables under impairments, activity limitations and participation 
restriction domains. The WHODAS 2.0 Manual provides an algorithm for calculating the 
percentage scores for each domain, with 0 representing the least activity limitation which was 
used to calculate domain scores. This included the ANOVA to determine which domains 
were the most affected, and a post-hoc Tukey to determine where the differences lay. 
Multiple regression analysis was used to identify which impairments were predictive of 
WHODAS 2.0 scores in the different domains that demonstrated internal consistency. 
Dummy tables were created for all impairments with variables =0 for no and mild problems, 
and =1 for moderate, severe and extreme problems.  All impairments were then entered in a 
stepwise regression to identify which contributed significantly to the variation. Those that 
were significant were then subjected to further analysis using the enter method (i.e. all 
variables entered simultaneously). Outliers whose residual scores were greater than two 
standard deviations from the mean were excluded and the regression was rerun with these 
scores excluded. Statistical significance was set at the .05 level. 
3.5 Results 
3.5.1 Demographic data 
Fifteen health centres throughout the country were visited between June and August 2010. 
Five hundred and twenty people met the inclusion criteria and volunteered to take part in the 
study (see Table 5). In all, 502 questionnaires were completed and were included in analysis. 
Eighteen questionnaires were excluded due to missing information.  
The subjects represented 35.7% (136/381%) of the males and 56.6% (384/678%) of the 
females who attended the clinics on the days of data collection. Of all those who attended, 
both male and female, 48.3% were interviewed. There was an association between gender 
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and being interviewed (Pearson Chi Square = 8.2398, df=1, p=0.004), with more females 
being interviewed.  
Table 5: Health Centres visited (n=15) 
District Hospital Urban/Rural Target Male 
Patients 
attended 
Number 
of males 
recruited 
Female 
Patients 
attended 
Number 
of 
female 
recruited 
Total 
number 
attended 
Total 
number 
recruited 
Gihundwe  Semi-Rural 25 36 3 71 22 107 25 
Gisenyi   Semi-Rural 25 22 7 50 13 72 20 
Mugonero   Rural 25 21 7  44 19 65 26 
Byumba  Semi-Rural 45 28 16  45 36 73 52 
Ruhengei D Semi-Rural 25 10 4 34 10 44 14 
Rutongo  Rural 25 8 1  18 18 26 19 
Nyamata  Semi-Rural 45  33 12 57 20 90 32 
Rwamagana  Semi-Rural 45 30 6 57 52 87 58 
Gahini  Rural 25  17 10  29 11 46 21 
Remera Rukoma  Semi-Rural 45 15 7 32 31 47 38 
Kabyayi  Semi-Rural 45 27 9 57 37 84 46 
CHUB Urban 40 27 9 46 24 73 33 
Kibagabaga  Urban 45 22 17 40 36 62 53 
Rwanda Military 
Hospital 
Urban 45 36 16 30 25 66 41 
Muhima  Urban 45 49 12 68 30 117 42 
Total 15 550 381 136 678 384 1059 520 
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The final sample consisted of 502 respondents, of whom 125 (25%) were male. Of these, 436 
(87%) declared themselves to be living independently in community, whereas 66 (13%) were 
assisted. 411 (82%) reported earning less than US$82, and 11 (2%) reported earning between 
US$85 and US$167 per month. 
3.5.1.1 Gender and age  
The mean age of the sample was 39.7 (SD=9.43, range 18-79 years):  the mean age of the 
males was 43.4 years (SD=10.2, range 18-75 years) and that of the females was 38.4 
(SD=8.8, range 18-74 years). Males were approximately five years older than the females and 
this was significantly different (t=4.82, using separate variances, df=189, p<.001). 
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Figure 5:  Age distribution  
As can be seen in the figure above, there were relatively few men or women below the age of 
25 years. 
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3.5.1.2 Gender and marital status 
Approximately one third of the sample was married or cohabitating and a similar percentage 
was widowed.  Marital status was associated with gender (Chi-Square =65.193
, 
df= 3 
.p<.001). The most common marital status was ‗married‘ in males (65%) and ‗widowed‘ in 
females (41%). Both groups had a similar number of ‗never married‘ respondents (14%) 
(Table 6). 
Table 6: Gender and marital status (N=502) 
Gender 
Marital Status Total 
Never married 
Married/  
Cohabiting 
Separated/
Divorced 
Widowed 
 Male N 17 81 12 15 125 
% n 
 
13.6% 64.8% 9.6% 12.0% 100.0% 
Female N 53 101 67 156 377 
%  
 
14.1% 26.8% 17.8% 41.4% 100.0% 
Total N 70 182 79 171 502 
%  13.9% 36.3% 15.7% 34.1% 100.0% 
 
3.5.1.3 Gender and employment 
A large majority of the respondents were self-employed (77%). Employment was associated 
with gender, (Chi-Square = 28.683, df= 7, p<.001) with more males in paid work (12% 
compared to 4%) and fewer males unemployed (7% compared to 15%) (Table 7). 
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Table 7: Gender and employment (N=502) 
 Occupation Total 
Paid work Self-
employed 
Non paid 
work 
/student 
Keeping 
house 
Retired Unemployed-
health/other 
reasons 
 Male N 15 97 0 1 3 9 125 
%  12.0% 77.6% .0% .8% 2.4% 7.2% 100.0% 
         
Female N 14 291 7 7 0 58 377 
% n 3.7% 77.2% 1.9% 1.9% .0% 15.4% 100.0% 
          
Total N 29 388 7 8 3 67 502 
% n 5.8% 77.3% 1.4% 1.6% .6% 13.3% 100.0% 
3.5.1.4 Gender, age and education 
Sixty percent (60%) of the respondents had achieved a primary school level of education. 
Gender was associated with education, (Chi-square=14.263, df: 4, p=.006) with more males 
attaining above secondary school level education (A level ) (13% compared to 5 %). There 
was a weak negative correlation between age and years spent at school (correlation 
coefficient (r) = -.149, p=.006). 
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Table 8: Gender and education (N=502) 
Gender Level of education Total 
None Primary 
education (1-
6) 
Secondary 
school  
(S1-3) 
Secondary 
school 
(S4-6) 
Tertiary 
education 
 Male N 15 68 26 16 0 125 
%  
 
12.0% 54.4% 20.8% 12.8% .0% 100.0% 
Female N 65 233 60 17 2 377 
%  
 
17.2% 61.8% 15.9% 4.5% 0.5% 100.0% 
Total N 80 301 86 33 2 502 
%  15.9% 60.0% 17.1% 6.6% 0.4% 100.0% 
3.5.2 Health status 
3.5.2.1 HIV symptoms and time from diagnosis with HIV 
As can be seen in Table 4.6, most of the participants had been diagnosed with HIV four to six 
years previously (36%), with about 80% having been diagnosed between one and nine years 
previously. There were few very recent diagnoses. 
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Table 9: Length of time with HIV diagnosis and HIV status (N=502) 
Time since diagnosis 
HIV status 
Total % of Total 
Asymptomatic Symptomatic 
1-6 months 
n 2 4 6 1.2 
% 33.3 66.7 100.0 
 
 
6-12 months 
n 6 12 18 3.6 
%  33.3 66.7 100.0 
 
 
1-3years 
n 53 68 121 24.1 
%  
 
43.8 56.2 100.0  
4-6years 
n 71 110 181 36.1 
%  39.2 60.8 100.0 
 
 
7-9years 
n 25 70 95 18.9 
%  26.3 73.7 100.0 
 
 
10-15years 
 14 48 62 12.4 
%  22.6 77.4 100.0 
 
 
More than 15years n 6 13 19 3.8 
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%  31.6 68.4 100.0 
 
 
Total n 177 335 502 100 
 %  35.3 64.7 100  
 
 
 
Figure 6: Percentage of participants who were symptomatic from time of diagnosis (N=502) 
The percentage of cases with symptoms was between 55 and 77%, while the percentage of 
participants who had had HIV for a longer period was higher.  
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3.5.2.2 HIV status and time started antiretroviral treatment  
 
 
 Figure 7:  Percentage of participants who had side effect symptoms per time on antiretroviral 
treatment (N=502)  
A higher percentage of those who had been on antiretroviral treatment for longer, reported 
having more symptoms; it can be seen that the longer the participants were on antiretroviral 
treatment, the more likely they were to be symptomatic. 
3.5.2.3 HIV status and CD4 count 
Almost two thirds (62.4%) of the participants had a CD4 count greater than 500. There was 
no difference in the CD4 count category (above and below 500) for participants who were 
symptomatic or asymptomatic (Table 10) (Chi-square =1.182, df=1, p=.277).  
  Table 10: HIV status and CD4 count (N=502)  
  
CD4 Count 
  
   Less than 500 More than 501 
  
n   % n  % Total (n) % 
HIV 
status 
Asymptomatic 61 34.5 116 65.5 177 35.3 
Symptomatic 128 39.4 197 60.6 325 64.7 
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Total  
 
189 100 313 100 502 
100.
0 
 
3.5.2.4 CD4 count and time since starting antiretroviral treatment 
The table below shows that, in general, the longer the participants had been on antiretroviral 
treatment, the greater their CD4 count (Table 11). 
Table 11: Antiretroviral treatment time period and CD4 count (N=502) 
 Time on ARVs CD4 count   
Less than 200 More than 500 Total 
 Less than a 
month 
n 1 0 1 
%  100.0% 0.0% 100.0% 
1-6 months n 28 1 29 
%  96.6% 3.4% 100.0% 
6-12 months n 30 7 37 
%  81.0% 18.9% 100.0% 
1-3 years n 143 56 199 
%  71.9% 28.1% 100.0% 
4-6 years n 114 88 202 
%  56.5% 43.6% 100.0% 
7-9 years n 18 13 31 
%  58.1% 41.9% 100.0% 
10-15 years n 2 1 3 
%  66.60% 33.30% 100.00% 
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Total n 336 166 502 
%  10.8% 33.1% 100.0% 
 
3.5.3 Functional status as measured by the WHODAS 2.0 
The functional status of participants is described below, starting with a description of their 
impairments, activity limitations and participation/social restrictions. Multivariate analysis is 
then presented to explore the interrelationship between activity limitation, participation/social 
restriction and impairment. 
Note:  The responses to some questions were missing or not applicable and these responses 
have not been included in the graphs. Consequently, percentages represented in the graphs do 
not always add up to 100. 
3.5.3.1 Impairments 
Impairments were present in all seven domains: (i) mental functions; (ii) sensory functions 
and pain; (iii) cardiovascular and respiratory system functions; (iv) digestive system 
functions; (v) reproductive functions; (vi) neuro-musculoskeletal and movement-related 
functions;, and (vii) skin functions. Domains are presented below in separate figures, each 
figure giving detailed information of the areas in which most problems were reported. 
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Mental functions 
 
Figure 8: Percentage of participants reporting problems with mental functions (N=502) 
Emotional functions were the most affected of the mental functions, with 61% reporting 
moderate, severe or extreme problems. This domain was followed by problems in the energy 
and drive category (60%). The area which gave the least problems was memory, with 35% 
reporting moderate or severe problems. 
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Sensory functions and pain 
 
Figure 9: Percentage of participants reporting pain as a problem (N=502) 
Pain was the only sensory function assessed. The majority of participants (69%) reported pain 
being a moderate, severe or extreme problem. 
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3.5.3.2 Cardiovascular and respiratory system functions 
 
Figure 10: Percentage of participants reporting problems with cardiovascular and respiratory 
problems (N=502) 
Under the cardiovascular and respiratory function, fatigue was the domain most affected, 
with 83% of participants reporting moderate, severe or extreme problems with fatigue, 
followed by respiratory problems (21%). The haematological domain was the domain with 
least problems, with only 4% reporting moderate problems.  
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Functions of the digestive system 
 
Figure 11: Percentage of participants reporting problems with digestive functions (N=502) 
Among the digestive domains, tolerance to food was the most affected, with 35% reporting 
moderate, severe or extreme problems; this was followed by sensations of nausea (32%). 
Problems with general metabolic functions were the least reported, with 5% of participants 
reporting only moderate problems.  
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Reproductive functions 
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None 73 29 28 67 31
Reproductive functions%  
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Figure 12: Percentage of participants reporting problems with reproductive functions 
(N=502) 
 Discomfort with sexual intercourse was reported by 33% of participants and was the domain 
most affected, followed by regularity of menstrual cycle, with 31% of female participants 
reporting moderate, severe or extreme problems.  
 Functions of the neuro-musculoskeletal and related movement  
 
 
 
Figure 13: Percentage of participants reporting problems with neuro-musculoskeletal and 
movement-related functions (N=502) 
There were two domains assessed under neuro-musculoskeletal and movement related 
functions: (i) muscle power and (ii) mobility of joints. Muscle power was most affected, with 
50% of participants reporting moderate, severe or extreme problems. There was evidence of 
positive correlations between the two domains and pain (Table 12).  
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Table 12: Correlations among neuro-musculoskeletal functions domains and with pain 
Note that all correlations were significant at a P=< 0.01 level. 
 Functions of the skin 
 
Figure 14: Percentage of participants reporting problems with skin functions (N=502) 
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Skin functions Skin sensation
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Mild 24 16
None 42 39
Skin functions % 
  Mobility of joint Muscle power Pain 
Mobility of joint 1.000 0.536 0.515 
Muscle power 0.536 1.000 0.405 
Pain 0.515 0.405 1.000 
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Under skin functions, some participants (46%) reported skin sensations to be the most 
affected by moderate, severe or extreme problems. Positive correlations were found between 
the two domains and pain (Table 13).  
Table 13: Correlations among skin functions domains and with pain 
  Skin function Skin sensation Pain 
Skin function 1.000 0.676 0.407 
Skin sensation 0.676 1.000 0.464 
Pain 0.407 0.464 1.000 
Note that all correlations were significant at a P=< 0.01 level 
3.5.3.3  Activity limitation and participation/social restriction 
Activity limitations and participation/social restrictions are presented under the WHODAS 2. 
0 domains: these include the cognition domain, the mobility domain, the self-care domain, 
the getting-along-with-people domain, the life activities domain and the participation domain.  
Domains are presented below in separate figures; each figure provides detailed information of 
areas where most problems occurred. 
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Cognition functions 
 
Figure 15: Percentage of participants reporting problems with cognition functions (N=502) 
Analysing and finding solutions to problems in day-to-day life was the most affected domain, 
with 49% reporting moderate, severe or extreme problems. This was followed by problems 
with learning new tasks (34%). Concentration was the domain that showed least problems, 
with 20% reporting moderate or severe problems.   
 
10 20 30 40 50 60 70
Concentration
Remembering
Analysing&finding solution
Learning new task
Understanding
start and maintain conversation
Concentration Remembering
Analysing&find
ing solution
Learning new
task
Understanding
start and
maintain
conversation
Extreme/unable 0 1 1 0 0 1
Severe 6 14 17 8 5 7
Moderate 14 17 31 26 20 21
Mild 18 20 16 15 31 28
None 62 48 35 31 43 43
Cognition function %  
 
 
 
   108 
 
 
 
 
 Mobility functions 
 
Figure 16: Percentage of participants reporting problems with mobility functions (N=502) 
Among the domains of mobility functions, ‗standing for long periods‘ was the most affected 
with 57% of participants reporting moderate, severe or extreme problems. This domain was 
followed by ‗problems in getting out of home‘ (38%).  ‗Moving inside your home‘ was the 
domain which participants experienced least problems with: 15% reported moderate or severe 
problems. 
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Self-care  
 
Figure 17: Percentage of participants reporting problems with self -care functions (N=502) 
In self-care functions, the domain of ‗staying by yourself for a few days‘ was the most 
affected, with 46% of the participants reporting moderate, severe or extreme problems. It was 
followed by ‗problems with washing the body‘, with 4% reporting moderate or severe 
problems. 
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Getting along with people 
 
Figure 18: Percentage of participants reporting problems with getting along with people   
‗Sexual activities‘ were the most affected, with 40% reporting moderate, severe or extreme 
problems. This domain was followed by ‗problems with making new friends‘, with 36% 
reporting moderate, severe or extreme problems. The domain which showed least problems 
was ‗dealing with people you do not know‘, with 14% reporting moderate, severe or extreme 
problems. 
 
  
10 20 30 40 50 60 70 80
Dealing with people you do not know
Maintaining friendship
Getting along with close people
Making new friends
Sexual activities
Dealing with
people you do
not know
Maintaining
friendship
Getting along
with close
people
Making new
friends
Sexual
activities
Extreme/unable 1 3 2 2 10
Severe 5 11 11 20 13
Moderate 8 14 10 14 17
Mild 9 7 7 5 5
None 76 65 70 56 31
Getting along with people functions%  
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Life activities  
Household activities 
 
Figure 19: Percentage of participants reporting problems with carrying out household 
activities (N=502) 
Among the activities involved in maintaining the household, ‗getting household activities 
done quickly as needed‘ was the most affected, with 47% reporting moderate, severe or 
extreme problems. This was followed by ‗getting all needed household activities done‘ 
(38%). The area which gave least problems was ‗taking care of household responsibilities‘ 
with 28% reporting moderate, severe or extreme problems.    
10 20 30 40 50
Taking care of household responsibilities
Doing important household well
Getting household done that you needed
to do
Getting your household done quickly
Taking care of
household
responsibilities
Doing important
household well
Getting household
done that you
needed to do
Getting your
household done
quickly
Extreme/unable 1 1 2 2
Severe 4 8 12 16
Moderate 23 21 24 29
Mild 31 29 20 11
None 42 42 42 42
Household activities% 
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 Work or school activities 
 
Figure 20: Percentage of participants reporting problems with carrying out work/school 
activities (N=502) 
Under work or school activities, ‗getting work done as quickly as needed‘ was the most 
affected, with 41% of participants reporting moderate, severe or extreme problems; this was 
followed by ‗problems in getting all the needed work done‘, with 32% reporting moderate, 
severe or extreme problems. In addition, 44% of the participants, compared to 56%, worked 
at a low level because of their health condition and 45%, compared to 55%, declared that they 
had earned less money because of their health condition.  
5 10 15 20 25 30 35 40 45
Day to day work/School
Doing important work/school well
Getting all the needed work done
Getting work done quickly as needed
Day to day
work/School
Doing important
work/school well
Getting all the
needed work
done
Getting work
done quickly as
needed
Extreme or cannot do 1 1 1 2
Severe 2 5 8 10
Moderate 17 17 23 29
Mild 27 25 15 6
None 39 39 39 39
Work or school activities % 
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Participation
  
10 20 30 40 50 60 70
problem joining in community activities
problem because of barriers in the world around
you
problem living with dignity because of attitudes of
others
Time spent on your health condition or its
consequences
Emotionally affected by health condition
Health been a drain on the financial resources of
you or your family
problem your family have because of your health
problems
problem you have in doing things for relaxation
problem
joining in
community
activities
problem
because of
barriers in
the world
around you
problem
living with
dignity
because of
attitudes of
others
Time spent
on your
health
condition or
its
consequenc
es
Emotionally
affected by
health
condition
Health been
a drain on
the financial
resources of
you or your
family
problem
your family
have
because of
your health
problems
problem you
have in
doing things
for
relaxation
Extreme/unable 3 1 4 0 10 10 9 7
Severe 15 17 25 12 27 30 39 35
Moderate 32 13 21 36 35 26 27 42
Mild 29 10 15 50 22 25 14 11
None 9 58 35 2 6 8 9 2
Participation in the community%  
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Figure 21: Percentage of participants reporting problems with participation in community 
(N=502) 
Domains under participation/social restriction functions were the most affected, compared to 
other domains described above. Relaxation functions came first, with 84% of participants 
reporting moderate, severe or extreme problems. This was followed by ‗problems the family 
experienced due to the health condition of the patient‘ (75%). Problems with emotional 
functions caused by the health condition‘ (72%) and ‗financial problems the family had 
because of the health condition of the patient‘ (66%) were also important. These were 
followed by ‗problems in living with dignity because of the attitudes and actions of others‘ 
(50%), and ‗problems in joining community activities‘ (50%). 
3.5.3.4 Days when difficulties/problems were present and household/work 
activities were reduced or not carried out (N= 502) 
Table 14: Days when household/work activities were reduced or not carried out 
Variable Mean 
Standard 
deviation 
In the past 30 days, days when household work was reduced or 
completely missed because of health condition. 
6.82 7.212 
In the past 30 days, days when work /school activities were 
reduced for a half a day or more because of your health 
condition. 
5.48 5.993 
Overall in the past 30 days, days when all difficulties were 
present. 
15.92 6.934 
In the past 30 days, days when usual activities/work could not be 
carried out because of health condition. 
3.16 4.033 
In the past 30 days, days when work/usual activities were cut 
back or reduced because of health condition. 
5.09 4.531 
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Table 14 indicates that the participants experienced all the symptoms for approximately half 
of the days every month.  Household /work activities were interfered with for about five days 
every month; there were three days in which the participants were completely unable to work 
because of their condition. 
3.5.3.5 The most prevalent problems in each grouping of functions in the 
impairment, activity and participation domains  
Table 15: The most prevalent problems in the impairment, activity limitation and 
participation/social restriction domains 
Function Domain % 
Relaxation Participation 84 
Fatigue Impairment function 83 
Problem to the family Participation 75 
Emotionally affected Participation 72 
Pain Impairment Function 69 
Financial impact on family Participation 66 
Emotional  function Impairment Function 60 
Energy & drive function Impairment Function 60 
Standing long periods Activity 57 
Muscle power Impairment Function 50 
Community activities Participation 50 
Living with dignity Participation 50 
Sleep function Impairment Function 50 
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3.5.3.6 Table 16 Domains in which more than 50% of the respondents reported 
moderate to extreme problems/difficulties with particular function 
comparison of percentage scores across the WHODAS 2.0 domains:  
Repeated measures ANOVA indicated that there was a significant difference between 
domains, with participation being the most affected (Current effect: F (3, 975)=188.31, 
p<.001). Table 16 illustrates how participation/social restriction is the most affected domain. 
 Table 16: Mean scores of the different domains (n=502) 
 
Mean Standard Deviation 
Understanding/Communicaton 23.1 21.3 
Life activities 26.3 27.1 
Getting around 25.5 20.4 
Participation 46.0 17.9 
 
A post-hoc Tukey test was performed which indicated that there were significant differences 
between the three domains (Understanding/Communication, Life Activities, Getting around) 
and Participation, and between Understanding/Communication and Life Activities. 
 
 
 
 
   117 
 
 
 
Mean scores of the different domains
Understanding
Getting around
Life activities
Participation
15
20
25
30
35
40
45
50
55
M
e
a
n
 d
o
m
a
in
 s
c
o
re
 
Figure 22: Post-hoc Tukey test for domains 
Figure 22 shows the mean scores of each domain with 95% CIs. F(3, 975)=188.31, p<.001. 
Note that ‗Self Care‘ and ‗Getting along with people‘ are excluded.  
Table 17 shows the difference between domains. 
Table 17: Results of the Post-hoc Tukey test comparing the mean scores of the different 
domains (n=502)  
 Mean Getting Around Life Activities Participation 
Understanding 
/Communication 
23.0 0.11 0.01 <0.001 
Getting around 25.5  0.88 <0.001 
Life activities 26.3   <0.001 
Participation 46.0    
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3.5.4 Determinants of scores in the different domains 
Multiple regression analysis was used to establish which functions were the most predictive 
of the scores in each of the WHODAS 2.0 domains that demonstrated internal consistency. 
3.5.4.1 Understanding and Communication/cognitive 
The results of the forward stepwise regression analysis are shown in Table 18 below. The 
items that were entered by the programme first and which contributed significantly were 
subjected to further regression analysis using the enter method. Outliers whose residual 
scores were more than 2 SDs from the mean were excluded. 
Table 18: Results of regression analysis predicting the score of understanding and 
communication (n=502) 
 Understanding 
/Communication 
Step-+in/-
out 
Multiple-
R 
Multiple-
R-square 
R-
square-
change 
F – to-
entr/rem 
p-value 
Memory functions 1 0.60 0.36 0.36 221.56 <0.001 
Energy and drive 
functions 
2 0.64 0.41 0.06 38.79 <0.001 
 Sensation related to 
the skin 
3 0.67 0.45 0.04 27.98 <0.001 
Discomfort with sexual 
intercourse 
4 0.69 0.47 0.02 15.29 <0.001 
Digestive functions 5 0.69 0.48 0.01 7.74 0.01 
Skin functions 6 0.70 0.49 0.01 5.90 0.02 
Respiratory  7 0.70 0.49 0.01 5.07 0.03 
Muscle power 8 0.71 0.50 0.01 3.67 0.06 
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Emotional functions 9 0.71 0.50 0.00 2.44 0.12 
Sensations related to 
digestive system 
10 0.71 0.51 0.00 2.70 0.10 
Sensation of Nausea 11 0.71 0.51 0.00 3.01 0.08 
Sexual  functions 12 0.716 0.512 0.003 2.687 0.10 
Body image  13 0.717 0.514 0.001 1.004 0.32 
 
Thirteen subjects were excluded as their standard residual scores were greater than 
2*standard deviation.  The final set of impairments is listed in Table 19 and accounted for 
55% of the variance (Adjusted R²= .55 F(7,384)=69.04 ). 
Table 19: Results of final regression analysis model predicting the score of Understanding 
and Communication (n=502) 
 Understanding and Communication B Std.Err. - of b t(384) p-value 
Intercept 3.9 1.4 2.7 0.007 
Memory functions 21.1 1.8 11.9 <0.001 
Energy and drive 8.6 1.7 5.2 <0.001 
Discomfort with sexual intercourse 6.7 1.6 4.2 <0.001 
Digestive  functions 5.9 2.4 2.5 0.014 
Respiratory  5.6 2.0 2.7 0.006 
Skin functions 4.4 1.9 2.3 0.021 
Sensation related to the skin  4.4 1.8 2.5 0.014 
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The items which caused the greatest increase in the Understanding and Communication 
domain (in other words, they ‗made it worse‘) were problems with Memory, which increased 
the score by 21%.  This was followed by problems in the Energy and Drive function item 
which added a further 9% to the score.  
3.5.4.2 Getting around 
The results of the forward stepwise regression analysis for getting around are shown in Table 
20.  
Table 20: Results of regression analysis model predicting the score of Getting Around 
(n=502) 
Getting around Step - 
+in/-out 
Multiple 
– R 
Multiple - 
R-square 
R-square - 
change 
F - to - 
entr/rem 
p-value 
Muscle power 1 0.483 0.234 0.234 148.4 <0.001 
Energy and 
drive 
2 0.601 0.361 0.127 96.9 <0.001 
Memory 
functions 
3 0.658 0.434 0.073 62.2 <0.001 
Mobility 4 0.693 0.481 0.047 43.8 <0.001 
Respiratory   5 0.721 0.519 0.039 39.1 <0.001 
Blood pressure 6 0.744 0.553 0.034 36.3 <0.001 
Digestive 
functions 
7 0.753 0.567 0.014 15.3 <0.001 
Pain 8 0.758 0.575 0.008 8.6 0.003 
Fat metabolism 9 0.762 0.580 0.006 6.3 0.012 
Weight 10 0.764 0.584 0.004 4.8 0.030 
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maintenance 
Haematological 11 0.766 0.587 0.003 3.0 0.082 
 
After the significant variables were entered, residual analysis resulted in the exclusion of 20 
subjects.  The final items accounted for 63% of the variance (Adjusted R²= .63 
F(10,471)=82.070). 
Table 21 shows the final set of impairments that significantly predicted Getting Around. 
Table 21: Results of final regression analysis model predicting the score of Getting Around 
(n=502) 
Getting around 
 
B Std.Err. t(471) p-value 
Intercept 5.11 1.253 4.075 <0.001 
Blood pressure 11.36 2.177 5.218 <0.001 
Mobility 11.25 1.448 7.773 <0.001 
Memory functions 9.13 1.473 6.202 <0.001 
Respiratory   7.83 1.616 4.842 <0.001 
Energy and drive 7.37 1.375 5.360 <0.001 
Digestive functions 7.29 1.907 3.820 <0.001 
Muscle power 5.12 1.432 3.574 <0.001 
Weight maintenance 4.80 1.651 2.905 0.004 
Pain 4.38 1.398 3.135 0.002 
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Fat metabolism 4.13 1.522 2.714 0.007 
 
The items which caused the greatest increase in ‗getting around‘ difficulties were problems 
with blood pressure and mobility, which increased the score, in each case by 11%.  
3.5.4.3 Life activities 
The results of the forward stepwise regression analysis for life activities are shown in Table 
22.  
Table 22: Results of regression analysis model predicting the score of life activities (n=502) 
Life activities Step - 
+in/-
out 
Multiple – 
R 
Multiple - 
R-square 
R-square – 
change 
F - to - 
entr/rem 
p-value 
Muscle power 1 0.463 0.215 0.215 116.9 <0.001 
Memory functions 2 0.569 0.324 0.109 69.1 <0.001 
Energy and drive 3 0.613 0.375 0.051 35.0 <0.001 
Pain 4 0.643 0.413 0.038 27.2 <0.001 
Respiratory   5 0.668 0.447 0.034 26.1 <0.001 
Sensation of nausea 6 0.682 0.465 0.018 14.6 <0.001 
Heart functions 7 0.694 0.481 0.016 12.8 <0.001 
Mobility 8 0.703 0.494 0.013 10.8 0.001 
Sexual function 9 0.712 0.507 0.013 11.4 0.001 
Weight 
maintenance 
10 0.718 0.515 0.008 6.9 0.009 
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 Discomfort with 
sexual intercourse 
11 0.722 0.521 0.006 5.0 0.025 
 
Life activities, after 17 outliers were excluded: the final items accounted for 60% of the 
variance (Adjusted R²= 0.59644608 F (11,400)=56.223 ). Table 23 shows the final set of 
impairments that significantly predicted life activities 
Table 23: Results of regression analysis model predicting the score of Life Activities (n=502) 
Life activities B Std.Err. - of b t(400) p-value 
Intercept -1.61 1.793 -0.899 0.369 
Heart functions 15.68 3.431 4.571 <0.001 
Mobility 10.25 2.157 4.751 <0.001 
Respiratory   9.12 2.45 3.725 <0.001 
Sexual functions 8.98 2.426 3.7 <0.001 
Memory functions  8.24 2.155 3.825 <0.001 
Muscle power 8.04 2.089 3.848 <0.001 
Pain 7.34 2.011 3.648 <0.001 
Energy and drive 6.94 1.966 3.53 <0.001 
Sensation of Nausea 6.91 2.052 3.365 0.001 
Weight maintenance  6.67 2.369 2.817 0.005 
Discomfort associated with 
sexual intercourse 
5.78 1.886 3.067 0.002 
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The items in the impairment function which most predicted problems in life activities were 
heart problems, which increased the score by 16%, followed by the mobility function item, 
which added a further 10% to the score. 
3.5.4.4 Participation 
The results of the forward stepwise regression analysis for Participation/Social Restriction are 
shown in Table 24.  
Table 24: Results of regression analysis model predicting the score of Participation (n=502) 
 Step - 
+in/-out 
Multipl
e – R 
Multiple - 
R-square 
R-square - 
change 
F - to - 
entr/rem 
p-value 
Emotional functions 1 0.480 0.231 0.231 127.2 <0.001 
Discomfort  with 
sexual intercourse 
2 0.583 0.340 0.109 69.6 <0.001 
Memory functions 3 0.631 0.398 0.058 41.0 <0.001 
Pain 4 0.656 0.430 0.032 23.4 <0.001 
Energy  and drive 5 0.675 0.456 0.026 20.4 <0.001 
Muscle power 6 0.683 0.467 0.010 8.2 0.004 
Fat  metabolism 7 0.688 0.473 0.007 5.2 0.023 
Body image 8 0.691 0.478 0.005 3.9 0.049 
Haematological 
functions 
9 0.695 0.482 0.004 3.6 0.059 
 
Following the deletion of the data from 22 outliers, the model accounted for 57% of the 
variance (Adjusted R²= .56785867 F(8,395)=67.196 p<0.0000 Std.Error of estimate: 11.019). 
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Table 25 shows the final set of impairments that significantly predicted Participation/Social 
Restriction 
Table 25: Results of final regression analysis model predicting the score of Participation 
(n=502) 
 
Participation 
B Std.Err. t(395) p-value 
Intercept 21.96 1.373 16.00 <0.001 
Emotional functions 10.24 1.294 7.91 <0.001 
Discomfort  with sexual intercourse 6.96 1.196 5.82 <0.001 
Energy and drive 6.74 1.261 5.35 <0.001 
Memory functions 5.82 1.311 4.44 <0.001 
Pain 5.19 1.354 3.83 <0.001 
Muscle power 4.92 1.265 3.89 <0.001 
Fat metabolism 2.23 1.590 1.40 0.161 
Body image 2.15 1.235 1.74 0.083 
 
The items in impairment which significantly predicted problems in the participation domain 
were emotional problems, which increased the score by 10%. This was followed by problems 
in the sexual discomfort function item, which added a further 7% to the score.  
Items contributing to decrease in WHODAS scores across the domains 
As can be seen in the Table 26 below, which summarises the results of the regression 
analysis, problems with energy and drive, memory and digestive functioning were predictive 
of higher scores (that is, worse functioning) in all domains. Problems with digestive 
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functions, muscle power, pain, respiratory functions and sexual discomfort predicted higher 
scores in three of the four domains. 
Table 26: Impairment items (X) significantly decreasing the different WHODAS domain 
functions. 
 Understanding Getting 
Around 
Life 
Activities 
Participation Total 
domains 
Energy and drive X X X X 4 
Memory  functions X X X X 4 
Digestive functions X X  X 3 
Muscle power  X X X 3 
Pain  X X X 3 
Respiratory functions X X X  3 
Discomfort with sexual 
intercourse 
X  X X 3 
Fat metabolism  X  X 2 
Mobility  X X  2 
Skin sensation  X   X 2 
Weight maintenance   X X  2 
Blood pressure  X   1 
Body image    X 1 
Emotional functions    X 1 
Heart functions   X  1 
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Sensation of Nausea   X  1 
Sexual functions   X  1 
Skin functions X    1 
3.5.5 Summary of main findings 
This chapter presents the results of the description of the profile and prevalence of 
impairment, activity limitation and participation/social restriction amongst people living with 
HIV.  Males were in general older than females, with an average difference of five years.  
The most common marital status was ‗married‘ for males and ‗widowed‘ for females. There 
were more females unemployed compared to males, and males were found to be more 
educated than females. The longer the participants had HIV and had been on antiretroviral 
treatment, the more likely they were to be symptomatic.  The longer since the participants 
had been diagnosed and had been on antiretroviral treatment, the higher the CD4 count. 
‗Problems with pain and fatigue‘ scored higher than problems found in other domains under 
impairment. Problems in Participation/social functions were the most commonly reported, 
compared to the other domains.  Various impairments of body function predicted functions in 
activity limitations and participation/social restriction domains, with energy and drive and 
memory impairments contributing to an increase in scores across all domains and hence a 
decrease in function. 
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4 CHAPTER FOUR: PERCEPTIONS OF PLWH OF THEIR IMPAIRMENTS, 
FUNCTIONAL ABILITY AND ENVIRONENTAL FACTORS – 
METHODOLOGY AND RESULTS 
4.1 Introduction 
Chapter Four provides the background and the aims and objectives of this sub-study. The 
methodology is described, and the findings are presented. 
4.2 Background 
Both physical and psychological functional limitations have been identified in PLWH 
(Harding, et al., 2012). Physical problems, such as lack of energy, fatigue and pain, are 
frequently reported (Wig et al., 2008), and it is claimed they contribute to functional 
limitations in many activities that are part of daily life; this also leads to reduced productivity  
(Crystal, et al., 2000; Nair, et al., 2009). Paraesthesia, reduced mobility, dizziness, skin 
hardening, lack of appetite, visual problems and lipodystrophy are also commonly found 
(Harding, et al., 2012). 
Psychological problems related to the emotions appear to be the major functional problem 
encountered by PLWH (Wig, et al., 2008). Additionally, various studies have demonstrated 
that HIV stigma is experienced as an intrapersonal problem by PLWH, and can have a 
negative effect on their health, most importantly on their psychological and emotional 
functioning (Kalichman, et al., 2009).  Stigma could also lead to low self-esteem and anxiety. 
It can also prevent people from disclosing their HIV status (Pearson, et al., 2009).  However, 
it is possible to find PLWH who have overcome the stress of internalised stigmatization; and 
who try to accept their situation. They develop self- acceptance and try to cope with their new 
life; their new image is ―being HIV-positive‖. They are capable of avoiding the negative 
thoughts and attitudes which could prevent them from achieving their goal, which is, ―living 
well with HIV‖ (Nam et al., 2008). 
It has been observed that many PLWH have managed to disclose their health status; this is 
usually because they have developed a positive relationship with HIV. Most of those who 
deny their status have difficulties with disclosure and end up internalising the stigma 
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associated with HIV. There is evidence that PLWH are more likely to disclose to only a few 
people, usually those whom they are close to, for example to best friends or relatives, or those 
who have similar problems (Chaudoir, Fisher, & Simoni, 2011). However, although some 
PLWH have demonstrated positive attitudes towards their HIV serostatus and have decided to 
disclose,  there is evidence that they continue to experience stigma and discrimination from  
their communities  (Genberg, et al., 2009),  and this could discourage disclosure (Duffy, 
2005).  
PLWH need quality care that responds to all their functional limitations, which are related to 
the infection or to the antiretroviral treatment; they should strive to improve their health 
status so as to live a better life with the disease. It has been indicated that most of the health 
care services for PLWH focus on medical and physical care and are orientated towards 
biomedical treatment; other domains such as psychological, social, community, spiritual and 
individual growth tend to be neglected. Health care planners ignore the complexity of HIV, 
which requires a more holistic approach (Taneja, et al., 2012). 
It is important to explore the experiences of PLWH, in particular their functional limitations 
and the influence of the intrapersonal factors such internalised stigma, and of external factors 
such as family or community discrimination or the hospital environment. It is important to 
document the burden of this multifaceted and chronic health condition, and to monitor the 
effect of the antiretroviral treatment. This will enable one to evaluate antiretroviral treatment, 
in particular its effect on quality of care for PLWH. This will assist one to measure the return 
on health-care investments and the contribution and role of health-care providers as well as of 
the community. In addition, examining the perceptions of PLWH will help to determine what 
is required in terms of comprehensive care to address their many challenging needs.     
4.3 Aims and Objectives 
4.3.1 Aim 
The aim in this part of the study was, among PLWH on antiretroviral treatment with 
associated disabilities, to explore the relationship between the impairments, functional 
limitations, participation restrictions and personal and environmental factors. 
 
 
 
 
   130 
 
 
 
4.3.2 Objectives 
 To describe the PLWH with associated disabilities‘ perceptions of the relationship 
between disease, medication and functional limitations and participation restrictions; 
 To explore the effect of personal factors such as emotional and spiritual factors on 
their functional limitations and participation restrictions; 
 To explore the effect of the medical environmental factors on their functional 
limitations and participation restrictions: 
o To describe the reported satisfaction with the hospital services; 
o To describe how the hospital services assist them with their functional 
limitations and participation restrictions.  
 To explore the effect of the community environmental factors on their functional 
limitations and participation restrictions: 
o To describe if the community provides the support they need; 
o To describe the challenges they encounter in daily life in the community 
environment. 
4.4 Methodology  
In the following section the research design that was chosen to achieve the objectives of this 
study is described. The research settings, the study population, the sample size and the 
sampling techniques used are all described. The screening tool that was used to select 
participants for the discussion and the interview guide used for the discussion are described.  
The data collection method and procedure, the data analysis, the strategies to ensure rigour of 
research and ethical considerations are all discussed.  
4.4.1 Research design 
An exploratory study using focus group discussions (FGDs) based on the approaches of 
Boeije (2010) and Merriam (2009), was conducted utilising qualitative research 
methodology. It was considered an appropriate method for understanding and interpreting the 
experiences of PLWH (Babbie and Mouton, 2001; Denzin and Lincoln, 2000). As Morse 
(2012) has described, qualitative methodology can be used to explore health and illness and is 
useful for eliciting emotions and perspectives, beliefs and values, and actions and behaviours 
for the purpose of understanding the participants‘ responses to health and illness, and the 
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meanings they construct about their experience, and their subsequent actions. This 
methodology was also used to understand the influence of environmental factors on the 
functional limitations (Hennink, Hutter, and Bailey, 2010). 
Furthermore, the qualitative methodology was used to explore and understand some of the 
findings in the survey (Chapter Three), for example; majority of the participants in the survey 
scored very highly in the ―problems with participation/social restrictions‖ domain compared 
to other domains. Moreover, statistical tests revealed the likelihood of certain impairments, 
such as emotional problems and difficulties with sexual intercourse. From the survey alone, it 
was difficult to understand the reason for this high frequency or the relationships between 
these problems or to determine possible influences on the problem. 
Additionally, by using the qualitative method the participants could also explore their 
experiences with regard to the health services and make suggestions for improvement. 
4.4.2 Research setting 
The study, using two FGDs, was carried out in two hospitals, one in each of two provinces in 
Rwanda.  
4.4.3 Study population, sampling technique and sample size  
Sampling was carried out to identify a diverse group of participants who would bring 
different experiences, perceptions and understandings to the group. 
4.4.3.1 Selection of provinces and hospitals 
One urban and one rural setting was selected to increase diversity. Kigali, the capital city of 
Rwanda, which forms an independent province was purposively selected as the urban setting 
as it reflects an urban setting most strongly. Simple random sampling was used to select one 
of the four other provinces that were involved in the survey (see Chapter Three), the Southern 
Province. Two hospitals that were involved in the survey were then purposively selected, one 
in each province. One hospital was in an urban area, Hospital A in the province of Kigali; the 
other hospital, Hospital B, was a hospital in the rural area of the Southern Province.  The two 
hospitals are both public government hospitals; however, Hospital B is a partially church-run 
hospital. Both hospitals are district hospitals.  
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4.4.3.2 Study population, sampling technique and sample size  
Participants were adult female and male PLWHs with associated disabilities and attending the 
ARV clinics at the selected hospitals. 
As the results of the FGDs were to be used to validate the use of the WHODAS 2.0 and the 
Impairments Questionnaire, participants of the survey were not eligible to take part as they 
would have been ―primed‖ by the items in the questionnaires.  This would have introduced an 
a priori bias in to their discussion. Therefore a different sample was identified.  
4.4.3.3 Sampling technique and sample size 
At each hospital, the nurse responsible for the ARV clinic explained the purpose of the 
researcher‘s visit and the activity to be carried out to all patients attending the clinic. The 
researcher then explained the purpose of the study to the patients. 
All patients on antiretroviral treatment were invited to participate in screening for functional 
limitations. The patients who agreed to participate were screened using a screening checklist 
(See Section 4.4.4). 
Purposive sampling was used to select the participants for FGDs from those who were 
screened. A diverse group of patients were selected with differences in relation to the gender, 
age, functional limitations and severity of disability. These patients were then invited to 
participate in the FGDs. The final groups at each hospital included eight participants, three 
male and five female. 
4.4.4 Screening checklist and interview guide  
4.4.4.1 Screening checklist 
The screening checklist (Appendix V) (developed by the researcher) was adapted from the 
Washington Group on Disability Statistics: Short Set Questions on Disability (CDC, 2010; 
Madans, Loeb, & Altman, 2011). The Washington Group developed a short question set on 
disability in a form of checklist to be used in a national census to gather information about 
functional limitations in a population in short time. The rationale for this checklist was to 
identify, in a given population, people with similar types and levels of limitation with regard 
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to performing basic activities.  The questions were designed to apply across nations, cultures 
and even across different economic statuses (CDC, 2010). 
However, in order to make the process more holistic, the screening checklist was adapted to 
include some questions based on the functional limitations identified among PLWH in the 
survey presented in Chapter Three. The screening checklist differed from the long 
questionnaire we used for the survey: it was structured differently, and was designed to 
gather key information on functional limitations in a short time. 
4.4.4.2  Interview guide 
An interview guide (Appendix VI), developed by the researcher, was used for the two FGDs. 
It was based on the outcomes of and issues emerging during the survey (see Chapter Three). 
It contained open-ended and probing questions based on the approach of Patton (2002) to 
allow participants‘ experiences to emerge. Probes were used to deepen the discussion. 
To understand participants‘ perceptions of the relationship between the disease, the 
medication and the functional limitations, the personal and the community factors: 
1. Are there things that you could do in the past and are no longer able to do since you 
became ill?  
2. How did taking medication change any of the things mentioned above? 
To understand participants‘ experiences of the medical environmental factors: 
3. Can you describe your experiences with how the hospital health care providers tried 
to assist you with the problems you have described above?   
4. Can you give your opinions or views on what can be done to improve the hospital 
services so as to assist you with your problems and to improve your quality of life? 
4.4.4.3 Translation of the screening checklist and the interview guide 
All translators were fluent in English, while Kinyarwanda was their native language. Forward 
and backward translation was done of both the screening checklist and the interview guide. 
The rationale of this was to make sure that the questions asked were well understood in the 
language that would be used by the participants during the screening and FGDs. Additionally, 
the translation was intended to ensure that during discussion the interviewer would be 
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spontaneous and conversant with the questions posed in the language used by participants; 
when hearing their responses, he would remain focused and allow the discussion to flow 
naturally.  Hennink et al. (2010, p. 148) indicated that ―it is recommended that the discussion 
guide be translated into the language in which the discussion will be conducted. Using a 
translated discussion guide takes a lot of pressure off the moderator, who would otherwise 
need to translate each question as it arises during the group discussion‖. 
The forward translation was done by two people. The first person was a physiotherapy 
lecturer who had participated in the consensus meetings for the translation of WHODAS 2.0 
(see Chapter Six). He had also participated in the screening and played the role of moderator 
in both FGDs.  Additionally, he was consulted during the transcription and translation of the 
FGDs‘ results from Kinyarwanda into English. The second forward translator was a 
Kinyarwanda teacher in a secondary school and an expert in linguistics. He also participated 
in the forward translation of WHODAS 2.0 (see Chapter Six) and in the consensus meetings 
(see Chapter Six) and he was the principal translator of the FGDs‘ findings into English.  
The backward translation was done by a qualified physiotherapist, who was also recruited as 
a research assistant for the screening of the participants for the FGDs; he also assisted in 
taking notes during FGDs and with the transcription and translation of the findings.  Another 
linguistic expert, a lecturer at Kigali Health Institute, assisted with proofreading, both of the 
screening checklist and the interview guide. Hennink et al. (2010, p. 148) said; ―it is 
extremely important to check the quality of the translated discussion guide and back 
translation is a common strategy for checking translations, whereby translated text is 
translated back into the original language and checked for accuracy‖. 
4.4.5 Data collection  
4.4.5.1 Data collection method 
Two FGDs were used to gather in-depth information from the participants. Eight participants 
were included in each group (Hennink, et al., 2010). 
This method of data collection was chosen to allow all participants the opportunity to share, 
listen and understand one another‘s opinions and to develop and generate ideas beyond their 
own original voices as the conversation progressed (Babour & Kitzinger, 2001; Patton, 
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2002).  It was considered the best method for exploring the participants‘ experiences, 
opinions, needs and concerns. It gave the researcher the opportunity to discover how 
participants complemented each other, reached a consensus or opposed each other‘s ideas 
(Babour & Kitzinger, 2001). This allowed a dynamism to develop that gave participants the 
opportunity to interact and build on each other‘s ideas and opinions, enriching the 
information that emerged and enhancing the quality of the data (Denzin & Lincoln, 2005; 
Patton, 2002). 
The method was chosen to enable people who might be intimidated by one-to-one/face to 
face interviews to participate in research by offering collective ways of communication 
(Patton, 2002). The participants who were from the same cultural background were 
encouraged to share their ideas, beliefs and attitudes towards HIV and functional limitations. 
The FGDs were also able to provide safety and build the confidence of people who seemed to 
be vulnerable when alone. The group gave them the opportunity to come together, with warm 
feelings creating bonding and the ability to share their own experiences with regard to 
particular functional limitations.  
The FGDs were done at the hospitals in a social context where the participants could consider 
their own views in relation to the views of others and through this process generating high 
quality data (Patton, 2002). In a little over one hour, the researcher was able to gather very 
rich information from eight people instead of from only one (Patton, 2002). 
4.4.5.2 Data collection procedure 
Step1: Obtaining permission 
In December 2011, prior to data collection, letters were sent to hospital managers to ask 
permission to collect data. Letters granting ethical clearance and letters from the same 
hospitals granting permission for the survey were attached. A letter to support the study was 
requested from the Ministry of Health/ Rwanda Biomedical Centre HIV division (RBC/HIV 
division) (see the ethical consideration, section 4.4.8). Permission was granted in February 
2012.  
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This was followed by visits to the two hospitals; one day was assigned to each hospital to 
prepare for fieldwork and ensure that hospital managers and health care providers in the ARV 
clinics understood and supported the study.  
 Step 2: Identifying participants: Inviting PLWH to clinic 
Visits were made to the two hospitals to prepare for data collection. The nurse responsible for 
the clinic assisted in choosing the day for data collection, based on the availability of the 
patients. 
Step 3: Training the moderator and note taker 
The site visits were followed by training over two days at the KHI to select the moderator and 
the note taker for the FGDs and to assist with screening. They were already familiar with the 
purpose of the study and the screening checklist as they had participated in its translation. 
Step 4: Identifying participants for screening 
Data collection took one day at each hospital.  At both sites the FGD took place in the 
morning as this time was preferred by patients so they could go home early and continue with 
daily activities.  
At each hospital the nurse responsible for the clinic had prepared three rooms for the 
screening, one for each interviewer, and a very comfortable room was prepared for the FGD. 
This nurse gave a general and brief introduction to all the patients at the clinic about the 
reason for our visit, and then the researcher explained the purpose of the study using the 
participant information sheet (Appendix VII).  She ensured that the participants understood 
that there were two stages. It was explained that only those patients who had been on 
antiretroviral treatment from 2009 or earlier were eligible to participate. The researcher 
explained that participants were allowed to withdraw from the study at any time should they 
feel uncomfortable. They were further assured that their participation in the study would 
remain confidential.   
Data collection started at Hospital A. A large number of patients attended the clinic that day 
for routine consultation and to receive antiretroviral treatment. Although the research team 
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arrived at the clinic opening time at 07h00, patients started arriving at 08h30. They were 
invited by the nurse to voluntarily join the screening after they had received their 
antiretroviral treatment. The patients signed the consent forms (Appendix VIII) prior to 
screening. At Hospital B the procedure was similar, the only difference being there were 
many patients at this clinic who wanted to take part in the screening. 
Step 5:  Screening to identity participants for FGD 
A screening session took at least 7 to 10 minutes. In total, 40 patients were screened at 
Hospital A and 50 at Hospital B, where many more had volunteered. However for 
consistency, at each hospital up to 20 patients were selected to be invited for FGDs; most had 
functional limitations categorised as severe to extreme; following the screening checklist 
rating scale (Appendix V). After screening, if a patient was considered suitable for the FGD, 
he/she was requested to wait.   
At Hospital A, the urban hospital, some people were reluctant to participate in the screening 
and in the FGD, despite the explanations by the nurse and the researcher. They spent time 
discussing this with one another, in the process affecting the time available for the screening 
and for the FGD. In addition, at first they did not want their voices to be recorded until they 
were sure about confidentiality. Things were different at Hospital B, the rural hospital, where 
the majority of people who were invited for the screening were enthusiastic, and even those 
who were not suitable to participate in the FGD asked if they could.  Of the twenty people 
found suitable for the FGD, 15 were willing to participate. This was a challenge for the 
research team as only eight people could participate and the researcher had to explain this to 
them. After the screening, the 20 patients eligible for the FGD were gathered in one room and 
invited by the researcher and the moderator to participate in the FGD.  
In both hospitals, more women than men volunteered to participate in the FGD.  As a 
consequence at each hospital there were five women and three men in the final sample for 
each FGD.  
Step 6: FGD 
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Before starting, the purpose of the research was again explained by the researcher in 
Kinyarwanda to the participants, by referring to the participant information sheet (Appendix 
IX). All participants were asked to sign a consent form agreeing to their participation in the 
FGD and allowing the use of the tape recorder in order to obtain accurate data (Appendix X). 
The researcher explained why each of the participants had been included and they were asked 
to feel free and relaxed during the discussion. 
The moderator facilitated the discussion in Kinyarwanda. He started by introducing the 
research team, explaining the discussion procedure, and giving assurances that ethical issues 
would be considered throughout the process of data collection. He then welcomed all the 
participants and asked them to introduce themselves. Participants were thanked for accepting 
the invitation to participate in the discussion. The moderator opened the discussion with jokes 
and humorous stories to create a relaxed atmosphere. A bottle of soda was provided to each 
participant as in Rwandese culture, when you invite people for a discussion or gathering, it is 
customary that you share a drink. Participants could then freely share their experiences of 
living with HIV and of how the hospital assisted them to deal with their new lives.  
Notes were taken by a trained research assistant. The researcher‘s role was to monitor the 
tape recording, to take notes using a pen and a notebook and to oversee what happened 
during the FGD. In the middle of the discussion, people who tended to be shy were 
encouraged by the moderator to contribute to the discussion. This was important, as certain 
participants were not very open about sharing their opinions, particularly at Hospital A.      
Before closing the discussion, the moderator, note taker and the researcher reviewed and 
summarized the main points from the discussion and reviewed the notes taken. Each said 
something or read a summary of what he/she had written about the subjects under discussion. 
Participants were then asked if they agreed with this record of the discussion, and any 
corrections or addition information were considered.  It was necessary to check if all the 
questions in the study had been covered and if the issues raised during discussion had been 
adequately dealt with. It was important to ensure the accuracy of the data before leaving the 
field, as this would to improve the reliability of the findings.  
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At the end of the review, the participants were thanked and were offered a transport ticket as 
a token of appreciation for their patience, as they would be leaving the hospital later than 
usual. This would enable them to travel by motorcycle which is faster (but more expensive) 
than a taxi bus and they would avoid arriving home too late. Participants at both sites, for 
their part, expressed their appreciation at being consulted and at being able to contribute to 
the improvement of their health care. The discussion lasted for one hour and forty minutes at 
Hospital A, while at Hospital B it took one hour and twenty five minutes.  One of the reasons 
for this difference might be that one of the participants at Hospital A became emotional, and 
this caused a break and a moment of silence during the discussion. 
4.4.6 Data analysis   
4.4.6.1 Step 1: Transcription 
Two days after data collection, verbatim transcription of the interviews commenced.   This 
was done by the researcher, the research assistant, the moderator and the translator, who was 
an independent person who did not participate in FGDs. The moderator‘s role was to read all 
the notes from the two sources; the researcher‘s responsibility was to monitor the recording; 
the research assistant played the role of rapporteur. The translator was invited as an observer.  
The involvement in transcription of all the people who participated in the FGDs was 
interesting and made the task much easier. They distributed the various roles among 
themselves and together they made sure what was discussed was accurately transcribed. It 
was also important to invite the translator so that he became familiar with the format of the 
conversation before translation. For example; he was supposed to know that it was important 
to take into account body language and emotional expression. 
The transcript included everything the participants said, taken directly from the tape recorder. 
Later handwritten notes that were made by the researcher and research assistant were 
integrated into this transcript text. These notes included observations about body language 
and emotional expression. The transcripts for the two hospitals were done separately. 
4.4.6.2 Step 2: Translation from Kinyarwanda into English 
After transcription, the transcripts were given to the translator to produce English versions. 
The researcher decided to choose a translator who was familiar with the rationale of the 
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study. He had participated in the translation of the WHODAS 2.0, the instrument used in the 
previous study, and in the translation of the screening checklist and the FGD interview guide. 
Thereafter, the whole team met for four days of consensus meetings at KHI to critically 
review both transcripts, comparing the translated English transcripts with the Kinyarwanda 
originals. There was an attempt to assess the integrity of the semantic and conceptual 
meanings. The team also considered whether the results met the objectives of the study and 
were accurate representations of issues and questions raised during the discussion.  
In discussing the translation into English, it was found that certain concepts or phrases, 
particularly medical terms, had lost their original meaning. Some words had been translated 
literally when this should not have happened. For example, participants used the word 
abasirikari in Kinyarwanda to mean ‗CD4‘ when the literal meaning of abasirikari in 
English is ‗military‘. The translator found the word did not fit in the sentence where it was 
used and decided to leave it for decision by the consensus meeting. Other words or phrases 
had been left out because the translator had found them problematic.  All these problematic 
words were identified during this consensus meeting and appropriate translations were finally 
found.  After this meeting the English version of the two transcripts was considered to be 
ready for further analysis. The experience gained during the process of translating WHO 
DAS 2.0 (see Chapter six) was extremely useful in the translation of FGD‘s transcripts and in 
the organisation of the consensus meeting. It was also helpful because the moderator and the 
translator had both participated in the translation of WHODAS 2.0 (Chapter Six).  
4.4.6.3 Step 3: Coding, categorising and creating themes 
Content analysis was used to analyse the data. The use of the interview guide helped to 
structure the data gathering so data analysis was facilitated in such a way that participants‘ 
responses were organised and relatively easily to identify, as they followed the questions 
formulated in the interview guide (Patton, 2002). Content analysis was used as results in 
categories which would describe the phenomenon under study (Elo & Kyngäs, 2008).  
Merriam (2009, p. 205) indicated that  
―in one sense, all qualitative data analysis is content analysis in that it is the content of 
interviews, field notes, and documents that is analysed. The process of content analysis 
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involves the simultaneous coding of raw data and the construction of categories that 
capture relevant characteristics of the document‘s content‖.  
The two transcripts, one from each FGD, were combined into one document, but the 
identities of each FGD were retained as A or B. The researcher read and reread the original 
transcripts to make sure she understood and was able to interpret the participants‘ views. This 
was done using the method described by Boeije (2010), who says that repeated reading 
allows the researcher to enter into the participant‘s world and engage with the data. 
The first step in the analysis was coding. The lines in the transcriptions were numbered. The 
researcher then wrote informative, exploratory and explanatory notes in the margins next to 
corresponding words or phrases to describe what the participant was saying. These notes 
were used to select codes (Creswell, 2009, 2013; Merriam, 2009). A table was then 
constructed to organise the codes and the corresponding data. 
Column 1 comprised data organised by grouped words, concepts or phrases cut from the 
transcript; the grouping was based on similarity in meaning. Column 2 consisted of codes. 
Each code was put next to the matching grouped words or concepts or phrases. 
There was a lot of line cutting and copying and pasting in the process of organising the data 
into sections identified by a code. Identification of the right code was considered essential, so 
before cutting and pasting sections of the text, transcripts were read critically several times to 
ensure the word or the phrase was assigned to the correct code.  As the researcher reviewed 
the transcripts some new codes were created or possibly renamed.  
Some codes were merged and this process continued and contributed to the identification of 
subcategories and then categories. From categories, themes were identified and appropriate 
words were found to name the themes (Creswell, 2009, 2013; Merriam, 2009).  The 
identification of codes, categories and themes was initially done by the researcher, assisted by 
her supervisor. Subsequently the moderator and the research assistant were consulted for their 
input and to check that no idea had been left out or allocated incorrectly (put into the 
incorrect theme). For example, they suggested some of the participants ―opinions‖ needed to 
be shifted from the theme ―How the hospital services help me to cope with my problems as a 
PLWH‖ to ―How the hospital services can improve, to respond to my needs as a PLWH‖. 
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Table 27: Example of coding and creating themes 
Data organised in grouped words/concepts Code Subcategory Category Theme 
L22 1A: I don‘t have the energy I had before! 
L25 3A: Ha!!! Afternoon I am already tired! Energy is longer 
there!!! 
L603 1B: In general, I feel getting weaker and weaker. This proves 
me that there is something wrong in the body, Hum! I just feel my 
body is longer the same!! 
Lack of 
energy/tiredness 
Physical problem Present from the 
onset of HIV 
My body 
problems 
L700 6B: Heeee! I can tell; you the medicines have caused much 
memory loss! I now forget like an old person! 
L702 7B: I also have a big problem of memory loss. 
Loss of memory Psychological 
problem 
Occurred when 
started 
medications 
My body 
problems 
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Data organised in grouped words/concepts Code Subcategory Category Theme 
L707 6B: There is also non-proportional increased body weight. 
You notice that one body part swells excessively while another is 
very thin. Hum!! This makes us wear trousers or long clothes in 
order to hide very small legs with visible tendons and blood vessels. 
They sometimes change our medicines, but not much improvement. 
L 292 3B: (Speaking with sorrow) when I started medicines 
(Triviro), After sometimes, my legs, arms and buttocks got thinner, 
the face and the belly swelled. In short, the whole body was 
deformed. 
Body image  Physical problem Occurred when 
started 
medications 
My body 
problems 
 
 
 
 
   144 
 
 
 
4.4.7 Rigour   
 To ensure rigour of the study, the following strategies were followed:  
4.4.7.1 Transferability 
Merriam (2009) suggested that one of the strategies to enhance the transferability of 
qualitative results could include maximum variation in the characteristics of the sample; this 
could be applied when selecting the sites for data collection or the participants.  As is 
described in the sampling section and in data collection procedure, in the present study, 
hospitals were selected from those chosen during the survey; one hospital was selected from 
an urban area and another from a rural area. Participants were men and women who varied in 
age, marital status, education and economic status and in length of time since starting on 
antiretroviral medication; however all had started on antiretroviral medication from 2009 or 
earlier. This was to ensure to allow consistency with the previous study (the survey). The use 
of purposive/judgement sampling was reported in Merriam (2009) and also in   Babbie and 
Mouton (2001) as a way of enhancing transferability. Purposive sampling was used to select 
hospitals and participants eligible for FGDs from different demographic and socio-economic 
background.   
4.4.7.2 Credibility 
Babbie and Mouton (2001) and Merriam (2009) stated that credibility of the findings in a 
qualitative study is crucial, and that one of the most important strategies to enhance 
credibility is triangulation. This could be achieved through the use of various investigators for 
data collection and analysis, or through the use of multiple sources, methods and materials for 
data collection. 
As it is stipulated in the sections on tools translation and the procedure for data collection, the 
researcher decided to involve the moderator, the research assistant and the translator (from 
the planning of data collection) to assist in preparation and with the translation, as they were 
familiar with the whole process of data collection and analysis, and they understood the 
objectives of the study; both the moderator and the translator had been involved in the 
elaboration of the instrument used in the survey and the research assistant had assisted in 
obtaining the necessary permission.  
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Thereafter, the moderator and the research assistant participated in the screening and in the 
FGDs and all three together participated in the data transcription and translation process. This 
consisted of consensus meetings to produce the final English transcript. The three experts 
were also consulted during other steps in the process, such as in the analysis and presenting 
and writing up of the findings. Additionally, all FGD discussions and observations were 
documented by the researcher and the research assistant; this included documenting 
participants‘ opinions, emotions, behaviour/attitudes etc.  Discussions were also audio-
recorded. All of these could influence the quality of the data obtained.  
Furthermore, Thomas and Magilvy (2011), Babbie and Mouton (2001) and Merriam (2009) 
recommended member checks as another important strategy for ensuring the credibility of the 
findings obtained.  Merriam (2009, p. 217) named this ―respondent validation‖. According to 
Babbie and Mouton (2001, p. 277) , ― the aim of member checks is to assess the intentionality 
of respondents, to correct for obvious errors, and to provide additional volunteer information. 
It also creates an opportunity to summarize what the first step of the data analysis should be 
and to assess the overall adequacy of the data, in addition to individual data points‖. 
For this current study, notes from both sources (the researcher and the research assistant) 
were compared for each site; before ending the session, data was repeatedly checked, and 
thereafter a summary was presented by the moderator to participants at the end of the FGD 
session. The participants‘ comments were solicited and considered to ensure that 
interpretation was valid and that nothing was left out.  
In order to improve the credibility of the findings in this study, the researcher has written a 
section on reflexivity, which describes her position during the whole process of data 
collection and how she sometimes looked at things at from her own perspective rather than 
from the participants‘ perspective. This was done as suggested by Thomas and Magilvy 
(2011) and also Merriam (2009, p. 219).  Merriam commented as follows: ―related to the 
integrity of the qualitative researcher; is another strategy to enhance credibility sometimes 
labelled researcher‘s position or reflexivity. The investigator needs to explain his or her 
biases, dispositions, and assumptions regarding the research to be undertaken. Such a 
clarification allows the reader to better understand how the individual researcher might have 
arrived at the particular interpretation of the data‖. 
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4.4.7.3 Dependability 
Babbie and Mouton (2001) indicated that the dependability or consistency of findings in 
qualitative research means that if the study had to be repeated with the similar participants 
and in the same context; it would produce similar findings. Thomas and Magilvy (2011) 
emphasized that one important strategy to improve dependability in qualitative research was 
to involve peers in the analysis of data. Merriam (2009) summarised as follows:  
triangulation, peer examination, the researcher‘s position or reflexivity and the audit trial are 
the most important strategies to use to enhance the dependability or reliability of the findings 
in qualitative research. Methods used for triangulation and for clarifying the researcher‘s 
position have been already described.  
In addition, to ensure the dependability or consistency of the findings; as recommended by 
Thomas and Magilvy (2011) and Merriam (2009), the researcher kept a research record 
where she recorded all the procedures for data collection, from the first day she visited the 
hospital to seek permission and to identify participants eligible for interview.  All that she 
observed, as well as comments from participants or health care providers, and challenges 
encountered, were included in the record. In addition, the researcher‘s thoughts about the 
understanding and interpretation of participants‘ comments and decisions on certain issues 
were also considered and documented. In a recent article by Houghton, Casey, Shaw, and 
Murphy (2013) it was reported that in qualitative study, thoughts and ideas recorded 
throughout the data collection process could be useful for the development of themes, not 
only to enhance dependability but also to emphasize the transparency of the process followed. 
Some of this data is presented in the section on methodology. This describes how data was 
collected, transcribed, translated and then coded by the student researcher, assisted by her 
supervisor, before being entered in the final report. The moderator, research assistant and the 
translator were consulted for peer examination.  
4.4.8 Ethical considerations 
Ethical approval was given by UWC (see Chapter Three Appendix I), and ethical clearance 
was also obtained from CNLS (see Chapter Three Appendix I) and the KHI IRB. In addition, 
on request, a supporting letter was provided by the Ministry of Health RBC/HIV division ; 
this is the organisation that currently coordinates all HIV programs in Rwanda. Hospitals 
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needed this supporting letter in order to update the permission that had previously been 
granted by the CNLS (Appendix I) as the responsibility for coordinating HIV programmes 
had passed from the CNLS to the Ministry of Health RBC/HIV division during the period of 
the study. Permission from the two selected hospitals to conduct the FGDs was granted. 
Two participant information letters (Appendices VII and IX) were used to explain the 
objectives and provide details of the study and to invite participants to take part in the study. 
The first letter was to invite their participation in the screening. The second letter was to 
invite their participation in the FGD. Participants were requested to sign consent form 
(Appendix VIII) agreeing to their participation in the screening, and those who were selected 
for the FGD completed another consent form agreeing to participate in the FGD and agreeing 
to the use of an audiotape recorder during the FGD (Appendix X).  All forms were developed 
in English but translated into Kinyarwanda before use.   
Participation was voluntary and participants were told that they had the right to withdraw 
from the study at any time and that this would not have any negative consequences for their 
care. Participants were guaranteed confidentiality but they were also requested to keep what 
was discussed in the FGD confidential.  Prior to data collection, the interview team decided 
to use pseudonyms when reporting.  At each site, immediately after the introductions, every 
participant was given a number and they were all understood that the numbers and the 
hospital label Hospital A and Hospital B  would be used when reporting instead of their 
names: for example, participant A 2.  Allocation of numbers followed the sitting 
arrangement. 
There was one incident where a participant became very upset. During the discussion at 
hospital A, a woman cried while telling the story of how the husband had mistreated her after 
she tested HIV positive.  The researcher was a trained counsellor, so prior to the discussion 
she was aware such reactions might happen. The counsellor at the HIV clinic had been asked 
make herself available if needed and the moderator was advised to allow a moment of silence 
if such a situation happened. When it occurred, the moderator stopped facilitating and 
immediately everyone in the room also kept quiet (without being asked) and seemed sad. The 
researcher utilised some counselling techniques for example, tapping on the back of the 
patient to assist her so she could continue to participate in the group.  After a while, she 
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stopped crying and chose to continue sharing with others.  At the end of the FGD she was 
referred to the clinic counsellor for follow up. 
4.5 Findings  
The purpose of the FGDs was to explore the perceptions of PLWH on ARV with associated 
disabilities the relationships between personal and environmental factors and the impairments 
and functional limitations. Sixteen participants took part in two focus group discussions, with 
eight participants per group. 
The findings are presented according to the six themes that emerged from the analysis: 
1. My body‘s impairments; 
2. Functional limitations and participation restrictions I experience; 
3. Personal factors that influence my functioning as a PLWH; 
4. Social relationship or community environmental factors that influence my functioning 
as a PLWH; 
5. Hospital environmental factors that influence my functioning as a PLWH; 
6. How the hospital services could respond to my functional limitations.  
The participants are not identified in the quotes. Interjections, such as ―hum‖, are included to 
assist the reader in understanding the contextual meaning and the emotions expressed by the 
participants. 
4.5.1 Socio-demographic profile of the participants 
The socio-demographic profile of the participants from Hospital A is presented in Table 28 
and that of participants from Hospital B in Table 29. 
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Table 28: Focus Group A: Hospital A  (Urban):  participants (n=8) 
Participant  
Number     
Age 
(Years) 
Sex Marital 
status 
Employment Years on 
ARV (n) 
1 47 Male Separated Assistant builder 4 
2 49 Male Married Bank cashier 5 
3 45 Female Widowed Tailor 9 
4 66 Female Widowed Waiter 7 
5 30 Female Single Assistant builder 3 
6 28 Male Single Watchman  3 
7 46 Female Cohabiting Vendor  5 
8 23 Female Married Student 4 
 
Table 29: Focus Group B:  Hospital B (Rural) participants (n=8) 
Participant  
Number     
Age 
(Years) 
Sex Marital status Employment Years on 
ARV (n) 
1 36 Female Married Farmer 6 
2 21 Male  Single (Orphan) Student 3 
3 38 Female Widowed (twice) Farmer 8 
4 44 Male Separated Farmer 6 
5 30 Male Married Driver 5 
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6 42 Female Married Tailor 8 
7 45 Female Married Housewife 3 
8 38 Female Married Teacher 8 
 
4.5.2 Theme 1: My body’s impairments 
Participants described the many body impairments they experienced in everyday life. These 
included tiredness/fatigue, body weakness/lack of energy, pain (knee pain, abdominal pain, 
headache and backache), paraesthesia in the legs and arms, dizziness, lipodystrophy and body 
image, memory loss and lack of concentration. Nausea, lack of appetite, intolerance to food, a 
persistent cough, breathlessness, skin hardening, fever and herpes zoster were also mentioned 
by some participants.  In urban and rural settings, the problems were similar. 
Participants said that the problems started after being infected with HIV and/or after starting 
the antiretroviral treatment, and sometimes impairments/problems might change overtime, 
they might either get worse or improve. Participants also complained about two, three or 
more problems occurring concurrently, especially after starting antiretroviral treatment. For 
example 1B (a 36 years old rural woman, who had been on antiretroviral treatment for 6 
years) said: 
Yeah, medicines brought me many problems: such as paraesthesia in legs and arms as 
well as abdominal pain and headache.  
3A: They have changed my medicines three times. Can you believe! At the last phase, 
my body weight decreased, I became weak, the knees started aching until now; I am 
worried! (Urban, female, 45 years old, 9 years on antiretroviral treatment) 
7A: The medicines they give us made my muscles and nerves ache. I am getting thinner 
and I have continuous paraesthesia. When they change them [the medicines], 
sometimes the pain gets reduced. (Urban, female, 46 years old, 5 years on antiretroviral 
treatment) 
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4.5.2.1 Lack of energy 
Participants described physical problems they experienced after being affected with HIV. 
They used the words lack of energy (kubura imbaraga), lack of force (kubura ingufu), 
tiredness or fatigue (umunaniro), and body weakness (gucika intege). Those terms were used 
interchangeably and frequently in both FGDs. Lack of energy was considered a chronic, but 
severe problem; it appeared to be a problem that had changed their bodies completely:   
1B: In general, I feel [I am] getting weaker and weaker. This proves that there is 
something wrong in the body, Hum! I just feel my body is no longer the same. (Rural, 
female, 36 years old, 6 years on antiretroviral treatment) 
4.5.2.2 Pain 
Pain was described by many participants, who used various descriptions. 
Pain experienced as severe   
Some participants (male and female, urban and rural), complained that the pain was severe 
 5B: Ah! 
5
I feel much pain. (Rural, male, 30 years old, 5 years on antiretroviral 
treatment) 
Pain experienced as chronic 
Some other participants (male and female, urban and rural) described pain as chronic 
8B: I Always suffer from abdominal pain. (Rural, female, 38 years old, 8 years on 
antiretroviral treatment)  
1B: I have suffered from headache for six months; until now it persists. (Rural, female, 
36 years old, 6 years on antiretroviral treatment) 
 
 
 
                                                 
5 Expression of emphasis 
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Pain experienced affecting many parts of the body 
Participants (male and female, urban and rural) said  that pain frequently affected almost all 
parts of the body. They complained about backache, headache, knee pain and abdominal 
pain. 
Pain experienced after starting antiretroviral treatment 
Many of the participants said they experienced pain after starting the antiretroviral treatment. 
1B: Hum!
6
  ARV brought chronic headache! (Rural, female, 36 years old, 6 years on 
antiretroviral treatment)  
4B: Haaa!
7
 It is painful. (Rural, male, 44 years old, 6 years on antiretroviral treatment) 
3B: Hum!
8
 The medicines (antiretroviral treatment) can cause many problems, I can 
tell you! For example dizziness and abdominal pain; it hurts like a wound! (Rural, 
female, 38 years old, 8 years on antiretroviral treatment) 
4.5.2.3 Paraesthesia 
Participants  in both FGDs complained also about parasthesia and described it as follows: 
Parasthesia sensations 
Particpants described parasthesia as being like itching with pins and needles sensations 
5B: I feel paraesthesia in the legs with pins and needles in the hips. (Rural, male, 30 
years old, 5 years on antiretroviral treatment ) 
Parasthesia experienced with pain 
Participants described paraesthesia as frequently occuring with pain; both were considered 
serious problems. 
                                                 
6 Expression of emphasis 
7 Expression of emphasis 
8 Expression of realisation and emphasis 
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3A: Knee pain and paraesthesia are serious. (Urban, female, 45 years old, 9 years on 
antiretroviral treatment) 
Paraesthesia experienced as a chronic problem 
Participants complained that paraesthesia, like pain, was a permanent problem. 
1B: I have suffered from paraesthesia for six months, until now it persists. (Rural, 
female, 36 years old, 6 years on antiretroviral treatment)  
Paraesthesia experienced as a localised problem  
Many of the participants described paraesthesia that occurred frequently in the lower limbs. 
For instance 8A said: Yeah we often have much paraesthesia in the legs. (Urban, 
female, 23 years old, 4 years on antiretroviral treatment) 
Paraesthesia manifest in certain positions 
Participants complained of having paraesthesia most of time; it occurred in specific positions, 
particularly when standing or sitting for long periods 
7A: I have paraesthesia when I am standing. (Urban, female, 46 years old, 5 years on 
antiretroviral treatment) 
Paraesthesia experienced after starting antiretroviral treatment. 
Like pain, some participants said they experienced paraesthesia after starting antiretroviral 
treatment. 
5B: Since I have started having antiretroviral treatment, my legs got paraesthesia. 
(Rural, male, 30 years old, 5 years on antiretroviral treatment) 
4.5.2.4 Dizziness 
Dizziness was also frequently experienced and particularly in a standing position. It was 
found to be exacerbated by hunger, thirst and the sun. 
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5A: I very often feel dizzy when I am standing. (Urban, female, 30 years old, 3 years on 
antiretroviral treatment) 
 8 A: Dizziness comes most of the time when I am hungry. (Urban, female, 23 years old, 
4 years on antiretroviral treatment) 
4.5.2.5 Lipodystrophy and body image 
Two female participants (one at Hospital A and another at Hospital B) brought up the 
symptoms of lipodystrophy which they linked to the antiretroviral treatment. It had continued 
despite the change of antiretroviral treatment.   
The one woman who complained about lipodystrophy was at Hospital A. She shared her 
experience with sadness and a lot of emotion, and said that despite many changes of 
medication, she had not seen any change or improvement. 
3A: Hum!
9
  When I started medicines (Triviro), I increased my body weight and felt 
very well.  After some time, my legs, arms and buttocks got thinner, the face and the 
belly swelled.  They have changed my ARV medicines three times! (Urban, female, 45 
years old, 9 years on antiretroviral treatment) 
These women complained that lipodystrophy had disfigured their bodies and it led to 
stigmatization. For example, the woman at Hospital B explained that she was ashamed of her 
legs because they had become very thin compared to other parts of her body, so she hid them 
with trousers or a long dress.  
6B: There is also non proportional increased body weight. You notice that one body 
part swells excessively while another is very thin. Hum!
10
 This makes us wear trousers 
or long clothes in order to hide very small legs with visible tendons and blood vessels.  
They sometimes change our medicines, but there is not much improvement. (Rural, 
female, 42 years old, 8 years on antiretroviral treatment) 
3A: In short, … the whole body was deformed. (Urban, female, 45 years old, 9 years on  
antiretroviral treatment) 
                                                 
9 Expression of regret and sadness 
10 Expression of pity and  regret  
 
 
 
 
   155 
 
 
 
4.5.2.6 Memory loss and lack of concentration 
Memory loss and a lack of concentration were also described. According to the participants, 
these two problems were exclusively a consequence of antiretroviral treatment; people had 
not experienced this problem while HIV positive but not on medication.  One woman 
compared herself to an old person because of her increased forgetfulness:   
6B: Heeee!
11
 I can tell you how the medicines have caused much memory loss! I now 
forget like an old person! (Rural, female, 42 years old, 8 years on antiretroviral 
treatment) 
8B: Hum!
12
 My sister is right; I think the memory loss and lack of concentration I am 
experiencing are caused by those medicines (antiretroviral treatment). (Rural, female, 
38 years old, 8 years on antiretroviral treatment ) 
Other addition problems described by a few participants were: fever, cough, breathlessness, 
herpes zoster, skin hardening, nausea, altered to tolerance to food, decreased body weight and 
paralysis. 
4.5.3 Theme 2: Functional limitations and participation restrictions I experience 
In this theme, participants discussed how body impairments affected their performance of 
activities in everyday life and their participation in social life. They expressed their 
frustration at living with these problems. 
4.5.3.1 Functional limitations 
Participants demonstrated how essential activities in everyday life, such as mobility activities, 
self-care activities, and household and work activities were limited and difficult to perform 
because of the body impairments. 
Difficulties with mobility activities  
Many of the participants in both FGDs reported how most of the time their mobility, 
including standing, climbing stairs and walking, was affected by pain, breathlessness, 
paraesthesia, and a lack of energy.  
                                                 
11 Expression of regret 
12 Expression of realisation 
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For example, one urban woman of 45 years and who has been on   for 9 years, said she 
experienced breathing problems and her heart rate increased when she climbed stairs:   
3A: (Showing sorrow) I hardly breathe when climbing up stairs. The heart pumps fast. 
One woman at Hospital B explained how she suffered from severe back pain and indicated 
how this had affected her walking: 
3B:   Ah!
13
 back pain! It hurts too much! Hum!
14
 Sometimes I am unable to walk. 
(Rural, female, 38 years old, 8 years on antiretroviral treatment) 
In FGD A, a man explained that he had difficulty with standing and walking due to knee 
pain, paraesthesia and a lack of energy.   
2A: I have difficulties with standing for a long time as well as to walk a long distance, 
because of knee pain, a lack of energy and much paraesthesia. (Urban, male, 49 years 
old, 5 years on antiretroviral treatment) 
Difficulty with self-care activities  
This man (2A) continued to complain and explained that, because of pain and paraesthesia in 
his legs, he was unable to wear shoes:  
2A: Do you know what? Ah!
15
 Due to much pain and paraesthesia in the legs, even 
wearing shoes has become difficult for me. (Urban, male, 49 years old, 5 years on 
antiretroviral treatment)    
Two participants in the group agreed with him they could not wear shoes because of pain and 
paraesthesia: 
3A: Yeah! We all have the similar problem!  (Urban, female, 45 years old, 9 years on 
antiretroviral treatment) 
                                                 
13 Expression of  emphasis 
14 Expression of  stress 
15 Expression of regret 
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 7A: Hum!
16
 That happens a lot to us! (Urban, female, 46 years old, 5 years on 
antiretroviral treatment) 
Difficulties with life activities 
This included difficulty in performing household activities and work activities.  Many 
participants, at both hospitals indicated that after being infected with HIV their level of work 
performance has decreased because of a lack of energy and also sometimes because of pain. 
One participant at Hospital B also spoke of a loss of memory.  Consequently, the participants 
found it difficult to perform certain household and work-related activities. 
Household activities 
A young woman of 23 years, demonstrated how difficulties with walking had affected 
fetching water, which is classified by ICF as a household activity. Although living in urban 
setting, water must frequently be collected from a long distance away. This tends to be a task 
done by women.   
8 A: I have difficulty doing a long walk. I could fetch water, but I cannot any longer 
(Urban, female, 23 years old, 4 years on antiretroviral treatment) 
A 44 year old man (4B), from rural area, who has been on antiretroviral treatment for 6 years, 
and whose main work activity was farming, explained how his work performance had 
decreased since he has been infected with HIV: he was limited in almost all physical 
activities, even household activities, due to a lack of energy. In Rwanda, it is not common for 
men to get involved in household activities, except sometimes, like this participant, in rural 
areas, the type of household activity men might do is cutting wood.  
 4B: We used to do work that required much energy before getting HIV infection and 
that has decreased … The household activities, farming, and even carrying heavy bags 
(with farm produce), are all difficult for me because I always feel weak.   
                                                 
16 Expression of realisation 
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Pain was also recognised by some participants as a factor that restricted their household 
activities.  
8B: I always suffer from abdominal pain. Therefore, I hardly walk.  Yet there is no 
possibility to do difficult [household] tasks. (Rural, female, 38 years old, 8 years on 
antiretroviral treatment) 
Work activities 
As it is shown in   
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Table 28: and Error! Reference source not found., in both FGDs many of the participants 
said they were involved in work activities and indicated that they were self-employed but 
apparently this was occasional employment. The participants, including men and women, 
said their work performance was good before they were infected with HIV but their severely 
reduced levels of energy affected their work output overtime and they have not returned to 
the pre-HIV energy levels.  
 1A: Work like building is reduced. Hum!
17
 I am saying this because I was a very good 
assistant builder! And for sure my performance has been reduced! I don’t have the 
energy I had before! (Urban, male, 47 years old, 4 years on antiretroviral treament) 
3A: Hum!
18
 I am a tailor. Since I have been infected with HIV, I only work before noon. 
Ha!
19
 By afternoon I am already tired!  My energy is no longer there!  (Urban, female, 
45 years old, 9 years on antiretroviral treatment) 
 6A: (Holding his forehead, like someone who is desperate) Hum!
20
 To work for myself 
is reduced really! (Urban, male, 28 years old, 3 years on antiretroviral treatment) 
Some participants believed that activities that required a lot of physical activity led to health 
problems: 
7A: Work that requires much energy is the most causing problems. (Urban, female, 46 
years old, 5 years on antiretroviral treatment) 
Some other participants avoided carrying out activities that required a lot of energy because 
of the potential health problems: 
 1A: For sure we do not do the tiring ones to prevent problems. (Urban, male, 47 years 
old, 4 years on antiretroviral treatment) 
                                                 
17 Expression of regret and realisation  
18 Expression of regret 
19 Expression of disappointment  
20 Expression of  disappointment  
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Some participants recognised that overtime they had needed to adapt to the changes in their 
bodies, the reduced energy levels and the weakness and, to avoid health problems, they 
advised others not participate in tiring jobs: 
2B: None can work as before because the strength is reduced. After being aware that 
you are infected with HIV, you need to change the way of working to minimize and 
prevent some health problems that can result from lack of energy and tiredness. (Rural, 
male, 21 years old, 3 years on antiretroviral treatment) 
Participants indicated that they were advised by other people to avoid tiring jobs. Some said 
they have been told that tiring jobs could worsen their condition, so they had to be careful and 
be more health-conscious. 
 2A: At work, we are told to forsake the tiring tasks. (Urban, male, 49 years old, 5 years 
on antiretroviral treatment) 
However, one woman stated that it was a challenge to accept and follow the advice to avoid 
tiring work. She said women had many responsibilities that required money and they did not 
have the option of any other work or any other financial support so they were obliged to carry 
on doing heavy work. Additionally they had childcare responsibilities and they ended up 
feeling very tired:   
3B: I have three children. I am both their father and mother. I am always told not to 
work much and I feel I do not have enough energy. But I cannot find time to rest 
because of those children. I try to use the little energy I have and work! This leads me 
to an endless tiredness. (Rural woman, 38-year-old widow with three children, who has 
been on antiretroviral treatment for 8 years) 
One married woman, only 42 years old , declared that she had lost her memory since she 
started taking antiretroviral treatment, but the most serious problem was that it had affected 
her usual work performance as a tailor: 
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6B: Heeee!
21
 I have also lost memory since I started taking medicine! I very often 
forget and I wonder where I will get treatment. This has caused shortcomings at my 
work. (Rural, female, 42 years old, 8 years on antiretroviral treatment) 
Limitations in productivity 
 Participants complained that not only was their work performance reduced, but their 
productivity also decreased; they said it was evident that the one influenced the other: 
7A: Ha! 
22
I am telling you, since I was infected with HIV; my daily productivity has 
significantly reduced! (Urban, female, 46 years old, 5 years on antiretroviral 
treatment)  
In FGD B, a 45-year-old unemployed housewife was unhappy about how she lost her work 
because her health condition had become a drain on her business. Her performance and 
productivity were reduced and she had even lost her capital.  
7B: I was a vendor before, but I did not know my health status. I later knew about 
myself when I was pregnant. After giving birth, I often fell sick. The money I used for 
buying things to sell was finished. After getting better, I had no capital (Rural, female, 
45 years old, 3 years on antiretroviral treatment) 
4.5.3.2 Restrictions in participation in social life 
Difficulties with participating in leisure activities   
 The particpants knew about leisure activities and recognised that they were good for their 
health and helped one to relax, but unfortunately they could no longer participate as one 
participant at the urban Hospital said and all the others voiced agreement with her. 
4A: Obviously! We most of the time watch [sport] and do not participate. (Urban, 
female, 66 years old, 7 years on antiretroviral treatment) 
                                                 
21 Expression of regret and disappointment  
22 Expression  of regret 
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Participants pointed out that failure to partcipate in leisure activities was largely due to their 
body weakness or lack of energy: 
3A: We just watch people playing football or dancing, but it is difficult to participate. I 
feel weak! (Urban, female, 45 years old, 9 years on antiretroviral treatment)  
 A 21-year-old boy born HIV-positive shared his bad experience with how his lack of energy 
had stopped him playing football: 
2B: I was a football player.  I often felt dizzy and fell down in the playground because 
of body weakness and lack of energy. Now, I gave up playing. (Rural, male, 21 years 
old, 3 years on antiretroviral treatment) 
A few participants also indicated that sometimes they cannot participate in leisure activities 
because of their limited financial means. 
 2A: To do leisure activities, sometimes depends also on one’s financial means. (Urban, 
male, 49 years old, 5 years on antiretroviral treatment) 
My body impairments interfere with my social relationships  
Some female participants explained that they were limited in their ability to connect with 
people around them due to a lack of energy.  
4A: I do not interact because of lack of energy. (Urban, female, 66 years old, 7 years on 
antiretroviral treatment) 
7A: Because of the body weakness, we are not able to visit friends. (Urban, female, 46 
years old, 5 years on antiretroviral treatment)  
My body impairments interfere with my spiritual practices 
Some participants explained how their spiritual practices had changed since becoming 
infected with HIV. Their routine of praying had changed and the frequency had decreased. 
They said it was largely due to their body weakness or a lack of energy. 
One female participant explained, while appearing sad: 
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8A: Now to pray for a long time is not easy for me.  I cannot afford to pray in the 
evening. (Urban, female, 23 years old, 4 years on antiretroviral treatment) 
Another woman said: 
3A: I go to pray before midday. But in afternoon I feel very tired and I am no longer 
able to, because of body weakness and I don’t have strength. (Urban, female, 45 years 
old, 9 years on antiretroviral treatment) 
My body impairments interfere with my sexual relations 
Participants in both FGDs revealed that they have problems in their sexual relationships; this 
was initially mentioned by men and who said it was because of decreased energy. At Hospital 
B, it was the very first problem that the participants started speaking about. At  Hospital A, 
one man explained that increasing the frequency of sexual intercourse can decrease the 
amount of energy you have, even though it is already low.  
5B: Since I have known that I am HIV-positive, sexual relations with my wife have 
become difficult. The way I used to do it before has now decreased; it is because of my 
body weakness. (Rural, male, 30 years old, 5 years on antiretroviral treatment) 
1A: You cannot have sexual relations several times, the force has decreased! If you 
frequently do it, you get worse. (Urban, male, 47 years old, 4 years on antiretroviral 
treatment) 
In both FGDs, women were not forward in talking about sexual relations. At the urban 
hospital, the doctor had to motivate them.  The female participants who spoke about sexual 
relations indicated that  not only was energy reduced, but there was no sexual desire, some 
women had been, threatened,  disappointed and consequently  were no longer interested in 
sex. This suggested that the problem was both physical and psychological: 
1B: Hum! Don’t mention about sexual relationship! The desire is not there, I am not 
motivated and my husband is always weak. (Rural, female, 36 years old, 6 years on 
antiretroviral treatment) 
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One female participant, a widowed (3A) explained how she had been infected by her 
husband, and then he died and also their only child. She said that she had been shocked by the 
two deaths. She associated sex with the deaths, subsequently, she has lost her sexual desire 
and this had a long lasting effect: 
3A: For 12 years now I have not done it (sexual intercourse) and I can even say that I 
forgot about it … I experienced how badly my husband died and gave up at once, I felt 
very threatened! I gave birth to a child who together with my husband got very sick 
before they died. (Urban, female, 45 years old, 9 years on antiretroviral treatment)  
Participants pointed out that their doctors had advised them to reduce the frequency of their 
sexual relationships as this affected their energy levels.    
2A: Doctors always tell us not to tire ourselves much because sexual relationship 
reduces the energy!  It is already lowered. (Urban, male, 49 years old, 5 years on 
antiretroviral treatment)  
One participant regretted this advice as he was still young and said that if it were not for 
the doctors‘ advice he would choose to have sex often. 
This urban 28-year old man (6A), 3 years on antiretroviral treatment smiled, but 
appeared sad saying: As I am still young, I would rather do it always but doctors tell us 
it weakens the body. 
4.5.4 Theme 3: Personal factors that influence my functioning as a PLWH  
This theme describes the personal or intrinsic factors, that is, those factors within the 
participants that could either facilitate or hinder their ability to perform the activities of daily 
life and participate in social life. 
4.5.4.1 Personal factors that act as facilitators of activity performance and social 
participation 
Intrinsic factors identified as facilitators of activity performance and social participation 
included:  spiritual beliefs, faith in God, and positive experiences with disclosure. These 
factors helped to overcome internalised stigma and to create awareness about HIV. Other 
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factors included:  a sense of belonging at the ARV clinic, a sense of solidarity, trust in other 
people, and the use of coping strategies. 
Participants‘ spiritual beliefs 
Some participants said prayers had a positive effect on their health despite challenges 
regarding participation due to their lack of energy.  They explained that when they were able 
to go to church, the church teachings boosted their strength and increased their motivation. 
4A: I could go to pray when I was young. This became less frequent after being infected 
with HIV. When I feel like having strength, I manage to go to church and the preaching 
makes me stronger and motivated. (Urban, female, 66 years old, 7 years on 
antiretroviral treatment) 
Participants‘ faith in God  
One male participant said that after being infected with HIV, people had a stronger faith in 
God and might start attending church, even those who had not previously attended. They 
indicated that they might feel safe and secure to be near God. 
2A: Hum!
23
 Even those who could not go to church before may go now so as to get 
closer to God. (Urban, male, 49 years old, 5 years on antiretroviral treatment) 
Another male participant In FGD B expressed her disappointment that on several occasions 
doctors were not available when he needed care. Nevertheless, he believed that Jesus could 
perform a miracle and still hoped he could heal their medical problems: 
 5B (with emotion): I have just told you that I feel much paraesthesia and pain. I am fed 
up with always coming and missing doctors here at Hospital B. I take my time and pray 
to my God! With hope, Jesus heals me! (Rural, male, 30 years old, 5 years on 
antiretroviral treatment) 
The other participants joined in and said enthusiastically ―He also heals! 
Positive experiences about disclosure as a strategy to improve psychological wellbeing  
                                                 
23  Expression of realisation and emphasis 
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A few participants at Hospital B indicated that it was sometimes good to ignore what other 
people might have thought or said about their serostatus, and they decided to disclose their 
HIV status. This gave a sense of relief and enabled the person to relax. They commented that 
once they felt better and their minds were free they might be able to assist the non-infected 
people in their community to protect themselves: 
 3B: I think sometimes to disclose your status is very good because it makes you feel 
released in the mind. And then, you help those who are not infected with HIV as well. 
(Rural, female, 38 years old, 8 years on antiretroviral treatment) 
Positive experiences about disclosure as a strategy to overcome internalised stigmatization 
Despite some community members‘ judgmental behaviour, some participants said that 
disclosure of their status helped them to accept themselves and move beyond their 
internalised stigma:  
6B: To tell others that you are infected with HIV helps you to accept yourself. (Rural, 
female, 42 years old, 8 years on antiretroviral treatment)  
One woman of 42 years who was a tailor shared how she believed, from her own experience, 
that disclosure of one‘s HIV status assisted people to move beyond being stigmatised. She 
said it could help someone to build trust in others, especially at their work places. It might 
prevent a person from being fired because of missing work when he or she went for routine 
consultation or for medication 
 6B: Haaa!
24
  Honestly, you cannot tell [disclose to] everybody. But, sometimes, it is 
necessary to say it. For example, your co-workers who always missed you because you 
went to get examined or when you are sick or went to collect medicines. They can 
wonder much about you. To disclose sometimes enables you to get out of 
stigmatization; hence you cannot be expelled from the job. (Rural, female, 42 years old, 
8 years on antiretroviral treatment) 
                                                 
24 Expression of hesitation and perplexity 
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The same woman indicated that she had really accepted her health status and managed to 
disclose her status, but she thought this was mainly because of the self- acceptance training 
she had undergone in the past.  
6B: But what helped me to achieve this [disclosure of my HIV status] was training 
aiming at self-acceptance that I did. It helped me a lot! (Rural, female, 42 years old, 8 
years on antiretroviral treatment) 
Many of the participants at Hospital B expressed the need for such training and suggested 
that it could be given in counselling sessions. 
Positive thoughts about disclosure as a strategy to create awareness about HIV  
Some participants said that disclosure was good and had to be encouraged as it could 
sensitize the community about the importance of HIV testing for those who were not infected 
and those who were already infected might be encouraged to seek care. They also said it 
would encourage people to adhere to the antiretroviral treatment. They said there were many 
people in the community, especially in rural areas, who were unaware of the availability and 
the benefits of antiretroviral treatment. 
8B: Actually, this is not the illness to be kept as a secret. It must be said [disclosed] to 
raise people’s awareness so that they can go to be examined and know their status. 
(Rural, female, 38 years old, 8 years on antiretroviral treatment) 
Even though disclosure was encouraged, by certain participants, they said it took time for 
some people to take decision to disclose their status but that it becomes easier overtime. For 
example, a 38-year-old widow shared the experience of how she had lost two husbands. The 
second husband died because she did not disclose her status and she eventually infected him. 
After that experience she decided to disclose her status so that her partners could protect 
themselves. 
3B: I became a widow when I was still young, and was left with HIV. I got married to 
a second man. While I was going to have sex with my husband, I did not reveal my 
status to him [looking sad]. He also died! But now, I first inform whom I am going to 
have sex with about my status. The important thing is that when you tell it to him, he 
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remembers to use a condom for protection. (Rural, female, 38 years old, 8 years on 
antiretroviral treatment) 
Sense of belonging at ARV clinic 
All participants felt secure and safe at the ARV clinic where they usually received care and 
they expressed their willingness to have their status known to these health care providers, but 
only to those in the ARV clinic. The participants knew that the ARV clinic health care 
providers knew their status as it was written in their files. They did not have to tell them. 
Thus there was no need for disclosure. However, there might not be the same sense of 
security outside the ARV clinic. 
3B: I cannot tell to another doctor about my status; I only feel free with the one of 
ARV clinic… (Rural, female, 38 years old, 8 years on antiretroviral treatment) 
Sense of solidarity 
Participants expressed a sense of solidarity and said they felt free and disclosed to other 
PLWH  
5A:  One female participant, an assistant builder, (looking overwrought), said ―I have 
never told it to anybody apart from people we share the same problem with, I mean 
other HIV infected [people]. (Urban, female, 30 years old, 3 years on antiretroviral 
treatment) 
Trust in family, parents and close friends 
Some male and female participants trusted only certain people and decided to disclose to 
them; this included their family, parents and close friends. 
4B: We do not tell everybody that we are HIV positive, apart from someone with whom 
we feel free, like a close friend or a parent. (Rural, male, 44 years old, 6 years on 
antiretroviral treatment) 
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7B: Heeeeeeeee!
25
 According to me, you cannot reveal your status to anybody except to 
your best friend. (Rural, female, 45 years old, 3 years on antiretroviral treatment) 
Trust in hospital health care providers outside the ARV clinic 
A few participants said that they decided to disclose their status to other health care providers 
outside ARV clinics when they fell sick and needed to be given medicine: 
6B: We disclose to other health care providers so that they give us medicines 
accordingly. (Rural, female, 42 years old, 8 years on antiretroviral treatment) 
Some participants mentioned they did not usually talk to the health care providers, not even 
those in ARV clinic, about issues concerning their functional problems. They believed these 
problems were related to HIV or the antiretroviral treatment, so they were destined to live 
with them. They did not think the doctors or other ARV health care providers could help. 
6B: Hum!
26
 Really, I did not tell my doctor at all! I thought the functional problems I 
have are related to HIV or to drugs so it is there for life! Really! We do not always tell 
all our problems we face to doctors. However, maybe if we tell them, they can help us. 
(Rural, female, 42 years old, 8 years on antiretroviral treatment) 
Coping strategies 
Participants explained how they strove to live normal lives.  They did not want people to be 
suspicious of their status and might decide to change behaviour. One participant explained 
how sometimes she was invited by her friends to go for a drink.  She would refuse and make 
an excuse without telling them the real reason, which was that she had been advised to stop 
drinking because of her health status: 
4A: Sometimes my friends invite me for drink. I never say that I do not drink anymore.  
I just apologize and say I am not in the mood today. Forgive me, forgive me!  (Urban, 
female, 66 years old, 7 years on antiretroviral treatment) 
                                                 
25 Expression of mistrust and disagreement  
26  Expression of hesitation and confusion 
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8A: Yeah! You take it as normal, as your own issue! What else can you do! (Urban, 
female, 23 years old, 4 years on antiretroviral treatment)  
4.5.4.2 Personal factors that act as barriers to activity performance and social 
participation 
Personal factors identified as barriers to activity performance and participation in society 
included internalised stigma and age. 
Internalized stigma  
Many of the participants demonstrated that they had internalised the stigma relating to HIV. 
They had low self-esteem and they lacked confidence in themselves. They described how 
they lived with feelings of being hurt, and of regret and shame, and with the thought of being 
judged, stigmatised or discriminated against by (for example) being fired, chased away and 
even abandoned by other people in their community once they were discovered to be living 
with HIV. This made them afraid and had a big impact on their social participation. Some 
even refused to disclose their status to their families. 
5A: (looking sad), Hum!
27
 For me, no one in my family knows that I am infected with 
HIV... (Urban, female, 30 years old, 3 years on antiretroviral treatment)  
Feelings of being hurt, feelings of regret and shame, guilt and remorse about HIV  
Many participants expressed feelings of being hurt, and feelings of regret and shame once 
they were discovered to be living with HIV; this led them to fear disclosure. At rural  hospital 
the 21 year old man who was an orphan expressed his worries about being hurt by negative 
comments which might be made by his peers or teachers at school – once they discovered he 
was HIV positive: 
2B: I am a student. When my colleagues and student supervisor notice that I cough too 
much, they ask me about my status, but I do not disclose because I think their comments 
cannot be good. (Rural, male, 21years old, 3 years on antiretroviral treatment) 
                                                 
27  Expression of revolt 
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One 45 year old woman who had lost her husband and her only child due to HIV, regretted 
what had happened and was ashamed of her status. She indicated how difficult it was to 
disclose her status: 
3A (Looking nervous): Hum!
28
 It is hard to say it! [I have HIV] (Urban, female, 45 
years old, 9 years on antiretroviral treatment) 
One young woman of 23 years indicated that immediately after being tested HIV-positive, 
she had not only felt terrified but also guilty, ashamed and wounded. At that time, when she 
thought about how she was infected through sexual intercourse it made her feel nauseous and 
she wanted to vomit when she looked at any man. Consequently, she had lost any desire for 
sexual intercourse. However, she did subsequently get married suggesting improvement 
overtime 
8A: Hum!
29
 After being infected with HIV, I was about to vomit just after looking at 
any man (Urban, female, 23 years old, 4 years on antiretroviral treament)  
Negative thoughts and imaginings 
Participants expressed their thoughts and how they imagined being stigmatized, abandoned, 
chased and fired from work once they were discovered to be living with HIV. 
Fear of being stigmatised 
Many participants thought about how they would be stigmatised by others in the community 
once they were discovered to be living with HIV; they therefore chose to keep quiet about 
their status: 
5A: We don’t disclose because we are afraid of being stigmatized! (Urban, female, 30 
years old, 3 years on antiretroviral treatment) 
6A: To tell other people that you are HIV positive is very difficult because they 
stigmatise you! (Urban, male, 28 years old, 3 years on antiretroviral treatment) 
                                                 
28 Expression of depression   
29 Expression of  displeasure   
 
 
 
 
   172 
 
 
 
Fear of being judged 
Many of the participants were afraid of being judged once other people discovered they were 
HIV positive. This fear of being judged made them reluctant to disclose their HIV status. One 
participant expressed how people judged them by their appearance and explained how this 
affected their feelings: 
6A:  Hum!
30
 People sometimes suspect you before even you have undergone HIV 
testing! You know when you hear people judging your appearance, it hurts you more 
and then it becomes difficult to disclose. (Urban, male, 28 years old, 3 years on 
antiretroviral treatment) 
Fear of being chased away 
Participants imagined being mocked and chased away by others in their community when 
these people found out about their HIV status. They explained that they felt comfortable and 
safe to be with others when these people did not know they were HIV-positive.  
8A: Hum!
31
 We manage to visit them because they do not know our problem. Once they 
are informed about it we can be chased away, stigmatized, or said to be useless. Truly, 
that is the problem we have. Not knowing our status makes them socialize with us; 
otherwise we cannot feel free with them! (Urban, female, 23 years old, 4 years on 
antiretroviral treatment) 
  
                                                 
30 Expression of depression and regret  
31 Expression of depression and disappointment   
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Fear of being dismissed from work 
One male participant expressed fear of being fired from work once his employer discovered 
his HIV status, although he believed it was a good thing to disclose his status. As a result, he 
was uncertain whether to disclose or not: 
 6A: When you do a monthly waged job, you are on antiretroviral treatment, and you 
have to go to a clinic every month, you have to tell your boss the truth to get 
permission. Sometimes, he/she may decide to suspend you because he/she knows your 
status. (Urban, male, 28 years old, 3 years on antiretroviral treatment) 
Participants in both FGDs expressed their thoughts and worries about the spread of the 
information from one person to another in their communities once their HIV status was 
disclosed. 
7B: We are afraid of people who may spread the information everywhere (Rural, 
female, 45 years old, 3 years on antiretroviral treatment) 
 Age 
One participant at the urban hospital who was older than all others (64 years old) explained 
that apart from paraesthesia she did not normally have many health problems. She was 
confused whether she should attribute paraesthesia or any other health problem she might 
encounter to HIV or to her age.  
4A: As for me I have a lot of paraesthesia when I stretch myself in the morning. 
(Smiling) but perhaps this is due to old age! (Urban, female, 66 years old, 7 years on 
antiretroviral treatment) 
However, age did not deter this same woman from saying she would like sex if she 
found someone who was interested in her. 
4A: (smiling) If someone proposes me to do it and caresses me, I may accept! (Urban, 
female, 66 years old, 7 years on antiretroviral treatmennt)  
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As mentioned in (sexual activity section) much younger participant in the group, FGD 
A, a 28 years old single man, found his age and parallel normal sexual desires were 
difficult to meet because of the HIV and his reduced energy levels. 
4.5.5 Theme 4: Social relationship or community environmental factors that 
influence my functioning as a PLWH 
This theme describes the extrinsic or social relationship factors in the community 
environment which could act as facilitators or barriers to activity performance and to 
participation in society. Participants in both FGDs, particularly women, spoke of facilitators, 
including support from other people and socialization with others, as being good strategies 
for maintaining psychological well-being. The barriers they spoke of included the negative 
behaviour and attitudes of other people around them once they discovered they were HIV 
positive, and conflict in their relationships with others.  
4.5.5.1 Family relationship environment  
This section includes factors that act as facilitators or barriers to function. 
Family relationship factors that act as facilitators 
A few participants said that their families had accepted them as PLWH and showed a positive 
attitude towards them, which included giving care and support. Sometimes, however, this 
amounted to overprotection, and led to some confusion between wanting and not wanting the 
support.  
For example at the urban hospital, one 45 year old woman, a widow, had lost her child who 
was born HIV positive. She shared her experience with her siblings. She indicated that they 
protected her and cared for her. However, sometimes they were too caring, and the family 
prevented her from doing household activities and treated her like a disabled person even 
when she thought she was able to carry out the tasks.  
3A: In my family, they really pay much attention, very much! They always make sure 
they know what is happening to me. I live with three of my sisters in the same 
compound; they give me what I need and even do all household activities for me … I 
think I am able to do some work, but they consider me unable and always want me to 
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rest!  They refuse to let me do some work, but I insist and do some [work] and tell them 
I am not a disabled. (Urban, female, 45 years old, 9 years on antiretroviral treatment) 
 4A: Yeah, they try not to hurt her!  (Urban, female, 66 years old, 7 years on 
antiretroviral treatment) 
2A: Yeah that is the way it is. Hum!
32
 They pity her and do not want to hurt her! 
(Urban, male, 49 years old, 5 years on antiretroviral treatment) 
3A: Yes! They have mercy. (Urban, female, 45 years old, 9 years on antiretroviral 
treatment) 
Family relationship factors that act as barriers  
At Hospital A, a 46-year-old woman shared her experience of what happened to her 
immediately after being diagnosed as HIV positive. Her own family, including her father, 
mother and siblings, did not accept her as a PLWH. They ostracised her and abandoned her 
completely. They did not even care how she was coping: she was left alone when she was 
most in need of support.  This made her very sad and caused her to become ill.  
 7A: (With great sorrow) Just after getting informed that I am infected, my family was 
unhappy. I was always lonely, sick and even hospitalized. Because of much painful 
emotions and loneliness I had chronic headache and then, paralysis. They really 
showed negative attitude towards my status, they were even unable to come near me. 
(Urban, female, 46 years old, 5 years on antiretroviral treatment)  
The woman explained how her family, particularly her father, but also other family members, 
were particularly harsh; she felt emotionally abused. 
7A: Can you imagine, even my father used to tell me that I am a dead person … Some 
[family members] managed to come and hurt me even more saying: “It is that bad 
illness! She will not survive…” (Urban, female, 46 years old, 5 years on antiretroviral 
treatment) 
                                                 
32  Expression of sympathy  
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Speaking very emotionally, with a great deal of sorrow, this woman explained how she was 
infected by her husband. Later, after mistreating her, and demonstrating disrespect and 
dishonesty, he abandoned her and their three children to go to other women. 
7A: I separated from my husband because of bringing other women, saying they were 
his sisters. He was telling me I was old and he was going to look for young ones. So, I 
felt crazy. I told him:  “Now I have a problem with my parents because of the disease 
you brought to me. Instead of facing the consequences of the problem together, you are 
the one causing me troubles.” (Urban, female, 46 years old, 5 years on antiretroviral 
treatment) 
She indicated that the accumulation of all these deceptions was so difficult to bear that she 
considered committing suicide. Her story was conveyed with so much emotion that she cried 
afterwards. Other participants showed empathy and kept silent for some minutes.   
7A: There was a time; I had an idea of committing suicide because of unhappiness. 
(Urban, female, 46 years old, 5 years on antiretroviral treatment) 
At the rural hospital another woman said she and her husband had different opinions about 
whether to have a child. Her husband wished to have a child; however, she was worried and 
believed that giving birth could result in health problems. This had caused problems in their 
relationship. 
6B: (Looking sad) I have another problem that overcomes my capacity until God only 
helps me. My husband always wishes he had a child, but it may cause me problems, I 
know! Hence misunderstanding! (Rural, female, 42 years old, 8 years on antiretroviral 
treatment) 
A 46-year-old woman spoke of being mistreated, disrespected and of experiencing a lack of 
care from her partner. This interfered with her sexual arousal and had an effect on their 
sexual relationship.  
7A: (Looking very sad) When you are in the misery, you cannot feel the desire to do it 
[sexual intercourse]! I have never been cherished by my partner; it is now deleted from 
my mind. (Urban, female, 46 years old, 5 years on antiretroviral treatment) 
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One participant at urban Hospital explained how her mother stigmatised and judged her 
according to her appearance. This made her disappointed in her mother‘s judgement of her 
appearance and this stopped her disclosing her HIV status. 
5A: Hum!
33
 You cannot believe! Even my mother judges me! I visited her and she 
said: “My child, have you been infected with HIV?” I replied: “I am really healthy.” 
(Urban, female, 30 years old, 3 years on antiretroviral treatment)   
4.5.5.2 Community relationship environment 
Community relationship factors that act as facilitators 
In both FGDs, a few participants recognised that there were people around them who 
understood their problems, who showed a positive attitude and gave support, and who 
respected and accepted them the way there were as PLWH. 
8A: There are people who are ignorant and have negative attitudes towards us; 
however, there are others who understand, take it easy, and even sometimes give us 
advice. Yet it depends on one’s mindset (Urban, female, 23 years old, 4 years on 
antiretroviral treatment) 
One participant at Hospital A explained that after being diagnosed HIV-positive, she was 
abandoned by her family; however some people in her community showed empathy and 
support and tried to convince her parents and siblings and advised them to show some care. 
7A: People approached them [my family] saying: “you should treat her like others”… 
(Urban, female, 46 years old, 5 years on antiretroviral treatment) 
Some participants at the rural hospital appreciated socializing and entertaining with others in 
the community. They encouraged other people in the group to entertain and recognised that 
entertaining and socializing with other people in the community was a good strategy to 
improve psychological wellbeing and contribute to a good state of mind. They also stated that 
they felt happy when they were with other people, to the extent of wanting to stay with them. 
                                                 
33 Expression of revolt 
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2A: Hum!
34
 I think we should sometimes forget about our problems and entertain, 
interact with others, and relax! (Urban, male, 49 years old, 5 years on antiretroviral 
treatment) 
3A: Yes! We relax the mind! (Urban, female, 45 years old, 9 years on antiretroviral 
treatment) 
8A: About entertainment, we do not feel upset when we are with others. We would 
rather stay with others. (Urban, female, 23 years old, 4 years on antiretroviral 
treatment) 
Community relationship factors that act as barriers 
One participant indicated that PLWH experience extreme forms of stigmatisation in their 
respective communities. It is as if they are considered non-existent in their communities, 
despite the fact that they are struggling to survive.  
5A: (very sad) Yeah!  People do not consider us like human beings. They comment that 
we are about to die. (Urban, female, 30 years old, 3 years on antiretroviral treatment) 
Certain participants at the urban hospital explained how the community stigmatised them 
according to their appearance. They explained how people in their community, even those 
whom they trusted and respected (for example, close friends) judged them or judged other 
people in their presence according to their appearance and concluded that they were HIV-
positive. They indicated that this disappointed and confused them, and decreased their trust in 
people, including those who were close to them. For example, one participant explained how 
disappointed she had been by the attitude of her best friend, who was also her godmother.  
The friend had assisted her and encouraged her to go for testing, but when she learnt of her 
status she still judged other people by their appearance, even when they were together. This 
has led to her to lose her trust in other people. 
4A: My godmother helped me to know that I am HIV-positive. We used to live as 
friends. She really assisted me; she buys me medicines if I get sick, milk, and whatever I 
                                                 
34 expression of resilience   
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want.  However when we are on the way to church if she sees someone, she says; “Look 
at him/her in face, is not that man/woman infected with HIV?” However, she knows she 
is with an HIV-positive person. Hum!
35
 When she tells me so, I feel sad, unhappy and 
disappointed.  Anyway, Hum!
36
 I don’t know whom to tell anymore and when! (Urban, 
female, 66 years old, 7 years on antiretroviral treatment) 
Participants revealed that they had experienced situations in their communities where people 
had disclosed their HIV serostatus and experienced stigma; this made disclosure even more 
difficult.  
7A: I know someone who said it and got stigmatized (Urban, female, 46 years old, 5 
years on antiretroviral treatment) 
In addition to stigmatization, participants explained that they experienced situations where 
people in their community gossiped about a person‘s serostatus, thereby indicating a lack of 
consideration and respect.  
8A: (Speaking scornfully) Hum!
37
 How can you not help saying that someone has a 
problem. You do not respect him/her and you do not give him/her much consideration. 
(Urban, female, 23 years old, 4 years on antiretroviral treatment) 
Another participant indicated that some people not only showed a lack respect towards them 
but also did not care about them, and this contributed to a reluctance to disclose their HIV 
serostatus. 
5A: Also I refused to tell it to anyone because nobody cares for me!  (Urban, female, 30 
years old, 3 years on antiretroviral treatment) 
Participants shared how judgement and stigmatization in their communities had an impact on 
their friendships and on the deep feelings they had towards other people. The hurt and 
emotional abuse caused by other people contributed to the isolation of both men and women. 
                                                 
35 Expression of perplexity  
36 Expression of doubt and mistrust  
37 Expression of revolt  
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5B: When I was visiting people, I could hear them saying: “See, he has herpes zoster, 
you can see the symptoms of that terrible disease!” Then, I felt very sad and stopped 
going back there. Because of that, I do not visit people any longer (Rural, male, 30 
years old, 5 years on antiretroviral treatment)  
 7B: In general, people stigmatize us. Love and friendship got cold! There are people 
who say; “Those are HIV positive”. Therefore, we are not motivated to visit each other. 
(Female, 45 years old, 3 years on antiretroviral treatment) 
4.5.6 Theme 5:  Hospital environmental factors that influence my functioning as a 
PLWH 
The following theme describes participants‘ experiences with hospital services, including at 
the ARV clinic and other hospital departments.  
4.5.6.1 Environmental factors: ARV clinic 
This section discusses the factors that acted as facilitators and those that acted as barriers 
within the ARV clinics. 
 
ARV clinic: environmental factors that act as facilitators 
The facilitators included the service in the ARV Clinic, the antiretroviral treatment, and the 
referral procedure to other hospital services. 
My satisfaction with the service in the ARV clinic 
Service in ARV clinics was the most appreciated of all services offered at both the hospitals.  
Participants were satisfied with the service provided, and were very happy with and trusted 
the health care providers at the ARV clinic. Participants were very clear that they only 
considered the ARV clinic to be good but not all the other services within the hospitals.      
One participant at the urban hospital, while emphasizing her appreciation of the health care 
providers at the ARV clinic, indicated that when PLWH visit other services, patients are not 
integrated and do not receive guidance 
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 3A: There is no problem with health care providers of this service. But when you go 
into other services you get lost and confused. (Urban, female, 45 years old, 9 years on 
antiretroviral treatment) 
7A: Only the staff in the ARV clinic help us with a follow up and provide us with 
essential medicines. (Urban, female, 23 years old, 5 years on antiretroviral treatment)  
One young woman at Hospital B thought that patients‘ satisfaction with the service might 
influence their acceptance of their HIV status.   
3B: Yeah! Do you know what? I would like to add this; not everybody has already 
accepted his/her status. But I think if one gets satisfactory care, it might help so much 
with the acceptance. (Rural, female, 38 years old, 8 years on antiretroviral treatment) 
Satisfaction with the antiretroviral treatment 
Participants were aware that, despite all the problems they had been experiencing, there was 
evidence that the antiretroviral treatment were very beneficial for their health. They believed 
that the health care providers at the ARV clinics were the most important people for them to 
relate to as they provided the most essential medicine, the antiretroviral treatment to treat the 
HIV infection. Participants said this solved their major life-threatening problem, and they 
could live with the other related problems. 
2B: The ARV doctor solves many of my problems by giving ARV drugs! Hum! Maybe it 
can be my mindset, when he gives me the medicines I feel other problems I can live 
with. (Rural, male, 21 years old, 3 years on antiretroviral treatment)  
Certain participants highlighted the benefits of antiretroviral treatment. They emphasized 
their increased energy, weight and improved general health status, and some participants 
indicated that the change occurs overtime.  
2B: After taking medicines, there was a change on my health. I got stronger compared 
to how I was before. (Rural, male, 21 years old, 3 years on antiretroviral treatment) 
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5A: I do not have any problem because I take medicines. I have increased weight and 
my body functions well. (Female, 30 years old, 3 years on antiretroviral treatment) 
Satisfaction with the referral procedure from ARV clinic to other services within the 
hospital  
Most of the participants indicated that they were satisfied that the health care providers at 
ARV clinic who referred them to other services within the hospital when they were not able 
to manage the problem. At times they were referred to the general practitioner at the 
outpatient service, where they had to go through the general consultation procedure like any 
other outpatient, and be referred from there to a specialist, either within the hospital or 
outside. 
2B: When we are ill, we come to get treated.  We first pass by here at the ARV service 
and they directly refer us to other services. (Rural, male, 21 years old, 3 years on 
antiretroviral treatment) 
6A: The ARV health care providers facilitate us; we can be transferred from here to a 
general doctor at the out-patient department. (Urban, male, 28 years old, 3 years on 
antiretroviral treatment) 
Environmental factors that act as barriers in the ARV clinic  
The barriers included a lack of assistance from ARV clinic with regard to functional 
problems, punishment by health care providers at the ARV clinic, difficulties regarding 
treatment of functional limitations, doctors who show a lack of concern about functional 
limitations, unavoidable functional limitations, a lack of awareness of specialist services, 
difficulties with the referral system and the use of multiple files. 
Lack of assistance from the ARV clinic regarding care related to functional limitations 
In both FGDs, participants said that, the health care providers from ARV clinic did not assist 
them with the functional problems they had described.  
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8B: We realize that our doctors in the ARV clinic cannot solve other problems except 
by giving us the medicines, the ARV medicines. (Rural, female, 38 years old, 8 years on 
antiretroviral treatment)  
Participants added that they had complained about their functional limitations or problems 
and reported them to the health care providers at the ARV clinic, but participants were only 
given their usual antiretroviral treatment, or a different antiretroviral treatment, or additional 
drugs to the antiretroviral treatment. When the problems persisted or recurred and they 
complained again, they were told the problems would be alleviated with time. They were not 
referred to other services for treatment of these functional limitations. 
3B: I suffered from back pain and they did not refer me anywhere. They only gave me 
medicines. I was not healed and I am still living with it, whereas it hurts too much! 
Hum!
38
 Sometimes I am unable to walk! (Rural, female, 38 years old, 8 years on 
antiretroviral treatment) 
3A: We are given drugs (antiretroviral treatment) in our clinic, but for paraesthesia, 
muscle and nerve pain, our doctors here tell us this will decrease and get better with 
time!  They always say those problems do not go away immediately or they will be 
cured by themselves. There was a time, pain had become too much; this time, they had 
given me painkillers only and told me it [the pain] will finish slowly. (Urban, female, 45 
years old, 9 years on antiretroviral treatment)  
Punishment by health care providers at ARV clinic  
One male participant brought up an issue related to the negative behaviour and discrimination 
by some health care providers at the ARV clinic; this was due to a misunderstanding of the 
patient‘s functional limitation or problem.  He explained that they did not understand his 
wife‘s problem with loss of memory and had refused to give her antiretroviral treatment. 
                                                 
38 Expression  of disappointment and emphasis  
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5B: Hum!
39
... One time, my wife forgot her appointment for ARV medicines because of 
memory loss. Health care providers from here (ARV clinic) punished her by refusing to 
give her the medicines and saying she should go and take them elsewhere! I found it is 
cruel! (Rural, male, 30 years old, 5 years on antiretroviral treatment) 
However, another participant in the group did not agree that this was discrimination and 
suggested it was rather a way of reminding and educating people about the benefits of 
medication and the importance of respecting appointments  
8B: Yeah! It is true. It happens doctors punish us, but it does not take longer. It 
happens sometimes, when we disrespect the appointment to come and take the 
medicines, whereas we are the beneficiaries. They punish us so as to make us change 
our mind. (Urban, female, 38 years old, 8 years on antiretroviral treatment) 
Participants’ assumptions about treatment of functional limitations at ARV clinic  
(1) My functional limitations or problems are difficult to treat  
Many of the participants presumed that the functional limitations or problems they 
experienced were difficult to treat because they were the consequence of HIV infection or the 
antiretroviral treatment.  Some were hesitant to report their functional limitations to their 
doctors at the ARV clinic or to ask for a referral to a specialist as they did not expect any 
improvement. 
1B: Our doctors manage what they are able to! But there are other conditions …   
which might be difficult to treat.  We always think maybe it is because there can be 
complications of the illness [HIV] or the medicines we take! (Rural, male, 36 years 
old, 6 years on antiretroviral treatment) 
(2) Our doctors are not concerned with our functional problems 
Participants assumed that the doctors at the ARV clinic were not concerned about their 
functional limitations. They reported the problems that they understood were directly related 
                                                 
39 Expression of regret  
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to HIV infection, and not the functional limitations, because they presumed their doctors 
could not manage the functional limitations. 
3B: … we decide to tell our doctor about problems related to the illness only, for 
example decreased CD4, but not those concerning our body function. (Rural, female, 
38 years old, 8 years on antiretroviral treatment) 
(3) My functional limitations are unavoidable 
Certain participants accepted that HIV was a chronic condition and assumed that the 
associated functional limitations were inevitable and permanent. Consequently, they did not 
see the need to ask for specialist care.   
 4B: Yeah! We live with HIV infection. We set in mind [believe] that complications 
are unavoidable, and they are there for life! That is why we do not continue to seek 
[help] from specialists for specific health problems. (Rural, male, 44 years old, 6 
years on antiretroviral treatment) 
(4) I am not aware of specialist services  
Most of the participants said that they did not know that there were specialist services that 
could manage some of their functional problems. Their health care providers at the ARV 
clinic had not told them about other services. 
1B: I do not know there are services where they can cure, for example chronic 
headache and paraesthesia!  (Rural, female, 36 years old, 6 years on antiretroviral 
treatment) 
6B: Hum!
40
 I know I have memory loss! I do not know that there is somewhere to be 
treated. I think I may live with it! (Rural, female, 42 years old, 8 years on antiretroviral 
treatment) 
  
                                                 
40 Expression of realisation 
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I experience difficulties with referral system   
Although participants recognised that the health care providers at the ARV clinic do refer 
them to various specialities, they said that there was no consistency in the procedure and 
method of referral, and this sometimes caused confusion. Usually they were referred to the 
outpatients department and from there to other services, but sometimes they were referred 
directly to specialised services. In other cases, there was no referral at all and they were given 
medicines at the ARV clinic. Sometimes rather than go to the ARV clinic they sought care at 
their own local health centre.   
7A: Yes! But sometimes, for those problems they are not able to manage, they give us 
transfers directly to other services within the hospital without passing through the 
outpatient service for general consultation. (Urban, female, 46 years old, 5 years on 
antiretroviral treatment) 
8A: Indeed you are right! It depends! Sometimes, we get transfer from our clinic here 
that allows us to go immediately to the specialists, but again there is a time, the 
transfer is to go through normal channel, which is from outpatient service then to 
specialists; this last option takes time!” (Urban, female, 23 years old, 4 years on 
antiretroviral treatment) 
Many of the participants at Hospital A indicated that “it [the referral process] is really a 
mess”: there was no clear procedure to follow for referral. 
A few participants in both FGDs mentioned departments they had been referred to including 
the ophthalmology clinic, the Ear, Nose, and Throat (ENT) clinic and the dermatology clinic. 
Certain participants had never been referred though they had encountered various problems; 
they were not informed about the possibility of referral from the ARV service to other 
services, or they had been informed too late, when complications had already occurred. 
However, in the course of the FGDs participants expressed the need for referral, including 
those who were not previously aware of the existence of these services. 
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4A: Hum!
41
 This is my first time to hear about transfers. I had chest pain recently and I 
was given medicines here in ARV clinic. Until now, it is not well healed. (Urban, 
female, 66 years old, 7 years on antiretroviral treatment) 
5B: Hum!
42
 It is not all the time they refer you! I have suffered from herpes zoster and 
it hurts! They only gave me ARVs and told me it will go! So I thought it is because it 
was related to HIV, so there is no any other medicine!  Now it has left me with eye 
problems [and] they have decided to give me a transfer to the ophthalmology service.  I 
have an appointment of going there next week. (Rural, male, 30 years old, 5 years on 
antiretroviral treatment) 
One participant shared her experience of the physiotherapy service and a few participants at 
urban Hospital, who had never been referred to physiotherapy, indicated that they thought 
that physiotherapy could help with the joint, muscle and nerve pains they experienced, 
however, to date they had only been given medicine.  
We need a single medical file 
Participants at the rural hospital pointed out that they had more than one medical file within 
the hospital, possibly a file for each service used, and this caused difficulties as all their 
medical history was not kept in a single file. They acknowledged that they contributed to this 
duplication when they went to the health centre/outpatient department without going via the 
ARV Clinic and so a new file would be opened. 
6B: For me, I have a medical file for each service I go through; I find it disturbing 
sometimes if I have to be interviewed all the time, like I am a new patient in this 
hospital! (Rural, female, 42 years old, 8 years on antiretroviral treatment) 
1B: In fact, we contribute to this file mess. We are always told to contact the ARV 
doctor in case we face any health problem. (Rural, female, 36 years old, 6 years on 
antiretroviral treatment) 
                                                 
41 Expression of realisation 
42 Expression of realisation and regret 
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One participant explained that he or she might decide to go directly to the outpatient service 
when doctors in ARV clinic appeared to be overwhelmed with too many patients and did not 
have much time for them.   
3B: Normally what happens when we come here in the ARV service and find that our 
doctor is busy with many patients, we prefer to go to [the health centre] where they 
make us other medical files for another doctor. (Rural, female, 38 years old, 8 years 
on antiretroviral treatment) 
4.5.6.2 Environmental factors and services beyond the ARV clinic  
The environmental factors in the hospital that act as facilitators and as barriers to function 
beyond the ARV clinic are described: 
Services outside ARV clinic environmental factors that act as facilitators 
The facilitators included rehabilitation services that assist with functional limitations or 
problems; involvement of PLWH community in their care, the extended care to the PLWH 
through the national medical insurance cover Mutuelle de Santé.  
Rehabilitation services assist with functional problems  
Very few participants with functional limitations or problems at either hospital had been 
referred to the appropriate rehabilitation service.  At Hospital A one participant had been 
referred for physiotherapy at another hospital, and another participant to the mental health 
service. At Hospital B one participant had also been referred to the mental health service.  
These participants were satisfied with the care they received from the two rehabilitation 
services. 
3A: (Showing happiness) There was a time they gave me a transfer to CHUK for 
physiotherapy. I had much paraesthesia and paralysis (muscle weakness). They really 
helped me and I was healed! (Urban, female, 45 years old, 9 years on antiretroviral 
treatment) 
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3B: I told the ARV Doctor that usually I have memory loss, [and] he sent me to mental 
health doctors. I am now having their medicines. (Rural, female, 38 years old, 8 years 
on antiretroviral treatment) 
Involvement of my community in care 
One woman explained how some health care providers in the ARV clinic think beyond the 
hospital environment and act holistically by considering not only the health care services at 
the hospital; they also seek to involve the patient‘s community, starting with their family, to 
provide further support. The nurses and doctors had assisted her by inviting her family 
members and the local leaders in her community for a discussion; the health care workers 
advised the family to give her as much support as possible, instead of mistreating her. 
7A: Three months ago, I came here, they examined me and found that the CD4 count 
has decreased. They asked me why and I explained that was maybe due to family 
problems I was facing. They called my family and the local leaders. They forbad them 
to ill-treat me. On the contrary, they should look after me as [they do] others. (Urban, 
female, 46 years old, 5 years on antiretroviral treatment) 
The national medical insurance cover - Mutuelle de Santé (Also see section 1.1.1)  
Many of the participants indicated that they could afford to have the inexpensive medical 
cover, the Rwandan National Insurance, Mutuelle de Santé. They explained how it had many 
advantages for their health; for example, when somebody was recognised as a PLWH with 
Mutuelle de Santé, all treatment was free. They explained that it would be a good reason for 
them only to use the medical file from the ARV clinic at all clinics.  
1B: We have the advantage of going to other services with the ARV medical file, 
because if you have the Mutuelle de Santé, you are treated for free, whereas others 
pay 10% [of all services and drugs]. (Rural, female, 36 years old, 6 years on 
antiretroviral treatment) 
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Services outside ARV clinic environmental factors that act as barriers 
The factors that acted as barriers included overcrowded facilities and long waiting times, 
participants‘ need for special consideration, participants‘ lack of awareness of the health care 
providers‘ responsibility to assist with functional problems, the inability of health care 
providers outside ARV clinic to assist with functional problems, poor communication, the 
negative attitudes of health care providers, the unavailability of doctors, the limitations of the 
national medical insurance and a preference for private rather than public facilities. 
Facilities overcrowded and long waiting time 
Many participants were not satisfied with the care they received from the other services they 
were referred to within the hospital. At the outpatient department and at the speciality 
services there were many other patients and they had to wait for a long time. This could have 
an impact on their condition.  
3B: (speaking with sadness) We have a problem! We sometimes go to see other doctors 
and find that they have many patients. Hum!
43
 We are worried about a long line that we 
must make waiting for meeting a specialist whereas we are not like other sick people. 
Us, we are weak. Consequently, our health condition gets worse. (Rural, female, 38 
years old, 8 years on antiretroviral treatment) 
Participants felt the need for special consideration as a PLWH 
Several male and female also reported that one reason why they did not appreciate the care 
provided by the services they were referred to was that they were treated in a similar way to 
all the other patients. They said that they had special problems/needs related to their HIV 
status, which meant they were different from others; thus they expected to receive special 
consideration, or special care. 
8A: (Looking nervous showing the seriousness of the problem) The way they treat us in 
other services, is not different from other patients, whereas I think we are different. We 
even sometimes tell them that we are HIV-positive but we are treated and considered in 
                                                 
43 Expression of disagreement and worry 
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the same way as other patients.  I usually ask myself why? (Urban, female, 23 years old, 
4 years on antiretroviral treatment)  
Likewise two other participants from Hospital A said that the health care workers in the other 
services gave them normal care, just like others, although they did not consider themselves as 
having the same needs as other patients: “We are different, we are not like others”. 
Three other participants added; “Yes! That is how it is, and sometimes we are in a severe 
condition!” 
6A: I think they should give us a special care! For sure, they do not care about us 
sufficiently. (Urban, male, 28 years old, 3 years on antiretroviral treatment) 
Participants‘ lack of awareness of the health care providers‘ responsibility to assist with 
functional problems  
Some participants were confused about whom they were being referred to. They were no 
longer certain who would look after them. They were not very sure which type of health care 
provider they were to be referred to, and who could assist them with the functional problems 
they were facing. In this situation, they ended up with a lot of extra stress (in addition to that 
usually associated with HIV). 
6A: Truly we do not know which type of health care providers to go to for the problems 
we told you! Only what we know when we are referred, we do not have a person who 
looks after us in particular. This makes it more stressful! (Urban, male, 28 years old, 3 
years on antiretroviral treatment) 
Health care providers outside ARV clinic are unable to assist with functional problems 
Various participants have mentioned that, as with the ARV clinic, health care providers at the 
other services did not always assist them adequately with their functional problems. They 
complained that the health care providers in other clinics were always overwhelmed with 
many patients and managed what they were able to by only prescribing drugs. The 
participants repeatedly brought up the issue of only having medicine prescribed: they said the 
medicines they were given were ineffective. 
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2A: The services where we are referred to, they are always too busy with many patients 
and they manage what they can by only giving us medicines. (Urban, male, 49 years 
old, 5 years on antiretroviral treatment) 
2A: Even for paraesthesia, nausea, backache and others, they prescribe medicines but 
we are not cured. (Urban, male, 49 years old, 5 years on antiretroviral treatment) 
8A: Yeah! It is because the drugs we are given for the complications are not efficient. 
(Urban, female, 23 years old, 4 years on antiretroviral treatment) 
One male participant, at Hospital B, suggested another reason for their difficulty with other 
services was that patients were not familiar with the health care providers working there.  
4B: Sometimes the care we receive from doctors from other services is not effective 
because we are not familiar with them. (Rural, male, 44 years old, 6 years on 
antiretroviral treatment) 
Poor communication 
The health workers did not communicate in the ways male and female participants in both 
urban and rural areas wanted. They wanted to be listened to, to have their health problems 
explained, and to be involved in decision-making about their health care.  
1B: Doctors do what they can! I mean their best!  But I think and wish really if we 
could have more doctors who can take time to listen to our problems it could be better. 
(Rural, male, 47 years old, 6 years on antiretroviral treatment) 
8A: We are not getting the detailed explanations of what we are suffering from. 
(Urban, female, 23 years old, 4 years on antiretroviral treatment) 
2A: The doctor just judges and takes decisions for you. He/she does not ask you many 
questions. (Urban, male, 49 years old, 5 years on antiretroviral treatment) 
Participants related the issue of communication to self-acceptance, saying good 
communication could improve acceptance of being HIV-positive.  They wanted “be given 
special consideration”  
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8A: We need communication more than others do, because we have special needs … 
Really, we are not considered differently from other patients. (Urban, female, 23 years 
old, 4 years on antiretroviral treatment) 
1B: Through interaction, they can teach us self-acceptance since many among us have 
not yet accepted their situation. (Rural, male, 47 years old, 6 years on antiretroviral 
treatment) 
Some participants attached so much importance to communication that they avoided being 
seen by particular doctors who did not interact with them or to listen to their problems. 
1B: For example, you may hear someone saying that I cannot get in if such a doctor is 
inside, just because he knows the doctor does not always have time to talk or to listen to 
his problems. (Rural, female, 36 years old, 6 years on antiretroviral treatment)  
They thought one reason doctors did not listen was because they were so busy.  
5B: I personally know one doctor, he is a friend of my brother, but he is very busy at 
work like others. I prefer to meet him at home and explain all my problems to him and 
then, he gives me appropriate advice. (Rural, male, 30 years old, 5 years on 
antiretroviral treatment) 
Health care providers‘ negative attitudes to PLWH  
Certain participants complained that at some health centres they visited, the health care 
providers did not show compassion; instead they discriminated against them once they 
discovered that they were PLWH. 
8B: When you go to a health centre and tell them the problem you have, they look in the 
file and tell you to go to the doctor who follows you. You realize that you are coldly 
received just because you are a person with HIV. (Rural, female, 38 years old, 8 years 
on antiretroviral treatment) 
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Doctors not available 
Sometimes, even on referral, doctors were not available for the patient despite having an 
appointment. This might be because the doctor has been called to an emergency. The patients 
would then have to continue with only the antiretroviral treatment or go to a private clinic, if 
they had the money.   
3B: You may frequently come to see a doctor, on appointment given and miss him 
whereas you are suffering much. This makes you either go to private clinics, if you have 
money or keep on taking the medicines (ARV). (Rural, female, 38 years old, 8 years on 
antiretroviral treatment) 
Limitations of the national medical insurance, Mutuelle de Santé 
At the rural hospital, some participants explained that Mutuelle de Santé had its limitations, 
and not all their needs could be met. It did not cover all the necessary medication, especially 
expensive medication, and did not include some specialists‘ services. Sometimes they paid 
separately for these services. 
 8B: Some medications are not covered by Mutuelle de Santé so we buy them 100% 
with our own money. (Rural, female, 23 years old, 8 years on antiretroviral treatment) 
 3B: Heeee!
44
 I had a problem of the eyes. The ARV service gave me a transfer to 
ophthalmology. Then, my medical insurance was refused. So, because I was suffering 
much, it required me to pay by myself for consultation. (Rural, female, 38 years old, 8 
years on antiretroviral treatment) 
Comparing care in private and public facilities 
Some participants, particularly men, had considered seeking care at private clinics. They had 
the impression that private health services were better than those in the state sector. They 
suggested that the public sector needed to recognise its weaknesses and refer them to these 
private clinics.  
                                                 
44 Expression of disappointment  
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1A: They prescribe inefficient drugs, instead of referring us to private clinics where we 
would get efficient treatment. (Urban, male, 47 years old, 4 years on antiretroviral 
treatment) 
They said they would go to private clinics if they were informed that appropriate drugs were 
not available at the hospital. 
1A: They [the government hospital] would tell us that they do not have the appropriate 
medicines for the problems we have. Thus, we would seek help in private clinics. 
(Urban, male, 47 years old, 4 years on antiretroviral treatment) 
Some male and female participants said that, at times, the quality of care in private services 
was better; some health care providers in the private sector had attended to their functional 
problems but participants appeared reluctant to discuss this, as if they feared being reported 
to the ARV clinic.  Other participants did not agree that the care was better at the private 
clinic:  
7A: I had pain in shoulders and back. I was given medicine here at this hospital, but 
there was no improvement. I went to private clinic where they also gave me medicine, 
but until now nothing changed. So it depends! (Urban, female, 46 years, 5 years on 
antiretroviral treatment) 
Care in private clinics was much more expensive, unless one had additional private health 
care insurance, for example RAMA.   
2A: (Seemed to hesitate, murmuring, like someone thinking of what he is going to say);   
Hum!
45
 I prefer to go to private clinics because it is where I get treatment and recover. 
Really medicines they give us here … do not help! And I think if one has means, to get 
treatment in private clinics it is not a problem. I use RAMA. In fact, all clinicians there 
[at the private clinic] receive patients with care. (Urban, male, 49 years old, 5 years on 
antiretroviral treatment) 
                                                 
45 Expression of hesitation 
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3A: You are right!  Long ago, pain in muscles and nerves became too much. I had some 
money and decided to look for a doctor in private. He had prescribed me a medicine; I 
went to buy it in a private pharmacy. It was expensive, but helped me much! It was the 
efficient medicine! (Urban, female, 45 years old, 9 years on antiretroviral treatment) 
4.5.7 Theme 6: How the hospital services could respond to my functional limitations  
This theme describes participants‘ recommendations regarding improvements in the hospital 
services to respond to their functional needs and improve their quality of life. This included 
recognition of their vulnerability, providing counselling, improving their human resources, 
and making use of appropriate treatment planning and management. 
4.5.7.1 Recognise the vulnerability of PLWH  
Participants felt that they were extremely vulnerable, with special needs, and emphasized that 
they needed to be given special consideration by the doctors and other medical staff; they 
required more attention than other patients, including referral to other services. They wanted 
to be treated by people who would understand their problems and who would support them.  
8A: I suggest, doctors where we are referred to, should take more care of us than they 
do for ordinary patients.  They should know that we have our special needs related to 
our health condition. Thus, we need special care. (Urban, female, 23 years old, 4 years 
on antiretroviral treatment)  
The participants wanted the health care providers in the services beyond the ARV clinic to 
understand their health condition and the problems they were facing and in particular to take 
more time to listen to them than they did with the other patients.   
4A:  We need health care providers from this hospital to understand our condition and 
the related problems, to listen to us more than they do for ordinary patients. (Urban, 
female, 66 years old, 7 years on antiretroviral treatment) 
4.5.7.2 Establish counselling programmes  
Many  of the participants wanted a counselling programme offered daily or at least once a 
month, as this was how often they attended the ARV clinic. They believed that group 
counselling sessions could help PLWH change their behaviours. This support should not only 
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include psychological care but should also include their quality of life and adherence to 
antiretroviral treatment.  
3A: There is a problem with counselling here! There should be group counselling every 
morning. There are some cases that shock me. For example, there are women who are 
continuing getting pregnant every year when they are HIV-positive. They are not well 
fed; they are poor, really they should be given some advice in particular. (Urban, 
female, 45 years old, 9 years on antiretroviral treatment) 
3A: We also need the group counselling for nutrition and dietetics. It would help us 
have our own control on body weight. (Urban, female, 45 years old, 9 years on 
antiretroviral treatment) 
 8A: And it (counselling) also teaches us the importance of medicines. (Urban, female, 
23 years old, 4 years on antiretroviral treatment) 
In FGD B, one participant said the counselling would strengthen them, and she related 
counselling training to self-acceptance. All other participants expressed the need for training.  
6B: Yeah; counselling is good.  During sessions; they should teach us about health 
care, rebuild our hearts, and give us advice concerning self-acceptance. (Rural, female, 
42 years old, 8 years on antiretroviral treatment) 
4.5.7.3 Human resources 
Most participants emphasized the need for health care providers to be available. 
Availability of medical doctors in ARV clinics 
At Hospital A, they wanted a medical doctor at the ARV clinic because there was not one. 
They said that if there was a doctor they would be examined and treated at the ARV clinic, 
and the doctor would only refer those cases he or she could not manage, and referral would 
be to the right specialists. They said this should improve the referral procedure. 
6A: The obstacle to referral is the lack of our own doctor here in our clinic. (Urban, 
male, 28 years old, 3 years on antiretroviral treatment)  
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2A: They complicate our life when they include us in the normal hospital referral 
procedure without first being examined by a doctor here in our clinic. It could be better 
if a doctor examines us here and refers to others if needed. (Urban, male, 49 years old, 
5 years on antiretroviral treatment) 
Participants at the rural hospital said they had one medical doctor at the ARV clinic. However 
they wanted for a second one to assist because the doctor was so busy. The doctor needed to 
attend to patients in other departments or to attend workshops and meetings. At times patients 
who came to get treatment left without receiving any because the doctor was not available. 
1B: In this ARV service, [it] would be better if we had another doctor who could work 
once the one we have is absent. He may have gone to attend training or work in other 
services, [or] to care for other patients, and sometimes, when one amongst us falls 
severely sick and comes to seek care and finds that the doctor is not there, sometimes 
he goes home without any treatment and his condition gets worse. (Rural, female, 36 
years old, 6 years on antiretroviral treatment)  
Participants wanted to be treated by the doctor they were familiar with.  
4B: Sometimes, the care we receive from different doctors is not effective because we 
are not familiar with them. (Rural, male, 44 years old, 6 years on antiretroviral 
treatment) 
Availability of rehabilitation specialists 
At both hospitals most of the participants wanted to be referred to the appropriate specialists 
to assist with their functional problems. 
3A: We would wish to have specialists for all the problems we have mentioned earlier; 
such as headache and paraesthesia. (Urban, female, 45 years old, 9 years on 
antiretroviral treatment) 
At Hospital B, the discussion was extremely vibrant and participants came up with interesting 
propositions. Most indicated that they would prefer to have specialists provide them with all 
the necessary care in the ARV clinic. 
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6B: It could be better if we have the specialists for the complications we told you, like 
paraesthesia, chronic headache, eye problems, back pain, and so on. We wish they [the 
specialists] could be close to us in ARV service. (Rural, female, 42 years old, 8 years on 
antiretroviral treatment) 
Participants assumed that this would solve the lengthy waiting time experienced at the other 
services. 
7B: Yeah! We would like the specialists here, close to us in this service, so as to avoid 
the long appointment. (Rural, female, 45 years old, 3 years on antiretroviral treatment) 
However, one participant at the rural hospital disagreed saying it would be unfair for other 
patients who needed to see that specialist.  
1B: According to me that is not possible! Instead, they can group together all patients 
with similar health problems and connect to the right specialists who can help them, 
because if he /she come here in this ARV service, other patients can miss him/her 
whereas they are also suffering. (Rural, female, 36 years old, 6 years on antiretroviral 
treatment) 
Team of health care providers exclusively for PLWH  
Participants not only wanted their own medical doctor but an entire team of health care 
providers in the ARV clinic or in any other service they visited within the hospital or outside 
the hospital. They explained that as they would always be patients they wanted health care 
providers whom they could trust and who would look after their problems, always to be there 
for them, and give them special consideration. They said this on-going contact with the health 
care providers would improve the quality of care. 
3B: Since we are permanent patients, we would rather have our own health care 
providers, who follow us and we tell them our problems. Otherwise, complaints are 
always there! We will always have problems. (Rural, female, 38 years old, 8 years on 
antiretroviral treatment) 
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Increased numbers of hospital health care providers 
Without specifying the profession, participants at both hospitals wanted an increase in the 
number of health care providers in both hospitals.  This would improve service delivery by 
reducing the waiting time, which was a serious problem.  
3A: Health care providers are few. They should increase their number. (Urban, female, 
45 years old, 9 years on antiretroviral treatment) 
2B: For me, I think care delivery in this hospital can be improved by increasing 
number of health workers. Service delivery needs to be improved really. (Rural, male, 
21 years old, 3 years on antiretroviral treatment) 
3B: Yeah, moreover, this hospital receives so many patients in the way that, sometimes 
they become intolerant [of] prolonged waiting periods which, therefore, may lead to 
grumbling and insulting the health care providers. If possible, there should be more 
health care providers who could quickly solve the patients’ problems. (Rural, female, 
38 years old, 8 years on antiretroviral treatment) 
Because of the shortage of health care providers, and the increased number of patients, some 
patients were referred to other hospitals and again might need to wait for an appointment. 
This waiting for an appointment had a negative impact on their health condition. 
5B: Indeed it is important that the number of health care providers be increased. Do 
you know that it sometimes happens to be sent to another hospital and then, be given 
another appointment from that hospital because of many patients? This exacerbates the 
disease we are suffering from. (Rural, male, 30 years old, 5 years on antiretroviral 
treatment) 
Nurse to be responsible for ARV medication at the health centre 
One male participant spoke about care outside the hospital and suggested that a nurse be 
made responsible for the ARV service at each health centre so as to improve services for 
PLWH from the primary level. 
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 4B: At each [health centre], there should be a nurse who is in charge of ARV service. 
(Rural, male, 44 years old, 6 years on antiretroviral treatment) 
4.5.7.4 Treatment planning and management for PLWH 
Participants spoke of the need for collaboration between health care providers, improved 
referral, and having a single medical file. 
Collaboration 
Participants at both hospitals said it would be good if the health care providers at the ARV 
clinic could work closely with those from other services within the hospital. They should 
have frequent meetings to identify the problems of PLWH and collaborate in planning 
effective care.  
2B: I think all health care providers in this hospital should work together; it is an 
important strategy to assist us with our problems and improve their service delivery. 
(Rural, male, 21 years old, 3 years on antiretroviral treatment)  
Three participants at the urban hospital said: ―We wish people could work together. It can 
solve many problems”. 
Referral 
Male and female participants wanted the health care providers at the ARV clinic to recognise 
their limitations in managing the patients‘ problems and refer them to other departments. The 
health care providers needed to consult with each other when deciding who the most 
appropriate person was to whom they should refer the patient.  
2B: They should think about referring us when they cannot manage the condition. 
(Rural, male, 21 years old, 3 years on antiretroviral treatement) 
6A: Really it would be better if they discuss our problems together with others and send 
us to particular specialists who can give us appropriate treatment for specific 
sicknesses. (Urban, male, 28 years old, 3 years on antiretroviral treatment)  
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 3B: If the Doctor realizes that he or she is not able to cure the disease, he/she should 
refer us to another who [would be] able to manage it. That is what collaboration 
means! (Rural, female, 38 years old, 8 years on antiretroviral treatment) 
Participants wanted appropriate referral so they did not need to find their own specialists. 
One woman at urban Hospital indicated that if the referral was well organized from the ARV 
clinic, patients would not need to look for specialists as they did not have the background to 
find the appropriate people.  
3A: We would like to be transferred to specialists from here if there is a need; without 
[having to use]our own initiative to look for them. We sometimes look for them by 
ourselves and do not find the right people. (Urban, female, 45 years old, 9 years on 
antiretroviral treatment)  
A single medical file  
Participants did not like to have a separate medical file in each department. They wanted to 
use one medical file for all services, regardless of where they were being referred to. The use 
of one medical file could foster collaboration and improve the referral procedure. It could 
improve patients‘ relationships with health care providers throughout the hospital. It could 
improve follow-up and the quality of service delivery.   
2B: We would like also to propose one medical file should be sent to the service a 
patient is transferred to. This would help the specialists refer to the progress notes of 
the ARV doctor or other doctors. It would then make us feel free with them like our 
ARV doctor. (Rural, male, 21 years old, 3 years on antiretroviral treatment) 
7B: This would be much better because one medical file can be used in every service 
we go through and we then have no difficulties with the treatment process. Even that 
mess of many medical files we mentioned earlier, would be over. (Rural, female, 45 
years old, 3 years on antiretroviral treatment) 
The moderator wanted to know if participants did not have problem with their status being 
known when moving the medical file from one service to another.  Contrary to what they said 
earlier, participants indicated that they did not mind their HIV status being known by all the 
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health care workers and that they would rather give priority and consideration to the quality 
of care.   
4.5.7.5 Improve the quality of National Medical Insurance: Mutuelle de Santé  
At both hospitals the participants wanted the quality of Mutuelle de Santé to improve so it 
would provide more benefits.  Alternatively, they wanted another type of medical insurance 
that would to cover their medical needs as PLWH.   
2B: If the quality of the National Medical Insurance is not improved they should find us 
a particular health insurance that enables us to have all diseases treated as happens 
for HIV/AIDS. (Rural, male, 21 years old, 3 years on antiretroviral treatment) 
A mother, 38 years old, wanted the poorer people to be assisted with the medical insurance 
fees of their children as they were not always able to pay. 
8B: It is better you helped us find health insurance for our children because we have 
much difficulty paying it for them. (Rural, female, 38 years old, 8 years on antiretroviral 
treatment) 
Participants at the urban hospital, were concerned about PLWH who were very poor, and thus 
unable to afford the medical insurance payments. They wanted them to be assisted and 
provided with medical insurance to cover their health needs.  
2A: It would be better to assist PLWH, especially those who do not have medical 
insurance because of poverty, to get it. (Urban, male, 49 years old, 5 years on 
antiretroviral treatment) 
3A: Yeah, for sure it could be a good thing really, they cannot afford [it] by themselves, 
they are miserable!   (Urban, female, 45 years old, 9 years on antiretroviral treatment)   
Other participants: “Hum!46 They really suffer much!” 
                                                 
46 Expression of sympathy  
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Participants wanted the hospital pharmacy to be well stocked. One participant said that 
sometimes the hospital pharmacy lacked essential drugs so the patients had to buy medicines 
from a private pharmacy without medical insurance. This was expensive.  
2B: However, the hospital also should be empowered to find enough medicines. 
Sometimes, we are prescribed medicines [when] they cannot be found in the hospital 
store. We are, then, required to buy them in private pharmacies at a higher price. 
(Rural, male, 21 years old, 3 years on antiretroviral treatment)  
4.5.7.6 Implementation of nutrition or food programs 
Participants at the rural hospital wanted nutrition and food support programmes for PLWH. 
Good nutrition was recognised as important for a healthy lifestyle for PLWH. They said that 
food was provided to PLWH in the past by non-government organisations (NGOs), through 
PLWH associations, and this was still needed.  
1B: There were associations through which donors supported people living with HIV 
infection by giving them food. We wish the programme to be restored and help us 
because these medicines require adequate diet. (Rural, female, 36 years old, 6 years on 
antiretroviral treatment) 
There was a suggestion to revisit the Girinka or ―One cow to one poor family‖ policy in 
Rwanda; this had been initiated to eradicate poverty. This was a national programme aimed at 
giving a cow to every poor Rwandan family to ensure that they would have some food. They 
wanted PLWH to benefit from this programme.   
6B: I suggest you advocate for us that “Girinka” should reach our associations so as to 
access milk which would help get proper diet. (Rural, Female, 42 years old, 3 years on 
antiretroviral treatment) 
Financial support for orphans 
One male student, an HIV orphan, wanted other HIV orphans who had stopped going to 
school due to a lack of school fees to be assisted financially so they could resume their 
studies. 
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2B: I suggest that you should help HIV- infected orphans who [have] stopped studying. 
You could help them find supporters who can pay their school fees. (Rural, male, 21 
years old, 3 years on antiretroviral treatment) 
Youth HIV clinic 
The young male student wanted to separate the children/youth service from the adult service.  
He said youth had different interests from adults and sometimes, when they were together 
waiting for treatment, children complained of being bored and annoyed by the adult 
conversation. He wanted school children to be provided treatment before other people so they 
could report in time for school.   
2B: We children, when we sometimes come here to take medicines, we normally 
become annoyed with uninteresting parents’ stories. And also our wish as students is 
that they should let us be treated before other patients so that we can go back to school 
early. (Rural, male, 21 years old, 3 years on antiretroviral treatment) 
Time management 
One female participant, at the urban hospital wanted health care providers to improve their 
time management, to respect the starting time of work and to avoid mixing social and work 
activities 
8A: We would like to request health care providers to start work on time. They begin 
when they want and when they are there at time; they keep on telling stories, just 
wasting time. (Urban, female, 23 years old, 4 years on antiretroviral treatment) 
Need for privacy 
At the urban hospital, the male participants wanted privacy. For example one man indicated 
how he wanted more privacy at the ARV clinic, and complained that there was a family 
planning clinic at the ARV clinic and he wanted this separated from the ARV clinic.  
6A: There is another problem; we used to be alone at this service. Now, we are with 
another service [family planning] which is bothering.  We wish we could have some 
privacy. (Urban, male, 28 years old, 3 years on antiretroviral treatment)  
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4.5.8 Summary 
The themes that emerged are presented in these findings. The first theme described the 
impairments that manifested in patients, due to HIV infection or to the antiretroviral 
treatment. The impairments mentioned were: lack of energy, pain, paraesthesia, dizziness, 
lipodystrophy, body image and memory loss and lack of concentration. Male and female 
participants, in both urban and rural hospitals, spoke of similar impairments. They indicated 
how severity might change overtime.  
The participants‘ impairments, especially lack of energy, which gets worse overtime, pain, 
paraesthesia, breathlessness and loss of memory, affected their function and performance of 
daily activities and their participation in social life. The activities most affected were: 
mobility, self-care, and life activities, including household and work activities.   All activities, 
except households, were reported by men and women equally. 
Reduced activity performance contributed to decreased productivity, which affected 
livelihood, and this occurs overtime.  Impairments, particularly lack of energy, restricted 
male and female participation in social life, including leisure activities, social relationships, 
spiritual practices and sexual relations. Males participants compared to females, spoke more 
about lack of energy causing decreased engagement in sexual intercourse. The female 
participants who talked, complained about lack of desire as a cause of decreased involvement 
in sexual intercourse rather than lack of energy. 
The third theme described the personal factors that either facilitated or limited participants‘ 
functioning. Personal factors that facilitated functioning included spiritual beliefs and faith in 
God; positive thinking about disclosure was identified as a strategy to improve psychological 
well-being, or to overcome internalised stigma and to create awareness about HIV. Other 
facilitating factors were: a sense of belonging at the ARV clinic; a sense of solidarity among 
PLWH; and trust in other people, especially parents, close friends and health care providers 
(this facilitated disclosure). Coping strategies that participants developed were described.  
Personal factors that limited functioning were also discussed. These included internalized 
stigma, expressed by feelings of being hurt, and feelings of regret and shame, and guilt and 
remorse about HIV. The participants had thoughts about being stigmatized, being chased 
away, being judged or being dismissed from work. Age was identified as personal factor that 
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could influence the ability to function well. Very few men were engaged in the discussion on 
disclosure. Although female participants spoke of positive and negative effects of disclosure 
the only man who spoke of disclosure indicated that it would lead to stigmatisation and it was 
not clear that he had disclosed his status to anyone beyond the ARV clinic. This was similar 
in both rural and urban areas. Certain women shared how disclosure becomes easier 
overtime. Likewise women dominated the discussion on stigma, in rural and urban areas. 
Other factors were spoken about by both men and women, in rural and urban areas. 
The fourth theme described the social relationship or community environmental factors that 
influenced the participants‘ functioning. Social relationships included participants‘ 
relationships with their families and with their communities. Family relationship factors that 
facilitated functioning included good family support and positive attitudes. Family 
relationship factors that hindered functioning were the negative attitudes of family members. 
Community relationship factors that acted as facilitators included good community support 
and positive attitudes,  that could lead to improvement overtime. Community environmental 
factors that limited functioning included community stigmatisation and discriminatory 
attitudes. Female participants compared to male, expressed easily their feelings and 
experiences regarding family and community relationship. It was not easy to know male 
participants‘ living experiences and relationship with their family and community after 
contracting HIV. 
The fifth theme described the factors in the hospital environment that influenced the 
functioning of PLWH. The hospital environment included the ARV clinic and services 
outside the ARV clinic environment. Environmental factors in the ARV clinic that facilitated 
functioning included the service provided by the ARV clinic, trust in these health care 
providers, and the referral procedure from the ARV clinic to other services within the 
hospital.  Environmental factors in the ARV clinic that acted as limitations to functioning 
included a lack of assistance concerning functional problems, the participants‘ lack of 
knowledge about specialist services that could help to manage the functional problems, the 
inconsistent referral procedure, and the use of multiple medical files for one patient within 
the same hospital. Environmental factors related to services beyond the ARV clinic that 
facilitated functioning included assistance with functional problems from the rehabilitation 
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services, involvement of the community in care, and aspects of the national medical 
insurance, Mutuelle de Santé. Environmental factors related to services outside the ARV 
clinic that limited functioning included overcrowding, long waiting times, the absence of any 
special consideration for PLWH, participants‘ lack of knowledge of health care providers 
who may assist with functional problems, the health care providers‘ inability to assist with 
functional problems, a concern about whether the private service was better than the public 
service, and this was more spoken about  by male participants, poor communication, health 
care providers‘ negative attitudes, the unavailability of doctors and inability of Mutuelle de 
Santé to respond to all the health care needs of PLWH.  
Theme six described the participants‘ recommendations for improving services at the 
hospitals. These included: recognition of the vulnerability of PLWH, the establishment of a 
counselling program, an increase in the number of health care providers, strengthened 
collaboration and an improved referral system within the hospital, a single medical file, 
improved quality of service by Mutuelle de Santé, a food programme, a dedicated youth HIV 
clinic, education support for PLWH orphans, health care providers to respect time 
management, and consideration for privacy at ARV clinics. Only male participants spoke 
about the need for increased privacy. 
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5 CHAPTER FIVE: DISCUSSION OF RESULTS OF THE QUANTITATIVE 
AND QUALITATIVE STUDIES 
 
5.1 Introduction 
This section discusses the findings of the quantitative survey and the FGDs. The findings are 
discussed using the conceptual framework of the ICF presented in Chapter One (Figure 3). 
The key findings of the survey that relate to the profile and prevalence of disability among 
PLWH were obtained through the measurement of impairments, activity limitations and 
participation restrictions among PLWH who were on antiretroviral treatment. Where relevant, 
the results of the survey are also triangulated with those of the FGDs. The discussion 
includes: the participants‘ personal factors, including the demographic profile and the impact 
of personal factors on functioning; the participants‘ HIV status (health condition); the 
impairments, activity limitations and participation restrictions profile; and the community and 
the hospital environmental factors that affect functioning. The chapter ends with reflections 
and the limitations. 
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Figure 23: The bio-psychosocial model of management for people in Rwanda 
5.2 Personal Factors 
In this section the socio-demographic profiles of the participants are presented and the effect 
on functional limitations and participation restrictions is discussed. The sample of over 500 is 
large in comparison with that in a number of other studies on function in HIV (Anandan, et 
al., 2006; Myezwa, et al., 2009; Van As, et al., 2009), and is likely to be large enough to 
allow for generalization of the results of those attending public clinics and receiving 
antiretroviral  treatment for more than one year in Rwanda. 
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5.2.1 Gender 
On the days of data collection at the ARV clinics for the survey 35.7% of all patients 
attending the clinics were males and 56.6% females. Of these, 48.3% of these patients were 
willing to participate in the survey and met the inclusion criteria of being on ARVs. These 
participants were interviewed in the final sample.  
In each of the FGDs, although there was an attempt to have an equal number of males and 
females in the group, the proportion was 3:5 male: female participants. Other men declined to 
participate. Although the socio-demographic findings of the FGD participants are not 
considered generalizable they are presented in the relevant sections. 
The survey sample shows an over-representation of women, as 75% of the respondents were 
female. More women than men came to seek care on the days of data collection, and a greater 
proportion volunteered to participate in the study. This over-representation may be because 
women are more at risk of being infected with HIV, or because more women than men attend 
public sector facilities, or it may be the result of a combination of both factors. Likewise in 
the FGDs a greater proportion of women volunteered to participate. Two other studies on 
HIV conducted in Rwanda also showed samples dominated by women (Mutimura, Stewart, 
Crowther, Yarasheski, & Cade, 2008; Uwimana & Struthers, 2008). Similarly, several other 
studies conducted in sub-Saharan Africa have demonstrated an over representation of women  
(Freeman, et al., 2007; Harding et al., 2012; Makoae, et al., 2008; Makoae et al., 2005; 
Myezwa, et al., 2009; Pearson et al., 2009; Van As, et al., 2009; Wanyama, et al., 2007).  In 
contrast, a review of various other studies on HIV from different places in the world, such as  
India, USA, Canada and Brazil, showed a higher proportion of men in their samples 
(Coleman, et al., 2006; Devnani, Gupta, Wanchu, & Sharma, 2012; Emlet, 2007; Gaidhane, 
et al., 2008; George, et al., 2009; Miaskowski, et al., 2011; Rusch, et al., 2004a; Taneja, 
Dixit, Yesikar, & Sharma, 2012; Toro, Burns, Pimentel, Peraza, & Lugo, 2006).  
There is a higher prevalence of PLWH in sub-Saharan Africa than other countries in the 
world (UNAIDS, 2012a, 2012b), and this mainly affects women (UNAIDS, 2012a).  
Findings from the recent demographic health survey in Rwanda have confirmed a higher rate 
of HIV infection in women than in men (4% vs. 2%, a ratio of 2 to:1) (National Institute of 
Statistics Rwanda, et al., 2012). This could explain why, in the current study and in other 
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similar sub-Saharan Africa countries, women have dominated the sample. In addition, as 
Uwimana and Struthers (2008) state in their article, women have specific health issues or 
conditions, such as gynaecological and obstetric conditions, that lead them to seek health care 
more often than men. It thus appears as though a combination of the higher prevalence of 
HIV infection in women and the lower attendance of men at public health facilities could 
account for the higher rate of female participation. If this were not so, the ratio of female to 
male presenting with HIV would be 2:1 (according to the national figures), or 66.6%: 33.3%.  
Another possible interpretation could be the influence of the masculinity characteristic of 
men: the traits associated with masculinity could also explain their lower rate of attendance 
and participation in the study. It has been observed that, unlike women,  men often only 
access health care when their health condition becomes severe and they are no longer in 
control of their health (Mavhu et al., 2010).  
In terms of generalizability, the findings are more likely to reflect the experience of women 
than that of men, and future research is needed to establish why men with HIV are less likely 
to attend clinics and volunteer for research projects in Rwanda. 
5.2.2 Age 
The mean age of the sample in the survey was 39.7 years. In the FGDs the mean age was 41.8 
years for FGD A and 36.8 years for FGD B. A study of HIV conducted in Rwanda by 
Mutimura et al. (2008), as well as several other studies on HIV conducted in other African 
countries, such as Kenya, South Africa, Tanzania and a multicentre study involving South 
Africa and Uganda, present the mean age of their samples as being between 36.5 years and 
38.6 years (Cettomai, et al., 2010; Harding, et al., 2012; Mullin, et al., 2011; Myezwa, et al., 
2009). Studies reviewed from Western countries have shown  a greater mean age  (=> 40  
years) in their samples  (Aouizerat, et al., 2010; George, et al., 2009; Holzemer, et al., 2009; 
Miaskowski, et al., 2011; Toro, et al., 2006).  
Worldwide, the prevalence of HIV has drastically decreased and the number of those newly 
infected has been significantly reduced. Between 2001 and 2011, Rwanda achieved a 
reduction of more than 50% in new infections (UNAIDS, 2012b). This might be the reason 
why there were fewer participants in the youngest group (15 to 30 years old) in the survey; 
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this group would otherwise have been expected to have more cases of HIV infection due to 
the recognised increase in sexual activity among this age group. Moreover, in Rwanda there 
has been a large investment in the prevention of HIV.  Various approaches have been used, 
such as mass media education campaigns; behaviour change programmes, such as voluntary 
testing and counselling; ensuring that condoms are available and accessible; and programmes 
to encourage male circumcision, among others  (Ministry of Health (MoH) Rwanda, 2011b).  
Findings from the recent Rwanda national demographic health survey demonstrated that the 
HIV infection is most prevalent among women between the ages of 35 and 39 years old 
(7.9%), whereas for males it is most prevalent between the ages of 40 and 44 years (7.3%) 
(National Institute of Statistics Rwanda, et al., 2012). This could be one of the reasons why, 
in this survey,  men were approximately five years older than women, the mean age for  the 
males was 43.4 years, whereas for the females, 38.4 years.  This is similar to a study 
conducted in South Africa which showed that men were almost five years older than women 
(Myezwa, Stewart, Mbambo, & Nesara, 2007).  In a study in Mozambique, the difference 
was slightly higher as the mean age for men was seven years more than that for women 
(Pearson, et al., 2009). In a study conducted in India,  the difference was  even greater: the 
mean age of men was ten years more than that of women (Devnani, et al., 2012).     
Another possible interpretation for this phenomenon (the men being older than the women) 
could be that, in general, younger women are more likely to be more exposed to HIV 
infection than men when they have sex with an older man. Factors, such as poverty, 
particularly among females, may help to explain this.  One should also take into account the 
influence of culture, which contributes to the women‘s inability to negotiate with regard to 
sex or the use of condoms. Sexual violence which may be linked to women having sex with 
older men, exposes women to unsafe sex and HIV infection (UNAIDS, 2010). 
5.2.3 Marital status 
In the survey, the most common marital status among males was ‗married‘ (65%) while 
‗widowed‘ was most common among females (41%).  In the FGDs the commonest marital 
status among the men was ‗married‘ (40%), the others were single or separated. No men 
indicted they were ‗widowed‘. Among the women, the commonest marital status was married 
(60%), widowed (30%). ‗Widowed‘ was highest (48% and 44%) in two other Rwandan 
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studies, with similar samples, but this applied to both sexes (Mutimura et al., 2008; Uwimana 
& Struthers, 2008). In contrast to this survey, findings from the national demographic health 
survey found that most women with HIV were married (50%), 47% men were married, 5% of 
women were widowed, and fewer than 1% of men were widowed (National Institute of 
Statistics Rwanda, et al., 2012).  
There are a number of reasons for these discrepancies. Firstly, the number of married men 
may reflect the belief that the respect, dignity and recognition of a man in the Rwandan 
culture is influenced by his marital status. Men may identify as married (whether legally or 
not) because they want to be recognized by the society as responsible, mature and respectable 
adults. Secondly, the survey indicates that many married women become infected; in some 
cases, their husbands have died and they are widowed. A widow may choose to live her life 
alone with her children, rather than getting married to another man. In contrast, most men 
remarry after losing their wives. Thirdly, the aftermath of the 1994 war and genocide could 
also explain these findings. During the genocide, many men were killed, leaving behind many 
widows (Jones, 2002; Newbury & Baldwin, 2000); many women were sexually abused 
during this period (Cohen, et al., 2009; Mukamana & Brysiewicz, 2008) and sometimes 
contracted HIV (Donovan, 2002). Among those women, there might have been young girls. 
A higher rate of widowed women was also found in one group of PLWH in India (Devnani, 
et al., 2012). 
The findings on marital status from the survey suggest the need for further research to test 
these assumptions and to provide more insight into the reasons for the significant difference 
with the findings of the national demographic survey. 
5.2.4 Education and employment 
In the survey findings, employment and education were associated with gender. Men were 
more likely to be employed and involved in regular, paid work (12% vs. 4%) than women; 
they were also found to be more educated (above secondary level, 13% vs. 5%) than women. 
These findings are in accordance with those of the national demographic health survey 
(National Institute of Statistics Rwanda, et al., 2012), and with those of another study 
conducted in India: in this study, in a group of PLWH reporting to an ARV clinic, most of  
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the men were found to be involved in paid labour; they were also more educated than women 
(some up to Masters level and above) (Taneja, et al., 2012). 
In Rwanda, as in other countries, employment, particularly paid work, depends on one‘s level 
of education. Furthermore, traditionally in Rwandan culture, a young girl has to do the 
housework; this includes cleaning the house, fetching water, preparing food, etc. In contrast, 
education is a priority for boys.  This is because a boy is viewed as having the responsibility 
for the continuity of his family, while a girl is expected to leave her family one day when she 
gets married and joins her husband‘s family. Currently, the government is striving for greater 
gender equality in both the education and employment sectors. The national demographic 
health survey reported that 18% of men have completed secondary school vs. 15% of women, 
while 91% of men and only  73% women indicated they were employed  (National Institute 
of Statistics Rwanda, et al., 2012). The lower levels of education and employment in the 
survey sample (compared to the recent national demographic survey) might be because the 
participants were older. 
Further research is needed to provide evidence as to why, in the era of promoting girls‘ 
education and equal employment opportunities in Rwanda, the gender difference for both 
education and employment was found to be more than double in the survey.    
5.2.5 Impact of personal factors on functioning 
Personal factors can act as both facilitators and barriers to activity performance and social 
participation. Factors such as age, gender, coping styles, and social background could have an 
influence on individual functioning (Geyh, et al., 2011; Threats, 2007).  The FGDs 
participants described factors within themselves that contributed positively to their 
functioning and participation and those which were barriers to functioning and participation. 
5.2.5.1 Spiritual beliefs 
Participants‘ spiritual beliefs and faith in God were highlighted. The practice of praying was 
described as a positive strategy that brought strength and motivation and contributed to their 
psychological well-being. Participants expressed a strong faith in God, and wished to 
surrender all their problems to God; they were certain of God‘s healing power. They felt 
more secure when they felt close to God. This is a similar to other findings that some PLWH 
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use spiritual beliefs and practices as coping strategies to help them deal with the HIV 
infection and its complications (Dalmida, et al., 2009; Freeman, et al., 2007; Litwinczuk & 
Groh, 2007; Makoae, et al., 2008; Maman, et al., 2009; Pittiglio & Hough, 2009).  
Participants in a qualitative study by Pittiglio and Hough (2009) indicated that they had a 
strong faith in God and that their relationship with God was so powerful that it gave them the 
confidence to live with HIV; they believed that their survival was part of God‘s plan. Like 
our participants, they indicated that they considered their relationship with God to be a source 
of hope; they had decided to surrender their illness to God. Maman et al. (2009) also found 
the participants had hope and a strong faith in God; like our participants, they believed in 
God‘s miracles and that He could cure them of their illness. However, these participants 
reported that their counsellor encouraged them to pray, suggesting that God may have the 
power to cure HIV (this was not the case in the present study). 
Two studies have demonstrated the effect of such spiritual beliefs on psychological 
functioning and well-being and on HRQL (Dalmida, et al., 2009; Frame, et al., 2005), and on 
social functioning (Frame, et al., 2005). Coleman et al. (2006) report that their participants 
used prayer as a self-care management strategy for the following impairments: fatigue, 
nausea, depression and anxiety.  
These findings suggest that consideration needs to be given to an intervention in the form of a 
spiritual programme to improve the psychological and social functioning of PLWH.  
5.2.5.2 Resilience 
In order to cope with the disease, participants built their inner strength and resilience through 
strategies that might assist them to appear normal and to live normal lives like anyone else in 
their society. They tried to avoid suspicion or the discovery of their status as a PLWH, and 
went to the extent of changing their appearance or behaviour. Nam et al. (2008) found 
participants had developed a new image of ―self‖ with the virus. Ownby and Dune (2007) 
found participants also tried to live a normal life despite the severe pain they were suffering 
from (a symptom of peripheral neuropathy). They would explain their condition as gout 
because peripheral neuropathy was a known complication of HIV, and if revealed, people 
might suspect that they had HIV.  
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Makoae et al. (2008) focused on identifying coping strategies that could assist in living a 
normal life with the HIV infection. Viewing the self as normal or ―okay‖ was courageous in 
the face of the illness and was highlighted among the possible strategies. Other coping 
strategies included using humour, educating others, letting go, remaining hopeful and keeping 
oneself active. These strategies seemed important in assisting PLWH to cope with the 
challenges of HIV infection and its multiple side effects, particularly stigma.  
Although these findings have similarities there is a need for further research to understand 
how to individualise coping strategies, and to understand the benefits or disadvantages of 
these strategies for the health of PLWH, particularly for their psychological functioning.       
5.2.5.3 Internalised stigma 
Despite an orientation towards positive strategies that help to build resilience, participants in 
both urban and rural area, particularly women, did not appear to have accepted their HIV 
status and lived with the internalised stigma. This was expressed through feelings of being 
hurt by other people‘s attitudes, and through behaviour and comments once the participants 
discovered they were PLWH. It was also expressed through feelings of regret, shame, guilt 
and remorse about their HIV serostatus.  They imagined being judged, being discriminated 
against at their workplaces, and being abandoned by other people in their community once 
their status became known. All this had a significant impact on the disclosure of their status 
and their participation in the society. Participants feared that people in their community might 
tell others their status once they had disclosed it. 
Other studies have also demonstrated the presence of considerable internalized stigma among 
PLWH and their reluctance to disclose their status.  Simbayi et al. (2007) reported that their 
participants expressed shame and feelings of guilt about their  HIV serostatus. Lee et al. 
(2002) found that PLWH felt embarrassed about having the HIV infection and consequently 
avoided others as they were not ready to disclose their status. Likewise Emlet (2007) found 
that PLWH wanted to keep silent because they feared they would be stigmatised and 
discriminated against by others in their communities. Gaskins et al. (2012) also found PLWH 
were worried about stigmatization and rejection and about other people spreading the news of 
their HIV serostatus. 
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 Li, Wang, He, Fennie and Williams (2012) found that when PLWH learnt that they were 
infected, they felt hurt and became very sensitive to other people‘s judgmental comments and 
behaviour. They expected other people in the community to be afraid of them and to 
discriminate against them once they found out they had HIV. They avoided others in their 
community. They blamed themselves for getting the virus and felt distressed for causing 
shame and becoming a burden to themselves and also to their families. This led to extreme 
negative thoughts, including the wish to die soon. Gaskins (2006), on the other hand found 
that participants were reluctant to disclose their status because they thought their community 
lacked knowledge about the HIV infection and as result would not accept them. 
In support of these views, our findings on internalised stigmatization among PLWH suggest 
an urgent need for a psychological intervention. This would help PLWH to accept themselves 
and develop strategies that could assist them in coping with the disease and adjusting to an 
environment in which they feel insecure and discriminated against because of their HIV 
serostatus. The engagement of the community might also be needed. Here the intervention 
could also focus on disclosure and perhaps assist people in the community to understand both 
its positive and negative consequences. 
5.2.5.4 Internalised stigma and disclosure 
Interestingly, some participants believed that disclosing their HIV status might be a good 
strategy that could improve psychological well-being and encourage self-acceptance. This 
could help combat the internalized stigmatization described above that many participants had 
been experiencing. Participants also believed disclosure was a good strategy for creating 
awareness about HIV; it could assist in disease prevention and encourage those who were 
already infected to seek care.  
In keeping with our study, several previous studies have reported on the willingness of 
PLWH to disclose their HIV serostatus and on their opinions of the possible benefits of this, 
or of the reasons for disclosure. Makoae et al. (2008) describe how participants said 
disclosure was beneficial because it reduced gossip and rumours. They decided to disclose in 
order to seek support from loved ones and other people in the community, and to create 
awareness about the HIV infection. Emlet (2007) says some participants thought that 
disclosing to others was helpful because these people could provide social support. Gaskins et 
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al. (2012) describe how participants believed disclosure could relieve stress, encourage social 
support and assist in education about prevention.  
Although our participants emphasised their willingness to disclose, and the good reasons for 
doing this, they thought they should not disclose to everybody, and insisted on the importance 
of trust. Several studies have made similar findings on the issue of confidentiality (Gaskins, 
et al., 2012; Sowell, et al., 2003).  Participants mentioned groups of people whom they 
trusted and felt able to disclose to. They trusted some of their family members and close 
friends. All of them trusted their fellow PLWHs and felt secure in revealing their HIV 
serostatus to them. This sense of solidarity and willingness to disclose is not surprising as 
PLWH all know that they have a similar problem and it might be helpful to share challenges 
and to comfort one another. 
In keeping with the findings our study, participants in Gaskins et al. (2012) agreed while they 
could disclose to all their family members, the mother was the most likely first recipient. 
They also mentioned PLWH counterparts and friends, but (like our participants) they trusted 
only very close friends. However, in contrast to our study, the sexual partner was identified as 
a person who was not always informed. Participants in Sowell et al. (2003) also agreed with 
the need to tell family members, including trusted relatives and close friends; however, in 
contrast to our study; their participants mentioned employers and also sexual partners as 
among the people they would disclose to. Participants who agreed to disclose their status to 
their sexual partners said this was important because of the risk of HIV infection. Participants 
in the study by Maman et al. (2009), trusted their partners, and unlike our participants, they 
also thought church leaders could be trusted because they could keep secrets and pray for 
them. 
Our participants said that they trusted and would disclose their status to the health care 
providers at the ARV clinics, but not to other medical staff in the hospital. Apparently, this 
was because they appreciated the care received at the ARV clinic, compared to that provided 
by other services within the hospital. They felt they belonged to ARV clinic. It was their own 
service provider and their entry point to the hospital. However, this should not be interpreted 
as disclosure as the health care providers from ARV clinic knew about the participants‘ HIV 
serostatus from the day of diagnosis. Some participants indicated that they sometimes trusted 
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health providers outside the ARV clinic and disclosed their HIV status when they needed 
medication. However, it appears that our participants may not have needed to disclose their 
status to any health care provider. Participants in other similar studies also agreed to tell 
health care providers, but (unlike in our study), they agreed to tell all their health care 
providers without exception (Gaskins, 2006; Sowell, et al., 2003).   
It is important to say that, in this study, in both urban and rural areas, women dominated the 
discussion about disclosure and internalised stigma and it not clear that some of the men in 
the FGD had ever disclosed their HIV status beyond the hospital. The findings around 
disclosure suggest that it is a useful strategy to fight internalised stigma, in addition to raising 
awareness regarding HIV. This is needed among both non-infected and infected people. 
PLWH did not always understand the importance of informing their sexual partners of their 
status, which could result in passing on the infection. This implies that any intervention that 
targets the management of internalised stigma needs to incorporate the need for disclosure. A 
health promotion programme would be recommended, and if possible it should utilizes a peer 
education strategy.  Disclosure could also improve PLWH‘s psychological and social 
functioning if based on an effective psychological intervention.   
The findings related to disclosure to health care providers highlight important issues. There 
was particular trust given to ARV clinic health care providers, while disclosure of their HIV 
status to health care providers outside ARV clinic only happened because of the need to 
obtain medication. Functional limitations or problems were often not reported, despite the 
need for treatment. This suggests there is a need to inform PLWH about rehabilitation 
services, such as physiotherapy and psychology, and their effectiveness in the management of 
functional limitations. Perhaps ARV clinic health care providers, as identified key caregivers, 
could play a role in advocating this. 
5.2.5.5 Age 
Age was mentioned as a possible contributing barrier to the optimal functioning of PLWH. 
This supports the findings of Crystal et al. (2000), where older participants demonstrated 
higher levels of physical impairment and functional limitation, compared to younger 
participants. The present study did not explore the impact of age on the functional limitations 
of PLWH. Future research is needed to provide a clearer understanding. 
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5.3 HIV status and health – Health condition 
The findings of the survey show that among the participants there was no significant 
difference in the CD4 count (above and below 500) between those who declared that they 
were symptomatic and those who were not. This information is consistent with findings from 
another study by Willard et al. (2009). In addition, Willard et al. (2009) suggested in their 
article that the term ―asymptomatic HIV disease‖ is not valid: findings from their study, as 
was the case with ours, revealed that PLWH experience symptoms regardless of their CD4 
count level. Furthermore, they recommended that clinicians should do a thorough subjective 
examination regarding the presence of symptoms, unrelated to the level of CD4 count, and 
plan for management of the symptoms.  
This survey showed that the longer the participants had been on antiretroviral treatment, the 
more likely they were to be symptomatic. If we refer to Chapter Two, the review of literature, 
this is not surprising, as many studies have demonstrated that antiretroviral treatment 
significantly increases the risk and incidence of symptoms. This finding was supported by 
several of the FGDs participants, women and men, in both urban and rural areas and who 
attributed their functional limitations to the medication rather than the underlying pathology 
and indicated that increasing symptoms occurred overtime. 
However in the survey, those who had been on antiretroviral treatment for a long period 
showed a higher CD4 count. Despite the side effects of antiretroviral treatment, and in line 
with the findings of previous research, these findings confirm the positive impact of 
antiretroviral treatment on the CD4 count  (Heaton, et al., 2011; Howard, et al., 2002; Ma, 
Chen, Chau, & Saberi, 2010; Smith et al., 2004). 
The survey findings have confirmed that the manifestation of symptoms of impairment 
among PLWH is not related to the CD4 count, but it is likely to be associated with the longer 
duration of antiretroviral treatment. Furthermore, the study strongly supports the evidence 
from several other studies that adherence to antiretroviral treatment for a long period is 
positively associated with increased CD4 count and with the manifestation of symptoms.  
The increase in symptoms over time, despite the increased CD4 count, may be linked to 
PLWH not reporting symptoms. As the FGD participants described, they did not necessarily 
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report their symptoms to the health care workers because they thought that as their problems 
were associated with HIV and the antiretroviral treatment, they could not be cured. As a 
result, they did not receive the appropriate medication or treatment.    
5.4 Impairments in PLWH 
5.4.1 Impairments in mental functions 
5.4.1.1 Energy/drive 
Mental/psychological functions were frequently affected among respondents in the survey 
and discussed in the FGDs. This is similar to the findings of several previous studies 
(Alexander, 2011; Ciesla & Roberts, 2001; Collins, et al., 2006; Freeman, et al., 2007; 
Myezwa, et al., 2009; Newshan, et al., 2002; Rusch, et al., 2004a; Van As, et al., 2009), 
including one also conducted in Rwanda (Uwimana & Struthers, 2008). 
According to Van As et al. (2009), the most common mental/psychological problems were 
emotional problems, problems with energy and drive, and sleep disturbances.  However, in 
our study, among the mental/psychological functions assessed, emotional problems were 
most commonly reported, with 61% of the sample reporting moderate, severe or extreme 
problems. The problem least reported was memory loss (35%). Emotional, energy and drive, 
and sleep problems were also reported as significant by the participants in Myezwa et al.  
(2009); however, all three problems scored higher than the scores in our study. Moreover, 
energy and drive was reported to be the most serious problem (75%), followed by problems 
with sleep (71%) and then by emotional problems (62%). However, these other studies used 
the categories ‗no problems‘ and ‗some problems‘, whereas our study used  the categories of 
‗no‘ or ‗mild and moderate‘ to ‗severe‘, and this might account for the lower numbers in our 
study. In addition, it is relevant to note that ‗fatigue‘ is not included  in the ICF checklist, 
which was the instrument used in their study, and that ‗energy and drive‘ maybe expressed as 
‗fatigue‘ (Myezwa, et al., 2009). Notably, in the present study, fatigue was assessed under the 
cardiovascular and respiratory domain and, as it is described below, it was found to be the 
most commonly reported impairment. 
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The impact of fatigue was clarified during the FGDs. In both urban and rural areas, women 
and men participants used the terms fatigue, lack of energy, tiredness and body weakness 
interchangeably. As it is discussed in literature section (2.4.1.12), similar descriptions were 
made by participants in other studies with similar study populations (Aouizerat, et al., 2012; 
Corless, et al., 2002; Siegel, et al., 2004; Sullivan & Dworkin, 2003). For example, in Corless 
et al. (2002), participants described fatigue as ―being tired, weak and [having] just no 
energy‖. Many of our participants recognised that they had experienced a lack of energy from 
the onset of the HIV infection, and viewed this as an immediate effect of the HIV infection. 
Similarly, in another qualitative study by Siegel, Bradley, and Lekas (2004), participants 
described the lack of energy associated with HIV infection and said: ―it is a symptom of the 
virus‖ or ―it comes with the virus‖.  
According to the literature, many factors may affect energy levels. For example; Siegel et al. 
(2004) indicated that age, being overweight, poor adherence to antiretroviral treatment, sleep 
problems, stress and poor nutrition could also be considered as contributing to the lack of 
energy. Poor adherence to antiretroviral treatment was also described by Corless et al. (2002) 
as a factor that exacerbated a lack of energy. They also found that a lack of energy or fatigue 
was associated with depression, sadness and difficulty with concentration (Corless, et al., 
2002). 
Although the participants did not mention other factors contributing to their lack of energy, 
many factors might have contributed to their chronic lack of energy. A deep understanding of 
the aetiology of HIV-related lack of energy, from the patients‘ perspective, is important.  
Women and men, in both FGDs in our study described lack of energy as a permanent 
problem that had transformed their bodies, and indicated that lack of energy might get worse 
overtime. Siegel et al. (2004) described a lack of energy as a symptom of disease‘s 
progression, especially because of its persistence after the initial HIV diagnosis. For example, 
one of their participants indicated:  “I felt the virus was getting more active in going through 
my body because I was feeling too tired…” (Siegel, et al., 2004, p. 216).  
Two other studies with a similar sample, but utilising quantitative methods, also reported a 
lack of energy as permanent problem. Participants in Aouizerat et al. (2012) experienced a 
lack of energy as a serious problem, with almost half of them describing it as constant, and 
 
 
 
 
   224 
 
 
 
others describing it as severe, and a small number indicating that it was very distressing. 
Findings from a prospective study by Pence et al. (2009) highlighted the persistent lack of 
energy among a similar sample of PLWH. The study, conducted over a fifteen-month period, 
demonstrated that participants with the highest baseline lack of energy scores were assessed 
as having significant scores over time, indicating that a lack of energy was a problem 
throughout the period of assessment.  
The findings in this study support the evidence that a chronic lack of energy is experienced 
by PLWH, including those on antiretroviral treatment. This is likely to have a serious effect 
on their physical and social functioning and would interfere with livelihood and their quality 
of life.  
Regular exercise, such as walking, jogging and other aerobic exercise as recommended in 
various studies, could assist in countering the chronic fatigue or the lack of energy 
experienced by PLWH (O‘Brien, et al., 2010; Smith et al., 2001). As this lack of energy 
appears to be a permanent problem, it could also be useful, as suggested by Corless et al. 
(2002), to educate patients on self-care strategies, such as the need for rest, good nutrition, 
sleep, and adjustments to levels of activity, or the need to think positively and exercise 
appropriately. 
5.4.1.2 Sleep 
Although more than 60% of the survey respondents reported that sleep was a problem, this 
was not mentioned by the FGDs participants. 
5.4.1.3 Memory 
Over 55% of the survey respondents reported problems with memory. The FGDs participants 
similarly reported memory loss and a lack of concentration as two cognitive problems and 
attributed these to the antiretroviral treatment. These problems have been reported in previous 
surveys with similar samples (Rusch, et al., 2004a; Simioni, et al., 2010). There is evidence 
that memory deficits or forgetting can lead to poor adherence to antiretroviral treatment 
(Becker, et al., 2011; Harzke, et al., 2004). However, according to participants in the FGDs it 
appeared as if ARV clinic health care providers did not understand the impact of forgetting 
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on adherence to antiretroviral treatment. If they had understood this they would have been 
unlikely to punish patients when they forgot their appointments for antiretroviral treatment.   
This finding also points to the need to train ARV clinic health care providers on the need for 
memory assessment of among PLWH in order to document changes and evaluate the risk of 
poor adherence. The training needs to emphasize the effect of a positive attitude and the need 
for support of by health care providers to improve patients‘ adherence to antiretroviral 
treatment, as is demonstrated by Harzke et al. (2004). ARV clinic health care providers need 
to work closely with psychologists, as specialists in the management of cognitive problems, 
in order to assist patients with memory and concentration problems. 
5.4.1.4 Emotional stress 
Similar to the survey in which over 60% of respondents reported emotional problems, a high  
rate of emotional problems was also found in  another group of PLWH in Rwanda (Uwimana 
& Struthers, 2008). Some FGDs participants displayed emotional distress in the group, 
evident by the exclamations of sadness and dismay. One woman reported contemplating 
suicide and many reported distress at ill treatment by family members and others. Worries 
and fears about the HIV infection and its related pathologies, along with stress arising from 
the complex side effects of antiretroviral treatment, could explain the high incidence of 
emotional problems in the survey population (Catalan, et al., 2000; Ciesla & Roberts, 2001). 
In addition, it should be noted that the 1994 war and the genocide in Rwanda have left many 
people, young and old, with severe psychological problems (Uwimana & Struthers, 2008), 
mostly caused by the loss of relatives and close friends, and also by the various methods of 
torture used by the perpetrators. This included rape, which would have increased the risk of 
HIV infection among women (Uwimana & Struthers, 2008). The consequences of HIV 
infection and the side effects of its treatment, combined with the lingering effects of the 
genocide, could explain the prevalence of emotional problems, as found in this study.   
The findings demonstrate a need for regular screening for the presence of emotional problems 
among PLWH; this could lead to referrals to mental health workers and would have the 
potential to improve the psychological rehabilitation of PLWH in Rwanda.  
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5.4.1.5 Body image and lipodystrophy 
Body image was identified by both the survey and the FGDs as being a problem. Body image 
was identified as being a problem by 40% of the survey respondents. Signs of lipodystrophy 
were also mentioned as a problem by some women in the FGDs who associated it with the 
antiretroviral treatment. This finding is similar to that in other studies (Miller, et al., 2003; 
Mutimura, et al., 2007; Power, et al., 2003). The FGDs participants explained how the 
lipodystrophy, including a distended abdomen and rounded face, with thin buttocks, legs and 
arms, had disfigured their bodies. In a qualitative study by Power et al. (2003), participants 
described similar lipodystrophy characteristics and explained how it had changed their 
bodies, making it difficult to recognise themselves.  
There is evidence that exercise has the potential to alleviate some of the physiological and 
physical side effects of lipodystrophy (Fillipas, et al., 2010; Mutimura, et al., 2008). 
However, no participants in the FGDs indicated they had participated in exercise for this 
purpose.  
The findings indicate that lipodystrophy affects the body image and the physical, 
psychological and social functioning of the individual. Any intervention that seeks to 
overcome lipodystrophy and body image should consider all these areas.  
5.4.2 Sensory impairments 
5.4.2.1 Pain 
Pain was the only impairment assessed under sensory functions in the survey and was present 
in 80% of respondents, who reported intensity and prevalence of pain as ‗high‘.  It was also 
mentioned by many of the FGDs‘ participants. A number of previous studies have also 
reported pain as being very common among PLWH  (Del Borgo, et al., 2001; Dobalian, et al., 
2004; Gray & Berger, 2007; Hughes, Jelsma, Maclean, Darder, & Tinise, 2004; Miaskowski, 
et al., 2011; Myezwa, et al., 2009; Rusch, et al., 2004a; Uwimana & Struthers, 2008; Van As, 
et al., 2009).  Pain was also found to affect quality of life of PLWH, with both their physical 
and psychological well-being affected (Gray & Berger, 2007; Larue, et al., 1997; Nair, et al., 
2009; Newshan, et al., 2002). Compared to other studies, the high prevalence of pain among 
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PLWH in our study could be related to the HIV infection and its associated pathologies and 
to the side-effects of antiretroviral treatment (Hewitt, et al., 1997; Larue, et al., 1997).  
As in other studies, the FGD participants said pain was caused by both the HIV infection and 
the antiretroviral treatment (Hewitt, et al., 1997; Miaskowski, et al., 2011; Singer, et al., 
1993). These participants described the pain as severe and chronic. As discussed in literature 
section, this finding is similar to that of other several studies. Richardson et al. (2009) 
reported that the participants in their sample experienced persistent pain, which most 
characterised as severe to extreme. Miaskowski et al. (2011) also reported that many 
participants in their study experienced chronic pain, lasting longer than six months, while the 
majority complained of moderate to severe pain. Participants in a study by Del Borgo et al. 
(2001) reported that the intensity of pain ranged from moderate to unbearable. 
The FGDs‘ participants indicated that pain affected many parts of the body; they often 
mentioned backache, headache, knee pain and abdominal pain. Men and women both spoke 
of pain. Likewise in Anandan et al. (2006), participants reported pain in different parts of the 
body: abdominal pain, painful joints and aching muscles. The description of pain as chronic 
and severe implies that pain was a very serious disabling problem, and the involvement of 
multiple body parts could have worsened the disability among our participants. It is likely 
that these levels of pain would have affected both the physical and psychological aspects of 
health, as well as social functioning and would have an impact on quality of life.  
There is a growing body of evidence that physiotherapy techniques such as massage and 
exercise can alleviate the pain experienced by PLWH (Hillier, et al., 2010; O'Brien & Nixon, 
2010; Ownby, 2006). Physiotherapists need to educate other health care providers about the 
benefits of their techniques for the relief of pain. This might improve referral to 
physiotherapy services and contribute to better management of pain. There is also a need for 
physiotherapists and other health care providers to educate patients about self-care strategies 
that could assist them to deal with their problems linked to pain. 
5.4.2.2 Paraesthesia 
Paraesthesia was not one of the specific items on the Impairment Questionnaire, which was 
an omission, in the light of the responses from the FGDs‘ participants who described a 
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sensation of itching or pins and needles that often occurred with pain.  They said it was 
chronic and frequently localised in the lower limbs, and mostly occurred when they had been 
standing or sitting for a long time. Like pain, paraesthesia was associated with antiretroviral 
treatment. This description of paraesthesia reflects the symptoms of peripheral neuropathy, 
particularly distal symmetrical peripheral neuropathy, which has been identified as a side 
effect of antiretroviral treatment.  For example, participants in a study by Luma et al. (2012), 
96.9% of whom were on antiretroviral treatment, were found to have peripheral neuropathy 
during assessment. They experienced the following symptoms: pain, numbness, and pins and 
needles, with the latter being the most common symptom. Similarly, Nicholas et al.(2002), 
and Van Oosterhout et al. (2005) found that pain and numbness in the lower limbs and 
symptoms of peripheral neuropathy were the most common complaints; they maintained that 
these were side effects of antiretroviral treatment. Mullin et al. (2011) found that people in 
their sample commonly experienced numbness, pins and needles and pain, which they 
described as an aching or burning pain.  
Several studies have demonstrated how peripheral neuropathy is a very serious and 
uncomfortable condition, particularly on account of the terrible pain it causes; it can lead to 
physical and social functional limitations among PLWH (Mullin, et al., 2011; Ownby & 
Dune, 2007). Participants in a qualitative study by Ownby and Dune (2007) explained that 
they had experienced so much pain that they characterised it as a sign of death or a 
punishment from God. One participant said: ―…it makes you feel like Lord; Jesus is my days 
getting short?  Is it coming to be my time?‖  Another participant indicated: “… I thought that 
was God‘s way of punishing me for the things I had done in my life‖ (Ownby & Dune, 2007, 
p. 51) 
Our finding suggests that future research needs to include an assessment and exploration of 
the manifestation of paraesthesia combined with pain in PLWH. Additionally, the link with 
peripheral neuropathy should be explored.  
5.4.2.3 Dizzyness 
Certain FG participants reported that they experienced dizziness, another omission from the 
Impairment Questionnaire. This was worse in standing and was exacerbated when 
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participants were hungry or thirsty or when they were in the sun. Dizziness was also 
mentioned by Lee et al. (2009).  
An intervention to control dizziness would need the patients‘ cooperation to limit the factors 
that lead to dizziness. These include being in standing position, feeling hungry or thirsty and 
being exposed to the sun. 
5.4.3 Impairments in cardiovascular and respiratory system functions 
Under cardiovascular and respiratory body function, fatigue was the most predominant 
problem in both groups of participants. Fatigue has been frequently reported as one of the 
most prevalent problems in various studies with similar population groups (Anandan, et al., 
2006; Henderson, et al., 2005; Jong, et al., 2010; Newshan, et al., 2002; Phillips, Sowell, 
Rojas, & Tavakoli, 2004; Rusch, et al., 2004a). It has been observed that in numerous studies 
the prevalence of fatigue ranges from 37% to 88% (Jong, et al., 2010). Remarkably, in the 
survey, fatigue was the most highly rated and the most severe body function impairment 
reported (83%, moderate to extremely bad).   
This finding supports that of Anandan et al. (2006), where fatigue was also the most highly 
rated impairment (84, 4%, mild to severe) in their study group. However, in our group the 
intensity (moderate to extremely bad) was greater. These two findings are far higher than 
those found in many other reviewed studies.  In some previous studies, fatigue was reported 
as being more closely related to HIV infection and its associated conditions rather than to 
antiretroviral treatment (Henderson, et al., 2005; Phillips, et al., 2004; Siegel, et al., 2004). A 
longitudinal study conducted by Ferrando et al. (1998) demonstrated that there was no direct 
relationship between chronic  fatigue among PLWH and their CD4 count or HIV viral load, 
but fatigue was found to be more severe in cases where the disease was advanced.  
Interestingly,  one observational study found that the use of antiretroviral treatment over a 
longer time period with the HIV infection  predicted low fatigue rates among PLWH (Pence, 
et al., 2009). Common causative factors of fatigue among PLWH, described in the literature, 
include  physiological  factors such as anaemia, which is a common problem in people with 
HIV (Barroso, 1999; Phillips, et al., 2004) and abnormality of thyroid gland  (Adinolfi, 
2001). However, researchers have emphasised that mental/psychological factors such as 
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depression, anxiety, stress, emotional distress and sleep disturbance have been also identified 
as most significant causative factors (Adinolfi, 2001; Aouizerat, et al., 2012; Barroso, 1999; 
Henderson, et al., 2005; Jong, et al., 2010; Pence, et al., 2009; Phillips, et al., 2004).  
Furthermore, certain studies have highlighted two socio-demographic factors, low income 
and being unemployed, as being strongly associated with the increased incidence of fatigue 
among PLWH (Jong, et al., 2010; Pence, et al., 2009; Siegel, et al., 2004). Some lifestyle 
behaviours, such as lack of rest or exercise, and inadequate diet and substance abuse, have 
also been identified as additional causal factors for increased fatigue among PLWH 
(Adinolfi, 2001). It was also reported by Ferrando et al. (1998) that fatigue was found to be 
an independent and strong contributor to physical limitations and disability among PLWH. In 
the present study, fatigue appeared to be independent of other significant impairments. We 
did not demonstrate any association between fatigue and the socio-demographic status of our 
population, or with emotional dysfunction.   
However, consistent with what has been reported in previous studies regarding fatigue and its 
related factors, the high incidence of fatigue in our study group could explain the low income 
levels among most of our study group (less than US$100 per month), and the high number of  
unemployed people in the sample. 
This shows that, as a result of fatigue, even those who reported that they were involved in 
some form of self-employment may not have earned sufficient income to cover their needs, 
for instance their nutritional needs. It is also possible that their jobs are manual in nature and 
require the use of physical force, which contributes to feeling very tired. Furthermore, fatigue 
could have contributed to the limitations in mobility function and could interfere with the 
ability to participate in household activities. However, there is a need for further research to 
apply sound scientific insight to the above interpretation and, additionally, to highlight the 
relationships between mental/psychological factors, especially emotional impairment and 
sleep disturbance; these were found to be significant impairments in this study.   
These findings need to be used to inform the health care providers involved in the 
management of PLWH in Rwanda that fatigue/lack of energy is a significant problem among 
PLWH and that regular assessment is required and that this has the potential to improve the 
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management of the disease.  The evidence of the existing literature is that there is a need for a 
holistic approach to care that will include rehabilitation to deal with fatigue or lack of energy 
and this could involve  physical rehabilitation, such as that provided by physiotherapy 
(O‘Brien, et al., 2010), psychological and social rehabilitation; for example improved 
nutrition and the provision of food supplements. 
Respiratory problems were the second most common impairment in this group, reported by 
21% of the sample in the survey. A few of the FG participants that reported coughing and 
respiratory conditions were not very common in this group.  The findings in our study are 
very similar to those in another study (22%) conducted in South Africa by Van As, et al. 
(2009).   It should, however, be noted that in the study by Van As et al. the sample was small 
(45 people), and scores were documented using a scale from ‗mild‘ to ‗moderate‘. Another 
study, also carried out in South Africa, (Myezwa, et al., 2009) demonstrated a prevalence of 
respiratory problems almost three to four times greater than in this study . This can be 
explained by the fact that, in our study people had been taking antiretroviral  medications for 
a longer period, and as a result their general health status had improved and, consequently, 
there was a lower risk of acquiring respiratory infections such as TB (Hull, et al., 2008; 
Wagner & Chaisson, 2003).  As is described in Chapter Two, various studies have 
demonstrated that respiratory problems among PLWH are related to the HIV infection itself 
and/or to its associated pathologies or opportunistic infections such as TB. These problems 
could also be a consequence of an autoimmune reaction to the antiretroviral medications.   
Further research that involves objective assessment is needed to determine the causative 
factors for the respiratory symptoms reported in the survey.  However, it should be noted that 
routine assessment of the associated impairments, such a shortness of breath and difficulty in 
breathing, should be done as well as the use of intervention strategies to minimise the 
impairment of functioning. Health care providers involved in the management of PLWH need 
to be made aware that physiotherapy, which uses exercise, can play a big role in the 
rehabilitation of those suffering from the effects of the cardiovascular and respiratory 
impairments mentioned above.  
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5.4.4  Impairments of the digestive and reproductive system functions  
Digestive problems were present among both study populations, the most common of these 
being intolerance to food, reported by 35% of the survey respondents, followed by sensations 
of nausea (32%). Other studies have also reported digestive problems in similar population 
groups (Alexander, 2011; Myezwa, et al., 2009; Rusch, et al., 2004a). Together with other 
problems, these were found to affect the general functioning of the patients (Myezwa, et al., 
2009). It is also possible that digestive problems present and prominent in the survey sample 
could have an influence on the general status of the study population and were likely to affect 
their physical and social well-being.  Therefore, it is recommended that regular assessment 
and management intervention strategies for general function status include digestive 
functions. 
5.4.5 Genito-urinary tract impairments 
Among reproductive functions, discomfort with sexual intercourse was the function most 
affected in the survey group (33%). Many of the men in the FGDs reported that sexual 
activity was reduced due to decreased energy levels, whereas for women, it was decreased 
libido. Similarly, in studies conducted by Van As et al. (2009), and by Rusch et al. (2004a), 
among the reproductive impairments, sexual dysfunction was commonly reported by their 
sample; it was suggested that it was caused by reduced libido.  Other studies have also 
demonstrated significant rates of sexual discomfort and/or sexual inactivity among PLWH. 
They suggest that sexual problems among PLWH could be a consequence of the 
physiological and, most importantly, the psychosocial effects of the HIV infection on the 
patient‘s body (Balaile, Laisser, Ransjö-Arvidson, & Höjer, 2007; Bell, et al., 2006; 
Scanavino & Abdo, 2010). Schrooten et al. (2001) discovered that antiretroviral treatment, 
especially PIs and most particularly Indinavir and Ritonavir, were associated with sexual 
problems and that the risk was increased among those who had lipodystrophy. Schrooten et 
al. (2001) postulated that the higher risk of sexual dysfunction in the group with 
lipodystrophy, apart from the possible influence of pathophysiological factors, could also be 
related to problems with body image.   
The findings on reproductive function problems have shown that discomfort with sexual 
intercourse was common. This could have an impact on the general status of the survey study 
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population and was likely to affect their physical, psychological and social well-being. 
Discomfort with sexual intercourse needs to be regularly assessed among PLWH, and 
management strategies should incorporate psychological and social rehabilitation strategies; 
this would result in the provision of more comprehensive care.  
5.4.6 Neuromuscular and skin impairments  
The survey findings demonstrated that neuromuscular impairment and skin functions were 
frequent (50% and 46% in our sample). In contrast, the FG participants reported general 
―body weakness‖ rather than specific muscle weakness. Impairment of neuromuscular and 
movement functions received a higher rating (over 70%) in the Myezwa et al. (2009), a study 
that was conducted with a similar population group. One reason for this could be their use of 
objective assessment (dynamometry and goniometry); another reason could be the general 
health status of their participants, as their sample was conducted among those who were in 
the advanced stage of the disease. The majority of their participants were in stage 3 or 4 on 
the WHO HIV disease classification, and more than half had a CD4 count below 100. In 
contrast, in Van As et al. (2009), a sample of  ambulatory PLWH reported low rate of 
problems with neuromuscular and movement functions compared to our findings, with 
approximately half (27% of the sample); however, only muscle power was assessed and, as 
with Myezwa and others, dynamometry was used. The low rate could be attributed to the 
small sample size (45 people) and to the use of one site for data collection. This could have 
led to an underestimation of the magnitude of the problem.  
 On the other hand, several previous studies reported pain as a significant and most important  
symptom for both the neuromuscular and the skin conditions that manifest in PLWH 
(Alexander, 2011; Cuellar & Espinoza, 2000; Gray & Berger, 2007; Mody, et al., 2003; 
Nicholas, et al., 2002; Patrice K Nicholas, et al., 2007c; Osborne, et al., 2003; Ownby & 
Dune, 2007; Sagar, et al., 2010; Singer, et al., 1993; Verma, 2001). Both neuromuscular and 
skin conditions in PLWH have been identified as consequences of the HIV infection itself or 
the antiretroviral treatment (Anwikar, et al., 2011; Kumarasamy, et al., 2008; Lopez, et al., 
2004; Owczarek, et al., 2005; Peltier & Russell, 2006; Sangle, et al., 2010; Scruggs & 
Naylor, 2008; Tschachler, et al., 1996; Walker, et al., 2008). This could explain why our 
findings showed evidence of a strong positive correlation between pain and neuromuscular 
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functions (for both mobility and muscle power) and skin functions (for both skin function and 
skin sensation).   
Pain was found to be very significant body function impairment in our sample: it was more 
likely to contribute to increased problems with regard to neuromuscular functions and 
movement and skin functions, as borne out by the highly significant correlation found 
between pain and muscle function and pain and joint mobility in the survey group. These 
findings suggest the need to pay attention to pain as a significant sensory impairment among 
PLWH and to its impact on neuromuscular and movement and skin functions. Health care 
providers involved in the daily care of PLWH should be aware that in clinical practice, 
routine assessment of pain is required, but problems with neuromuscular and movement and 
skin functions should also be detected and documented.  They should also plan for more 
comprehensive management with the aim of reducing the impact of pain and of problems 
with neuromuscular and movement and skin functions on the daily functioning of PLWH.  
Physiotherapy is a rehabilitation discipline that deals with pain and the effects of pain on 
neuromuscular and skin functions (Hillier, et al., 2010; O'Brien & Nixon, 2010); therefore, it 
should be involved in any intervention program.  Furthermore, there is need for further 
research that uses objective measurements in order to provide more reliable knowledge 
regarding the magnitude of pain, and problems with neuromuscular systems and movement, 
and with skin functions, and the influence of these problems on the daily functioning of 
PLWH. 
5.5 Activity limitations and participation/social restriction 
Participants in both, the FGDs and the survey in this study indicated that they experienced 
difficulty in performing various activities that were part of daily living and also that their 
participation in society was restricted. The ICF defines difficulty in executing a task as an 
activity limitation. Difficulties with involvement in life situations are defined as participation 
restrictions (Coster & Khetani, 2008; Vanleit, 2008). Participants in the FGDs described how 
activity limitations and participation restrictions were caused by various impairments. These 
findings support those of other studies with similar study populations, but many of these 
studies utilised quantitative methods (Myezwa, et al., 2009; O'Brien, et al., 2008; Rusch, et 
al., 2004a; Van As, et al., 2009).  
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Consistent with the findings of a qualitative study by O‘Brien et al. (2008), reported in the 
literature (section  2.4),  the limitations in functioning or disability were multidimensional in 
nature with a connection between the different dimensions. For example, findings of the 
FGDs indicate that lack of energy as an impairment was associated with limitations in work 
performance and in participation in social relationships. However, unlike the findings of  
O‘Brien et al. (2008) which reported that participants experienced disability as episodic and 
as characterised by unpredictable periods of wellness and illness, the FG participants 
described disability or functional limitations as a permanent problem. They said; “our 
problems are there for life”, whereas O‘Brien et al. reported that participants used the terms: 
―nothing is constant with HIV” and indicated how they often considered themselves healthier 
after overcoming an unhealthy episode. 
5.5.1 Cognitive domain 
Cognitive functions were commonly affected in both study groups. Similar studies have also 
demonstrated significant cognitive problems in their respective samples (Ciccarelli, et al., 
2011; Salawu, et al., 2008; Simioni, et al., 2010). In the survey in this study, analysing and 
finding solutions to problems in day to day life was reported as most problematic (49%), 
followed by problems in learning new tasks. The domain that showed the least problems was 
concentration, with 20% people reporting moderate to extreme bad performance. In a study 
by Van As et al. (2009), participants also reported some cognitive problems, even where 
assistance was provided. These problems were mainly with learning, but also with applying 
knowledge. In contrast to the findings of this survey, difficulty with concentration was the 
only cognitive impairment reported by 75% of participants in a study by Anandan et al. 
(2006). Participants in a study by Simioni et al. (2010) reported  that the most commonly 
experienced cognitive problems were memory loss (18%), followed by a slowing of mental 
function and a reduced attention span. Salawu et al. (2008) indicated that those in their 
sample also reported experiencing significant cognitive problems, the most common being 
problems with attention/concentration and calculation (30%), followed by memory loss 
(27%) and orientation to place (27%).  
Most of the respondents in the survey had been receiving the antiretroviral treatment and had 
been living with the HIV infection for many years. It is possible that the changes that were 
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happening in their lives were due to the HIV infection and the adverse effects of antiretroviral 
medications, as well as to worry and uncertainty about what the future would hold. Many 
people in the survey sample were cognitively affected to the extent that they were unable to 
achieve self-efficacy and did not have the ability to resolve problems and learn new things. 
This could have a significant impact on their self-development.  As was discussed earlier (in 
the literature review), various studies have shown a positive correlation between cognitive 
problems in PLWH and psychological distress. An intervention strategy that emphasizes 
mental health and psychological rehabilitation could assist to overcome the problem. 
However, there is need for further research to demonstrate the relationship between the 
emotional problems that were found to be prevalent among participants in this study, and the 
cognitive problems that were reported.  
5.5.2 Mobility domain 
The mobility function was severely affected in both study groups: in the survey problems 
with standing for long periods was the most prevalent, with 57% of people rating this as 
‗moderate‘, ‗severe‘ and ‗extremely bad‘. The next most commonly affected function was 
‗getting out of home‘ (38%), while ‗moving inside home‘ received the lowest score (15%). 
The mobility function was also found to be a problem in other studies.  In Myezwa et al. 
(2009) this received an even higher rating than in our study, with 75% of participants 
experiencing difficulties without help, perhaps because of their general health status: these 
participants were in-patients and some had a CD4 count below 100; most required some 
assistance.  
Van As et al. (2009) and Hughes et al. (2004) indicated that 40% and 30.9% respectively of 
their samples reported that their overall mobility was affected. The respondents in a study by 
Crystal et al. (2000) also reported mobility problems; however, unlike our subjects, they 
complained about the limitations in activities involving considerable energy expenditure, 
such as walking long distances, and other vigorous activities.  
It was interesting that ‗getting out of home ‗came second in the survey and was more highly 
rated in difficulty than other important functions in the mobility domain, such as ‗walking 
long distances‘ and ‗standing from sitting down‘. Likewise, subjects in a study by Myezwa et 
al. (2009) revealed  that they were reluctant to go out into the community. They gave 
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numerous reasons for this, among which they mentioned fear of stigma. It is also possible 
that fear of being stigmatised was the reason why many participants did not want to leave 
their homes.  
The FGDs‘ participants said that mobility activities, such as walking, standing and climbing 
stairs, were usually limited on account of decreased energy, pain, breathlessness and 
paraesthesia. Similar studies have reported that mobility limitations were associated with 
decreased energy and pain, paraesthesia or breathlessness (Crystal, et al., 2000; Lorenz, et al., 
2001; Ownby & Dune, 2007; Van As, et al., 2009). Mobility is very important for physical 
functioning, and limited mobility is likely to affect the physical and social functioning of an 
individual. This finding indicates the need for identification by routine screening followed by 
effective management of the identified impairments 
The findings reveal that both physical and psychological factors could contribute to limited 
mobility. This implies that there is need for a coordinated intervention strategy that includes 
physical rehabilitation, such as physiotherapy and mental health/psychological rehabilitation, 
to improve mobility among PLWH. However, further research is needed to provide more 
insight into this problem, specifically regarding the influence of psychological factors on 
mobility. 
5.5.3 Self-care domain   
The functions in the self-care domain were among the functions least affected that were 
assessed in this survey. The respondents were able to care for their bodily hygiene and feed 
themselves.  ‗Staying by yourself a few days‘, scored highest in this domain, with 46% of the 
people reporting moderate, severe and extreme problems in this regard. This item received a 
ten times higher rating than other functions assessed in this domain and, as will be discussed 
in the validation of the WHODAS.02 Chapter Error! Reference source not found., did not 
it well within the construct of self-care. For example, it was rated ten times higher in 
difficulty than ‗washing your body‘ (4%), which was the second most affected function.   
This contributed to low internal consistency in the self-care domain thus there was an 
inability to measure the same construct as the others. 
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When discussing the function of ‗staying by yourself a few days‘, many participants 
expressed a fear of being alone for some time, not because they were unable to care for 
themselves at that time, but because they were uncertain of what might happen to them, 
despite the positive effects of the antiretroviral treatment. Who would be able to assist if their 
situation deteriorated?  
Rusch et al. (2004a), in their study conducted with a large sample of PLWH in British 
Columbia, Canada, showed a higher rating of difficulty given to personal care functions, such 
as showering (10%), dressing (9%) and eating (20%). However, staying by yourself for a few 
days was not one of the variables measured in their study. The differences with our study 
could arise from the data collection method:  the use of self-administered anonymous surveys 
mailed through the post as a method of collecting data in the study by Rusch et al. could limit 
perceptions of the extent to which those activities were affected. In addition, there was no 
specification regarding the stage of the disease among those who experienced difficulties in 
self-care, and there was no specification as to whether all the PLWH involved in the study 
were on antiretroviral treatment. Our survey might have excluded those who were most 
severely affected as they might have been unable to leave the house, whereas as a postal 
survey could have included them. 
Furthermore, in contrast to the present study, Gaidhane et al. (2008) reported that in their 
study conducted among PLWH at a rural tertiary care hospital in India; 65% of the sample 
reported that one or more self-care activity was affected. The following activities were 
assessed: washing ones whole body, caring for body parts, using the toilet, eating and 
drinking, and looking after one‘s health. However, it is relevant to note that all respondents in 
their study were hospitalised and all had met the WHO stage criteria for the diagnosis of 
AIDS. Therefore, it is possible that they were more severely affected than our participants. 
This could explain the increased difficulty in completing those activities which were found 
not to be a problem in our study. It should also be noted that, in comparison to both the above 
described studies, scores in our study ranged from moderate, severe and extremely bad, and 
not from mild.  
There is need for further research in order to explore in depth the reasons why a large number 
of respondents in the survey in this study expressed worry and fear about staying alone for 
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few days, while most reported they were able to care for themselves independently.  In 
clinical practice, health care providers involved in the management of PLWH should be 
aware of the problem in order to put in place an appropriate management strategy that could 
include mental health/psychological rehabilitation and social rehabilitation.  However, in 
conclusion, this finding suggests that staying by oneself should not be regarded as self-care as 
there are too many cultural and other variables, such as socio-economic factors, which could 
impact on this. 
The FGDs‘ participants identified pain and paraesthesia in the legs as the major contributor to 
difficulty in performing self-care activities.  Pain and sensory impairments have been 
reported in other studies as factors contributing to decreased physical functioning and 
difficulties with self-care activities (Myezwa, et al., 2009; Ownby & Dune, 2007). The pain 
combined with the paraesthesia experienced by our participants could be attributed to 
peripheral neuropathy. Ownby and Dune (2007) describe participants complaining not only 
about unbearable pain and other symptoms of peripheral neuropathy, such as numbness and 
pins and needles, but also about the difficulty having to depend on other people in order to be 
able to perform the activities of daily living. 
5.5.4 Getting along with people function  
The function most affected in ‗getting along with people‘ was sexual activities, which scored 
40%, whereas the least affected function was ‗dealing with people you do not know‘, which 
scored 14%.  As it is described above in Section 5.4.5, sexual dysfunction was also reported 
as a significant impairment of body function. The FGDs yielded interesting insights as to the 
factors contributing to dysfunction or a lack of interest in sexual activity as an independent 
function among PLWH. The decreased energy levels of male participants led to a reduced 
frequency of sexual intercourse. Additionally, participants believed that increasing the 
frequency of sexual intercourse would decrease a person‘s energy levels. It is important to 
mention that decreased energy levels as a leading factor of decreased frequency of sexual 
intercourse was only reported by men, in both urban and rural areas. Similarly, in a 
qualitative study, however conducted among women only, Balaile et al. (2007) found that 
women believed that more frequent sexual intercourse could lead to decreased energy levels; 
it could also strengthen the virus and lead to premature death. As with women in the FGDs, 
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women in Balaile‘s study did not indicate that a lack of energy caused decreased frequency of 
sexual intercourse.  
This lack of energy which (it is believed) reduces the frequency of sexual intercourse 
combines with the belief that increased frequency of sexual intercourse contributes to a lack 
of energy, but this needs some teasing out. The first part involves physical and social 
functioning while the second part involves physical and psychological and social functioning. 
This demonstrates the need for a multi-disciplinary intervention strategy which will include 
physical, psychological and social functioning. This needs to target the impact of a lack of 
energy on sexual intercourse and the effect of an increased frequency of sexual intercourse on 
energy levels. However, due to the sensitivity of discussing sexual activity, individualised 
rather than collective intervention strategies are likely to be more acceptable.  
In this study, women in both rural and urban areas reported that a reduction in sexual desire 
affected participation in sexual intercourse. Other studies have reported similar findings. 
Balaile et al. (2007) reported decreased frequency of sexual intercourse due to reduced sexual 
desire. As with some of the women in our study, their participants feared getting involved in 
relationship where it would be impossible to abstain; they tried to avoid any involvement in 
sexual activity. They continued to have feelings of guilt and lived with the perception that 
sexual intercourse was the source of HIV. Bell et al. (2006) also found a lack of desire, 
leading to decreased sexual intercourse, and highlighted the fear of transmission of HIV and 
the fear of disclosure of their HIV status to a partner; this would involve negotiation over 
condoms and fertility issues. 
There could be many reasons for the reported lack of desire for sexual intercourse among our 
female participants. Like participants of a study by Balaile et al. (2007), it is possible that our 
participants have been traumatised by HIV and experienced feelings of remorse and believed 
that sex was the source of HIV. With careful consideration an effective intervention program 
that includes psychological functioning could have an impact on levels of sexual activity. 
These findings reinforce the need for mental health/ psychological rehabilitation intervention 
strategy to overcome the problem. 
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The second function most affected in this domain was ‗making new friends‘ (36%). A similar 
group of people in Van As et al. (2009) also reported problems with relationships. However, 
these were mostly limited to creating relationships with strangers, which is similar to dealing 
with people you do not know; here problems were also found in forming social relationships, 
and also with family and intimate or sexual relationships. Unfortunately, there was no 
information on the rating of these functions. It would be interesting to determine the 
relationship between lack of interest in sexual activity and making new friends who could be 
new partners, especially among women, as in the present study most of the participants were 
widowers.  
5.5.5 Life activities 
Household and work or school activities were the two activities assessed in life activities and 
problems in both of these areas were prevalent. However,  FGDs findings demonstrated that 
except for one man in rural area, it appeared that household activities were frequently 
performed by women. ‗Getting the activity done as quickly as needed‘ was the function most 
affected in both cases. Least affected in household activities was ‗taking care of household 
responsibilities‘ (28%) and ‗day to day work/school activities‘ (20%) in work or school 
activities. Moreover, activities were interfered with for almost five days in every month, and 
there were approximately three days in which the participants were completely unable to 
work because of their health condition. Consequently, 44% of the participants declared that 
they worked at a low level because of their health condition and, as a result, 45% reported 
that they earned less money. In support of the present study, over half of the subjects in a 
study by Crystal et al. (2000) demonstrated difficulties in carrying out housework and work 
or school activities at least some of the time.  In a study by Van As et al. (2009), subjects 
experienced problems with school and work activities, but mostly with remunerative work  
and as with our subjects, they could not earn sufficient money. Consequently, they reported 
that they were unable to sustain themselves and their families financially. 
The quantitative data are supported by the comments of the FGDs participants, who 
additionally identified the reasons for decreased productivity and the effect on  livelihood. 
Due to a lack of energy, participants‘ involvement in work and household activities was 
reduced. Anandan et al. (2006) also report that participants experienced difficulty performing 
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routine physical activities related either to work or to household tasks. As in our study, they 
suggested this was due to significant levels of fatigue. Our participants, both women and men 
believed that work that demanded a lot of energy could exacerbate their condition.  Siegel et 
al. (2004) indicated that working too hard could contribute to decreased levels of energy. 
Crystal et al. (2000) also described the difficulties experienced in executing physical tasks, 
particularly those demanding more energy.  
Careful assessment of the pattern of lack of energy, including the factors contributing to its 
exacerbation (such as vigorous activities), and an evaluation of its influence on the 
performance of PLWH is necessary. This finding suggests that to improve the work 
performance of PLWH, interventions need to first target problems with lack of energy.  
Therefore, both physical and social functioning should be considered. 
Work and household activities were reduced because of pain. Crystal et al. (2000) found that 
significant levels of pain were associated with physical limitations and with difficulty in 
carrying out physical activities such as work and school activities and household activities. 
Our finding points to the need for special interventions regarding pain management among 
PLWH with the broader goal of improving physical activities and facilitating work and 
household activities. 
Loss of memory affected work and household activities. There is a dearth of published 
studies that demonstrate the impact of memory loss on the performance of work and 
household activities. Several researchers have reported on the effect of memory loss on 
adherence to antiretroviral treatment (Becker, et al., 2011; Harzke, et al., 2004). Our findings 
demonstrate that memory loss not only interferes with participants‘ work and household 
activity performance, but also impacts on their social roles in the home and the workplace. 
Improving work and household activity performance will need an intervention that is aimed 
at overcoming memory difficulties among PLWH. Routine screening for the presence of 
memory loss is required. However, a change in performance in the home or at work will 
necessitate an intervention using expertise related to both psychological and social 
functioning.  
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As it is mentioned above, participants in FGDs indicated that these limitations in the 
performance of activities affected their productivity overtime, and this could have a negative 
impact on the livelihood.   This implies that the impairments were so severe that they affected 
the participants‘ physical ability to work effectively.  Although the participants did not report 
on their income, the decrease in productivity was likely to affect their income. Thus the 
impairments also affected their socio-economic functioning, and any intervention intended to 
overcome physical and psychological functional limitations should also target the social and 
economic functioning of the patient. 
Activity limitations in carrying out housework activities were also reported to be prevalent in 
studies by Rusch et al. (2004b) and Rusch et al. (2004a), in which they also found 
associations with social role restriction. In contrast, participants in Myezwa et al.‘ study  
(2009) reflected a different picture with regard to general activity performance, as their 
limitations were more with the basic activities of daily living, rather than with social role 
activities, as in our study. An explanation for this could be that most of the respondents in 
their study were at an advanced stage of the disease, some with a CD4 count below 100, and 
there was no certainty regarding the patients‘ adherence to antiretroviral treatment. This 
could have contributed to their inability to perform even the simple activities of daily living 
without help.   
These findings substantiated the discrepancy found between the survey respondents and the 
sample from the Rwanda national demographic survey regarding levels of education and 
employment status, especially paid work. In the survey there was a very small percentage of 
respondents who were in paid work particularly among female respondents, who were in the 
majority. Not only was the performance of the activity affected, but most importantly, their 
productivity and livelihood, and this had a substantial negative impact on the participants‘ 
socio-economic status. This could explain why the majority of the participants declared that 
they earned less than US$100 per month.  The findings suggest the need for social 
rehabilitation and social workers involved in the management of PLWH to be made aware of 
this. This would assist them to plan for intervention strategies that target the development of 
income generating projects that have the potential to improve the socio-economic status of 
PLWH in Rwanda.  
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5.5.6 Participation/social role restriction 
As it is stated above, functions in the participation/social restriction domain were the most 
significantly affected of all the functions assessed in this study. The FGDs‘ participants 
shared that their social activities and ability to take part in leisure activities were severely 
curtailed. Similarly, respondents in a study by Rusch et al. (2004a) experienced a more 
problems with regard to overall social role functioning (93.2%). In this present study, in the 
survey, ‗participation in relaxation or pleasure activity‘ was the most function most affected, 
with a score of 84%, followed by ‗problems the family have due to the health condition of the 
patient‘ (75%). The least affected area was ‗problems because of barriers in the world around 
you‘, with 21% of the people in the sample reporting moderate, severe and extreme problems.  
It was very interesting that many of our participants declared that they had significant 
problems with involvement in relaxation/pleasure activities: which apparently most of them 
thought was similar to involvement in sexual intercourse; this in fact referred to other 
activities, such as playing games or getting together with others and playing music. Mental 
health/ psychological rehabilitation, social rehabilitation and education intervention strategies 
could be effective in dealing with restrictions relating to participation in relaxation/pleasure 
activities.  
Further research is also recommended to explore why our respondents could not think about 
other relaxation activities. Perhaps this reflects a lack of knowledge and/or a lack of those 
activities or barriers to those activities in their community. Additionally, it would be 
interesting to explore the relationship between involvement in relaxation/pleasure activities 
and involvement in sexual intercourse. The second most affected function under participation 
was ‗problems that the patient‘s family encountered due to his or her health condition‘. One 
interpretation of this finding could be that patients‘ families did not accept the patients‘ 
status, or they might have experienced problems in their community resulting from issues 
with regard to discrimination and the stigmatization of the HIV infection. This could result in 
a lack of family and/or social support and this could increase problems with emotional 
functions. These were found to be significant problems in our study group and came third, 
with 72% of the participants rating this as moderate, or severe and extremely bad. Problems 
included financial problems the family was experiencing because of patient‘s health 
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condition, problems with ensuring the patient was able to live with dignity, and problems in 
joining community activities; 50% or more of participants reported problems in these areas.   
Participants‘ family financial problems were not unexpected as the socio-demographic 
findings show that our study group consisted of adults, the majority of whom were either 
married or widowed, which meant that it was likely they had children to care for. However, 
the evidence showed that their socio-economic status, especially of women, might be poor 
compared to that of the general Rwandan population. For example; the recent national 
demographic survey   found that 11% of women were not working at the time of data 
collection (National Institute of Statistics Rwanda, et al., 2012), whereas our findings showed 
that 15.4% of the women in our study were unemployed.  
Similarly, participants in studies by Van As et al.  (2009), and Anandan et al. (2006), 
complained about financial problems and how to manage finances. These problems interfered 
with their role as parents and their responsibilities towards their immediate families. Another 
study, also conducted in Rwanda by Uwimana & Struthers (2008), found out that financial 
problems were the most prevalent (77%) among a group of PLWH who participated in their 
study. However, as was mentioned earlier, their study focused on palliative needs. This 
finding reflects on the way functional limitations among our study group were multifaceted 
and not simply determined by the impairment of body functions. Problems the patient 
experienced in living with dignity and problems in joining community activities could be 
consequences of social discrimination and stigmatization; these problems suggest a lack of 
social support and this could also affect the psychological functioning and well-being of the 
patient. 
Restrictions to participation in social life were also influenced by impairments, particularly 
by a lack of energy. As was also found in a study by Basavaraj, Navya and Rashmi (2010), In 
both rural and urban areas, our participants were generally unable to socialise with others in 
the community because of a lack of energy. They experienced difficulty with some important 
socialising activities: they failed to participate in leisure activities, and their spiritual practices 
decreased due their lack of energy. It appeared as if this lack of energy had isolated the 
participants from their social worlds. This may not only have affected their social functioning 
but also their psychological functioning. On the other hand, it is possible that psychological 
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factors such as a lack of motivation, coupled with lack of energy, could have worsened these 
difficulties with social participation.   
As was found in a study by O‘Brien et al. (2009), few participants in our study recognised the 
way their limited financial means restricted participation in leisure activities. As stated by 
Anandan et al. (2006), many PLWH have significant financial difficulties as well as physical 
or psychological functional limitations, and this results in an inability to participate in 
productive work. 
This finding points to the need for effective multiple intervention strategies to deal with lack 
of energy as a physical factor and to improve socialisation and participation in leisure and 
spiritual activities. It is also important also to consider a person‘s psychological functioning 
and social-economic status. A multidisciplinary rehabilitation intervention programme that 
involves the community would be beneficial. 
Our findings with regard to participation/social restriction revealed a multidimensional 
picture and suggest that the society plays a considerable role in the everyday functioning of a 
PLWH. This implies that in clinical practice, health care providers involved in the 
management of PLWH should put greater emphasis on rehabilitation intervention strategies; 
these should involve the family and the community of PLWH and this will help to ensure a 
comprehensive and holistic approach to care.  
5.6 Predictors of activity limitations and participation/social restriction 
Multivariate analysis has demonstrated to what extent various impairments predicted 
patients‘ activity performance limitations and restrictions on their participation in society. 
Associations between impairment, activity limitation and participation/social restriction were 
also demonstrated in other studies with similar study groups (Myezwa, et al., 2009; Rusch, et 
al., 2004a; Van As, et al., 2009).  
5.6.1 Understanding and communication/cognitive 
Several body function impairments, as described in results section of the survey, were likely 
to increase problems with understanding and communication/cognitive functions.  Among 
these, memory and energy and drive were found to be the best predictors. Despite being the 
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least scored function in mental impairments, it was not surprising that memory was also a 
strong predictor for cognitive functions; memory is part of the cognitive domain and 
increased scores by 21%.  Poor memory was also reported as interfering with work and 
household activities by FGDs‘ participants. 
However, it was not so clear how energy and drive could worsen the cognitive domain and 
added a further score of 9% to the problems experienced. A possible explanation for this is 
that PLWH in our study were so demoralised that they had lost trust in themselves. This was 
probably a result of the changes that were happening in their lives because of the HIV 
infection and the compound adverse effects of antiretroviral medications.  Consequently 
some participants become demotivated and were unable to think clearly, or to find solutions 
for their problems and or to take the initiative in learning new tasks (these were the two most 
serious problems in the cognitive domain). Surprisingly, and contrary to the findings of our 
study, an unusual finding from a study conducted by Van As et al. (2009) revealed that 
neuromuscular impairment was a strong predictor of cognitive function, particularly with 
regard to learning and applying knowledge. 
A likely interpretation of this finding could be that those who were most affected by the HIV, 
experienced the most problems across all domains. In other words, those who were the most 
ill experienced problems in both the cognitive and energy and drive domains. However, 
further investigation is required to determine the effect of patients‘ motivation on the 
cognitive functions, such as understanding, learning new tasks, analysing and finding 
solutions, concentration etc. Notably few of these items emerged as problems during the 
FGDs. 
5.6.2 Getting around/mobility 
The getting around/mobility function was adversely affected by various impairments to body 
function that were identified among our subjects. The greatest adverse affect was due  to 
problems experienced in the mobility body function (this was assessed together with muscle 
power under neuromuscular movement impairment) and the blood pressure function, with 
both having the same contribution rate of 11%. In two similar studies conducted by Van As et 
al. (2009) and Myezwa et al. (2009), getting around/mobility was also affected by impairment 
of neuro-musculoskeletal movement, particularly relating to muscle power, but also to pain. 
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In our study, pain was also identified as a predictor for the mobility/getting around function, 
but it was not as strong a factor as mobility and blood pressure.  
It was not unexpected that the mobility impairment should predict getting around/mobility, 
but in the case of blood pressure; this was an unusual finding, especially at it rated equal to 
mobility. Blood pressure was among the least common impairments in the cardiovascular and 
respiratory domain. However, its observed influence on the mobility function could be a 
result of its known symptoms, such as dizziness and headache, which might impact on the 
ability to stand for long periods or to leave the home; both of which were identified as the 
most affected abilities in mobility function. Fatigue, which was found to be the most 
prevalent impairment of body function in this study, and which could also be a symptom of 
blood pressure, could also play the role of mediator between blood pressure and getting 
around/mobility. 
It is difficult to draw conclusions from the assumptions we have made above as we did not 
perform a thorough subjective examination. However, the analysis of the FGDs supported the 
results of the regression analysis with many participants reporting that their mobility was 
affected by pain, breathlessness and lack of energy.  The survey did not include paraesthesia 
which was an omission as this was identified by the FGDs‘ participants as also affecting their 
mobility function. 
More importantly, a clinical/ objective examination is needed to confirm clinically what was 
reported by the participants. Further research that involves a comprehensive clinical 
examination is required to confirm evidence regarding the association between blood 
pressure and mobility, and the mediation of its symptoms, especially fatigue, is required.      
5.6.3 Life activities domain 
Heart problems were the first most significant predictor for life activities and increased the 
score for life activities by 16% (i.e. made them worse). This was followed by mobility, which 
added a further 10%.   As in Myezwa et al. (2009), it was understandable and to be expected 
that mobility impairment will predict problems in life activities functions that include 
household and work activities. However, in this present study, it was somewhat unclear and 
rather unexpected that this would be true for heart problems. Interestingly, the influence of 
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this factor was more significant and increased the problem six times more than mobility. As 
was demonstrated earlier, the greatest limitation with regard to life activities was how quickly 
the activities were done. The speed and intensity involved in performing activities could have 
been worsened by heart disease problems.  
The FGDs supported the negative impact of poor energy and drive, poor memory, weakness 
and pain as contributors to problems in the life activities domain. As was the case with blood 
pressure, the finding on heart problems was obtained from the self-reported views of our 
respondents. There was no clinical examination to confirm the evidence regarding the 
severity of the disease or its impact on life activities. This finding underlines the need to 
investigate the problems of heart disease and their influence on the life activities of PLWH. 
5.6.4 Participation/social restrictions domain 
Emotional problems, which increased the scores by 10%, were followed by the sexual 
discomfort function, which added a further 7% to the score; these were the most significant 
predictors for participation/social restriction. Decreased sexual desire, linking sexual activity 
to the contracting of HIV and a fear that sexual activity would result in a decreased amount of 
energy were all discussed in the groups. It may be that the impairment, sexual discomfort, in 
fact relates to a wider range of problems and was not interpreted simply as physically 
experienced pain. The other significant predictors were similar to those reported by the 
FGDs‘ participants, with decreased energy emerging as the greatest limitation to 
participation.  
Respondents in a study by Rusch et al. (2004a) also demonstrated that mental problems and 
sexual activities influenced their participation in society, whereas Benedict, Mezhir, Walsh, 
& Hewitt (2000) discovered that mental impairment contributes to incapacity to perform 
work and consequently leads to an increased rate of unemployment among PLWH. The 
predictive function of sexual intercourse confirmed the earlier discussion concerning patients‘ 
view that sexual intercourse was the most important activity for relaxation/pleasure. It is 
possible that the greater rate of limitations in the participation in the relaxation/pleasure 
activity that dominated all other functions assessed in this study could have been mediated by 
problems in sexual intercourse. 
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Further research is required to understand how emotional problems experienced by our 
respondents and sexual discomfort are the most significant impairments that adversely affect 
their participation in the society. It will also be interesting to find evidence regarding the 
factors that could mediate between participation/social restriction and emotional problems 
and sexual discomfort, for example, stigma, discrimination and lack of support.  
5.6.5 Conclusion regarding interrelationship between factors 
It appears that decreased energy combined with muscle weakness (described as bodily 
weakness) and decreased exercise tolerance are the primary impairments which are perceived 
to impact on function. These impairments are amenable to physiotherapy treatment in many 
cases and by increasing endurance and building up exercise tolerance the functioning of 
PLWH might be improved. Neuropathic pain and paraesthesia are additional impairments 
which are difficult to treat but certain physiotherapy interventions, such as joint mobilisation 
and vibration have been reported to be effective (Benjamin & Jelsma, 2014) 
5.7 Influence of environmental factors on functioning 
As discussed in the literature review, in the ICF model environmental factors are described as 
factors that are external to an individual and include aspects of the physical, social and 
attitudinal factors in the context in which people live and conduct their lives. These may have 
a positive or negative impact on a person‘s functioning (Schneidert, et al., 2003). 
Environmental factors were examined exclusively through the use of the FGDs as there were 
no items relating to environmental factors included in the survey. 
5.7.1 Influence of family and community social relationships on functioning  
Factors in the social relationship environments that acted as facilitators or barriers to 
performance of activities and to social participation were described by the participants. In 
both rural and urban areas, women and men shared their positive and negative feelings and 
experiences about their relationship with their family and community after contracting HIV.  
Some participants recognised that their family members had accepted their HIV status and 
given them support. This finding corresponds with the findings of other studies (Edwards, 
2006; Majumdar, 2004; Serovich, Kimberly, Mosack, & Lewis, 2001). As Gaskins (2006) 
has also reported, one participant in our study stated that at times her family showed too 
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much support; this verged on overprotection. It is possible that the family considered the 
PLWH to be vulnerable and regarded her as a dependant. However, it is important to 
recognise how PLWH understand and view their abilities and situation. 
On the other hand, some participants related how they experienced non-acceptance, negative 
attitudes, rejection and stigmatization from their family members. This is in accordance with 
the findings of other similar studies (Brashers, Neidig, & Goldsmith, 2004; Emlet, 2007; 
Nichols, Tchounwou, Mena, & Sarpong, 2009; Zukoski & Thorburn, 2009).  
The findings regarding family support for the PLWH point to the need for a comprehensive 
intervention programme beyond the hospital environment that involves the families of PLWH 
in their usual caring roles. The intervention could include training families and bringing them 
together to educate one another about how to deal with the needs of PLWH. The intervention 
could also target PLWH and educate them about the benefits of and the ways of 
strengthening family relationships.  
As in other studies (Brashers, et al., 2004; Majumdar, 2004; Serovich, et al., 2001), certain 
participants said that there were people in their community, such as friends, who accepted 
their HIV status and demonstrated positive attitudes and support. Some participants 
acknowledged the support from the community, encouraged socialization, and indicated that 
it improved psychological well-being overtime. Their positive attitude could assist the 
implementation of community programmes to foster the involvement of the community in the 
holistic care of PLWH. 
However, our findings are similar to those which indicate that PLWH continue experiencing 
negative attitudes, discrimination and stigmatization from their community members, 
including from their close friends (Emlet, 2007; Majumdar, 2004; Zukoski & Thorburn, 
2009). A 64 year old man in Emlet (2007, p. 746) revealed; “…I could drop dead in my 
house and no one might know about it for three weeks”.  Given this finding, there is a need 
for further exploration of the community situation in order to understand more fully the 
awareness of, perceptions of and attitudes towards HIV. The aim would be to inform the 
community regarding the need for awareness and behaviour change towards PLHW; this 
could have long term QoL benefits. 
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5.7.2 Influence of the hospital environment on service provision and utilisation 
The findings of this study described the factors within the hospital environment that acted as 
barriers or facilitators to the functioning of participants. The participants felt that they 
belonged in the ARV clinic, trusted the health care providers from the ARV clinic, and had a 
good relationship with them. They appreciated the service provided by the ARV clinic more 
than the other services provided within the hospital. Similar studies have found that PLWH 
had a good relationship with their health care providers and appreciated the services provided 
(Bakken et al., 2000; O'Brien, et al., 2009).  
O‘Brien et al. (2009) reported in their article that patients felt secure and had confidence in  
their health care providers because of their knowledge and skills and because of the support  
they provided. Bakken et al. (2000) indicated that any improvement in the relationship 
between health care providers and patients was important as it influenced patients‘ adherence 
to antiretroviral treatment. Our participants‘ sense of belonging in an ARV clinic, their trust 
in and appreciation of the health care providers were founded on the value they attributed to 
the antiretroviral treatment and its health benefits.  
However, despite their appreciation of and trust in the health care providers, participants also 
described a number of problems that led to a failure to effectively provide the necessary 
holistic care. Lack of assistance from the ARV clinic concerning the treatment of 
participants‘ functional limitations or problems was emphasized. The ARV clinic did not 
provide adequate treatment for their functional limitations. Although they often complained 
about these problems and sometimes had their antiretroviral treatment changed, most of time 
they did not receive help. Occasionally, they were told to be patient and, with time, the 
problems would pass. 
There are many explanations for what participants described as ineffective care of their 
functional limitations.  It is possible that their functional limitations were difficult to treat, or 
that the health care providers at the ARV clinic were not concerned with their functional 
limitations: they did not always do a comprehensive assessment and they did not think about 
providing a holistic treatment. It is possible that what mattered to them was to provide the 
antiretroviral treatment while ignoring its possible side effects or other complications 
associated with the HIV infection. It is also possible that health care providers at the ARV 
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clinic lacked knowledge about the effectiveness of the rehabilitation services, such as 
physiotherapy and the psychological management of functional problems.  
There are no published studies in Rwanda that determine the knowledge of health care 
providers with respect to rehabilitation services such physiotherapy and psychology; 
functional limitations require treatment by skilled rehabilitation professionals. Future 
research could explore the extent of understanding and knowledge on the part of health care 
providers at ARV clinics with regard to rehabilitation services for PLWH.  
Furthermore, it is also recommended that the hospital organisation should develop a training 
plan for health care providers at the ARV clinic in order to ensure appropriate screening and 
referral.  Rehabilitation specialists, including physiotherapists and psychologists, could be 
instrumental in creating awareness among ARV clinic health care providers of the services 
they provide. They could teach basic assessment skills to detect impairment and identify 
functional problems among PLWH. This would result in a more holistic assessment of 
PLWH and would be an important step towards holistic management.  
Participants were particularly appreciative of the initiative that health care providers from the 
ARV clinic had taken regarding the involvement of their families and their communities in 
their care. Following the profile of their functional limitations, described previously in the 
sections on impairment, activity limitations and participation restrictions, this finding needs 
to be understood in the context of the need for holistic care that goes beyond the hospital 
setting. It implies that apart from the usual clinical care, based on the provision of 
antiretroviral treatment, health care providers from the ARV clinic need to consider including 
the patients‘ family members in their efforts to care for PLWH.  
The involvement of the community could result in the development of community-based 
health care programmes. This might assist in removal of barriers in the family and 
community that lead to discrimination and that stigmatise PLWH. Parker and Aggleton 
(2003) also suggest that interventions targeting stigma and discrimination could require 
community involvement. Such interventions might result in improved psychological and 
social functioning and improved quality of life for PLWH.    
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Similar studies have also found that, despite the manifestation of multiple impairments 
requiring rehabilitation services among PLWH, there are very few referrals to rehabilitation 
services such as physiotherapy or psychology (Freeman, et al., 2007; Myezwa, et al., 2007). 
Our findings have revealed that not only were there few referrals to rehabilitation services or 
to any other service within the hospital from ARV clinic, but there were also weaknesses and 
inconsistencies in the referral procedure. Normally, according the referral procedure at the 
hospitals where the study took place, referrals should be made by the ARV clinic directly to 
the outpatient service, and from there, if necessary, to the specialized services. However at 
times, participants were referred from the ARV clinic directly to specialized services without 
passing through the out-patient service. At other times, when there was no referral: 
participants who felt they needed treatment for functional limitations would take the initiative 
to seek further care, even if did not know of the existence of these specialized rehabilitation 
services. This created difficulties as it led to there being multiple files for one patient within 
one hospital. Moreover, using their own initiative without guidance could result in PLWH 
looking for inappropriate care.  
There were no policies in place at either hospital regarding the referral procedure within the 
hospital. At times patients from ARV clinic would decide to visit other services on their own 
initiative. It is possible that the health care providers at the ARV clinic considered their clinic 
to be a special service and separate from other services within the hospital; they may have 
found it difficult to fully integrate their health care services within the hospital structure. 
Some NGOs have been described as having more interest and investment in HIV health care 
delivery than in other health services (Parker, 2002). The ARV clinic health care providers in 
Rwanda may also have the impression that they are independent of other services provided by 
the same hospital organisation, hence the temptation to make their own rules and plans about 
health care delivery with the support of NGOs.   
To ensure that appropriate treatment is given for functional limitations, there is a need for the 
development of guidelines or a protocol that would guide referral procedures within the 
hospital, in particular with regard to the ARV clinic and the provision of rehabilitation 
services. Future research should consider looking at policies and procedures regarding 
referral systems within the hospital setting and their impact on other services; in particular, 
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they should consider the use of one combined medical file. A procedure needs to be laid 
down for referral from the ARV clinic to other services, particularly rehabilitation services.  
Participants strongly recommended collaboration among all health care providers at the 
hospital; they wished the ARV clinic health care providers would improve their referral 
procedure and they advocated the use of one file per patient for all hospital services. 
Interestingly, they believed that collaboration would improve the referral procedure and 
significantly improve the management of their functional problems, and that the use of one 
medical file would improve collaboration, enhance the referral procedure, and benefit the 
patient-health care provider relationship, and also assist with patient follow-up.  
It is interesting and encouraging that participants thought of strategies to improve the referral 
procedure, which they believed would contribute to better management of their functional 
limitations.  Importantly, their recommendations go beyond the issue of referral procedure 
and suggest the need for changing the systems in place in hospitals: these are responsible for 
encouraging team spirit and team work and are important in a patient-centred approach to 
care. The ultimate goal was improve the management of the functional limitations of PLWH 
in holistic way. Apparently, planning for changes in the referral procedure could involve 
several health care providers within the hospital setting, particularly those from rehabilitation 
services. However, ARV clinic health care providers should play a big role in driving these 
changes. 
Our study added to the  existing evidence that  prolonged  waiting times and the 
unavailability of doctors would lead to difficulties in accessing care and have an effect on 
patients‘ appreciation of health care delivery (Kennedy, Rhodes, Walls, & Asplin, 2004; 
Wouters, Heunis, van Rensburg, & Meulemans, 2008). The majority of participants who 
visited other services following referral from the ARV clinic explained that they always had 
to wait too long to receive care and that sometimes doctors were not available, so they were 
not attended to. The most important reasons for this (also mentioned in other studies) are the 
shortage of health care providers, particularly doctors, and the great number of patients (Hoot 
& Aronsky, 2008; Wouters, et al., 2008).  
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5.7.3 Participant recommendations regarding hospital services 
Our participants also recognised that there was of shortage of health care providers and made 
the following recommendations: 
(1) They suggested that the ARV clinic health care providers should advocate at the 
hospital level for more medical doctors in the ARV clinic. This would improve the 
assessment and treatment of their problems, reduce the number of cases for referral, 
and improve the referral procedure, particularly by ensuring referral to competent 
specialists for their functional limitations.  
(2) Participants suggested that the ARV clinic health care providers should advocate for 
an increase in the other types of health care provider for the entire hospital. This 
implies that PLWH recognised the need for other health care providers to contribute 
to the improvement of their care. Hospital managers should be aware of this need in 
order to ensure the augmentation of their staff; this would have a positive impact on 
the care provided for PLWH. 
(3) A special recommendation was that the ARV clinic health care providers should 
advocate at the hospital level for rehabilitation specialists to be more available, as this 
would assist with the treatment of functional limitations. Participants proposed that 
rehabilitation specialists could either be integrated in ARV clinic team or provide 
their own services, to which the PLWH could be referred. This recommendation 
applies to the health care providers at the ARV clinic, but the hospital authorities 
should also recognise the need for rehabilitation services for PLWH.  Perhaps a 
reorganization of the ARV services is required, with the aim of integrating the 
rehabilitation services. However the health care providers at the ARV clinic should 
remain the key people in providing a continuum of care.  
(4) Finally, participants recommended that the ARV clinic should advocate for their own 
identified team of health care providers. This could be provided at their usual clinic in 
the hospital or at the ARV clinic. They believed ―their own‖ health care providers 
would give them greater consideration, reduce waiting times and improve care. This 
suggests that there is need for stronger education and intervention strategies that 
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would assist PLWH to understand that improvement of the hospital services as a 
whole would also benefit them.  
It should be noted that Rwanda lost a large number of health care providers during the 
genocide (Logie, et al., 2008; Rusa, et al., 2009). Additionally, despite the efforts made by 
the government through the Ministry of Health to retain health care providers in public 
hospitals (by providing incentives through performance-based financing) (Logie, et al., 2008; 
Price, et al., 2009), there has been an internal migration of health care providers, particularly 
doctors, from the public service to international NGOs and donor agencies which pay better 
salaries (Logie, et al., 2008).   
Our findings testify to the growing problem of staff shortages in public (government) 
hospitals in Rwanda. Ways must be found of encouraging staff retention, beyond the 
performance-based financial incentives. Government health sector managers need to assist 
the government to look into the issue and propose strategies which would reduce long waiting 
times and reduce the unavailability of heath care providers.  The finding invites further 
research to explore the problem from the perspective of health care providers, whose opinions 
and experiences need to be understood.    
Another important finding was that PLWH need special consideration.  The participants 
believed that they were different and had special needs as a result of the severity and the 
chronic nature of their illness. Similarly, participants in another qualitative study by Hughes, 
Davies, and Gudmundsdottir (2008) also expressed the need for special consideration, but 
they used the term ―dignity‖; they explained that being treated with dignity meant being 
treated with respect, which included having their medical needs met in timely manner, and 
not being ignored. Noticeably, our participants also complained that they were lost in those 
services to which they were referred, because they did not have someone in particular to look 
after them, as in the ARV clinic, and they did not know the health care provider responsible 
for assisting with their functional limitations.  
Apparently participants considered themselves to be very vulnerable and wanted to be 
protected and be considered as patients with special needs, due to the permanent nature of 
their health condition. Male participants could not accept being mixed in with other patients.  
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It is also possible that participants did not easily fit into the organisation of the hospital as a 
whole. They considered themselves to belong at the ARV clinic, and not to the hospital as a 
whole. They were not like any other patient. Therefore, participants recommended that ARV 
health care providers should advocate for greater consideration for PLWH, for recognition of 
their special needs and for respect for their privacy. Participants also wished that their health 
care providers would respect their time at while on duty and avoid mixing work and 
socialising. 
Health care providers at the ARV clinics need to play a role in educating PLWH about the 
hospital‘s organisation, structures and procedures, and in assisting  them to integrate into the 
hospital system like any other patient seeking care (and not primarily as a PLWH). If this 
were to be achieved, it might reduce the levels of social discrimination and stigmatization. 
The finding suggests further research is needed to clarify and explore the meaning of the need 
for ‗special consideration‘ from the perspective of both PLWH and the health care providers. 
Participants‘ recommendations with regard to time management apply to the health care 
providers engaged in caring for PLWH and perhaps a behaviour change intervention strategy 
at the hospital would be beneficial.  
Another finding related to poor communication by those services situated outside the ARV 
clinics. A study by Ownby and Dune (2007) found similar complaints about communication 
by health care providers. Interestingly, a review of the relevant literature by Stewart (1995) 
has found that good communication between health care provider and PLWH could improve 
the patients‘ general health status. In our study, participants wished that they were listened to 
and emphasized the need for good communication. They said this would improve self-
acceptance. This was also suggested by Stevenson, Cox, Britten, and Dundar (2004), who 
said that effective communication with health care providers was needed if patients were to 
understand their health condition and to be involved in decision-making regarding their care; 
this would also lead to greater understanding of their treatment.  Participants in our study 
wanted improved communication to empower them, rebuild trust and contribute to self-
acceptance. Interventions were needed to provide communication skills training programmes 
for health care providers. However, it could also be valuable to develop the communication 
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skills of PLWH, as this would enable them to express their problems with clarity and 
confidence.   
Our findings confirm the generally accepted evidence that PLWH experience stigmatization 
and discrimination from their health care providers (Emlet, 2007; Zukoski & Thorburn, 
2009). Our participants explained that health care providers at the referred services 
demonstrated negative attitudes once they discovered their HIV serostatus. Participants in 
studies by Zukoski and Thorburn (2009) and by Emlet (2007) highlighted the discriminatory 
attitudes and behaviour of health care providers, who feared contamination.   
It is possible that participants‘ expressed wishes for special consideration and better 
communication that would assist them with self- acceptance and contribute to their 
empowerment might be hindered by the negative attitudes of health care providers. There is a 
need for an intervention programme to develop strategies to combat stigma and 
discrimination on the part of health care providers within the hospital setting. It is possible 
that health care providers from the ARV clinics could assist with advocacy, since they had 
accepted PLWH and shown positive attitudes. They could serve as resources for the 
development of strategies to combat stigma and discrimination towards PLWH from 
colleagues working in other hospital services    
Another important finding in our study was that those services to which PLWH were referred 
by the ARV clinic were not able to treat their functional limitations adequately. The health 
care providers did not have enough time for them because of the number of patients and they 
only prescribed medicines for their functional limitations. These medicines were not always 
effective and often failed to bring healing. This finding reinforces the evidence from previous 
studies that doctors generally only provide drugs and do not attend to the functional 
limitations experienced by PLWH, especially pain (Larue, et al., 1997; Nair, et al., 2009; 
Ownby & Dune, 2007). 
This finding suggests that participants‘ needs and expectations were not met by the services 
to which they were referred. Although participants knew that antiretroviral treatment caused 
some of their functional limitations, they appreciated the care received from the ARV clinic 
because antiretroviral treatment is recognised and had assisted with the major problem.  
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Apparently they thought that the services to which they were referred outside ARV clinic 
were specialised in the management of their functional limitations or problems and they 
expected to be assisted with the problems which could not be solved by the ARV clinic.  
This finding suggests that doctors and other health care providers working in different 
services within the hospital to which PLWH are referred might require further training to 
improve their knowledge of the functional limitations or problems experienced by PLWH. 
This training could be linked to the development of guidelines and appropriate assessment 
tools in order to enable a thorough assessment and to plan for effective management. The 
training would need to focus on an awareness of the rehabilitation services‘ ability to deal 
with functional limitations or problems. It could stimulate doctors to recognise their 
boundaries and refer patients when needed. 
A few participants indicated that the rehabilitation services, particularly physiotherapy and 
psychology or mental health, had been successful in the management of functional 
limitations. After the other participants heard about these rehabilitation services, they 
indicated that they needed to visit them. Additionally, they recommended that a counselling 
program be established at their clinic as they believed this would support behaviour change, 
adherence to ARV medication, and improve psychological well-being and the quality of life. 
These findings add to the limited evidence regarding the effectiveness of rehabilitation 
services in treating the functional limitations experienced by PLWH (Fillipas, et al., 2010; 
Freeman, et al., 2007; Mutimura, et al., 2008; Ownby, 2006). There is little published 
research conducted in Rwanda that has attempted to describe the utilisation of rehabilitation 
services such as physiotherapy by PLWH. Future research should therefore explore the use of 
the various rehabilitation services by PLWH; this will assist with planning interventions to 
improve the utilisation of these services by PLWH. Rehabilitation health care providers need 
to make other health care providers and PLWH aware of the benefits of their services for 
reducing functional limitations among PLWH. This might result in increased referrals to 
rehabilitation services and motivate PLWH to seek rehabilitation. PLWH who have 
experienced an improvement in functioning as a result of rehabilitation could assist with a 
peer education strategy during the awareness-raising intervention program.  
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Failure to get help for their functional problems led some participants to seek treatment 
elsewhere, including at a private clinic and even at a doctor‘s home, and this was more 
reported and encouraged by men in both rural and urban areas. Although they seemed 
uncomfortable that their visit to the private clinic might be ―discovered‖, the majority of 
those who visited private clinics appreciated the care they received. However, participants 
indicated that it was too expensive, compared to the service provided by a public hospital. 
They indicated that only those who had a higher quality health insurance such as ―RAMA‖ 
would be able to afford private care. 
It appears that participants who went to private clinics felt strongly about the ineffective care 
they were receiving for their functional limitations and the poor referral procedure. They felt 
they did not have any other choice. If they had received better care for their functional 
limitations at the hospital (similar to the effective treatment of HIV through antiretroviral 
treatment) they would not have considered seeking care outside the hospital. This finding 
suggests that there is great need to strengthen the public health care system as a basis for 
providing effective and comprehensive care for PLWH. However, this finding also suggests 
that it might be advisable to engage with the private sector in broader health care planning, 
particularly with regard to the management of the functional limitations experienced by 
PLWH.  
The majority of participants used the Rwanda National Insurance medical cover; Mutuelle de 
Santé (see section 1.1.1). They appreciated its benefits, particularly because it covered all the 
treatment costs in almost all the services they made use of.  However,  as  indicated by Logie 
et al. (2008), it only provides basic services and does not cover all the necessary care. It does 
not cover all of the costs of special care, and sometimes participants had to pay the extra costs 
from their own pockets.  
Participants wished they could be provided with services beyond those covered by Mutuelle 
de Santé or get a more comprehensive medical cover. Participants‘ income status was not 
determined but their employment status (see section 5.2.4) suggests that they might not be 
able to afford more expensive medical insurance or to contribute towards the extra costs of 
such cover. There may be a need for a special grant to assist them with the extra costs, instead 
of relying on special insurance medical cover; this might be difficult to obtain as it would 
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require changing government policy. Perhaps there is also a need for NGOs that have HIV 
care on their agenda to be informed of this problem.  
This study supports the findings of other studies that recognise the benefits of nutrition 
support and the effect of good nutrition on the health of PLWH (Ivers et al., 2009; Serrano et 
al., 2010). Participants expressed the need for food programme support to be provided to all 
PLWH without exception. Community based intervention projects that aim to empower 
PLWH and improve their income, were also needed. Community social workers and 
nutritionists could assist in planning effective interventions. It is possible that the advocacy 
for a food program should go beyond the hospitals and involve other sectors, such as PLWH 
associations, NGOs and the Ministry of Health. It might also require changes in government 
policy  
5.8 My reflections on perceptions of how the hospital services address the 
functional limitations of PLWH with associated disabilities  
I am a physiotherapist by profession, and an educator and a trained counsellor.  Initially, I 
was prompted to look in-depth into PLWH, in particular the associated disabilities and 
functional limitations of PLWH, and to explore to what extent the hospital services were able 
to respond to their functional limitations. This emerged, firstly, because of the issues raised 
during the survey (see Chapter Three). In addition, what motivated me to conduct the study 
was my experience with regard to the management of physiotherapy provided to PLWH for 
treatment of their disabilities. From my observations in Rwanda, when a PLWH with an 
associated functional limitation (such as low back pain) comes for treatment to a 
physiotherapy department, the main focus of the physiotherapist during treatment is the 
functional limitation which brought the patient to seek help; the original problem, which is 
HIV, is ignored, even though this could be the underlying cause of the functional limitation. 
In additional, the patient could have other problems which might need assistance from other 
services existing within the hospital and these were not investigated. 
5.9 Limitations  
These studies have limitations that must be acknowledged.  
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5.9.1 Limitations of the Quantitative study 
It is possible that the use of a cross-sectional design could have resulted in a failure to capture 
the entire picture of disability among our participants, particularly because the nature of the 
reported functional limitations varies across time. Cross-sectional design could have 
contributed also to an inability to draw some causal inferences from the findings.  
Additionally, our findings relied on self-reported diagnoses rather than on clinical 
examination; its findings have not been confirmed clinically. During data collection, 
participants retrospectively recalled their difficulties with functioning. It is possible that they 
could have experienced difficulty in remembering details of their past experience; this applies 
especially to those with memory problems. In this present study we did not determine the 
relationship between socio-demographic factors, such as age, education and employment, and 
the functions assessed, and this has limited the ability to make findings regarding causal 
relationships and the variation of impairment and other functional variables across socio-
demographic and economic variables.  
However, despite these limitations, the present study, in a form of a survey, is one of the few 
studies that describe the profile of disability among PLWH, using a standardized and reliable 
instrument. The study used also a large sample obtained from numerous settings, and this 
enabled its findings to be generalised.    
5.9.2 Limitations - Qualitative study 
Although this part of the study has provided rich information for understanding the 
experiences of PLWH, particularly with regard to their functional limitations (and how 
contextual factors influence their functioning) there are some limitations.  
The data was obtained from only two focus group discussions, with each group consisting of 
eight people. The study was conducted in only two purposively selected hospitals out of a 
total of 45 hospitals in the country. Future research should consider conducting more group 
discussions and involving more hospitals so as to achieve a broader understanding of the 
problem. The hospitals were in an urban and a semi-rural setting. However PLWH from a 
rural area might provide a different perspective because of the influence of demographic, 
socio-economic and cultural factors. They would be influenced by a culture which is more 
traditional than that found in the urban areas.  
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Data was collected at the ARV clinic, the place where the participants received daily care. 
This might be considered as a limitation as participants might have left out some information 
for fear of offending their health care providers. But this may also be a potential strength 
because of the selection of a familiar and safe environment for the participants.  
Another possible limitation of the study has to do with the nature of the focus group 
discussion. Due to the sensitivity of certain topics, such as sexual activity behaviour and 
stigma, it is possible that participants were reluctant to freely express their feelings and 
opinions about these issues. It is possible that individual interviews would have led to a 
different understanding. It is recommended that if further research is conducted that aims to 
explore the influence of sensitive problems on the functioning of PLWH, individual 
interviews should also be used. 
Despite the strength of the discussions, which provided thick and rich information, and 
exceeded the researcher‘s expectations, some issues emerged, such as spirituality, stigma, 
sexual behaviour and disclosure that were beyond the expertise of the moderator. We 
recognise the limits to our exploration of these topics, and recommend that further research 
should be conducted by an interdisciplinary team.  
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6 CHAPTER SIX: VALIDATION OF INSTRUMENTS 
 
6.1 Background 
Rehabilitation professionals need a valid and reliable tool to measure disability amongst 
people seeking rehabilitation services, such as physiotherapy and psychotherapy.  Disability 
tools or instruments are used to determine functional limitations among people who 
encounter problems with health conditions that can affect their functional status. Various 
studies have shown that PLWH encounter numerous functional limitations that affect their 
health-related quality of life (Gale, 2003; Rusch, et al., 2004a). There is no instrument in 
Kinyarwanda that assesses functional limitations, particularly among PLWH. The WHODAS 
2.0 was identified as a suitable instrument.  
 WHODAS 2.0 was developed based on the ICF which utilises a bio-psychosocial model. It 
was chosen because of its multidimensional character, as it assesses several important areas 
of functional status, including physical, mental/psychological and social status. In addition, it 
can be used for any disease or health condition. It has been developed for use in a number of 
countries with their own languages and has been shown to be appropriate across cultures   
(Üstün et al., 2010b).  Three versions of WHODAS 2.0 were developed: a 36-item, a 12-item 
and a 12+24 item version. Of the three, the 36-item version of WHODAS 2.0,which is 
interviewer-administered, was selected by the researcher because it is the most detailed and it 
allows users to generate scores for the six domains of functioning (cognition, mobility, self-
care, getting along, life activities and participation) (Üstün, et al., 2010a). 
WHODAS 2.0 has been translated into 27 languages ( Üstün, et al., 2010b), following WHO 
translation guidelines. There are only a few African language translations: these include 
Yoruba, one of the Nigerian languages (Üstün, et al., 2010b), and isiXhosa (personal 
communication, Maart, University of Cape Town, 2012). The reliability and validity of 
WHODAS 2.0 as a tool to measure the functional limitations of various population groups 
and health conditions has been established.  The internal consistency of the WHODAS 2.0 
domains has been found to be satisfactory. In addition, the tool has displayed consistency in 
repeated measurements. WHODAS 2.0 also displays concurrent validity: its results correlate 
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highly with the results of other disability tools that measure the same problems ( Üstün, et al., 
2010b).  
It remains an on-going challenge to translate different instruments from the source language 
to local languages and a common process entails the use of both forward and backward 
translation. The translation approach followed in this study is similar to those used in several 
other studies that have also described the procedure followed for the translation of various 
clinical and research tools across cultures. For effective translation, the whole process 
typically goes through many stages. These include forward translation, a first consensus 
meeting, backward translation, a second consensus meeting, a third consensus meeting, 
proofreading and, finally, a fourth consensus meeting, after a debriefing interview (Cha, Kim, 
& Erlen, 2007). This process can result in the development of an instrument which is clear, 
concise and valid.  
It was demonstrated that the translation process of ―the European Quality of Life 5-
dimensions (EQ-5D)‖ from English to the Shona language (spoken in Zimbabwe by more 
than half the population) started with forward translation, carried out independently by two 
native Shona speakers, and followed by a consensus meeting. Thereafter, the Shona version 
was backward translated independently by two translators, and this was also followed by a 
consensus meeting and, finally, by the testing of the instrument (Jelsma, Chivaura, De Cock, 
& De Weerdt, 2000). Furthermore, it was reported that the ICF checklist was translated into 
the isiXhosa language, one of the South African languages, and went through the following 
procedure: forward translation by two independent translators; then a consensus meeting to 
compare the two versions; thereafter backward translation to produce an English version; 
followed by a consensus meeting to compare with the original version (Toni, 2007).  
Various scientific papers have also examined instrument translation experiences in Asian 
countries and shown how they follow translation procedures similar to those used in the 
present study.  For example, a Korean version of the ―hip disability and osteoarthritis 
outcome score (HOOS)‖, was produced. The process entailed forward translation; a first 
consensus meeting involving translators and three orthopaedic surgeons; backward 
translation; followed by a second consensus meeting that included the backward translators, 
the three orthopaedic surgeons and, in addition, one medical professional whose first 
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language was English, a native speaker of Korean English with a speciality in education 
psychology and, finally, a research assistant specialist in orthopaedic scoring systems (Lee et 
al., 2011).  
In another research paper, also produced in Korea, it was reported that ―a Korean version of 
the disability of arms, shoulder, and hand outcome questionnaire (K-DASH)‖ was developed 
through cross-cultural adaptation using the following methodology: forward translation by 
two translators whose first language was Korean, one of whom had a medical background; 
this was followed by a review and a synthesis of the translation, and then by consensus.  The 
second step was backward translation into English followed by a consensus meeting that 
involved health professionals, linguistic professionals and the translators. Finally the 
instrument was tested on a group of patients with upper extremity problems to produce a final 
―K-DASH‖ Korean version (Lee, Lim, Oh, & Ko, 2008).   
In China, development of a Chinese version of the ―Diabetes Management Self-efficacy 
Scale (DMSES)‖ went through the following stages: forward translation by two bilingual 
professional translators, followed by the first consensus meeting, which involved the two 
forward translators, two bilingual Chinese researchers and a diabetes educator who did the 
checking before the instrument moved to the next stage. Then a focus group discussion was 
conducted, involving two diabetes educators, a bilingual Chinese researcher and three 
patients considered experts on providing opinions on the cultural equivalence. Thereafter, a 
backward translation was carried out; this included two native English-speaking translators 
with experience in biomedical Sciences and nursing. They were blind to the DMSES original 
version.  Backward translation was followed by a consensus meeting consisting of two native 
English-speaking researchers and a bilingual Chinese researcher. Their role was to compare 
the backward-translated instrument with the original in order to check for differences in 
meaning (Wu et al., 2008).  
WHODAS 2.0, like any other instrument, has limitations and, more importantly, it excludes 
the impairment domain. For this reason, an ICF condition regarding a set of impairments of 
body functions was included in the study. The study aimed at identifying impairment among 
PLWH, across two countries: Brasilia and South Africa (Myezwa, Buchalla, Jelsma, & 
Stewart, 2011) 
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The English versions of the two instruments were translated into the Kinyarwanda language, 
following the translation guidelines in the WHODAS 2.0 manual and the WHO guidelines for 
translation. The WHO has developed a method for translating an English instrument into any 
other targeted language, producing a conceptual meaning equivalent to that of the original 
version rather than a literal or word-for-word meaning (World Health Organisation (WHO), 
2012). Therefore the integration of both the linguistic or semantic meanings of the words in 
the instrument and the conceptual meaning were considered in order to ensure a cultural 
understanding of certain concepts. 
The aim of the translation was to produce Kinyarwanda versions of these two instruments 
which were linguistically and culturally valid, and which were able to test associated body 
function limitations among PLWH and receiving Antiretroviral Treatment. Cultural 
equivalence can help to determine how people from different linguistic and cultural groups 
interpret and give meaning to the questions under study (Pena, 2007). The translation 
included the WHODAS 2.0 section on background and demographic information, questions 
in WHODAS 2.0 assessing activity limitations and participation restrictions, and an ICF core 
set of impairment questions.   
It is hoped that the translated Kinyarwanda version can be used in clinical practice to assess 
the functional needs in the Rwandese population and that it will help rehabilitation 
professionals to plan and monitor holistic intervention programs. It is possible that it could 
also serve as a cultural instrument model for other countries in the same region: Burundi has 
a similar culture and language to Rwanda, and in East Congo (DRC) there is a group of 
people with a culture similar to that of Rwanda and whose mother tongue is also 
Kinyarwanda.   
However an instrument may be valid within one context but inappropriate for use in another. 
It was therefore necessary to establish the cultural appropriateness and validity of the 
Kinyarwanda version of the WHODAS 2.0 and the impairment questionnaire.  Validity 
incorporates face, content and construct validity. In addition, reliability needs to be proven. 
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Figure 24: Conceptual framework for validation of the instruments 
Definition of cultural appropriateness is taken from Beaton, Bombardier, Guillemin, and 
Ferraz, (2000) and Wild et al. (2005). 
Definition of face validity is from DeVon et al. (2007) and Neuman (2003). 
Definition of content validity is from Neuman (2003) and Punch (2005). 
Definition of construct validity-convergent is from Neuman (2003) and Punch (2005). 
Definition of reliability is from DeVon et al. (2007) and Neuman (2003). 
 
Cultural 
appropriateness 
Definition: Appropriate, 
courteous and 
comprehensible within 
the context of use   
Translation process  
and cognitive 
debriefing 
Were equivalent words 
identified which 
encompassed the same 
meaning? Did the 
respondents report that 
the questionnaires 
were appropriate in 
length and content? 
Face validity 
Definition: A  judgment 
whether the 
measurement which is 
being used is really 
valid  and it provides 
insight about how 
respondents might 
interpret and respond 
to  the items   
Information from FG 
discussions 
Cogntivie debriefing 
and  FG  discussions 
Content validity 
Definition: tests if the 
full content of a 
conceptual definition is 
represented in a 
measurement. 
Cross referencing FG 
and survey results 
Identify impairments 
and functioning items 
in the instruments  that 
were not mentioned by 
the FGDs 
Construct 
validity - 
convergent 
Definition: applies for 
measures of the same 
construct but with 
multiple indicators and 
determines if the 
indicators converge or 
are associated with one 
another 
Compariison of  the 
results of the two 
survey instruments  
Establish if there is a 
significant difference in 
the means of the 
WHODAS 2.0 domain 
scores for each level of 
response to a intuitively 
connected item on the 
impairments scale (or 
income in the case of 
life activities) 
Reliability  
Definition: an indication 
of consistency of a 
measurement  
WHODAS 2.0 survey 
data 
Determine the overall 
Cronbach's alpha  
coefficient and determine 
if any items decrease the 
reliability of the 
instrument by decreasing 
the alpha co-efficient. 
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6.2 Aims and Objectives 
6.2.1 Aim 
The aim of this chapter is to establish whether the translated Kinyawanda versions of the 
WHODAS 2.0 and the ICF core set of questions were valid instruments with which to 
document the presence of impairments and functional limitations.  This entailed interrogating 
the face and content validity, as well as the reliability and construct validity. 
6.2.2 Objectives 
1. To explore the cultural appropriateness, linguistic equivalence and face validity of the 
translated questions by describing the process of forward translation (from English to 
Kinyarwanda) and backward translation (from Kinyarwanda to English) of the ICF 
core set of questions regarding impairment of body functions and the WHODAS 2.0 
outcome instrument and to document and report difficulties encountered during 
consensus meetings or analysis due to linguistic differences or cultural influence. 
2. To establish the content validity by comparing the items included in the instruments 
with the impairments and activity limitations and participation restrictions that 
emerged during the focus group discussions. 
3. To establish the construct (convergent) validity of the WHODAS 2.0 by establishing 
whether there was a significant difference in the means of each domain for each level 
of response to an intuitively associated impairment or income level. (Cognition 
domain and level of memory problems, Mobility domain with mobility impairment 
levels, Self-Care domain with muscle power impairments, Getting Along with people 
with Emotional impairments, Life Activities with Income category and Participation 
with impairment level in Energy and Drive).  
4. To determine the reliability of the impairments questionnaire and  the WHODAS 2.0 
through determining the internal consistency of the instrument and the component 
domains.  
6.3 Methodology 
This chapter includes a description of the translation process and the difficulties encountered 
in reaching a consensus as to culturally appropriate translation of certain concepts and items. 
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The further validation of the instrument was done post hoc and the data gathered in the FGDs 
and during the survey of functional limitations and participation restrictions was utilised for 
this purpose.  
6.3.1 Participants 
6.3.1.1 Participants in the forward and backward translations  
Participants in the forward and backward translation, the consensus meetings and the proof 
reading were drawn from different backgrounds, thus increasing the validity of the 
instrument. The translation process and consensus meetings included the following 
disciplines: linguistics, physiotherapy, psychology and medicine. The first language of all 
participants was Kinyarwanda, and they were all fluent in English and had experience of 
translation. Four individuals were selected, two physiotherapists and two professionals in 
linguistics, as well as two translators per translation, one being a professional in linguistics 
and the other a physiotherapist. The professional linguist in forward translation was a 
Kinyarwanda secondary school teacher who had been involved in translation consultancies 
before, and was very experienced in the field of translation. The professional linguist in 
backward translation was working in the Department of Language Studies at KHI and was 
employed to teach English.  The linguistically trained translators had no knowledge of 
medical terminology, thereby ensuring that the translation was appropriate for lay people. 
Both were qualified to translate, and were well placed to understand and retain concepts 
while integrating them within the local cultural context. The physiotherapist translators held 
masters degrees and were both lecturers in the Physiotherapy Department at KHI. 
Consequently they were highly qualified in the field of disability, were knowledgeable with 
regard to medical terminology, and had experience in HIV research. As Rwandese, these 
professionals were also equipped with cultural insight and were able to link this to certain 
concepts used in the instrument.   
6.3.1.2 Participants in consensus meetings and debriefing cognitive interview 
Four consensus meetings were held. The first consensus meeting was held following the 
forward translation. Participants in this meeting were: the researcher, whose role was to 
moderate and occasionally take notes during discussion; the two forward translators; two 
lecturers in the physiotherapy department at KHI; and one physiotherapist working in the 
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Hospital.  All the participants were familiar with either HIV or with disability studies. One of 
the research assistants was a newly qualified physiotherapist. Apart from the researcher, the 
participants in the first consensus meeting did not participate in the second meeting, thus 
ensuring that the first discussion did not influence the backward translation.   
The second consensus meeting was held following the backward translation.  Participants in 
this meeting included: the researcher, the two backward translators, one lecturer in the 
Physiotherapy Department at KHI, and one of the research assistants, who was also a newly 
qualified physiotherapist. The third consensus meeting included all participants from the 
first and the second consensus meetings.  
The cognitive debriefing interview took place at Muhima Hospital.  It was conducted by the 
researcher, the physiotherapy lecturer who participated in the forward translation, and the two 
selected researcher assistants. The interview involved 24 participants, all PLWH and on 
antiretroviral treatment.  
The last consensus meeting took place after the cognitive debriefing interview and it 
included the researcher, the two research assistants, the physiotherapist translator who 
participated in forward translation, and the professional linguistic translator who participated 
in the backward translation. The selection of the last two participants was based on their 
availability. The rest of the participants were involved in proof reading before the finalization 
of the first draft; this draft was used for the cognitive debriefing interview. The people who 
participated in the final proof reading were: a medical doctor working in the Ministry of 
Health/HIV division, two psychologists (both lecturers in the Mental Health department at 
KHI), and two qualified physiotherapists working in the hospital setting. 
6.3.1.3 Participants in the validation studies 
The responses of participants of the prevalence survey (described in Chapter Three) and in 
the focus group discussions (described in Chapter Four) were used to determine the validity 
of the study.  
6.3.2 Instrumentation  
The original WHODAS 2.0, 36-item version, interview administered, was downloaded in 
PDF format as it was received from the WHO. However, the characters were not very legible, 
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so the researcher decided to retype the instrument, with all the instructions, without changing 
any words.  Questions measuring impairment among PLWH were also typed in words but, to 
allow for a smooth flow during the interview, these were added to the questionnaire after the 
Demographic and Background Information section. Certain background information specific 
to PLWH (clinical variables such as time since diagnosis, CD4 cell count, etc.) was also 
included at the suggestion of participants in CNLS to whom the project was presented.  Some 
of these questions were taken from The World Health Organisation Quality of Life 
(WHOQOL-HIV BREF).  
The instrument for translation (See Appendix XI) consisted of two parts, divided into four 
sections:  
Section 1: entitled face sheet, which covered interviewer and interviewee identification (ID) 
information, such as interviewer and respondent ID numbers, and the interviewee‘s living 
situation. 
Section 2: questions in this section covered demographic and background information, such 
as sex, age, and marital status, taken from WHODAS 2.0. In the first paragraph, instructions 
were provided explaining the purpose of developing the interview questionnaire as well as 
instructions concerning ethical considerations.  
Section 3: included questions assessing impairment in PLWH using the HIV code set 
identified by Myezwa et al.  (2011). Two paragraphs on the first page contained information 
explaining impairment, the nature of the health condition, the time since onset, and the 
severity. 
Section 4: was about activity limitations and participation restrictions.  This section started 
with three paragraphs of instructions. The first paragraph dealt with information regarding 
ethical considerations, while the second paragraph covered the meaning of health conditions, 
the difficulties experienced in doing an activity, the time since onset and the severity.  
Following these instructions, the WHODAS 2.0 domains which were to be assessed were 
described: these were cognition, mobility, self-care, getting along with people, daily activities 
(comprising household activities and work or school activities) and participation. Instructions 
were repeated before each domain.  
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6.3.3 Procedure of translation – Cultural appropriateness 
The two forward translators were given the English version to translate into Kinyarwanda. 
Each translator developed a spread sheet in Kinyarwanda. Thereafter, the two backward 
translators were given the Kinyarwanda version developed after the first consensus meeting 
which took place after the forward translation. The backward translators developed a spread-
sheet in English, but had no sight of the original transcripts. 
The process was lengthy and was delayed due to various factors. Permission for the 
translation was obtained from the WHO, the CNLS (the national institution supervising and 
coordinating all activities regarding HIV in Rwanda), the KHI IRB, which represented the 
National Ethical Research Committee, and from the hospital selected for the cognitive 
debriefing interview. This took a considerable amount of time. In addition, the availability of 
translators was a limiting factor, particularly for consensus meetings, where the time 
allocated to translation had to be extended. (For example instead of the envisaged 10 days, 
each group spent 14 days doing translation, as a result of the translators‘ other obligations). 
Immediately after approval, all participants in the translation were approached to give their 
consent. 
6.3.3.1 Forward translation 
After the selection of the two forward translators by the researcher, they were invited to a 
meeting clarifying the required translation procedure. It was explained that they should each 
produce one translation aimed at addressing a multi-audience group. The translations should 
not simply be linguistic or semantic translations, which could result in literal translation, but 
should take the Kinyarwanda cultural context into account.  They were also instructed to 
highlight and report terms and phrases which caused problems so that these could be 
discussed during consensus meetings; the date for the consensus meeting was also decided 
upon. In addition, each translator was instructed to work independently, and to produce an 
individual transcript. After two weeks, the consensus group then met to analyse and compare 
the two Kinyarwanda versions in order to produce one final forward translation. 
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6.3.3.2  Backward translation  
After the Kinyarwanda version was developed in the first consensus meeting, the two 
selected backward translators were given the Kinyarwanda transcript to translate into English. 
They were asked to each do one translation and they were requested to take cultural issues 
into account. Translators at this point had not seen the original English version and were 
instructed to produce individual work. It took them two weeks to complete the translation. 
6.3.3.3  Cognitive debriefing interview 
The purpose of the cognitive debriefing interview was to get feedback with regard to the 
length of the interview from a group similar to the final participants. Were the questions easy 
to understand and answer? Was there clarity with regard to both the linguistic and cultural 
meanings? The debriefing took place at a randomly selected ARV clinic at Muhima hospital, 
in Nyarungege District, Kigali City. Prior to the interview, all interviewers were asked to 
keep notes on ambiguous words or concepts and to note any alternative suggestions regarding 
wording.  Face-to-face interviews were conducted. All PLWHs on antiretroviral treatment 
who attended the ARV clinic on the day of the debriefing interview were invited to 
participate in the interview. The study was explained to the participants using the Participant 
Information sheet. It was emphasised that participation was voluntary, and that 
confidentiality and anonymity would be maintained. Participants were also requested to give 
permission to access their medical records. The interview lasted for three hours. 
6.3.4 Ethical considerations 
Ethical approval was obtained from UWC and from the KHI IRB and CNLS, and permission 
for the cognitive debriefing interview was obtained from the WHO, CNLS and Muhima 
hospital.  
6.4 Data management /analysis  
6.4.1 Cultural appropriateness, linguistic equivalence and face validity 
Analysis started during the first consensus meeting held after the forward translation. 
During analysis the WHODAS 2.0 manual was occasionally consulted, particularly when the 
consensus team failed to clearly understand the meaning of an English word or phrase. The 
meeting took place at KHI, and was held over one day, five hours in the morning and three 
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hours in the afternoon, with a one hour break in between. Before discussion commenced, 
team members were briefed and the procedure for the analysis was agreed upon. Team 
members were requested to focus on both the linguistic meaning and on cultural nuances 
during the discussion.  
The analysis was based on the translated transcripts submitted by the two translators in the 
target language, Kinyarwanda, with reference to the source version in English. The consensus 
group analysed all the sections mentioned above, sentence by sentence, and discussed the 
nuances of the words or phrases in order to arrive at the linguistic meaning.  Appropriateness 
with regard to Rwandan culture was also considered. Firstly, every translator had to read the 
sentence, before meeting with the other consensus team to discuss the linguistic meaning of 
the concept.  Discussion and analysis was done phrase by phrase, while comparing the two 
Kinyarwanda versions and also referring to the source, the English version. Consensus teams 
attempted to identify ambiguous or difficult words, or those which were translated differently 
by the translators, and to determine whether they could propose more appropriate alternatives 
to the words chosen. Deliberation continued until all team members were satisfied and in 
agreement about the correct option. Difficult phrases or words, where consensus could not be 
reached, were highlighted for the attention of the backward translators, and a decision was 
taken after backward translation.  
The discussion was recorded. The researcher had to moderate the discussion and notes were 
taken by one physiotherapy lecturer team member. The professional translator assisted in 
transcription of the recorded information and, before producing the final forward version, the 
team member who was taking notes, the transcriber and the researcher met to discuss whether 
all comments had been considered and integrated into the transcript developed during the 
consensus meeting; thereafter, the final forward version was completed.  
The second stage of the analysis was conducted in the second consensus meeting, held after 
backward translation. It went through the same procedure as the first meeting. The consensus 
group met at KHI and consisted of five team members. The meeting lasted for two half days, 
for three hours each day. Once again, analysis took place, by reading one translation after the 
other, sentence by sentence and then analysing phrase by phrase. At this stage, however, a 
comparison was made of the concepts in the two English transcripts produced by the two 
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backward translators and those in the Kinyarwanda version, with reference to the source in 
English. Emphasis was placed on the Kinyarwanda version, with the aim of improving its 
validity and reliability.  Highlighted and difficult words that the previous consensus meeting 
had identified with were given much consideration.  Contentious issues identified in the first 
consensus meeting were raised, and there were a few phrases where consensus could not be 
reached. All these cases were highlighted and kept for analysis and discussion in the third 
consensus meeting.  
The third stage of the analysis was conducted in the third consensus meeting, which took 
place at KHI and lasted for two hours. The meeting involved twelve team members and 
brought together members of the first consensus meeting and those involved in the second 
meeting. The debate focused on the cases highlighted in the second consensus meeting, that 
is, on ambiguous words or phrases where consensus could not be reached. At this stage, the 
first draft of the Kinyarwanda version was completed.  
However, there were few words which remained ambiguous and did not have a definitive 
equivalent in Kinyarwanda. The fourth step of the analysis was performed by a 
multidisciplinary group of health professionals, selected to participate in proof reading 
the text. The transcript was then given to two psychologists, one medical doctor and two 
physiotherapists working in hospital. Ambiguous words were identified words for which we 
had failed to find an agreed interpretation in the three consensus meetings. The problematic 
words/phrases were clarified and, at this stage, definitive Kinyarwanda terms were agreed 
upon and the transcript was ready for the cognitive debriefing interview. The last step 
followed the cognitive debriefing interview. The researcher, the two researcher assistants, the 
physiotherapy lecturer who participated in forward translation and the cognitive debriefing 
interview, and the professional linguist who participated in forward translation finally met to 
discuss and analyse the outcome of the interview. All problems raised were resolved and a 
final translation was produced (Appendix XII). 
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Figure 25: Diagram representing translation procedure and data management 
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6.4.2 Content validity 
The thematic analysis of the Focus Group Discussions was used to identify the impairments 
and functional limitations and the participations restrictions that the participants had 
identified.  These were then tabulated against the corresponding items of the WHODAS 2.0 
and the Impairments Questionnaire. 
6.4.3 Construct validity  
The one-way ANOVA was used to establish convergent validity of the WHODAS 2.0. It was 
not possible to do this with the Impairments Questionnaire. 
6.4.4 Reliability 
Cronbach‘s Alpha was calculated to test for internal consistency of the Impairments 
questionnaire and the WHODAS 2.0. This was calculated for the entire scale and for the 
subsections of the scale. In addition the contribution of each item to the overall correlation 
was examined by calculating the alpha with each item included. If the correlation increased 
once the item was excluded, it implied that the item did not fit well with the construct of the 
domain. 
6.5 Results – Cultural appropriateness and Face validity 
6.5.1 Cultural appropriateness, language equivalence and face validity 
The following section discusses the results of the analysis. As explained above in the analysis 
section, definitive terms were chosen at various stages after consensus had been reached. The 
main aim of the analysis was to capture conceptual equivalents of the English version, but 
there were certain concepts for which, at various stages, consensus could not be reached. This 
was due to changes in the meaning of words between the two languages, and the cross-
cultural challenges that arose. Provincial variations of the Kinyarwanda language were also 
considered, and the choice of one of several possible words (with the same English meaning) 
was sometimes based on the whether the word was commonly used in most of the provinces. 
For example, people in the Northern Province not only share certain specific concepts, but 
their pronunciation also differs. This was taken into consideration during the training of the 
research assistants for the survey (see Chapter Three).   
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6.5.1.1 Face sheet section 
It was noticed that ―complete‖ and ―filling‖ are translated by one word in Kinyarwanda, 
―uzuza‖. 
― F1‖: The respondent identification number (ID), produced discussion and disagreement 
during the forward consensus meeting. Some consensus team members proposed recording 
the respondent identity number (ID), while another group suggested recording the hospital 
code number of the respondent. This was because the use of the ID as the identification 
number would not facilitate easy tracing and identification of the respondent in the hospital. 
It was also indicated in the manual that the respondent‘s or subject‘s identification number 
should simply be recorded.  It was decided that F1 (respondent ID) was to be translated using 
the ARV clinic /hospital code number of the respondent, ―Nomero iranga ubazwa‖. During 
the cognitive debriefing interview, it was observed that every respondent had an 
identification card with an ARV clinic identification number. It was decided to add a code for 
each hospital after the cognitive debriefing interview during the fourth consensus meeting. 
For ―F2‖: interviewer identification number, it was decided that every interviewer should be 
provided with a code number used for identification, particularly during data checking. It was 
translated as, ―nomero iranga ubaza‖.  
―F3‖: the assessment time point, was a source of confusion, and there was no detailed 
explanation in the WHODAS 2.0 manual. After great deal of discussion, it was decided that it 
would be translated as how many times the interview is conducted, ―inshuro ibazwa 
rikoreshejwe‖.  It was decided that the interview date would start the page, so automatically 
―F5‖ replaced ―F4‖. 
The term ―community‖ was difficult to translate as there is no exact concept in Kinyarwanda 
that describes community as it is understood in English. The Kinyarwanda word does not 
have the sense of belonging, as in English; it usually simply denotes a group of people. It was 
translated as ―muryango‖ which means a group of people who share same activities. 
―Muryango‖ can also mean a family. 
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6.5.1.2 Demographic and background information 
Difficulties found in the demographic and background sections arose more from differences 
across culture than from linguistic differences. This section began with instructions.  The 
term ―health condition‖, which is repeated several times in the instructions, was translated in 
each section as ―ndwara/ uburwayi‖, which, in a literal sense in Kinyarwanda, means 
―illness‖ or ―disease‖. There is no precise word for the broader concept of ―health condition‖. 
The two terms (―ndwara” and “uburwayi”) mean the same and were used interchangeably, 
depending on the context. “Ndwara” is more precise and specific to the kind of the disease, 
whereas ―uburwayi” is a more general term used to signify illness or disease.  
There are two words in Kinyarwanda expressing ―being married‖, ―warashatse” and 
―urubaste”, and they both have the same meaning. The forward team consensus opted for 
―urubaste‖, while the backward team consensus chose ―warashatse‖, but, when the two 
teams met, they agreed on ―warashatse‖, which is more commonly and widely used. 
However, being married in the Kinyarwanda culture does not only mean ‗officially married‘, 
or ―warasezeranye imbere y’amategeko” , it can also mean ―traditionally married‖, 
particularly in rural areas, where this entails the involvement of the two families and 
sometimes bride price payment. There are certain cases (similar to cohabiting)  in both rural 
areas and urban areas, where people decide to live together and may have children without 
necessarily having the involvement of their families; with time, eventually these relationships 
become recognised by their specific community. Although the law doesn‘t recognise these 
relationships as it does an official marriage, the couple may subsequently decide to make 
their relationship official.   
―Cohabiting‖ could be expressed in the following phrases in Kinyarwanda: ―kubana 
nk’inshuti, kubana n’undi bitemewe n’ amategeko” or “kubana n’undi mutarasezeranye”. It 
is, however, inappropriate and unacceptable in Kinyarwanda culture. It would be considered 
inappropriate and embarrassing to ask anyone if he or she were cohabiting, and he or she 
would feel very uncomfortable about admitting this. As explained above, cases of 
cohabitation do exist, but most of the time they are recognised as being equivalent to 
marriage. In order to avoid offence, ―cohabiting‖ was translated with the following phrase, 
―Mubana n’undi by’igihe gito”, which means ―living with someone for a short time‖. Guided 
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by the WHODAS 2.0 manual, it was recommended by the team consensus that, during the 
interview, when it came to the marital status question, the interviewer should simply inquire 
about the marital status of the respondent, without reading out the choices in advance, and 
then, based on the response, the interviewer would choose and tick among the options.  
―Work‖ (A4) was first translated as ―Akazi” in Kinyarwanda. However, ―work‖ has two 
possible linguistic meanings in Kinyarwanda, ―Akazi” and ―Imirimo‖. Depending on the 
context in which the concept is used, a distinction can be made between ―Akazi”, which 
generally involves a specific payment, and ―Imirimo”, which is broader and includes ―Akazi” 
as well as other types of activity (paid or unpaid). As the following phrases included broad 
activities, for ―self- employed such as owning your own business or farming‖, and for 
―keeping house/homemaker‖, ―Imirimo” was used. After the cognitive debriefing interview, 
it was agreed to include ―income‖ in the questionnaire because it was observed that 
respondents were more concerned with what they earn than with the work they did. Monthly 
income was included, because in Rwanda, in both public and private institutions, a salary is 
normally a monthly package.  
The question ―How many years in all did you spend studying in school, college or 
university?‖ resulted in an interesting debate in the forward consensus meeting. Discussion 
was focused on whether to retain only ―in school‖ and leave out ―college or university‖, or to 
keep the phrase as it is but inform the interviewer that, in order to avoid offence, during the 
interview it would not be necessary to read out ―college or university‖.  In Rwanda, the level 
of education, particularly in rural areas and among women, is still low, and there are many 
older people who did not go to school, or who dropped out at a primary level. Consequently, 
the question was translated as, ―wamaze imyaka ingahe mu buzima bwi’ishuli?” which means 
―How many years did you spend at school?”.  It was proposed that options regarding the 
level of education should be added before the years spent studying in school, allowing 
respondents to remember the level, and then use that to indicate the years. Options ranging 
from ―never went to school‖ to ―tertiary education‖ were proposed, as these would enable 
respondents to respond appropriately.  
The term ―tertiary education‖ has two meanings in Kinyarwanda, ―Amashuri makuru”, and 
―Kaminuza”. “Amashuri makuru” is the accurate idiomatic equivalant of tertiary education 
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in Kinyarwanda. It was first suggested in the forward consensus meeting, but following 
discussion in the third consensus meeting it was rejected, and ―kaminuza” was chosen as it 
was regarded as the more commonly used and more familiar term to an audience from 
different provinces. ―Kaminuza‖ is possibly preferred by many people because it suggests 
speciality and mastery, which helps to differentiate between secondary and tertiary level 
education. 
 It was suggested during the interview that in the interests of sensitivity, it was preferable to 
avoid repeating the term ―HIV/AIDS‖, and ―uburwayi‖ was recommended instead, which 
means ―health condition‖.    
6.5.1.3 Impairments of body functions 
The section on impairments presented several problems as the respondents were less familiar 
with medical terms.  Translation of the phrase ―impairments of body functions‖ brought 
confusion and stirred a debate in both the forward and backward consensus meetings. There 
is no word or concept which means ―impairment‖ in Kinyarwanda. In forward translation, the 
professional linguistic translator claimed that ―impairments‖ translates as ―Kumerwa nabi‖  
or ―Kumerwa nabi m’ umubiri‖  (the latter if it refers to impairments of body functions; it 
literally means to ―feel bad‖/―feel bad in the body‖,  and can mean ―disease‖). 
On the other hand, the second translator, a physiotherapy lecturer, claimed the correct 
translation was ―kononekara kw’ibice n’imikorere by’umubiri‖, which means ―problems in 
anatomical and physiological function‖. The debate in the forward consensus meeting was on 
finding a tangible concept in Kinyarwanda which positioned ―impairment‖ between ―disease‖ 
and ―disability‖ but which was not overly scientific or medical, and would be clear to the 
audience. One member of the consensus team group was of the opinion that ―impairment‖ in 
Kinyarwanda means ―disability‖, which can be translated as ―ubumuga‖; he indicated that 
there is no difference between ―disability‖ and ―impairment‖ in Kinyarwanda.  Other group 
members disagreed, and suggested that ―impairment‖ was synonymous with ―disease‖ 
(―uburwayi‖).This view was based on different questions under the impairments section, 
which were consequences of the disease rather than of disability.  
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The aim was to find a word or phrase that meant neither ―disease‖ nor ―disability‖, but which 
would include both concepts and be simple enough for respondents to understand. It was 
difficult in Kinyarwanda to find such a word.  The following Kinyarwanda phrase, which is 
simple and short, ―Ibibazo by’umubiri‖, and which literally means ―problems of the body‖, 
was agreed upon by the forward consensus meeting, but this was later rejected by the 
backward consensus meeting, which opted for ―ibibazo by’uburwayi‖ which means ―disease 
problems‖. Finally, in the third consensus meeting, after discussion, the two consensus teams 
agreed on ―ibibazo by’umubiri‖, but proposed to highlight the phrase and the two proposed 
meanings for the medical doctor‘s assessment during proofreading. The doctor subsequently 
agreed with the consensus teams on the meaning of ―ibibazo by’umubiri‖ and agreed that it 
would be understandable for the audience.  
The paragraph of instructions, which is repeated on each page, was more applicable for 
activity and participation, rather than for impairment, so some changes were necessary to 
adjust it for the impairment section. For instance, ―problems or changes in body structure or 
body function‖ was replaced by ―difficulties doing activity‖. It was observed that ―health 
conditions‖, ―disease‖ or ―illness‖ were repeated in the instruction but that they all meant the 
same in Kinyarwada, ―uburwayi/indwara‖; where ―disease‖ and ―illness‖ were found 
together; one word could be used for both concepts. The phrase ―mental or emotional 
problems‖ produced discussion in both consensus meetings. It was translated in the same way 
by both translators in forward translation, ―Ibibazo by’ihungabana‖, which literally means 
psychological ―trauma problems‖. After much debate it was supported by team consensus in 
both the forward and backward consensus meetings. The debate in both meetings was about 
the fact that psychological trauma was a stronger concept than simply emotional problems. It 
was concluded that in Kinyarwanda, ―ihungabana‖ is appropriate when emotional issues are 
linked to health problems. It was also suggested in the third consensus meeting that the 
phrase and its meaning in Kinyarwanda should be highlighted for the psychologist‘s input 
during proof reading. This was supported and accepted by the psychologist, although, he 
explained that ―emotional‖ could have another meaning: it did not necessarily mean ―health 
problems‖. For example ―emotional feelings‖ that could refer to either positive emotional 
feelings or negative emotional feelings, literally translated as ―Amaranga mutima‖ in 
Kinyarwanda, which also means ―sentiment‖. Finally ―ibibazo by’ ihungabana‖ was used.  
 
 
 
 
   285 
 
 
 
The word ―effort‖ was also found in the instructions, and was translated as ―imbaraga‖ in 
Kinyarwanda, which also means ―energy‖ or ―force/power‖. 
There was a difference between the translators when it came to translating the scales 
described in the instructions that are used for each question: ―none, mild, moderate, severe 
and extreme or cannot do‖. The first translator suggested the following:―none‖: ―ntabyo‖; 
―mild‖: ―biroroheje‖; ―moderate‖: ―biringaniye‖; ―severe‖: ―birakomeye‖; ―extreme or 
cannot do‖: ―birenze urugero‖ or ―byarananiranye‖. However, the second translator 
translated as follows: ―none‖: ―Nta na rimwe‖; ―mild‖: ―buhoro‖; ―moderate‖: ―biringaniye‖; 
―severe‖: ―cyane‖; ―extreme or cannot do‖: ―bikabije‖. The consensus team in the first and in 
the second meetings indicated that both sets of words were similar and suggested different 
levels of difficulty. However, the second version was accepted as the suggestions of the first 
translator were very literal and might not be familiar to people in certain provinces.   
Different impairments were described and divided into domains and each domain was 
identified by a particular impairment. The word ―domain‖ was translated as ―ishami‖ in 
Kinyarwanda. 
Domain 1 (D1), which applies to ―mental functions‖ was translated by the phrase, ―imikorere 
yo mu mutwe‖, ―imikorere‖ being ―function‖ and ―mu mutwe‖ being “mental‖. However, 
―mutwe‖ also means ―head‖. The phrase, ―energy and drive function‖ was the first 
impairment listed for mental functions. There was a debate on ―energy and drive‖ in both the 
forward and the backward consensus meetings. The major problem was to consider only 
mental factors, and exclude physical factors, and to find a word or expression that would be 
clear and easy for the audience to understand. The phrase ―Ingufu n’imikoranire y’ibice  
by’umubiri‖ was agreed upon in the forward consensus meeting, and literally means, ―energy 
and body parts functioning‖. The consensus team based their agreement on the idea of brain 
functioning being like that of an engine which makes the body parts move and function. 
However, they realised that the phrase was ambiguous, and they decided to refer it to the 
backward translators for their opinion. The backward consensus meeting preferred 
―Imbaraga n’imikoranire y’ibice by’umubiri‖, where ―Imbaraga‖ is used for ―energy‖, 
instead of ―Ingufu‖; as it was thought that Ingufu was jargon and a rather abstract word. The 
consensus team was still not fully satisfied with this expression, as they felt it was 
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linguistically and conceptually imprecise. A final, more acceptable and simpler phrase was 
found by the psychologists. It was agreed that ―Imbaraga nu’mwete‖ would be appropriate, 
as it means the ―energy and courage and the will to do something‖. 
Another word/phrase in this domain which brought about confusion was ―emotional 
functions‖. The problem was due to the contrast between what was understood as the 
meaning of ―emotional problems‖ in the instructions paragraph, and what both translators 
produced as a translation of ―emotional functions‖, namely “Kwakira ibikubayeho‖, which 
literally means ―how someone deals with or manages what affects him or her‖. In fact, the 
difference arose because the previous phrase consisted of the words ―emotional and 
problems‖, while the second instead included ―emotional and functions‖. This last phrase has 
a more general meaning, while ―emotional problems‖ means simply when ―something goes 
wrong with the emotional function‖.  The two words,―problem‖ and ―function‖, influenced 
the choice of the translation.  
After discussion, the team in the forward consensus meeting agreed and supported the 
translators. They understood that emotional functions are general in nature, involving all the 
emotional issues, and how one manages or deals with feelings in general can have a large 
impact on one‘s life. 
 ―Haematological system functions‖ was translated as ―ibigize amaraso‖ with the support of 
the medical doctor during proofreading; it literally means ―blood compositions‖. During the 
cognitive debriefing interview, the concept seemed to be a bit complicated. It was understood 
by the majority of respondents to refer to ―anaemia‖, which translates as ―kugira amaraso 
make‖, whereas ―blood pressure‖, translated literally as ―umuvuduko w’amaraso‖, was very 
familiar to the respondents. ―Immunological system functions‖ translated as 
―ubudahangarwa bw’umburi‖, meaning ―body protectors‖; this was quickly understood 
during the cognitive debriefing interview to refer to a ―CD4 count‖; the respondents were 
very concerned with changes to CD4 and how these could affect their health.  
―Digestive functions‖ was translated as ―igogorwa ry’ibiryo‖. During the cognitive interview, 
it was observed that respondents would explain only the digestive process in the stomach and 
the intestine, and would forget that the digestive process begins in the mouth. Instead, 
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problems relating to the mouth were mentioned in relation to ―tolerance to food‖. For 
instance, some respondents complained about an inability to chew and swallow food due to 
wounds in the mouth.  Another difficult word found while describing impairments of the 
digestive function was ―tolerance to food‖, translated by the first translator as ―kubasha 
ibiryo‖, meaning ―managing food‖, and by the second translator as ―kuyobokwa ibiryo‖, 
meaning to ―tolerate food‖. After discussion, the consensus team decided to keep both 
concepts, ―kubasha‖ and ―kuyobokwa‖, in addition to ibiryo which means ―food‖.  The 
implication was that ―tolerance to food‖ means that one is able to manage food, so that, for 
instance, one has an appetite and at the same time one tolerates food and does not have any 
adverse reaction to food. Finally, ―kubasha no kuyobokwa n’ibiryo‖ was the phrase chosen.  
―Regularity of menstrual cycle‖was translated in Kinyarwanda as ―ukudahinduka kw’ibihe 
by’imihango‖, which means ―no changes in menstrual periods or cycle‖, and this was agreed 
upon in the forward consensus meeting. However, there were objections in the backward 
consensus meeting, and ―ukudahinduka kw’iminsi y’imihango‖, meaning ―no changes in 
menstrual days‖, was agreed upon by both teams during the third consensus meeting.  This 
was supported by the medical doctor during proofreading, who indicated that it is the most 
widely used phrase. 
―Muscle power‖ was translated similarly by the two first translators as ―Imbaraga 
z’imitsi/z’imikaya‖. The two terms mean exactly the same thing but ―imitsi‖ is more 
frequently used in many provinces. Both consensus team groups (forward and backward) 
supported the translators but were concerned with the concept ―imitsi‖, which can also mean 
―well nerves and vessels‖. This could produce confusion during the subjective physiotherapy 
assessment. 
The following terms, ―system‖, ―function‖ and ―sensation‖, were frequently used with other 
concepts in this impairment section. A general comment regarding those words was that, 
when aiming at a conceptual and concrete meaning of the word/phrase in Kinyarwanda, these 
words were found to be very broad and abstract, and were sometimes excluded to avoid 
changing the meaning or confusing the audience. ―System‖ and ―function‖ were only used in 
domains and were generally excluded when describing impairments in each domain. 
―System‖ was translated as ―urwungano‖ and ―function‖ as ―imikorere‖, which also means 
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―activities‖. In the forward consensus meeting, ―imikorere‖ was excluded in certain domains 
such as ―sensory functions and pain‖, and ―functions of cardiovascular and respiratory 
systems‖. However, the backward consensus team recommended that it be included simply to 
have a complete phrase and not for the sake of any additional linguistic meaning. 
There is no single general meaning for the word ―sensation‖ in Kinyarwanda.  Its meaning 
depends on the context in which it is used and sometimes it is excluded. ―Imyumvire‖, which 
means ―sensation‖ in one context, might mean ―understanding‖ in another context.  The only 
situation in which it is commonly used and has a concrete meaning, is in the sense of 
touching or physical feeling, and it was included here.  ―Sensation related to the skin‖, 
―imyumvire idasanzwe y’uruhu‖, literally means ―unusual sensation of the skin‖. However, 
for other impairments the word ―sensation‖ was excluded. For example, ―sensation of 
nausea‖ was translated as ―kugira sesemi‖, which literally means ―to have nausea” and 
―sensation associated with the digestive system‖ was translated as ―kugubwa nabi mu nda‖, 
meaning ―feeling an upset stomach/stomach full of gas‖.  
During the debriefing interview, it was realised that there were certain questions on 
reproductive functions which were not appropriate for men, such as ―menstruation function‖, 
translated as ―kujya mu mihango‖, so a decision was made during the last consensus meeting 
to add ―not applicable‖ (NA) to the scale.  
6.5.1.4 Activity limitations and participation restrictions 
 As mentioned previously, the researcher decided to give the title of ―activity limitations and 
participation restrictions‖ to the second part of the instrument, which includes the WHODAS 
2.0 domains. The first translator in forward translation translated ―activity limitations and 
participation restrictions‖ as ―aho ibikorwa n’ubwitabire bigarukira‖, literally meaning 
―where activities and participation are limited‖, whereas the second translator translated it as 
―Ingorane mu mikorere no m’ubwitabire‖, which literally means, ―difficulties/problems or 
limitations in activities and participation‖. 
 The consensus team was concerned with the appropriateness of the two meanings, and 
realised that the phrase would sound better if reference were made to a person having 
difficulties in performing certain actions in his or her everyday life. The phrase in 
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Kinyarwanda was therefore changed to ―Ingorane mu mikorere yawe n’ubwitabire mu 
bikorwa mu buzima busanzwe‖, which literally means, ―difficulties/problems or limitations in 
your activities and participation in daily life‖. This was also supported by the backward 
consensus team. 
 ―Activities and participations‖ was divided into domains. The term ―cognition‖ (domain 1), 
was translated by the first translator in forward translation as ―ibijyana n’ubwenge‖, which 
literally means ―regarding intelligence‖, while the second translator translated it as 
―ubwenge‖, which means ―intelligence‖. The consensus team recommended that the phrase 
―ubwenge n’ubumenyi‖, meaning ―intelligence and knowledge‖, be used, based on what is 
described in the WHODAS 2.0 manual: “the domain asks questions about communication 
and thinking activities”.  It was concluded that in Kinyarwanda the word ―ubwenge‖ alone 
did not adequately reflect the meaning of ―cognition‖. In addition, culturally, a person is 
recognised as intelligent when he is able to express and to defend his intelligence and this 
requires knowledge. The phrase ―ubwenge n’ubumenyi‖ was chosen by team consensus in the 
second meeting. 
There was an interesting debate regarding the phrase ―understanding and communicating‖ in 
the first consensus meeting. The first translator‘s translation was ―gusobanukirwa no 
kuvugana n’abandi‖, where ―gusobanukirwa‖ means ―comprehension‖, and ―kuvugana 
n’abandi‖ means ―communicating with others‖. However, in some contexts, the word 
―gusobanukirwa‖ can also be used to mean ―understanding‖ or even ―conception‖. The 
second translator suggested ―bijyanye n’imyumvire n’imivuganire‖, ―bijyanye n’imyumvire‖ 
means ―regarding understanding‖, and ―n’ imivuganire‖ means ―communication‖. The 
concern was that in Kinyarwanda, if you have understood in the context of cognition, then 
you know and you are able to explain what you have understood. After a long discussion, 
assessment of the items listed under ―understanding and communication‖ and based on the 
description in the manual: ―communication and thinking activities‖, the following phrase was 
chosen by the consensus team, ―gusobanukirwa, gusobanura, kumvikana n’abandi‖. This  
literally means ―comprehension or understanding, explanation and 
understanding/communication between people for effective communication‖. The consensus 
team in the backward consensus meeting was satisfied with this. 
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―Concentrating on doing something for ten minutes‖ was translated by the first translator as 
―gushira ingufu mu gukora ikintu mu minota icumi‖, meaning ―put effort in doing an activity 
in ten minutes‖, and by the second translator as ―kumara iminota cumi ukora‖, which means 
―spend ten minutes doing something‖.. The consensus team in the forward consensus meeting 
criticised both meanings as they were more oriented towards physical-functions while this 
section was focused on mental functions, and the word ―concentration‖ was seen as the most 
important. After discussion, they produced the following translation, ―kumara iminota cumi 
ukora ushishikaye‖, which means, ―spend ten minutes doing something while you 
concentrate‖.  
There was a disparity between the forward and the backward consensus meetings regarding 
the word ―finding‖ in the phrase ―analysing and finding solutions to problems in day to day 
life‖. This was first translated as ―kuvumbura‖, which means ―to discover‖. The backward 
consensus recommended a more literal translation of ―finding‖, which is ―kubona‖. This is 
more concise and convenient, and was adopted in the third consensus meeting.  
The phrase‖ learning a new task, for example learning how to get to a new place‖ was 
translated literally as ―kwiga igikorwa gisha‖, meaning ―to learn a new task‖ , and ―uregero 
kwiga ukuntu wagera ahantu utari uzi‖, meaning ―for example learning how to get to a new 
place‖. This produced confusion during the debriefing interview, particularly with regard to 
the example, ―learning to get to a new place‖. The respondents found the example rather 
inappropriate as they regarded themselves as being mentally normal and as being able to 
learn how to get to a new place. Instead, they were more concerned with learning a new 
task/activity, such as a new job.  It was decided during the consensus meeting, after the 
debriefing interview, to not use the example and to only inquire about difficulties experienced 
in learning a new task.  
The term ―mobility‖ (domain 2) produced an interesting debate in the forward consensus 
meeting. The first translator‘s translation was, ―kwinyagambura/kunyeganyega‖, which 
means ―moving the body‖, while the second translator‘s translation was, ―kugendagenda‖, 
meaning; ―moving around or walking around‖. There was no consensus in the first meeting 
as to which translation to adopt, and the consensus team highlighted the two concepts for the 
backward translators‘ input. During the backward consensus meeting, following analysis of 
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the items in the mobility domain and their description in the manual, it was decided to keep 
both ―kunyeganyega‖ and ―kugendagenda‖, and an observation was made by the two 
physiotherapists, in the proofreading process, that there was no specific word which means 
―mobility‖ in Kinyarwanda.  
It was decided after the debriefing interview to include examples for the phrase ―moving 
around inside your home‖, meaning in Kinyarwanda, ―kugendagenda mu rugo‖, such as 
―moving from your bedroom to the bathroom‖, and ―from bedroom to the toilet‖, because, 
without examples, respondents did not grasp the tangible meaning and the context in which 
the action is done.  
The word ―eating‖ in the ―self-care activities‖ section has no single meaning in Kinyarwanda. 
It translates as, ―kurya‖, "gufungura‖, ―kwigaburira‖ and ―kwitamika‖, and the meaning 
sometimes depends on the context and the province in which the word is used.  ―Kurya‖ is 
normally the direct and literal translation of ―eating‖. ―Gufungura‖ means the same as 
―kurya‖, but it is more polite. It is common in Rwanda‘s culture to have words that show 
more respect than others while conveying the same meaning. ―Kwigaburira‖ and 
―kwitamika‖ both indicate somebody‘s ―ability of doing the action of eating‖. However 
―kwigaburira‖ could also mean ―being able to provide food for yourself‖, so it might involve 
socio-economic status. 
 The first forward translator chose ―gufungura/kurya‖, whereas the second translator 
preferred ―kwigaburira‖. In the first consensus meeting, it was agreed to keep 
―kwigaburira/kwitamika‖ with regard to the ability of performing the eating activity in self-
care activities. However, in the second consensus meeting, ―kwigaburira‖ was rejected on the 
grounds that it was very broad, and it was proposed to keep only ―kwitamika‖, which 
specifies the ―action of being able to put food into the mouth‖. In the third consensus, which 
brought the two consensus groups together, after consulting the explanation in the manual, it 
was agreed to keep the two concepts, ―kwigaburira‖ and ―kwitamika‖, for both generalisation 
and specificity. This was also supported and recommended by the two physiotherapists 
during proofreading. 
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The phrase ―dealing with people you do not know‖ in the ―getting along with people 
domain‖, was given the translation ―kubana n’abantu utazi‖ in the first consensus meeting, 
which literally means ―living with people who don‘t know‖. This was not accepted in the 
backward consensus meeting. Based on the description given in the manual, 
―kumvikana/gusabana n’abantu utazi‖, it was suggested, meant ―getting along and interacting 
with people you don‘t know‖.  This was then adopted, as it was explicit and concise. 
The term ―household‖, translated as ―mu rugo‖, has other meanings in Kinyarwanda. It can 
also mean ―at home‖ and ―family‖. In forward translation, the phrase ―doing your most 
important household tasks well‖ was translated by both translators as ―gukora neza imirimo 
ushinzwe‖, which literally means ―doing activities/tasks which are under your responsibility 
well‖, and this was accepted by the consensus team. However, the backward consensus 
meeting was concerned that ―most important‖ and ―household‖ were not included in the 
phrase.  The team suggested the following translation: ―gukora neza imirimo yawe y’ingenzi 
yo mu rugo‖, which means ―doing your important household activities/tasks well‖, and this 
was adopted in the third consensus meeting. 
With regard to the phrase, ―getting all the household work done that you needed to do‖, the 
forward translators as well the consensus team agreed that the translation should be 
―kurangiza imirimo yo murugo yose n’kuko byakagombye‖, which literally means ―getting 
your household work done as it is needed‖. However, the backward consensus team found 
that there was a problem with ―n’kuko byakagombye‖, which literally means ―as it is needed‖ 
or ―supposed to be‖, and not exactly ―as you needed to do‖ or ―as you would like it to be‖, 
which translates as ―n’kuko wabyifuzaga‖ and involves the self-appreciation of the person 
who is doing the activities. The phrase was then adapted to ―kurangiza imirimo yo murogo 
yose n’kuko wabyifuzaga‖ and this was adopted in the third consensus meeting. The 
expression ―getting your household work done as quickly as needed‖, was translated literally 
in the forward translation and the consensus team agreed upon ―kurangiza imirimo yo 
murogo vuba n’kuko byakagombye‖. The backward consensus team recommended ―n’kuko 
bikwiye‖ instead of ―n’kuko byakagombe‖, and indicated that both meant ―as needed‖, but 
that ―n’kuko bikwiye‖ was more courteous and appropriate. 
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The word ―school‖ literally means ―ishuli‖ in Kinyarwanda when it indicates a school as a 
place of studying. It changes its meaning when it involves school activities and one of the 
following terms is used: either ―imirimo yo ku ishuli‖ or ―amasomo‖, but ―amasomo‖ can 
also mean ―courses‖, ―modules‖ or ―subjects‖. For school activities, both ―imirimo yo ku 
ishuli‖ and ―amasomo‖ were used. 
6.5.2 Content validity  
The cross tabulation of the items in the two questionnaires that were specifically mentioned 
in the focus group discussion indicate that the majority were represented in both the 
questionnaires and the FG discussions. 
Table 30: Items in the Impairments questionnaire that were referred to during the Focus 
Group Discussions 
Questionnaire  Focus Group 
Energy and 
drive 
X They used the words lack of energy (kubura imbaraga) 
Sleep   
Memory X I can tell you how the medicines have caused much memory loss!  
Emotional  X I had an idea of committing suicide because of unhappiness 
Body Image X After some time, my legs, arms and buttocks got thinner, the face and 
the belly swelled.   
Pain X Ah I feel much pain.  
Heart X The heart pumps fast.  
Blood 
Pressure 
  
Haematologial   
Immune 
system 
X HIV status 
Respiratory X Cough, breathlessness,  
Fatigue X They used the words….. tiredness or fatigue (umunaniro),  
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Digestive X I always suffer from abdominal pain.  
Tolerance to 
food 
X Complained of altered tolerance to food 
Defecation   
Weight 
maintenance 
X I am getting thinner  
Sensations 
associated 
with digestive 
tract 
  
Sensation of 
nausea 
X : Even for..nausea, …., they prescribe us medicines but we are not 
cured 
Metabolic 
functions 
  
Fat 
metabolism 
  
Endocrine    
Sexual  X Don’t mention about sexual relationship! The desire is not there, I am 
not motivated and my husband is always weak.  
Menstruation   
Regularity of 
the menstrual 
cycle 
  
Genital and 
reproductive 
functions 
X My husband always wishes he had a child, but it may cause me 
problems 
Discomfort 
with sexual 
intercourse 
X After being infected with HIV, I was about to vomit just after looking at 
any man  
Muscle power X In general, I feel [I am] getting weaker and weaker.  
Joint mobility   
Skin functions X skin hardening 
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Skin sensation X I feel paraesthesia in the legs with pins and needles in the hips 
Missing items   
Dizzyness  I very often feel dizzy when I am standing. 
Visual 
problems 
 Now it has left me with eye problems [and] they have decided to give 
me a transfer to the ophthalmology service 
 
 
Nineteen of the thirty items (63%) were referred to, either obliquely or directly. Dizzyness 
and visual problems were the two impairments which were mentioned by the participants but 
which were not included in the questionnaire. 
Table 31: Items in the WHODAS 2.0 that were referred to during the Focus Group 
Discussions 
WHODAS 2.0 Focus Group 
Concentration X I think the… lack of concentration I am experiencing are 
caused by those medicines  
Remembering X I can tell you how the medicines have caused much 
memory loss!  
Analysing   
Learning   
Understanding   
Conversation    
Standing for long periods X I have difficulties with standing for a long time  
Sitting to standing   
Moving around the home X Sometimes I am unable to walk.  
Getting out of the home X  
Walking a long distance X : I have difficulties with standing for a long time as well as 
to walk a long distance,  
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Washing   
Dressing X even wearing shoes has become difficult for me. 
Eating   
Staying alone   
Dealing with unknown 
people 
  
Maintaining a friendship X Because of the body weakness, we are not able to visit 
friends 
Getting along with people 
close to you 
X In my family, they really pay much attention, very much 
New friends   
Sexual activities X Since I have known that I am HIV-positive, sexual 
relations with my wife have become difficult.  
Household responsibilities X I could fetch water, but I cannot any longer 
Household tasks well  X This has caused shortcomings at my work. 
Completing household 
tasks 
X My daily productivity has significantly reduced! 
Housework done quickly   
Day to day work X The household activities, farming, and even carrying 
heavy luggage, are all difficult for me because I always 
feel weak 
Work well X  I am saying this because I was a very good assistant 
builder! And for sure my performance has been reduced! 
Work completed X  I only work before noon. 
Work tasks quickly X None can work as before because the strength is reduced. 
Joining community 
activities 
X Because of that, I do not visit people any longer  
Barriers in world around X We don’t disclose because we are afraid of being 
stigmatized! 
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Living with dignity  X They really showed negative attitude towards my status, 
they were even unable to come near me 
Time spent on health 
condition 
X but again there is a time, the transfer is to go through 
normal channel, which is from outpatient service then to 
specialists; this last option takes time!” 
Emotional effect of health 
condition 
 I had an idea of committing suicide because of 
unhappiness 
Drain on financial 
resources 
X After getting better, I had no capital  
Problem to the family X Can you imagine, even my father used to tell me that I am 
a dead person 
Relaxation/pleasure X I was a football player...Now, I gave up playing.  
Missing   
Stair climbing 
 
 
 I hardly breathe when climbing up stairs 
Spiritual activity  When I feel like having strength, I manage to go to church 
and the preaching makes  me stronger and motivated 
 
Comments relating to 24 out of the 31 items could be mapped to a corresponding item 
(77.5%). Stair climbing and spiritual activity were mentioned by several respondents but 
were not represented in the transcripts. 
6.5.3 Construct validity – Convergent validity 
The following graphs indicate that there was a significant difference between the means of 
the relevant domain of respondents scoring different levels of the impairment scales. In every 
case the ANOVA indicated that there was a significant difference between the means and as 
the plots indicate, the scores were higher (indicating poorer functioning) as the impairment 
level increased. In the case of the Life Activities, the categories indicate increasing levels of 
income and the score thus decreased as the categories increased. 
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F=87.4, p<.001 
Figure 26: The mean scores of the Cognition domain for each level of the memory 
impairment. 
 
F= 51.1, p<.001 
Figure 27: The mean scores of the Mobility domain for each level of the mobility impairment  
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F= 14.9, p<.001 
Figure 28: The mean scores of the Self care domain for each level of the Muscle Power 
impairment item 
 
 
F= 12.1, p<.001 (Note that there were only two respondents with a 5 and these were 
excluded) 
Figure 29: The mean scores of the Getting Along with people domain for each level of the 
Emotional functioning impairment item 
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F= 1.2, p=.151 (Note that there were only two respondents with a 4 and these were excluded). 
Higher domain scores denote more limitation and higher Income categories indicate better 
income). 
Figure 30: The mean scores of the Life Activities  domain for each level of Income.  
 
F=25.2, p<.001 
 (Note that there were only two respondents with a 4 and these were excluded 
Figure 31: The mean scores of the Participation domain for each level of the Energy and 
Drive impairment item 
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6.5.4 Reliability 
6.5.4.1 Testing internal consistency 
The Impairments Questionnaire yielded a Cronbach‘s Alpha score of .85, with no item 
pulling the scale down. This falls within the good category of reliability, as did the 
WHODAS domains of Understanding and Communication (.872, six items); Moving around 
(.840, five items); Life activities (.947, seven items) and Participation (.829, eight items). As 
the value fell below acceptable levels in the domains of Self-care (.204, four items), and 
Getting along with people (.543 five items), these domains were subjected to further analysis. 
6.5.4.2 Self-care 
Table 16 shows that in Self-care, the item ‗staying alone‘ was the least correlated and, if 
deleted, the Cronbach‘s Alpha increased considerably.  
 Table 32: Internal consistency of the self-care section of the WHODAS 2.0 (n=502) 
 Scale mean if 
item deleted 
Scale 
variance if 
item deleted 
Corrected item-
Total correlation 
Cronbach's 
Alpha if item 
deleted 
Washing whole body 6.39 2.793 0.236 0.071 
Getting dressed 6.46 3.031 0.305 0.103 
Eating 6.50 3.300 0.234 0.185 
Staying by yourself 
for a few days 
3.17 0.668 0.085 0.688 
 
6.5.4.3 Getting along 
Table 17 shows that no single item was identified in the ‗Getting along with people‘ domain 
that threatened the internal consistency of this domain. However, as noted above, Cronbach‘s 
Alpha was low. 
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Table 33: The internal consistency of the getting along with people section of the WHODAS 
2.0 (n=502) 
 Scale mean 
if item 
deleted 
Scale variance 
if item deleted 
Corrected Item-
Total correlation 
Cronbach's Alpha if 
item deleted 
Dealing with people you do 
not know 
9.02 13.802 .356 .478 
Maintaining a friendship 8.70 11.873 .481 .396 
Getting along with people 
who are close to you 
8.83 13.281 .331 .480 
Making new friends 8.31 10.825 .435 .401 
Sexual activities 7.13 12.032 .106 .674 
 
The Cronbach‘s Alpha value for the whole scale was 0.933 (35 items) which is regarded as 
representing excellent internal consistency.  
Table 34: The internal consistency of the impairments questionnaire and WHODAS 2.0 
(n=502) 
Cronbach's Alpha Internal consistency 
α ≥ 0.9 Excellent 
0.8 ≤ α < 0.9 Good 
0.7 ≤ α < 0.8 Acceptable 
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0.6 ≤ α < 0.7 Questionable 
0.5 ≤ α < 0.6 Poor 
α < 0.5 Unacceptable 
(Wikepedia, 2013) 
6.6 Discussion  
The WHODAS 2.0 and the impairments of body functions questionnaire were translated by a 
group of people whose mother tongue was Kinyarwanda, and who were all fluent in English, 
with an aim of developing an instrument in the target language (Kinyarwanda) which would 
be linguistically and conceptually equivalent to the source language version (English). The 
requirement was that it would be used to collect valid data across cultures and countries 
regarding impairments, activity limitations and participation restrictions among PLWH. The 
final instrument appeared to meet these requirements.  The process highlighted problems with 
cross-cultural translation, specifically with requirements related to cultural sensitivity, 
contextual factors and linguistic issues (such as a lack of equivalent words in the target 
language), in some cases several words had the same meaning as the words or phrases used in 
the source language. This brief discussion will consider the process and the problematic 
concepts identified during the translation. 
6.6.1 Translation process  
All the translators were Rwandese in origin and were fluent in English, but they came from 
different educational backgrounds. Thus, they were familiar with both the culture and the 
languages of Rwanda. Bringing together translators with similar linguistic backgrounds and 
with experience in translation, and including others with rehabilitation/disability backgrounds 
and with experience in disability and HIV research, provided for a rich diversity of 
experiences and skills, and produced interesting and constructive debate during consensus 
meetings and analysis. The input of the rehabilitation multi-disciplinary team in proofreading 
also proved very valuable and assisted in attaining a clear understanding of some more 
abstract and difficult concepts or words.  The testing of the questions on the target population 
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provided for the inclusion of lay people‘s opinions with regard to clarity, effectiveness and 
the definitive meaning of the items.   
6.6.2 Tension between literal translations and cultural contexts 
 The issue of culture applicability in the Kinyarwanda language is complex and could affect 
conceptual equivalence. An example of this is the difficulty of finding a translation for 
―cohabitation‖ (discussed above). Cohabitation as a practice actually exists in the country, but 
because it is not accepted by the Rwandese culture, it was impossible to find an appropriate 
or equivalent term. Similarly, in isiXhosa, one of the indigenous languages in South Africa, 
cohabitation was found to be difficult to translate appropriately for similar reasons: it is not 
acceptable in Xhosa culture for a man and a woman to live together while they are not 
recognised as being traditionally married. Marriage involves mutual understanding between 
two families and payment of the dowry (Toni, 2007). 
In another African country, Tanzania, the SF-36 health survey was translated from English to 
the Kiswahili language, which is regarded as the indigenous language for the whole 
Tanzanian population. It was observed that most of the concepts related to physical 
functioning, for example, ―pushing a vacuum cleaner, playing golf‖, had to be changed to 
expressions such as ―drawing water‖, ―washing clothes‖ and ―carrying a baby‖, activities that 
were familiar to the target population, in order to make sense within  the Tanzanian  culture.  
The activity of climbing a ―flight of stairs‖ resulted in debate simply because many 
Tanzanians traditionally do not climb stairs. Translators had to think carefully and search for 
another word to translate the activity of climbing and to produce a phrase that could convey 
the meaning of ―climbing a flight of stairs‖. Finally they decided to use a word “Mulima‖, 
which literally means ―hills‖.  Apart from issues related to physical functioning, other 
concerns arose, such as the appropriate time frame considered for judging a person‘s health 
status. In the SF-36 source instrument, it was to recommend that one should think back ―for 
the past four weeks‖. However, translators preferred to use the word ―Mwezi‖, which literally 
means ―a month‖, but can also signify ―the moon‖.  The reason why the term “Mwezi” was 
chosen was because translators believed people in Tanzania routinely think in terms of a 
month for the purposes of forward planning (Wagner et al., 1999). It is possible that other 
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African countries might encounter similar problems with cultural influence when translating 
research instruments into their indigenous languages. 
In some Asian countries as well, cultural influence was found to be a factor in the translation 
of other health measurement instruments. For example, The World Health Organisation 
Quality of Life (WHOQoL-BREF) was translated from English to Malayalam, one of the 
Indian languages, and it was shown that conceptual equivalence of certain words or phrases 
was difficult to achieve due to cultural influence.  For instance, it was difficult to retain the 
expression, ―Are you able to accept your bodily appearance?‖ simply because Indian culture 
does not consider place much importance on the physical appearance. Translation of the item, 
―Sex life‖, was also problematic. Translators thought that it might be insensitive to ask people 
who had lost their recognised partners,  or people who were advanced in age, if they had been 
involved in sexual activity (Menon, Cherkil, Aswathy, Unnikrishnan, & Rajani, 2012).  
In Korea when translating an instrument developed to assess disability of the upper 
extremities, ―Disabilities of arm, shoulder and hand (DASH)‖, various items lacked 
corresponding words/concepts in the Korean language because they were not recognised in 
the Korean culture. For example, a ―jar‖ could literally be translated into the Korean language 
as “dan-ji”, but because the “dan-ji” in the traditional Korean culture has a different shape 
from a jar, it was difficult and it took time to explain that a jar could mean “dan-ji” (Lee, 
2008).  In the same group, cultural sensitivity was associated with gender roles in the 
traditional society.  For example, the term, ―prepare a meal‖, was not appropriate for a group 
of older males because in Korea, traditionally, cooking is the responsibility of women and not 
men (Lee. 2008).   
6.6.3 Problems with translation of some specific concepts 
English is a rich and very explicit language, and allows for generalisation while at the same 
time ensuring specificity and precision.  Kinyarwanda is also rich, but very complex in that 
you may find that one word in English may have two, three or more different meanings in 
Kinyarwanda, depending on the population‘s characteristics and background, the context in 
which the word is used, and the region in which the word is used. Sometimes the exact word 
to express the equivalent meaning is lacking. Several problems were encountered while 
trying to achieve linguistic and conceptual equivalence.  
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For instance, it was difficult to find an exact word in Kinyarwanda that means ―community‖, 
a word that conveys a sense of belonging (in English). The Kinyarwanda word literally 
signifies a group of people. Community was translated as “Muryango”, which means ―a 
group people who share the same activities‖. But “Muryango” can also mean ―a family‖. 
Similarly the word ―work‖ was found to have two linguistic meanings in Kinyarwanda and 
both meanings are commonly used. Firstly, “Akazi” is used where a specific payment is 
made; secondly, “Imirimo‖, includes all types of activities (paid and unpaid) in which one 
may be involved. “Imirimo‖ was used and found to be appropriate because of its broader 
connotations. In contrast, during translation of an ICF checklist into isiXhosa, for the term 
―work‖, translators preferred to use the word “phangela” which means ―paid work‖ instead 
of “uyasenbeza” which is more general and involves other types of activity which are not 
necessarily paid (Toni, 2007). 
Translation of the phrase ―impairments of body functions‖ was problematic, primarily 
because of the translators‘ consideration of the background of the target population or 
audience. Secondly, there was a debate about whether to classify ―impairment‖ as a disease 
or a disability. After much discussion, it was agreed that a simple word or concept which 
included both meanings, should be found, provided that it was not a specialised medical term. 
Finally, ―Ibibazo by’umubiri”, which literally means ―problems of the body‖, was agreed 
upon. In his study, Toni (2007) indicated that in isiXhosa, one cannot differentiate 
impairment from disability. He declared that it was difficult to find words or concepts that 
mean ―disability‖ in isiXhosa; during translation of the ICF checklist, the translators agreed 
to use “ukhubazeko”, a Nguni word commonly used in isiZulu. The word ―disability‖ in 
Kinyarwanda is linguistically specific and precise: “ubumuga”. 
 There was a major problem in finding a specific equivalent of the phrase ―emotional 
problems‖ in Kinyarwanda. After a lengthy debate and much disagreement, it was agreed to 
use the expression “Ibibazo by’ihungabana”as a translation; this literally means 
―psychological trauma problems‖. However, it was observed that the meaning of the word 
―emotional‖ always depends on the context in which the word is used. For example, it was 
found that the word ―emotional‖, when it is not related to a health problem, could have 
another meaning. The concept of ―emotional problems‖ also provoked discussion during 
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translation of the SF-36 Health survey from English to Kiswahili. Translators could not find 
an exact equivalent for ―emotional problems‖ in Kiswahili. They decided to use “mawazo 
mengi”, which literally translates the English concept ―many thoughts‖ (Wagner, et al., 
1999). 
It was found that there was no one specific linguistic or conceptual equivalent for the term 
―mobility‖ in Kinyarwanda, as the whole activity of moving. After several discussions and 
after consulting of the WHODAS 2.0 manual, it was decided to use two terms, 
―kunyeganyega”, which literally means ―moving the body‖, and “kugendagenda”, which 
means ―moving around or walking around‖. This was important to ensure that the full 
meaning of the term ―mobility‖, as it is described in the manual, was retained. Similarly, 
when translating the ICF checklist to isiXhosa, translators chose the concept “Intshukumo 
nemo yokuhamba”, because it literally means ―moving the entire body‖ and not only the 
limbs (Toni, 2007).  Surprisingly, during the translation of the EQ-5D from English to 
isiXhosa, after discussing many options, the translators decided to use the term “ukuhamba”, 
which literally means ―to walk‖, but also could also mean ―moving from one place to 
another‖(Mkoka, Vaughan, Wylie, Yelland, & Jelsma, 2008).  
It was indicated that during translation of WHOQoL-BREF from English to Malayalam, it 
was difficult to find the equivalents of certain expressions, such as ―blue mood‖, ―How safe 
do you feel in your daily life‖ and the activity of ―getting around‖, which is  part of what is 
meant by ―mobility‖. Translators had to find concepts which expressed more or-less the same 
meaning (Menon, et al., 2012). 
Other important words in this study which were difficult to translate were ―sensation‖ and 
―eating‖. It was difficult to find a single equivalent for the word ―sensation‖ in Kinyarwanda.  
Its meaning depends on the context in which it is used. It has a clear and concrete meaning 
only when it is related to physical feeling, for instance, when touching the skin. The word 
―eating‖ also has no single meaning in Kinyarwanda. Its meaning depends on the context and 
in which province the word is used. 
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6.6.4 Content validity 
The mapping of the comments of the respondents to the different items in the two instruments 
indicated that most of the domains were relevant to this group of PLWH. The items related to 
homeostatis such as metabolism and blood pressure were not mentioned by this group, and 
neither were functions related to menstruation. The WHODAS  2.0  performed better with 
more than three quarters of the items represented in the responses.  It appears that the more 
severe items, specifically to do with eating and self-care are not a problem in this group.  This 
is likely to be as a result of the ARV medication preventing the development of full blown 
AIDS with the corresponding severe functional loss. It is suggested that the WHODAS 2.0 
demonstrates acceptable content validity but that items relating to stair climbing and 
spirituality be included (albeit that spirituality can be regarded as a personal factor within the 
ICF, it was clearly of great importance to the respondents). 
6.6.5 Construct validity 
The WHODAS 2.0 demonstrated good construct validity in that in almost every case the 
domain scores increased with each level of impairment. Although it was not possible to 
assess divergent validity as there was a strong relationship between the items and those who 
were more affected scored worse in both instruments, it was clear that those domains which 
were more directly associated with the impairment chosen had higher F values (such as 
Cognition domain and Memory impairment, F=87.4, Mobility domain and Mobility 
impairment F=51.1) compared to those with a less strong intuitive link (such as the Getting 
Along with People domain and Emotional impairment, F=12.1). The lack of significance in 
the means of the different income categories is likely to be due to the small number of 
respondents who reported anything other than a 2 level (18 compared to 410 in category 2). It 
would appear that the convergent construct validity of the WHODAS 2.0 was acceptable. 
6.6.6 Internal consistency and reliability of the WHODAS 2.0 
Internal consistency and reliability of the responses for the questions related to activity 
limitations and the participation/social restriction domains assessed under WHODAS 2.0 
scale and for the whole scale were obtained. The Cronbach‘s Alpha for the Impairments 
Questionnaire was good and it can be concluded that the internal consistency and reliability 
are acceptable within this context. The Alpha of the whole WHODAS 2.0 scale was very 
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high with a score of 0 .933, which represents excellent internal consistency. With regard to 
the respective domains, Cronbach‘s Alpha for four domains was very good. These were the 
domains of understanding and communication, moving around/mobility, life activities and 
participation/social restriction, but Cronbach‘s Alpha fell below acceptable levels for the 
domains of self-care and getting along with people. Subsequently, these two domains were 
not subjected to further analysis. In self-care, the item ‗staying alone for some time‘ 
correlated least with the other items assessed under this domain; if this was removed, the 
Cronbach‘s Alpha increased. On the other hand, for ‗getting along with other people‘, the 
overall Cronbach‘s Alpha score was low, and there was no single item that threatened the 
internal consistency of this domain.  
As it is described early in this present study, the development of the WHODAS 2.0 has been 
found to have high internal consistency (Cronbach‘s Alpha: 0.86), and good concurrent 
validity was obtained when compared with other recognised disability measurements(T. B. 
Üstün, et al., 2010). As was the case with our study group, the WHODAS 2.0 has also 
demonstrated good to excellent internal consistency for its applicability to assessments of 
disability in other health conditions. For example, Schlote et al. (2009) indicated that the 
internal consistency of the WHODAS 2.0 was found to be good to excellent, with Cronbach‘s 
Alpha of 0.81-0.99 among stroke patients (this was obtained from both patients and their 
relatives‘ opinions).  Also, in a study conducted with a large group of schizophrenia patients, 
Guilera et al. (2012) found that the internal consistency of the WHODAS 2.0 was also very 
high, with Cronbach‘s Alpha of 0.94. It was also reported in a very recent article that the 
internal consistency of the WHODAS 2.0 was tested among  patients from a large sample of 
people with breast cancer in China, and this showed satisfactory internal consistency (0.72-
0.92) (Zhao et al., 2013). 
As supported by other studies that used the WHODAS 2.0 in other health conditions, our 
findings confirmed that the WHODAS 2.0 is a very reliable instrument to measure functional 
limitations/disability across health conditions, countries and cultures but it is less reliable as a 
measure for the self- care and getting along with people domains.    
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6.7 Conclusion 
To conclude, the whole process of translation was challenging but proved fruitful. Debate in 
consensus meetings would continue until consensus was reached and the consensus team was 
satisfied with the meaning. In difficult situations, the word or phrase was highlighted and was 
referred to the next stage for further discussion. The rigorous translation process made it 
possible to come up with a WHODAS 2.0 tool in Kinyarwanda, which has appropriate 
linguistic and cultural meanings, and uses clear and understandable expressions.  
The difficulty of finding appropriate words and phrases relating to impairment and disability 
concepts highlights the role of language in defining how people conceptualise issues relating 
to disability. By identifying appropriate words, the translation process can introduce new 
concepts into a language, as indeed the ICF did by redefining disability in terms of 
impairment and activities and participation and environmental and personal factors. 
Unfortunately there was no ―gold standard‖ instrument that has been validated in Rwanda 
with which to test the concurrent validity. Similarly, there were no appropriate markers to 
explore divergent construct validity. 
The resulting translated instruments demonstrated reasonable content validity; good construct 
validity and good reliability.  It is suggested that both instruments yielded valid data and that 
the results of this study demonstrate good internal validity. The translated instruments could 
be used with confidence in similar studies in Rwanda with participants who speak 
Kinyarwanda. 
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7 CHAPTER SEVEN: CONCLUSION 
This chapter includes the summary of the thesis, conclusion, limitations and the significance 
and recommendations of the study. 
7.1 Summary  
In Rwanda the health system uses the bio-medical approach to health care and many PLWH 
are on antiretroviral treatment (Ministry of Health (MoH) Rwanda, 2012b) and, as a result 
HIV has become a chronic disabling disease which requires rehabilitative intervention. Using 
the ICF as the conceptual framework, this thesis explored the experience of living with HIV 
in Rwanda through the lens of the bio-psychosocial model of health care. This model could 
be used to plan and manage the health related support given to PLWH including rehabilitative 
interventions. In this model the personal factors and the health condition are considered 
central to the experience the person living with HIV. There is recognition of the interaction 
between the personal factors, health condition, impairments, functional limitations, 
participation restrictions and the hospital and external environments. Disability is defined in 
the ICF as ―impairments, activity limitations and participation restrictions‖ (Vanleit, 2008; 
World Health Organisation (WHO), 2001). The ICF is considered an appropriate framework 
for identifying impairments, activity limitations and participation restrictions among PLWH 
(Hanass-Hancock & Nixon, 2009a; Myezwa, et al., 2009).  These can be identified using the 
ICF checklist and WHODAS 2.0.  
The aim of the study was therefore to explore the need for and nature of care that PLWH 
living in Rwanda receive from their health care providers using a bio-psychosocial 
framework. A further aim was to determine if the Kinyawanda version of the WHODAS 2.0, 
which was used to gather the functional data, was valid within the Rwandan context. A mixed 
methods approach was used. 
7.1.1 Research question 1 
In answer to the first research question: Who is receiving ARVs? In other words what are the 
personal factors, e.g., gender, educational factors of PLWH who are receiving ARVS? 
On the days of data collection at the ARV clinics for the survey 35.7% of all patients 
attending the clinics were males and 56.6% females. The survey sample shows an over-
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representation of women, as 75% of the respondents were female. This indicates that more 
women than men came to seek care on the days of data collection, and more volunteered to 
participate in the study. Likewise in the FGDs more women than men volunteered to 
participate; the proportion was 3 male participants: 5 female participants. Other men declined 
to participate.   
The mean age of the sample in the survey was 39.7 years. In the FGDs the mean age was 41.8 
years for FGD A and 36.8 years for FGD B. In the survey, the most common marital status 
among males was ‗married‘ (65%) while ‗widowed‘ was most common among females 
(41%).  In the FGDs the commonest marital status among males was ‗married‘ (40%), there 
was no widowed, the rest was either single or separated. Among females, the commonest 
marital status was as well married 60%), followed by widowed (30%). In the survey findings, 
there were more females unemployed compared to males, and males were found to be more 
educated than females. 
The FGDs participants described factors within themselves which built resilience that 
contributed to their well-being and assisted them to deal with the HIV infection, but also 
factors that limit their functioning.   
Personal factors that facilitated functioning included: spiritual beliefs; faith in God; and 
positive thinking about disclosure as a strategy to improve psychological well-being, to 
overcome internalised stigma and to create awareness about HIV. Coping strategies that 
participants developed were also described. Personal factors that limited functioning  
included internalized stigmatisation, expressed by feelings of being hurt, and feelings of 
regret and shame, and of guilt and remorse about HIV. PLWH had negative thoughts about 
being stigmatized, being chased away, being judged or being dismissed from work. Age was 
identified as personal factor that could influence the ability to function. 
In both urban and rural areas, the discussion in the FG about whether or not to disclose, and 
the positive and negative effects of disclosure as well issues around stigma, were reported 
more frequently by women compared to men. The only man who spoke of disclosure, 
indicated that it would lead to stigmatization and it was not clear that he had disclosed his 
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status to anyone beyond the ARV clinic. Other factors were spoken about by both men and 
women, in rural and urban areas.  
7.1.2 Research question 2 
In answer to the second research question: How effective is the ARV treatment received in 
terms of diminishing symptoms and improving the functioning of PLWH? Is there any need 
for further intervention and support? If it is effective, it is suggested that there will be few 
functional limitations present, the functional limitations will be less as the CD4 count 
increases and the longer that the PLWH receive ARVs, the better their functioning will be. 
The findings of the survey show that among the participants there was no significant 
difference in the CD4 count (above and below 500) between those who declared that they 
were symptomatic and those who were not. However, this study showed that the longer the 
participants had been on antiretroviral treatment, the more likely they were to be 
symptomatic.  This finding was supported by several of the FGDs participants, women and 
men, in both urban and rural areas and who attributed their functional limitations to the 
medication rather than the underlying pathology and indicated that symptoms occurred 
overtime. However, despite the side effects of antiretroviral treatment, in the survey, those 
who had been on antiretroviral treatment for a long period showed a higher CD4 count. The 
survey findings have confirmed that the manifestation of symptoms of impairment among 
PLWH is not related to the CD4 count, but it is likely to be associated with the longer 
duration of antiretroviral treatment and this was confirmed by the participants in both FGDs 
as they had spoken about symptoms changes that occurred overtime. 
7.1.3 Research question 3 
In answer to the third research question: What are the perceptions of PLWH with associated 
disabilities of the health services that address their functional limitations, in a hospital setting, 
in Rwanda? Are they satisfied that the care that they receive addresses all or a majority of 
their health related problems? 
Two FGDs were carried out in two hospitals; the first hospital was located in urban area and 
the second one in rural area. Each FGD involved a final sample of eight (five females and 
three males) PLWH on ARVs with associated disabilities.  
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The study included the influence of the hospital environment and services on the functioning 
of PLWH; this included the ARV clinic and hospital services outside the ARV clinic 
environment. Environmental factors in the ARV clinic that facilitated functioning included 
the service provided by the ARV clinic, trust in the health care providers, the provision of 
antiretroviral treatment, a sense of belonging at the ARV clinic and the referral procedure 
from the ARV clinic to other services within the hospital.  
Environmental factors in the ARV clinic that acted as limitations to functioning included a 
lack of assistance concerning functional limitations, health care providers also discriminated 
between patients due to misunderstanding of their functional limitations, and participants‘ 
lacked  knowledge about specialist services that could help to manage these functional 
limitations. Other factors were the inconsistent referral procedure and the use of multiple 
medical files for one patient within the same hospital. 
Environmental factors related to hospital services beyond the ARV clinic that facilitated 
functioning included assistance from the rehabilitation services, the involvement of the 
community in caring for PLWH, and aspects of Mutuelle de Santé. Environmental factors 
related to hospital services outside the ARV clinic that limited functioning included 
overcrowding, long waiting times, the absence of any special consideration for PLWH, the 
participants‘ lack of knowledge of health care providers who might assist with functional 
limitations, the health care providers‘ inability to assist with functional limitations, a concern 
about whether the private  health care service was better than the public service, and this was 
more spoken about by male participants, poor communication, negative attitudes on the part 
of health care providers, the unavailability of doctors and the inability of Mutuelle de Santé to 
respond to all the health care needs of PLWH. 
Participants made recommendations that could improve services at the hospital. These 
included: recognition of the vulnerability of PLWH, the establishment of counselling 
programmes, an increase in the number of health care providers, strengthened collaboration 
and an improved referral system within the hospital, a single medical file, improved quality 
of service by Mutuelle de Santé, a food programme, a dedicated youth HIV clinic, education 
support for PLWH orphans, health care providers‘ ability to respect time management, and 
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consideration for privacy at ARV clinics. Only male participants spoke about the need for 
consideration for privacy.  
7.1.4 Research question 4 
In answer to the fourth research question: What are the profile and the prevalence of 
impairment and functional limitations among PLWH in Rwanda?  Is functional limitation 
common? If it is prevalent, then it is possible that the medical model of care does not result in 
complete recovery of functioning.  
The aim of this part of the study was to determine the profile and the prevalence of disability 
among PLWH, by measuring impairment, activity limitation and participation restriction 
amongst PLWH who are also on antiretroviral treatment. In addition the relationship between 
functioning and medication is explored. 
To determine the profile and the prevalence of disability among PLWH, a cross-sectional 
study was conducted.  Fifteen hospitals were randomly selected in the five provinces in the 
country, and these hospitals were visited.  Using an outcome instrument, 520 PLWH who 
were on antiretroviral treatment were approached to participate in face-to-face interviews. 
The Kinyarwanda version of the ICF core set of questions measured PLWH impairments and 
WHODAS 2.0 questions in Kinyarwanda were used to document impairments, activity 
limitations, and participation restrictions were identified among PLWH. These findings were 
then supplemented with the results of the focus group discussions.  
Problems with pain (69%) and fatigue (83%) were more prevalent than problems found in 
other domains measured under impairment.  Among the activity limitations, problems with 
mobility functions were most frequently reported (57%). The domain in which the highest 
number of people reported problems was the participation domain and in this domain, 
problems with participation in relaxation or pleasure activities (83%) were the most 
prevalent. The mean scores of the different domains were significantly different with 
participation scoring the highest (46%, with 100% the worst score rate). It was also found 
that participants experienced problems on approximately half of the days every month, and 
that there were three days in a month in which the participants were unable to work because 
of their health condition. Various impairments of body function predicted functional 
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limitations with regard to activities and the participation/social restriction domains. Energy 
and drive and memory functions were predictive of the means scores of all the domains. 
Male and female participants in both urban and rural hospitals experience impairments and 
they indicated that these impairments were caused either by the HIV infection or the 
antiretroviral treatment and the severity might change overtime. The most frequently 
mentioned impairments were: lack of energy, pain, paraesthesia, dizziness, lipodystrophy, 
poor body image and memory loss and lack of concentration. The participants‘ body 
impairments, especially lack of energy, pain, paraesthesia, breathlessness and loss of 
memory, affected the performance of their daily activities and their participation in social 
life. The activities most affected were mobility, self-care and life activities, which included 
household and work activities. All activities, except households, were reported by men and 
women equally. Reduced activity performance contributed to decreased productivity, which 
affected livelihood.  Body impairments, particularly lack of energy, restricted participation in 
social life, including in leisure activities, social relationships, spiritual practices and sexual 
relations. Male participants spoke about lack of energy as a leading factor of reduced 
frequency of sexual intercourse, whereas female participants complained about lack of desire 
as a cause of decreased involvement in sexual intercourse rather than lack of energy. 
7.1.5 Research question 5 
In answer to the fifth research question: it is necessary to validate the primary data collection 
tools to ensure that the data collected during the survey of impairments and functional 
limitations were a true reflection of the functional abilities and health of PLWH within the 
context of the study.  
The aim was to establish whether the translated Kinyarwanda versions of the WHODAS 2.0 
and the ICF core set of questions were valid instruments with which to document the 
presence of impairments and functional limitations.  This entailed interrogating the face and 
content validity, as well as the reliability and construct validity. 
It was necessary to produce a valid and understandable Kinyarwanda version of the ICF core 
set of questions and the WHODAS 2.0 in order to understand the impact of HIV on 
functioning. Chapter six documented the process of translating into Kinyarwanda the original 
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English version of the ICF core set of questions regarding the impairment of body functions 
identified among PLWH (Myezwa, et al., 2011) and of the WHODAS 2.0 outcome 
instrument and highlighted any problems that were encountered, whether related to linguistic 
meaning or to cultural influence.  
Forward and backward translations were conducted with a consensus meeting after each 
translation; and a third consensus meeting was held that brought together the two previous 
meetings. Proofreading by a team of multidisciplinary health care providers comprising a 
medical doctor, two physiotherapists and two psychologists was completed before a cognitive 
debriefing interview that aimed to test the clarity of the outcome instrument.  After this 
interview, a final consensus meeting was held; this involved participants in the previous 
consensus, and was conducted to come up with the final Kinyarwanda version, which was 
expected to yield valid data with regard to disability among PLWH. An ICF core set of 
questions regarding the impairment of body functions and a WHODAS 2.0 questionnaire in 
Kinyarwanda, which has appropriate linguistic and cultural meanings, and uses clear and 
understandable expression, was produced. 
This process demonstrated that ensuring cultural applicability in the Kinyarwanda language is 
complex and could affect conceptual equivalence. It was also found that English is a rich and 
very explicit language that allows for generalisation while at the same time ensuring 
specificity and precision.  Kinyarwanda is also rich and very complex. For example, one 
word in English may be translated by using two, three or more words in Kinyarwanda, 
depending on the population‘s characteristics and background, the context in which the word 
is used, and the region in which the word is used.  
Sometimes it was not possible to find exact words to express the equivalent meaning. Thus, 
several problems were encountered while trying to achieve linguistic and conceptual 
equivalence.  The difficulty of finding appropriate words and phrases relating to impairment 
and disability highlights the role of language in defining how people conceptualise issues 
relating to disability. By identifying appropriate words, the translation process can introduce 
new concepts into a language, as indeed the ICF did by redefining disability in terms of 
impairment and by taking into account activities and participation and environmental and 
personal factors. 
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The thematic analysis of the FGDs was used to identify the impairments, functional 
limitations and participation restrictions that the participants had identified, for content 
validity.  These were then tabulated against the corresponding items of the Impairment 
Questionnaire and the WHODAS 2.0.  
For the impairments questionnaire, nineteen of the thirty items (63%) were referred to, either 
obliquely or directly. Dizzyness and visual problems were the two impairments which were 
mentioned by the participants but which were not included in the questionnaire. For the 
WHODAS 2.0, comments relating to 24 out of the 31 items could be mapped to a 
corresponding item (77.5%). Stair climbing and spiritual activity were mentioned by several 
respondents but were not represented in the transcripts.  
The one-way ANOVA was used to establish convergent validity of the WHODAS 2.0. It was 
not possible to do this with the Impairments Questionnaire. There was a significant difference 
between the means of the relevant domain of respondents scoring different levels of the 
impairment scales. In every case the ANOVA indicated that there was a significant difference 
between the means, the scores were higher (indicating poorer functioning) as the impairment 
level increased. In the case of the Life Activities, the categories indicate increasing levels of 
income and the score thus decreased as the categories increased. 
Cronbach‘s Alpha was calculated to test for internal consistency of the Impairments 
Questionnaire and the WHODAS 2.0. This was calculated for the entire scale and for the 
subsections (domains) of the scale. In addition the contribution of each item to the overall 
correlation was examined by calculating the alpha with each item included. If the correlation 
increased once the item was excluded, it implied that the item did not fit well with the 
construct of the domain. The Impairment Questionnaire yielded a Cronbach‘s Alpha score of 
0.85, with no item pulling the scale down . This falls within the good category of reliability. 
The Cronbach‘s Alpha value for the whole WHODAS 2.0 scale was 0.933 (35 items) which 
is regarded as representing excellent internal consistency. For the subsections of the 
WHODAS 2.0 scale, domains of Understanding and Communication (.872, six items); 
Moving around (.840, five items); Life activities (.947, seven items) and Participation (.829, 
eight items). As the value fell below acceptable levels in the domains of Self-care (.204, four 
items), and Getting along with people (.543 five items), these domains were subjected to 
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further analysis. It was found out that in Self-care, the item ‗staying alone‘ was the least 
correlated and, if deleted, the Cronbach‘s Alpha increased considerably. For getting along 
with people, no single item was identified in the domain that threatened the internal 
consistency of this domain; however, Cronbach‘s Alpha was low. 
7.2 Conclusions 
The study findings of both the survey and the FGDs confirm the interrelationship among the 
components of disability supporting the assumption of the ICF model that there is interaction 
and connection between all the disability components, and that there is mutual influence. It 
implies that intervention programmes to overcome disability among PLWH need to be 
comprehensive to address the three components including impairments, activity limitations 
and participation restrictions, and that interventions should also consider the influence of 
contextual factors including both personal and environmental factors that are found to 
exacerbate or alleviate disability. For example, energy and drive and memory functioning 
were found to affect all aspects of functioning and attempts to only improve the function (e.g. 
household activity)  without addressing the underlying impairment would be futile.  
The study supports that the bio-psychosocial model would result in a better approach to 
intervention in Rwanda. It could be used to plan and manage health related support given to 
PLWH.  
The ICF framework is also useful in understanding how health service delivery within the 
hospital setting assists PLWH to overcome the multidimensional disabilities they encounter 
in everyday life. Findings from FGDs suggest that PLWH had a strong sense of belonging in 
the ARV clinic environment and preferred the care provided there to that provided by other 
hospital services. Their appreciation was primarily based on the provision of antiretroviral 
treatment in these clinics. However, health care providers from ARV clinic were unable to 
manage functional limitations adequately, and they did not refer patients to other experts in 
the hospital for management of those limitations.  Of all the hospital services utilised by 
PLWH, including the ARV clinic, only the rehabilitation services (though in a very limited 
way) were recognised as being able to assist with their functional limitations.   
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It is evident that antiretroviral treatment should continue to be provided by the ARV clinic, 
but further regard to functional limitations is needed; it is evident that the use of rehabilitation 
services within or outside the hospital needs to be encouraged. This could be done using a 
vertical services approach, with the integration of rehabilitation services into ongoing HIV 
programmes offered in ARV clinic. Alternatively, it could also be done by strengthening the 
existing horizontal services approach. This would require referral of PLWH from ARV clinic 
to rehabilitation services, as happens with other chronic health conditions. This second option 
appears to be the more appropriate strategy as it would only require the reinforcement of 
existing capacities and policies. In contrast, the vertical services approach would require the 
restructuring and transformation of existing structures and policies. 
The horizontal services approach would be more successful if it adopted the 
recommendations suggested by the PLWH in this study, especially with regard to 
collaboration among health care providers, including those in rehabilitation services. This 
would include the recommendations about the restructuring of referral systems within the 
hospital and the use of one medical file.  If well planned, this approach to rehabilitation 
would help to reduce the stigma that was identified as a big problem by PLWH; it would help 
them to consider themselves as belonging to the hospital as a whole and not just to the ARV 
clinic.  
Based on the findings on service provision and on the profile of disability, many health care 
providers from different disciplines need to be involved in the rehabilitation care of PLWH. 
Those include medical doctors, nurses, nutritionists, mental health professionals/ 
psychologists, physiotherapists, occupation therapists and social workers. The ICF model has 
the potential to bring people together who have a common approach to health problems, 
while recognizing one another‘s expertise (Shaw & MacKinnon, 2004). This could serve as a 
model to encourage collaboration among all these health care providers. The finding 
concerning the inability of health care providers in ARV clinics to accomplish a thorough 
assessment of functional limitations and their inability to make referrals to the appropriate 
rehabilitation services when necessary, suggests a need for training programmes that deal 
with knowledge about disability and PLWH and that the ability of rehabilitation services to 
manage functional limitations or disability. An education program on disability and HIV and 
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the need and benefit of rehabilitation services, targeting PLWH, is also essential as this could 
create awareness and help PLWH to take full advantage of the hospital services throughout 
their continuum of care. 
It was possible to translate the majority of the concepts of the WHODAS 2.0 into 
Kinyarwanda; however, the concept of disability is not well represented in the Kinyarwanda 
language. Disability cannot be addressed if it is not understood and the correct words are not 
used. The rigorous translation process allowed for the collection of valid data through the use 
of appropriate instruments. Additionally, the translated instruments demonstrated good 
content and construct validity and good reliability.  It is suggested that both instruments 
yielded valid data and that the results of this study demonstrate good internal validity. It is 
concluded that the translated instruments could be used with confidence in similar studies in 
Rwanda with participants who speak Kinyarwanda. 
7.3 Outcomes and significance of the study 
1. The study has produced a validated ICF core set of impairment questions and a 
WHODAS 2.O questionnaire in Kinyarwanda, with the aim of assessing functional 
limitations among PLWH in Rwanda. 
2. Using the ICF framework, the study has identified and documented a profile of the 
disabilities or functional limitations present and the relationship between them among 
PLWH in Rwanda. 
3. The study has documented the experience of functional limitations among PLWH in 
Rwanda 
4. The study has explored the extent to which the hospital services have addressed the 
functional limitations of PLWH in Rwanda. 
5. The study has contributed to an awareness amongst PLWH of the rehabilitation care 
available in Rwanda. 
6. The study has found that PLWH recognise the need for interdisciplinary collaboration 
among health care providers in the hospital setting, as this would improve the quality 
of care. 
7. The study has contributed to identifying the need for further research in the area of 
disability among PLWH in Rwanda including the role of rehabilitation interventions. 
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The significance of the study lies in the confirmation that disability is a very common 
problem in PLWH in Rwanda and that although medical treatment is well managed and 
effective, the functional needs of these people are not being met. The complex 
interrelationship between impairments and functional limitations demands an inter-
disciplinary approach to management. This is not currently being provided as the bio-medical 
approach is used. This could be addressed by using the bio-psychosocial approach suggested 
through the use of the ICF. 
7.4 Recommendations 
The use of the ICF framework has demonstrated that PLWH on antiretroviral treatment in 
Rwanda experience multiple disabilities or functional limitations as a result of the infection 
itself and/or the antiretroviral treatment. In Rwanda the majority of PLWH who are eligible 
have access to antiretroviral treatment. It is possible that in the coming years, there might be 
even more PLWH with disabilities. The health system delivery for PLWH in Rwanda needs 
to be able to address the chronic nature of the disease. 
Exploration of the perceptions of PLWH with associated disabilities about hospital services 
that seek to address their functional limitations has indicated that rehabilitation services based 
on the ICF, using a horizontal approach, could be the appropriate way to overcome disability 
among PLWH in Rwanda. 
The following recommendations arose from this study. (Note
47
) 
7.4.1 Recommendations for clinical practice 
1. Change in practice: Outcome measures based on the bio-psychosocial model using the 
ICF should be used by health care providers to assess disability among PLWH on 
antiretroviral treatment in Rwanda.  
2. Strategies should be put into place to reinforce interdisciplinary collaboration among 
health care providers; including those in rehabilitation services, within the hospital 
setting. 
                                                 
47
 For other specific recommendations, see chapter 5  
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3. A referral protocol should be developed to guide the referral of PLWH from the ARV 
clinic to rehabilitation services and from one rehabilitation service to another and back to 
the ARV clinic.   
4. The use of a referral card for PLWH would assist with the following up of patients from 
one service to another. 
5. The development of a screening tool based on the ICF core set of questions on 
impairments and the WHODAS 2.0 would help to identify functional problems among 
PLWH and should be used in each service, starting with the ARV clinic. 
7.4.2 Recommendations for education 
1. The development of a training programme for health care providers (particularly those in 
ARV clinic) with regard to the ICF would help them to plan for the management of 
PLWH with functional limitations or disabilities, using a holistic approach. 
2. An integrated bio-psychosocial model, utilising the ICF, should be used as a framework 
for understanding disability and outcome measures for the pre-service and in-service 
curriculum for health care providers; including doctors and nurses. 
3. An education program based on bio-psychosocial model, utilising the ICF, should be 
developed for PLWH, this would help to create awareness about disability and the 
potential role of rehabilitation services in the management of disability. 
7.4.3 Recommendations for research  
1. Research is needed to test the effectiveness of training students, medical professionals 
and PLWH with regard to the ICF.  
2. Research is needed to develop and test the effectiveness of a referral protocol. 
3. Research is needed to conduct a longitudinal study to assess when functional 
limitations manifest in the course of the disease. 
4. Research is needed to test the effectiveness of specific rehabilitation techniques such 
as an exercise programme, or a counselling programme in the management of 
functional limitations. 
5. Research is needed to test for the reliability and internal consistency of WHODAS 2.0 
after excluding the item ―staying alone‖ in the self- care domain and the getting along 
with people domain. 
 
 
 
 
   324 
 
 
 
 
Although much has been done in Rwanda to manage the scourge of HIV and improve the life 
expectancy of those who have this disease, there is still much to be done. It is not enough to 
simply prevent death, what is now important is to ensure that the life that is saved is worth 
living. This can be done through increasing our understanding of the impact of HIV on the 
functioning of patients and by using this information to mobilise health professionals from 
different disciplines to come together to provide an integrated effective service. It is hoped 
that the findings of this research will contribute to improving the lives of all the brave men 
and women with HIV who struggle daily with their disease. 
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9 APPENDICES 
9.1  Appendix I: Letters of permission from UWC and from the National 
Aids Control Commission, Rwanda 
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9.2 Appendix II:  Permission letter to conduct research in hospitals, in 
Rwanda 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X17, Bellville 7535, South Africa 
Tel: +2721-959, Fax: 27 21-959 
DEPARTMENT OF PHYSIOTHERAPY 
 
The Director of Hospital 
Rwanda 
28
th
 April 2010 
Dear Sir/Madam, 
Re: Permission to conduct research in hospitals, in Rwanda 
I am a Rwandan PhD student at the University of the Western Cape in Cape Town, South 
Africa. I am expected to undertake a research project for the requirements of a Doctorate 
degree in Physiotherapy. The study is entitled ―   Rehabilitation for people living with HIV 
with associated disability on antiretroviral treatment‖. Permission to conduct the study has 
been obtained from the Higher Degrees Committee of the University of the Western Cape. 
 The aim of the research project is to determine   ―the profile and the prevalence of disability 
among PLWH, by measuring impairment, activity limitation and participation restriction 
amongst PLWH who are also on antiretroviral treatment‖. 
The information will be gathered by way of interview questionnaire. It is hoped that the 
results of this study would contribute to the knowledge of the extent of disability among 
people living with HIV and who are on antiretroviral treatment. 
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I hereby wish to request permission from your hospital to carry out the above-mentioned 
project. Ethical issues will be taken into consideration, participation in the study will be 
anonymous and voluntary and the information gathered will be treated with respect and 
confidentiality. The results will be made available to you as soon as they have been analysed. 
The co-operation from both the Health care providers and patients will be much appreciated. 
Looking forward to your co-operation  
Yours sincerely 
 
Jeanne Kagwiza 
 
Prof. Patricia Struthers Prof. Jennifer Jelsma 
Supervisor Supervisor 
 
 
 
 
 
 
  
 
 
 
 
   378 
 
 
 
9.3  Appendix III:  Information sheets to participate in the survey 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959  
 
 
Title of the main Research Project: Rehabilitation for people living with HIV with 
associated disability on antiretroviral therapy, in Rwanda. 
 Information sheet: for potential participants in a survey about ―determining disability among 
people living with HIV and who are on antiretroviral treatment.  
My name is Jeanne N. Kagwiza and I am a postgraduate student (PhD), in the physiotherapy 
Department at the University of the Western Cape, Cape Town, South Africa. I am currently 
conducting a study in Rwanda in the field of disability, HIV and rehabilitation. The aim of 
the study is to determine “the profile and the prevalence of disability among PLWH, by 
measuring impairment, activity limitation and participation restriction amongst PLWH 
who are also on Antiretroviral Treatment”. 
 .  
The whole study is divided in three parts. You are kindly invited to participate in the second 
part of this study, which is ―the prevalence and profile of disability among PLWH, in 
Rwanda. In this study, you will be interviewed, to find out prevalence and profile of disability 
and the questionnaire will be assessing a number of items such as pain, mobility of joint, 
walking, self-care activities, community life, recreation and leisure, maintaining a friendship 
etc. It will take approximately 45 minutes to answer questions. I will also like to look at your 
medical record/file to take note of any information that is required for this study. The study 
will be done at the ARV clinics of the fifteen hospitals selected for this study.   All 
information you provide will be kept confidential and anonymity will be maintained. Your 
name will not be included on the questionnaire; a code will be placed on the questionnaire; 
through the use of identification key, the researcher will be able to link your questionnaire to 
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your identity; and only the researcher will have access to the identification key. Also the 
results of this research may be published but you will not be identified as an individual. 
Nevertheless, the information you give may be disclosed if required by the law. 
 
The results of the whole study may help the investigator to find out the extent of disability 
among PLWH. We hope that in the future, other people might benefit from this study through 
improvement of rehabilitation services to PLWH associated with disability. There are no 
known risks associated with participating in this research project. However you reserve the 
right to withdraw from the study at any time and thus will not have any effect on continuing 
accessing your usual treatment or decisions for being referred for treatment where necessary. 
You will continue getting updates of the study both during the course of the study and after. 
 Please read and sign the attached consent form if you agree to participate in the study. If you 
require further information please feel free to contact me through my contact details below.  
 
Yours sincerely       Date 
Physiotherapist and principal researcher 
Jeanne N. Kagwiza  Tel: (250)08755364   
 E-mail: jkagwiza@yahoo.fr/jkagwiza@uwc.ac.za  
 
Kigali/Rwanda 
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9.4 Appendix IV:  Informed consent to participate in the survey 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959  
CONSENT FORM 
Title of Research Project: Rehabilitation for people living with HIV with associated 
disability on antiretroviral treatment, in Rwanda.  
Phase two, Survey: Prevalence and profile of disability among people living with HIV 
associated disability in Rwanda.  
The study has been described to me in language that I understand and I freely and voluntarily 
agree to participate. My questions about the study have been answered. I understand that my 
identity will not be disclosed and that I may withdraw from the study without giving a reason 
at any time and this will not negatively affect me in any way.   
Participant‘s name……………………………………. 
Participant‘s signature……………………………….                                  
Date………………………………………………………. 
Witness name………………………………………………. 
Witness signature ………………………………………….. 
Date …………………………………….. 
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact the study coordinator: 
Study Coordinator‘s Name: Jeanne N. Kagwiza 
Physiotherapist and principal researcher. Cell phone: (250) 08755364 
E-mail: jkagwiza@yahoo.fr/jkagwiza@uwc.ac.za 
Kigali/Rwanda 
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9.5  Appendix V:  Screening checklist 
Demographic and Background information 
Respondent Identity number:………. ….                 Date: …………… 
1. How old are you now? Age in years..................... 
2. Gender:       Male 
Female 
The next questions ask about difficulties you may have doing certain activities because of a 
health problem. 
Do you have difficulty in doing the following? No- no 
difficulty 
Yes- some 
difficulty 
Yes- a lot 
of 
difficulty 
Too much 
difficulty 
3. Seeing, even if wearing glasses?     
4. Hearing, even if using a hearing aid?     
5. Problem with tolerance to food?     
6. Walking?     
7. Climbing stairs?     
8. Standing for long periods such as 30 minutes?     
9. Remembering or concentrating?     
10. Self-care; e.g. washing your body, dressing?     
11. Household activities?     
12. Work or school activities?     
13. Communicating by using your customary language,     
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for example understanding or being understood? 
14. Things for relaxation or pleasure?     
15. Sexual activities?     
16. Living with dignity because of the attitudes and 
actions of others? 
    
17. Difficulty because of barriers or hindrances in the 
world around you?  
    
18. Getting along with people; e.g. immediate family, 
friends, community members? 
    
19. Getting financial resources?     
 
Do you experience the following problems? No- not 
all 
Yes- 
sometimes 
Yes- a lot Too much 
20. Pain, e.g., headache, backache?     
21. Abnormal/unusual skin sensations, e.g., 
pins & needles, numbness, tingling? 
    
22. Fatigue?     
23. Emotional problems? 
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9.6  Appendix VI: Focus group interview guide 
1. Are there things that you could do in the past and are no longer able to do since you 
became ill? 
Probes: 
 Walking for some distances  
 Climbing stairs 
 Standing for long periods 
 Going to work or school  
 Household activities 
 Sexual activities 
 Activities for relaxation or pleasure 
 Going to church 
 Visit friends sometimes 
 Visit your families  
 Getting along with your friends, family and other people in your community 
 Living with dignity because of the attitudes and actions of others 
 
2. How did taking medication change any of the things mentioned above? 
3. Can you describe your experiences with how the hospital health care providers tried 
to assist you with the problems you have described above?   
Probes: 
 Which health care providers do you usually see to help you with the problems you 
have mentioned? 
 Do you think you get chance to speak about your problems? 
 If yes, what do you tell them? 
 What do they do? 
 What are the problems do you find difficulty to tell them? 
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 What are the problems do you have and you think they do manage? 
 What are the problems do you have and you think they do not manage? 
 Do they refer you to other health care provides for those problems they are not able to 
manage? 
4. Can you give your opinions or views on what can be done to improve the hospital 
services so as to assist you with your problems and to improve your quality of life? 
I appreciate your time and your contribution 
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9.7  Appendix VII: Information sheet to participate in the 
screening 
UNIVERSITY OF WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959  
Title of the main Research Project:  Rehabilitation for people living with HIV with 
associated disability on antiretroviral treatment, in Rwanda.  
 Information sheet: for potential participants in a screening recruiting people living with HIV with 
associated disabilities to participate in a focus group discussion 
My name is Jeanne N. Kagwiza and I am a postgraduate PhD student, in the Physiotherapy 
Department at the University of the Western Cape, Cape Town, South Africa. I am currently 
conducting a study in Rwanda on the provision of rehabilitation services for people living with HIV 
who have difficulties associated with HIV. I would like to invite you to answer some questions about 
difficulties you may experience related to daily activities. Depending on what I learn I may invite you 
to take part in a group discussion.  
All the information you provide will be kept private and confidential. Your name will not be included 
in the report. The results will only be looked at, by the researcher and the research assistant. The 
results of this screening may be published but you will not be identified as an individual. 
Nevertheless, the information you give may be disclosed if required by the law. 
 There are no known risks associated with participating in this screening. However, you reserve the 
right to withdraw from the screening at any time and this will not have any effect on continuing your 
usual treatment or on decisions for being referred for treatment where necessary.  
Please read and sign the attached consent form if you agree to participate in the screening. If you 
require further information please feel free to contact me through my contact details below.  
Yours sincerely       Date 
Physiotherapist and principal researcher Kigali/Rwanda 
Jeanne N. Kagwiza  Tel: (250)08755364   
 E-mail: jkagwiza@yahoo.fr/jkagwiza@uwc.ac.za  
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9.8  Appendix VIII:  Informed consent to participate in the screening 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959 
 CONSENT FORM 
Title of Research Project: Rehabilitation for people living with HIV with associated 
disability on antiretroviral treatment, in Rwanda.  
Screening for focus group discussion: The screening is to select participants for a focus group 
discussion involving PLWH with associated disability on antiretroviral treatment.  
The procedure and the aim of the screening have been described to me in language that I understand 
and I freely and voluntarily agree to participate. My questions about the screening have been 
answered. I understand that my identity will not be disclosed and that I may withdraw from the 
screening without giving a reason at any time and this will not negatively affect me in any way.  I 
agree to keep everything I hear confidential. 
Participant‘s name……………………………………… 
Participant‘s signature to participate in the screening…….                                 
Date………………………………………………………. 
Witness name……………………………………………. 
Witness signature ………………………………………. 
Date ……………………………………………………… 
Should you have any questions regarding this screening or wish to report any problems you have 
experienced related to the screening, please contact the study coordinator:  
Study Coordinator’s Name: Jeanne N. Kagwiza Physiotherapist and principal researcher. Cell 
phone: (250) 08755364 Kigali-Rwanda 
E-mail: jkagwiza@yahoo.fr/jkagwiza@uwc.ac.za 
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9.9  Appendix IX: Information sheet to participate in the focus group 
discussion 
  
UNIVERSITY OF WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959 
 
Title of the main Research Project: Rehabilitation for people living with HIV with 
associated disability on antiretroviral treatment, in Rwanda.  
Information sheet: for potential participants in a focus group discussion exploring the 
perceptions of people living with HIV with associated disabilities on how the hospitals 
services address their functional limitations. 
My name is Jeanne N. Kagwiza and I am a postgraduate PhD student, in the Physiotherapy 
Department at the University of the Western Cape, Cape Town, South Africa. I am currently 
conducting a study in Rwanda on the provision of rehabilitation services for people living 
with HIV who have difficulties associated with HIV. The aim of the study is to explore how 
you feel the hospital services is addressing your functional limitations or problems. I hope 
this information will be used to improve the rehabilitation service for people living with HIV.  
You are kindly invited to participate in the group discussion. During the discussion, notes 
will be taken and I would like to use an audiotape recorder to ensure that I can remember all 
that the participants in the group say.  All the information you provide will be kept private 
and confidential. Your name will not be included in the report. The recording and the notes 
taken will only be listened to, or looked at, by the researcher and her supervisors. The results 
of this research may be published but you will not be identified as an individual. 
Nevertheless, the information you give may be disclosed if required by the law. 
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We hope that you will benefit from this study through the improvement of referral for 
rehabilitation. There are no known risks associated with participating in this research project. 
However, you reserve the right to withdraw from the study at any time and this will not have 
any effect on continuing your usual treatment or on decisions for being referred for treatment 
where necessary.  
In the consent form you will be asked to agree to keep all that is discussed confidential to 
protect other participants or other people who may be discussed. 
Please read and sign the attached consent form if you agree to participate in the study, and to 
be audio-taped during your participation in this study. If you require further information 
please feel free to contact me through my contact details below.  
Yours sincerely       Date 
 
Physiotherapist and principal researcher 
 
Jeanne N. Kagwiza  Tel: (250)08755364  Kigali/Rwanda 
 
 E-mail: jkagwiza@yahoo.fr/jkagwiza@uwc.ac.za  
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9.10 Appendix X: Informed consent to participate in the focus group 
dscussion 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X17, Bellville 7535, South Africa 
Tel: +27 21-959, Fax: 27 21-959 
 
 CONSENT FORM 
Title of Research Project: Rehabilitation for people living with HIV with associated disability on 
antiretroviral treatment, in Rwanda. 
Qualitative study; focus group discussion: The focus group discussion is to explore the perceptions of 
PLWH about how hospital services address their functional limitations. 
The study has been described to me in language that I understand and I freely and voluntarily agree to 
participate. My questions about the study have been answered. I understand that my identity will not 
be disclosed and that I may withdraw from the study without giving a reason at any time and this will 
not negatively affect me in any way.  I agree to keep everything I hear during discussion confidential. 
Participant‘s name……………………………………… 
Participant‘s signature to participate in the study……. 
Participant‘s signature to be audio-taped………………Date   
Witness name……………………………………………. 
Witness signature ……………………………………… Date  
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact the study coordinator: 
Study Coordinator‘s Name: Jeanne N. Kagwiza. Physiotherapist and principal researcher. Cell phone: 
(250) 08755364 Kigali/Rwanda 
E-mail: jkagwiza@yahoo.fr/jkagwiza@uwc.ac.za 
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9.11 Appendix XI: English outcome instrument for translation 
Section 1.  Face sheet  
Complete items F1-F4 before starting each interview 
F1 Respondent identity number   
F2 Interview identity number   
F3 Assessment time point (1, 2, etc.) 
 
 
F4 Interview date    
  Day Month Year 
 Living situation at time of interview 
(Circle only one) 
Independent in community 1 
Assisted living 2 
Hospitalised 3 
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Section 2.  Demographic and Background information 
 Instructions 
Dear respondent, 
This interview has been developed by the World Health Organisation (WHO) to better 
understand the difficulties people may have due to their health conditions. The information 
that you provide in this interview is confidential and will be used only for research. The 
interview will take 15-20 minutes to complet 
 
A.1 Interviewer: record the gender of 
the respondent as observed 
1. Male 1 
2. Female 2 
 
A.2 How old are you now? Age completed in years  
A.3 What is your current marital 
status? 
1. Never  married 1 
2. Currently married 2 
3. Separated 3 
  4. Divorced 4 
  5. Cohabiting 5 
  6. Widowed 6 
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A.4 
 
 
 
Which describes your main 
work status best? 
 
 
 
Paid work 1 
Self employed, such as 
own your business or 
farming 
2 
Non-paid work, such as  
Volunteer or charity  
3 
Student 4 
Keeping 
house/homemaker 
5 
Retired 6 
Unemployed (health 
reasons) 
7 
Unemployed(other 
reasons) 
8 
9.Other  
(Specify) 
9 
 
A5. What is your monthly income? 
1. None 
2. Less than 50.000frw 
3. 51.000-100.000frw 
4. 101.000-150.000frw 
5. More than 150.000frw  
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A6. What is your level of education? 
1. None 
2. Primary education (1-6) 
3. Secondary school (S1-3) 
4. Secondary (S4-6) 
5. Tertiary education  
A7. How many years in all did you spend studying in school college or University? 
Number of years……………………. 
The information below could be checked in the patient record 
A8.   When were you diagnosed from HIV? 
1. Less than one month 
2. 1-6 months ago 
3. 6-12 months ago 
4. 1-3 years ago 
5. 4-6 years ago 
6. 7-9 years ago 
7. 10-15 years ago 
8. More than 15 years ago 
A.9  What is your HIVserostatus?  Asymptomatic/Symptomatic/AIDS converted 
A.10   Are you on ARVs?  Yes/No 
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A.11   For how long have you been on the ARVs? 
1.  Less than a month 
2. 1-6 months 
3. 6-12 months 
4. 1-3 years 
5. 4-6 years 
6. 7-9 years 
7. 10-15 years 
8. More than 15 years 
A.12   What type of ARVs do you take? 
1. Triviro-30 (D4T+3TC+NVP) 
2. Duovir-N (AZT+3TC+NVP) 
3. TDF+3TC+NVP 
4. TDF+3TC+EFV 
5. TDF+3TC+Kaletra 
6. D4T+3TC+EFV 
7. ABC+3TC+EFV 
8. ABC+DDI 
9. DT4+AZT+Kaletra 
10. AZT+3TC+ Stocrin 
11. 3TC+NVP 
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A.13   What is your CD4 cell count? 
1. Less than 200 
2. 201-350 
3. 351-500 
4. More than 500 
Section 3.  Impairments of body functions 
Instructions 
Section 3 is about difficulties or changes people have in body structure or body function 
because of health conditions. By health conditions I mean diseases or illnesses, or other 
health problems that may be short or long lasting; injuries, mental or emotional problems, and 
problems with alcohol or drugs. 
Remember to keep all of your health problems in mind as you answer the questions. When I 
ask you about difficulties in doing an activity think about: 
Increased effort 
Discomfort or pain 
Slowness 
Changes in the way you do the activity 
When answering, I do like you to think back over the past 30days. I would also like you to 
answer these questions thinking about how much difficulty you have had, on average, over 
the past 30 days, due to the health conditions mentioned below in the table. 
Use this scale when responding: None, mild, moderate, severe, extreme or cannot do. 
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  Domain None  Mild Moderate Severe Extreme or 
cannot do 
D.1 Mental Functions 
Energy and drive 
functions 
1 2 3 4 5 
Sleep Functions 1 2 3 4 5 
Memory Functions 1 2 3 4 5 
Emotional functions 1 2 3 4 5 
Body Image 1  2 3 4 5 
D.2 Sensory Functions and Pain 
Pain 1 2 3 4 5 
D.3 Functions of Cardiovascular and Respiratory Systems 
Heart Functions 1  2 3 4 5 
Blood Pressure functions 1  2 3 4 5 
Haematological system functions 1 2 3 4 5 
Immunological system functions 1  2 3 4 5 
Respiration (Breathing) 1 2 3  4 5 
Fatigability  1  2  3 4 5 
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D.4 Functions of the Digestive System 
Digestive functions 1 2 3 4 5 
Tolerance to food  1  2  3 4 5 
Defecation 1 2 3 4 5 
Weight Maintenance 1 2 3 4 5 
Sensations associated 
with the digestive 
system 
1  2 3 4 5 
Sensation of nausea 1 2 3 4 5 
General metabolic 
functions 
1 2 3 4 5 
 Fat metabolism 1 2 3 4 5 
Endocrine gland 
functions 
1 2 3 4 5 
D.5 Reproductive Functions 
Sexual Functions 1 2 3 4 5 
Menstruation functions 1 2 3 4 5 
Regularity of menstrual 
cycle 
1 2 3 4 5 
Sensations associated 
with genital and 
reproductive functions 
1 2 3 4 5 
Discomfort associated 1 2 3 4 5 
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with sexual intercourse 
D.6 Neuromusculoskeletal and Movement related Functions 
  
Mobility of Joint 1 2 3  4 5 
Muscle Power 1 2 3 4 5 
D.7 Functions of the Skin 
Skin functions 1 2 3 4 5 
Sensation related to the 
skin 
1 2 3 4 5 
 
Thank you. We will now go to the second questionnaire 
 
Section 4.  Activity limitations and Participation restrictions  
Instructions 
I would like to remind you that the information that you provide in this interview is 
confidential and will be used only for research. 
The interview in Section 4 is also about difficulties people have because of health conditions.  
Hand flashcard #1 to respondent and say:  
Remember by health conditions, I mean diseases or illnesses, or other health problems that 
may be short or long lasting, injuries, mental or emotional problems and problems with 
alcohol or drugs. I remind you to keep all of your health problems in mind as you answer the 
questions, and like before, when I ask you about difficulties in doing an activity think about: 
Point to flashcard #1 and explain that ―difficulty with an activity‖ means:  
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 Increased effort 
 Discomfort or pain 
 Slowness 
 Changes in the way you do the activity 
Say to respondent: 
I again remind you, when answering; I would like you to think back over the past 30 days. I 
would also like you to answer these questions thinking about how much difficulty you have 
had, on average over the past 30 days, while doing the activity as you usually do it. 
Hand flashcard #2 to respondent and say: 
Use this scale when responding: None, mild, moderate, severe, extreme or cannot do. 
Ensure that the respondent can easily see flashcards #1 and #2 throughout the interview 
DOMAIN REVIEWS 
DOMAIN 1   Cognition 
I am now going to ask some questions about understanding and communicating  
Show flashcards #1 and #2 to respondent 
In the past 30 days, how much difficulty did you have in:  
  None 
 
Mild 
 
Moderate Severe 
 
Extreme/ 
Cannot do 
 
 
D1.1 Concentrating on doing 
something for ten minutes? 
1 
 
 
2 3 4 5 
D1.2 Remembering to do important 1 2 3 4 5 
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things? 
D1.3 Analysing and finding solutions 
to problems in day to day life? 
 
1 2 3 4 5 
D1.4 Learning a new task, for 
example, learning how to get to 
a new place? 
1 2 3 4 5 
D1.5 Generally understanding what 
people say? 
 
1 2 3 4 5 
D1.6 Starting and maintaining a 
conversation? 
1 2 3 4 5 
 
DOMAIN 2   Mobility 
I am now going to ask you about difficulties in getting around 
Show flashcards #1 and #2 
In the past 30 days, how much difficulty did you have in: 
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  No 
 
Mild 
 
Moderate Severe 
 
Extreme/ 
Cannot do 
D2.1 Standing for long periods such as 
30 Minutes? 
1 2 3 4 5 
D2.2 Standing up from sitting down? 1 2 3 4 5 
D2.3 Moving around inside your 
home? 
1 2 3 4 5 
D2.4 Getting out of your home? 1 2 3 4 5 
D2.5 Walking a long distance such as a 
kilometre (or equivalent)? 
1 2 3 4 5 
 
 
 
DOMAIN 3 Self- care 
I am now going to ask you about difficulties in taking care of yourself 
Show flashcards #1 and #2 
In the past 30 days, how much difficulty did you have in: 
 
  No  
 
Mild  
 
Moderate 
 
Severe 
 
Extreme/ 
Cannot do 
D3.1 Washing your whole 1 2 3 4 5 
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body? 
D3.2 Getting dressed? 1 2 3 4 5 
D3.3 Eating? 1 2 3 4 5 
D3.4 Staying by yourself 
for a few days? 
1 2 3 4 5 
 
 
 
DOMAIN 4 Getting along with people 
I am now going to ask about difficulties in getting along with people. Please remember that I 
am asking only about difficulties that are due to health problems. By this I mean diseases or 
illnesses, injuries, mental or emotional problems and problems with alcohol or drugs.  
Show flashcards #1 and #2 
In the past 30 days, how much difficulty did you have in: 
 
  None Mild Moderate Severe Extreme/ 
Cannot 
do 
D4.1 Dealing with people you do not 
know? 
1 2 3 4 5 
D4.2 Maintaining a friendship? 1 2 3 4 5 
D4.3 Getting along with people who are 1 2 3 4 5 
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close to you? 
D4.4 Making new friends? 1 2 3 4 5 
D4.5 Sexual activities? 1 2 3 4 5 
 
DOMAIN 5 Life activities 
It includes: 
1. Household Activities 
I am now going to ask you about activities involved in maintaining your household, and in 
caring for the people who you live with or are close to. These activities include cooking, 
cleaning, shopping, caring for others and caring for your belongings. 
  Show flashcards #1 and #2 
Because of your health condition, in the past 30 days, how much difficulty did you have in: 
 
 
 
  None 
 
Mild  
 
Moderate 
 
Severe 
 
Extreme/ 
Cannot 
do 
D5.1 Taking care of your household 
responsibilities? 
1 2 3 4 5 
D5.2 Doing your most important 
household tasks well? 
1 2 3 4 5 
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D5.3 Getting all the household work 
done that you needed to do? 
1 2 3 4 5 
D5.4 Getting your household work 
done as quickly as needed? 
1 2 3 4 5 
 
If any of the responses to D5.2-D5.4 are rated greater than none (coded as ―1‖), ask: 
D5.01 In the past 30 days, on how many days did you reduce or 
completely miss household work because of your health 
condition? 
Record number of days 
……………………….. 
 
If respondent works (paid, non-paid, self-employed) or goes to school, complete questions 
D5.5-D5.10. Otherwise, skip to D6.1  
2. Work or school activities 
Now I will ask some questions about your work or school activities 
Show flashcards #1 and #2 
Because of your health condition, in the past 30 days how much difficulty did you have in: 
 None  Mild Moderate Severe Extreme 
or 
Cannot do 
D5.
5 
Your day-to-day Work/School? 1 2 3 4 5 
D5.
6 
Doing your most important 
work/School tasks well? 
1 2 3 4 5 
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D5.
7 
Getting all the work done that you need 
to do? 
1 2 3 4 5 
D.8 Getting your work done as quickly as 
needed? 
1 2 3 4 5 
D5.
9 
Have you had to work at a lower level because of a health condition? No 1 
Yes 2 
D5.
10 
Did you earn less money as the result of a health condition? No 1 
Yes 2 
 
 If any of D5.5-D5.8 are rated greater than none (coded as ―1‖), ask: 
 
D5.02 In the past 30 days, 
on how many days 
did you miss work 
for half a day or more 
because of your 
health condition? 
Record number of 
days……………………………………. 
    
 
Domain 6 Participation  
Now, I am going to ask you about your participation in society and the impact of your 
health problems on you and your family. Some of these questions may involve problems 
that go beyond the past 30 days, however in answering, please focus on the past 30 days. 
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Again I remind you to answer these questions while thinking about health problems: physical, 
mental or emotional, alcohol or drug related.  
Show flashcards #1 and #2 
In the past 30 days 
 
 
 
  None Mild 
 
Moderate Severe 
 
Extreme/ 
Cannot 
do 
D6.1 How much of a problem 
did you have joining in 
community activities (for 
example, festivities, 
religious or other 
activities) in the same way 
as anyone else can? 
1 2 3 4 5 
D6.2 How much of a problem 
did you have because of 
barriers or hindrances in 
the world around you? 
1 
 
 
 
2 3 4 5 
D6.3 How much of a problem 
did you have living with 
dignity because of the 
1 2 3 4 5 
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attitudes and actions of 
others? 
D6.4 How much time did you 
spend on your health 
condition, or its 
consequences? 
1 2 3 4 5 
D6.5 How much have you been 
emotionally affected by 
your health condition? 
1 
 
 
 
 
2 3 4 5 
D6.6 How much has your health 
been a drain on the 
financial resources of you 
or your family? 
 
 
1 2 3 4 5 
 
D6.7 
 
How much of a problem 
did your family have 
because of your health 
problems? 
 
1 
 
2 
 
3 
 
4 
 
5 
D6.8 How much of a problem 
did you have in doing 
things by yourself for 
1 2 3 4 5 
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relaxation or pleasure? 
 
 
 
 
H1 Overall, in the past 30 days, how many days were 
these difficulties present? 
Record number of 
days………………………. 
H2 In the past 30 days, for how many days were you 
totally unable to carry out your usual activities or 
work because of any health condition?  
Record number of 
days………………………. 
H3 In the past 30 days, not counting the days that you 
were totally unable, for how many days did you cut 
back or reduce your usual activities or work 
because of any health condition? 
Record number of 
days………………………. 
 
 
This concludes our interview, thank you for participating. 
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9.12 Appendix XII: Kinyarwanda  outcome instrument 
 
URUTONDE RW‘IBIBAZO 
Urutonde rw‘ibibazo nomero………………..Tariki ya……/……../……… 
 
Icyiciro 1. URUPAPURO RW‘IBANZE 
URUTONDE RW‘IBIBAZO 
 
Uzuza kuva kuri nomero F1 kugeza kuri F4 mbere yo gutangira buri bazwa 
F1 1.Nomero iranga ubazwa na  
 
2. Nomero ya telephone 
1. 
 
2. 
F2 Nomero iranga ubaza  
F3 Inshuro ibazwa rikoreshejwe (1, 2 etc.)  
F4 Uko ubayeho mu gihe cy‘ibazwa (shyira 
akaziga ku mubare umwe ) 
Wibeshejeho mu 
muryango 
1 
Urafashwa mu buzima 2 
uba mu bitaro 3 
 
Icyiciro 2. UMWIRONDORO N‘IMIBEREHO BY‘UBAZWA 
Amabwiriza 
Muvandimwe, 
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Iri bazwa ryateguwe n‘Umuryango mpuzamahanga wita ku buzima mu rwego rwo kurushaho 
kumenya ingorane abantu baba bafite zishingiye ku ndwara zitandukanye. Amakuru utangaza 
muri iri bazwa ni ibanga kandi azakoreshwa mu bushakashatsi gusa. Ibazwa rigusaba 
kwigomwa iminota iri hagati ya 25 na 30. 
 
A.1 
 
Ubaza: andika igitsina 
cy‘ubazwa 
1. Gabo 1 
  2. Gore 2 
A.2 Ufite imyaka ingahe? Umubare w‘imyaka ………………..Imyaka 
A.3 Umwimerere wawe ni 
uwuhe? 
1. Ingaragu 1 
2. Warashatse 2 
3. Muba ukubiri 3 
4. Mwaratandukanye 4 
5.Mubana n‘undi by‘ighe gito  5 
6. Umupfakazi 6 
A.4 
 
 
 
 
 
Ukora akahe kazi? 
 
 
 
 
 
1.Akazi k‘umushahara 1 
2.Urikorera, nk‘imirimo yawe 
bwite cyangwa umuhinzi 
mworozi 
2 
3. Akazi kadahemberwa 
nk‘umukorerabushake 
cyangwa ibikorwa 
by‘urukundo 
3 
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4.Umunyeshuli  
 
4 
5. Ukora imirimo yo mu rugo 5 
6. Uri mu kiruhuko 
cyi‘zabukuru 
6 
7.Ntukora (kubera ibibazo 
by‘uburwayi) 
 
7 
8.Ntukora (kubera izindi 
mpamvu) 
8 
9. Ibindi (sobanura) 9 
A.5 Ugereranije winjiza 
amafaranga angahe mu 
kwezi? 
Ntayo 1 
munsi ya 50.000frw 2 
Hagati ya 51.000-100.000 
frw 
3 
Hagati ya 101.000-150.000 
frw 
4 
Hejuru ya 150.000 frw 5 
A.6 Ufite amashuli angahe? 1. Ntiwize 1 
2. Abanza, 1-6 2 
3. Ayisumbuye, 1-3 3 
4. Ayisumbuye, 4-6 4 
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5. Kaminuza  5 
A.7 
 
 
Wamaze imyaka ingahe mu buzima bw‘ishuli? 
 
 
 
 
Umubare w‘imyaka 
 
 
A.8 Niba wibuka neza, hashize igihe kingana iki umenye ko ufite ikibazo cy‘ubwandu 
bw‘agakoko gatera SIDA? 
 
1. Munsi y‘ukwezi 1 
2. Hagati y‘ukwezi 1   -   n‘amezi 6 
3. Hagati y‘amezi 6    -   n‘amezi 12 
4. Hagati y‘umwaka 1 -   n‘imyaka 3 
5. Hagati y‘imyaka 4   -   n‘imyaka 6 
6. Hagati y‘imyaka 7   -   n‘imyaka 9 
7. Hagati y‘imyaka 10  -   n‘imyaka 15 
8. hejuru y‘imyaka 15 
 
 
Amakuru akurikira ashobora gushakirwa mu ifishi y‘umurwayi 
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A.9 Uburwayi bwawe buhagaze bute? ntabimenyetso, hari ibimenyetso by‘uburwayi, 
uburwayi bukabije 
 
A.10 Waba ufata imiti igabanya ubukana?      Yego/oya 
 
A.11 Umaze igihe kingana iki ufata imiti igabanya ubukana? 
 
1. Munsi y‘ukwezi 1 
2. Hagati y‘ukwezi 1   -   n‘amezi 6 
3. Hagati y‘amezi 6    -   n‘amezi 12 
4. Hagati y‘umwaka 1 -   n‘imyaka 3 
5. Hagati y‘imyaka 4   -   n‘imyaka 6 
6. Hagati y‘imyaka 7   -   n‘imyaka 9 
7. Hagati y‘imyaka 10 -   n‘imyaka 15 
8. hejuru y‘imyaka 15 
 
A.12 Ni ubuhe bwoko bw‘imiti igabanya ubukana ufata? 
 
1. Triviro-30 (D4T+3TC+NVP) 
2. Duovir-N(AZT+3TC+NVP) 
3. TDF+3TC+NVP 
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4. TDF+3TC+EFV 
5. TDF+3TC+Kaletra 
6. D4T+3TC+EFV 
7. ABC+3TC+EFV 
8. ABC+ddI 
9. D4T+AZT+Kaletra 
10.  AZT+3TC+Stocrin 
11.  3TC+NVP 
 
A.13 Ufite abasirikare bangahe?   
1. Munsi cyangwa bangana na 200 
2. Hagati ya 201-350 
3. Hagati ya 351-500 
4. Hejuru ya 500 
 
Icyiciro cya 3. IBIBAZO BY‘UMUBIRI 
Amabwiriza 
Icyiciro cya 3 kirarebana n‘ingorane cyangwa impinduka abantu bagira ku miterere cyangwa 
ku mikorere y‘umubiri, bitewe n‘ibibazo by‘uburwayi. Ibibazo by‘uburwayi nshaka kuvuga 
ni nk‘indwara cyangwa ibindi bibazo by‘ubuzima byaba iby‘igihe gito cyangwa kinini; nko 
gukomereka, ibibazo byo mu mutwe cyangwa by‘ihungabana, ndetse n‘ibiterwa n‘inzoga 
nyinshi cyangwa ibiyobyabwenge. 
 
Ugerageze kwibuka ibibazo byose ufite by‘ubuzima mu gihe usubiza ibibazo. Mu gihe 
nkubaza ingorane ugize icyo ukora utekereze kuri ibi bikurikira: bigusaba imbaraga nyinshi, 
birakubangamira/birakubabaza, ubikora buhoro, bigusaba guhindura  imikorere. 
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Mu gihe usubiza, nifuzaga ko watekereza mu minsi 30 ishize. Nkifuza nanone ko wasubiza 
uzirikana ku ngorane wagiye uhura nazo mu minsi 30 ishize, bitewe n‘impinduka z‘imiterere 
n‘imikorere y‘umubiri ivugwa hasi. 
 
Koresha ibibigereranyo mu gihe usubiza: nta na rimwe, buhoro, biringaniye, cyane, bikabije. 
 
 
 
Ishami  Nta na 
rimwe 
Buhoro Biringaniye Cyane Bikabije NA 
D.1Imikorere yo 
mu mutwe 
       
 Imbaraga 
n‘umwete 
1 2 3 4 5 6 
 Ibijyanye no 
gusinzira  
1 2 3 4 5 6 
 Kwibuka 
ibyakubayeho 
1 2 3 4 5 6 
 Kwakira 
ibikubayeho 
1 2 3 4 5 6 
 Imihindukire 
y‘umubiri 
1 2 3 4 5 6 
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D.2Imikorere y‘ 
Ibyumviro 
by‘umubiri 
n‘ububabare 
       
 
 
 
 
 
 
 
 
 
 
Ububabare 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 
D.3 Imikorere y‘ 
Urwungano 
rw‘amaraso 
n‘ihumeka 
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 Imikorere 
y‘umutima 
1 2 3 4 5 6 
 Umuvuduko 
w‘amaraso 
1 2 3 4 5 6 
 Ibigize amaraso 1 2 3 4 5 6 
 Ubudahangarwa 
bw‘umubiri 
1 2 3 4 5 6 
 Guhumeka 1 2 3 4 5 6 
 Umunaniro 1 2 3 4 5 6 
D.4 Imikorere y‘ 
Urwungano 
ngogozi 
 1 2 3 4 5 6 
 Igogorwa  ry‘ibiryo 1 2 3 4 5 6 
 Kubasha no 
kuyobokwa 
n‘ibiryo 
1 2 3 4 5 6 
 kujya kwituma 1 2 3 4 5 6 
 Kudahinduka 
kw‘ibiro 
1 2 3 4 5 6 
  Kugubwa nabi mu 
nda 
1 2 3 4 5 6 
 Kugira isesemi 1 2 3 4 5 6 
 Uko umubiri 
ukoresha ibyo 
1 2 3 4 5 6 
 
 
 
 
   418 
 
 
 
wariye 
 Uko umubiri 
ukoresha ibinure 
1 2 3 4 5 6 
 Imikorere 
y‘imisemburo 
1 2 3 4 5 6 
 
 
 
 
 
D.5  
Imyororokere 
       
 Imikorere 
y‘imyanya 
ndangabitsina 
1 
 
2 3 4 5 6 
 Kujya mu mihango 
 
1 2 3 4 5 6   
 Ukudahinduka 
kw‘iminsi 
y‘imihango 
1 2 3 4 5 6 
 Kumererwa nabi 
bitewe n‘imyanya 
ndangabitsina 
1 2 3 4 5 6 
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n‘imyororokere 
 Kumererwa nabi 
bitewe 
n‘imibonano 
mpuzabitsina 
1 2 3 4 5 6 
D.6 Imikorere 
y‘amagufa, 
ingingo n‘imitsi 
       
 Imikorere 
y‘ingingo 
1 2 3 4 5 6 
 Imbaraga z‘imitsi/ 
z‘imikaya 
1 2 3 4 5 6 
D.7 Imikorere 
y‘uruhu 
       
 Imikorere y‘uruhu 1 2 3 4 5 6 
 Imyumvire 
idasanzwe y‘uruhu 
1 2 3 4 5 6 
 
 
Murakoze. Noneho tujye ku rutonde rw‘ibibazo nomero 2 
 
Icyiciro cya 4. Ingorane mu mikorere yawe n‘ubwitabire mu bikorwa mu buzima busanzwe 
Amabwiriza 
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Nagiragango nkwibutse ko amakuru utangaza muri iri bazwa ari ibanga kandi ko 
azakoreshwa mu bushakashatsi gusa. 
 
Ibazwa ryo mu cyiciro cya 4 naryo riribanda ku ngorane abantu bahura nazo kubera ibibazo 
by‘ubuzima. 
 
Hereza ubazwa ikarita # 1 hanyuma uvuge: 
Wibuke ko iyo mvuze ibibazo by‘ubuzima mba nshaka kuvuga uburwayi cyangwa ibindi 
bibazo by‘ubuzima byaba iby‘igihe gito cyangwa kinini, gukomereka, ibibazo byo mu mutwe 
cyangwa iby‘ihungabana hamwe n‘ibiterwa n,inzoga nyinshi cyangwa ibiyobyabwenge. 
Ndakwibutsa gukomeza kuzirikana ibibazo by‘ubuzima ugira, usubiza ibibazo nk‘uko 
wabigenje mbere. Igihe nkubajije ibijyanye n‘ingorane uhura nazo mu gukora akazi utekereze 
kuri ibi bikurikira:  
 
Erekana ikarita #1 hanyuma usobanure ko “ingorane mu gikorwa bivuga: bigusaba 
imbaraga nyinshi, birakubabaza/birakubangamira, gukora buhoro, bigusaba guhindura 
imikorere. 
 
 
Bwira usubiza:  
Mu gihe usubiza, nifuzaga ko watekereza mu minsi 30 ishize. Nkifuza nanone ko wasubiza 
uzirikana ku ngorane wagiye uhura nazo mu minsi 30 ishize, igihe wagiraga icyo ukora 
nk‘uko bisanzwe.  
 
Hereza ubazwa ikarita # 2 hanyuma uvuge: 
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koresha ibi bipimo mu gihe usubiza: Nta na rimwe, buhoro, biringaniye, cyane, bikabije. 
 
Umenye neza ko usubiza ashobora kubona ku buryo bworoshye amakarita iya 1 n‘iya 2 mu 
ibazwa ryose uko ryakabaye.  
 
AMASHAMI Y‘IBANDWAHO 
Ishami 1 UBWENGE N‘UBUMENYI 
 
Ubu ngiye kubaza ibijyanye no gusobanukirwa, gusobanura, kumvikana n‘abandi 
 
Ereka ubazwa amakarita iya 1 n‘iya 2 
 
Mu minsi 30 ishize wahuye n‘ingorane zo kuruhe rwego mu gukora ibi bikurikira: 
 
 
  Nta na 
rimwe 
Buhoro Biringaniye Cyane Bikabije 
D1.1 Kumara iminota 
10 ukora 
ushishikaye? 
1 2 3 4 5 
D1.2 Kwibuka gukora 
ibintu 
1 2 3 4 5 
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by‘ingenzi? 
D1.3 Gusesengura no 
kubona 
ibisubizo 
by‘ibibazo byo 
mu buzima bwa 
buri munsi? 
1 
 
 
 
 
 
 
 
 
2 3 4 5 
D1.4 Kwiga igikorwa 
gishya, urugero 
kwiga ukuntu 
wagera ahantu 
utari uzi? 
1 2 3 4 5 
D1.5 Gusobanukirwa 
muri rusange 
nibyo abantu 
bavuga? 
1 2 3 4 5 
D1.6 Gutangira no 
gukomeza 
ikiganiro? 
1 2 3 4 5 
 
Ishami 2 KUGENDAGENDA/ KUNYEGANYEGA 
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Ubu ngiye kubaza ibijyanye no kugendagenda/ kunyeganyega 
 
Ereka ubazwa amakarita iya 1 n‘iya 2 
 
Mu minsi 30 ishize wahuye n‘ingorane zo kuruhe rwego mu gukora ibi bikurikira: 
 
  Nta na 
rimwe 
Buhoro Biringaniye cyane Bikabije 
D2.1 Guhagarara umwanya 
munini nk‘iminota 30? 
1 2 3 4 5 
D2.2 Guhaguruka wari 
wicaye? 
1 2 3 4 5 
D2.3 Kugendagenda mu rugo? 
(urugero; kuva mu 
cyumba kugera muri 
douche, kuva mu cyumba 
kugera k‘  musarani, 
n‘ahandi) 
1 2 3 4 5 
D2.4 Kuva mu rugo?  
 
1 2 3 4 5 
D2.5 Kugenda intera ndende 
n‘amaguru nka 
kilometero 1? 
1 2 3 4 5 
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Ishami 3 KWIYITAHO 
 
Ubu noneho ngiye kukubaza ku ngorane uhura nazo mu kwiyitaho. 
 
Mu minsi 30 ishize wahuye n‘ingorane zo kuruhe rwego mu gukora ibi bikurikira: 
 
 
  Nta na 
rimwe 
Buhoro Biringaniye cyane Bikabije 
D3.1 Kwiyuhagira umubiri 
wose? 
1 2 3 4 5 
D3.2 Kwiyambika? 1 2 3 4 5 
D3.3 Kwigaburira/kwitamika? 1 2 3 4 5 
D3.4 Kubaho wenyine mu 
minsi mike? 
1 2 3 4 5 
 
 
Ishami 4 Kubana n‘abandi 
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Ubu noneho ngiye kukubaza ingorane uhura nazo mu mibanire n‘abandi. Rwose wibuke ko 
ibyo nkubaza biganisha gusa ku ngorane ufite ziterwa n‘ibibazo by‘ubuzima. Aha ndashaka 
kuvuga indwara, gukomereka, ibibazo byo mu mutwe n‘ibyihungabana hamwe n‘ibijyanye 
n‘inzoga nyinshi cyangwa ibiyobyabwenge. 
 
Erekana amakarita #1 na #2 
 
Mu minsi 30 ishize wahuye n‘ingorane zo kuruhe rwego mu gukora ibi bikurikira: 
 
 
 Nta na 
rimwe 
Buhoro Biringaniye cyane Bikabije 
D4.1 Kumvikana/gusabana 
n‘abantu  utazi? 
1 2 3 4 5 
D4.2 Gukomeza ubucuti? 1 2 3 4 5 
D4.3 Gusabana n‘abantu 
bawe bahafi? 
1 2 3 4 5 
D4.4 Gushaka inshuti 
shya? 
1 2 3 4 5 
D4.5 Kugira imibonano 
mpuzabitsina? 
1 2 3 4 5 
 
 
Ishami 5 IMIRIMO ISANZWE YO MU BUZIMA 
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Iyo mirimo irimo: 
1. Imirimo yo mu rugo 
Ndagirango noneho nkubaze ibijyana n‘imirimo yo kwita ku rugo ndetse no gufata neza abo 
mubana cyangwa abantu bawe ba hafi. Iyo mirimo ni nko guteka, gusukura, guhaha, kwita ku 
bandi no ku byawe. 
Erekana amakarita #1 na #2 
Mu minsi 30 ishize wahuye n‘ingorane zo kuruhe rwego mu gukora ibi bikurikira: 
 
 Nta na 
rimwe 
Buhoro Biringaniye Cyane Bikabije 
D5.1 Kwita ku 
nshingano zawe 
mu rugo? 
1 2 3 4 5 
D5.2 Gukora neza 
imirimo yawe 
y‘ingenzi yo mu 
rugo? 
1 2 3 4 5 
D5.3 Kurangiza 
imirimo yo mu 
rugo yose 
nk‘uko 
wabyifuzaga  
1 2 3 4 5 
D5.4 Kurangiza 
imirimo yo 
1 2 3 4 5 
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murugo vuba 
nk‘uko bikwiye 
 
Niba hari ibisubizo kuva kuri D5.2 Kugeza kuri D5.4 byabaye byinshi kurusha ―nta na 
rimwe‖ (igaragazwa na nomero ―1‖) baza  
 
D5.01 Mu minsi 30 ishize, n‘iminsi ingahe wagabanije cyangwa 
waretse burundu imirimo yo mu rugo bitewe n‘uburwayi 
bwawe 
Andika umubare 
w‘iminsi 
…………….. 
 
Niba ubazwa ari umukozi (uhembwa, ubwitange/umukorerabushake, wikorera) cyangwa 
wiga, uzuza ibibazo kuva kuri D5.5 kugera kuri D5.10. Nibitaba ibyo usimbuke ufate D6.1 
2. Imirimo isanzwe cyangwa yo ku ishuli 
Noneho ngiye kukubaza ibijyanye n‘imirimo isanzwe cyangwa yo ku ishuli 
Erekana amakarita #1 na #2 
Mu minsi 30 ishize wahuye n‘ingorane zo kuruhe rwego mu gukora ibi bikurikira bitewe 
n‘ibibazo by‘ubuzima: 
 
 Nta na 
rimwe 
Buhoro Biringaniye cyane Bikabije 
D5.5 Imirimo/amasomo 
ya buri  munsi? 
1 2 3 4 5 
D5.6 Gutunganya neza 1 2 3 4 5 
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imirimo/amasomo 
yawe y‘ingenzi? 
D5.7 Kurangiza ibyo 
ugomba byose 
neza? 
1 2 3 4 5 
D5.8 
 
Kubona umurimo 
wawe ukozwe 
vuba nk‘uko 
byakagombye? 
1 2 3 4 5 
D5.9 Waba warakoze bidahagije bitewe n‘uburwayi? Oya 1 
Yego 2 
D5.10 Waba warinjije amafaranga make kubera ikibazo 
cy‘uburwayi? 
Oya 1 
Yego 2 
 
Niba muri ibi bibazo kuva kuri D5.5 kugeza 5.8 hari icyashubijwe hejuru ya ―nta na rimwe‖ 
(igaragazwa na ―1‖) baza: 
 
D5.02 Mu minsi 30 ishize ni iminsi ingahe 
wasibye akazi igice cy‘umunsi cyangwa 
kirenga bitewe n‘uburwayi 
Andika umubare w‘iminsi 
……………………………… 
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Ishami 6 UBWITABIRE MU BIKORWA BYO MU BUZIMA BUSANZWE 
Noneho ngiye kukubaza uruhare ugira mugufatanya n‘abandi n‘ingaruka byaba bigira ku 
buzima bwawe no ku muryango wawe. Ndagusabye wibande ku minsi 30 ishize. Nanone 
wibuke gusubiza utekereza ku bibazo by‘ubuzima nk‘uburwayi bw‘umubiri, gukomereka, 
ibibazo byo mu mutwe n‘ibyihungabana hamwe n‘ibijyanye n‘inzoga nyinshi cyangwa 
ibiyobyabwenge 
Erekana amakarita #1 na #2 
Mu minsi 30 ishize wahuye n‘ingorane zo kuruhe rwego mu gukora ibi bikurikira: 
 
 
  Nta na 
rimwe 
Buhoro Biringaniye Cyane Bikabije 
D6.1 Ni kuruhe 
rugero wahuye 
n‘ikibazo igihe 
wifatanyaga 
n‘abandi  
mu mirimo (nko 
mu minsi 
mikuru, mu 
masengesho 
cyangwa ibindi) 
wakoze ku 
buryo bumwe 
n‘undi wese? 
1 2 3 4 5 
D6.2 Ni kuruhe 1 2 3 4 5 
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rugero wahuye 
n‘ikibazo bitewe 
n‘inzitizi zaho 
uba 
n‘ibigukikije? 
D6.3 Ni kuruhe 
rugero 
ubwisanzure 
n‘icyubahiro 
byawe 
byabangamiwe 
n‘ibikorwa 
cyangwa 
imyitwarire 
n‘ibikorwa 
by‘abandi? 
1 2 3 4 5 
D6.4 Byagutwaye 
igihe kingana iki 
wita k‘uburwayi 
bwawe cyangwa 
ingaruka zabwo 
1 
 
 
2 3 4 5 
D6.5 Ni kuruhe 
rugero 
wahungabanye 
mu bitekerezo  
bitewe 
n‘uburwayi 
1 2 
 
 
 
3 4 5 
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bwawe?  
 
 
 
D6.6 
Ni kuruhe 
rugero imiterere 
y‘ubuzima 
bwawe 
yakubujije 
kwikungahaza 
ubwawe 
cyangwa 
umuryango 
wawe? 
1 
 
 
 
 
 
2 3 4 5 
D6.7 Ni kuruhe 
rugero 
umuryango 
wawe wahuye 
n‘ibibazo bitewe 
n‘uburwayi 
bwawe? 
1 2 3 4 5 
D6.8 Ni mubuhe 
buryo wahuye 
n‘ikibazo igihe 
wakoraga 
ugamije 
kwidagadura 
cyangwa 
kwishimisha? 
1 2 3 4 5 
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H1 Hejuru y‘ibi byose , mu minsi 30 ishize ni iminsi ingahe 
wahuye n‘izi ngorane zavuzwe? 
Umubare 
w‘iminsi…………. 
H2 Mu minsi 30 ishize, ni iminsi ingahe wananiwe burundu 
kurangiza imirimo yawe bitewe n‘imwe mu mpamvu 
z‘uburwayi? 
Umubare 
w‘iminsi…………. 
H3 Mu minsi 30 ishize, ukuyemo iyo waretse burundu, ni 
iminsi ingahe wagabanije imirimo yawe cyangwa akazi 
usanzwe ukora ku mpamvu y‘uburwayi?  
Umubare 
w‘iminsi…………. 
 
Aha niho dusoreje ibazwa, tubashimiye uruhare mwagize. Mwakoze 
 
 
 
 
 
